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PREFACE 
 
This is a book written by students of diverse disciplines, and 
intended for students and educated lay people. We intend this book 
to serve several functions. First, we want to make the field of 
epigenetics accessible to lay readers. Second, and more 
importantly, we want to excite further interest and concern 
regarding the social, ethical, legal, health, and policy implications 
that this field will have for all arenas of our lives. Third, we want 
to arm our readers with knowledge and wariness so that they can 
understand and critique the nuanced debates that will inevitably 
arise when costs and benefits must be weighed: while the effects of 
epigenetics upon us as individuals may be subtle, the demographic 
implications and costs are huge. 
 
The book is organized into discrete sections, each of which can be 
read on its own, although we recommend reading the first chapter 
as a primer to get the general gist of the larger picture, 
implications, concerns, and agenda. Given the extensive 
ramifications of epigenetics to most realms of our lives, students of 
public health, ethics, law, medicine, biology and philosophy should 
find the contents useful. 
 
We have highlighted some of the technical terms and included a 
glossary, and the end of each chapter terminates with a non- 
comprehensive list of questions and solutions intended to stimulate 
thought and debate. 
 
Each chapter has been reviewed and assessed by experts in the 
field. We have endeavored to check our facts and references 
rigorously, and to ensure the originality of our work. We hope you 
will find the effort of reading stimulating, provocative, and 
rewarding. 
  
1  
 
 
 
 
 
Chapter 1 
Not Your Mendelian Genetics… 
(Your genome is far from Mendel’s pea plants) 
 
Michael Crawford, Melissa Woghiren, Kendall Diemer, 
and Kaela Scott 
 
 
 
Abstract  
The DNA sequences that encode our genes interact  with 
and are regulated by associations with many other molecules, 
and this constellation of players regulates how we respond to 
our environment. The sequence of DNA itself remains 
unchanged: the additional factors that package the genome into 
chromosomes create a dynamic architectural structure that 
modulates DNA activity and accessibility. More recently, it has 
become clear that the reverse is also true - our  experience of 
our environment, including social relations, records and 
inscribes changes to the way that our genes behave, and this in 
turn has implications for our future health. In the  years since 
the human genome was sequenced, it has become apparent that 
this higher order of architectural organization is much more 
complex and subtle than formerly acknowledged. An ever- 
expanding list of influences impinges upon it, and the changes 
that are installed are referred to as the: epigenome, 
epigenomic/epigenetic imprint, or sometimes simply as 
imprinting. Some of the packaging and behavioral changes are 
transient, and others may persist to affect our health decades 
later. Some might even transmit to our offspring.  The   diverse 
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influences that modify our epigenome include: eating habits, 
socio-economic status, education level, drugs, and toxin 
exposure to name but a few. Since an individual’s epigenetic 
status can affect health decades - even generations later - the 
social, medical, ethical, and demographic impact of epigenetics 
are likely to be huge. We introduce the breadth of influences 
that need to be considered, and outline our agenda for 
discussion. 
 
 
1.1 Introduction: What is Epigenetics? 
Have you ever stopped to wonder why identical twins are 
never completely identical? When watched closely, unique 
characters become apparent. As individuals, they may differ in 
preferences of dress, foods, and what interests them most. They 
grow and develop their own quirks and differences that amplify 
with age. This is often written off as the result of different 
experiences, molding them through development… But what about 
variances in health? What can be said of the identical twin who 
develops bipolar disorder or is highly susceptible to depression 
while their counterpart is not? If they share  the  same genomes, 
then why are they not identical in every respect? For that matter, 
why does a 1700s painting of my father-in-law’s ancestor look like 
the descendent managed to transport back through time to pose in 
dress-up clothes for the portrait? The genes for facial 
characteristics should have been diluted 1 in 32. Something has 
always been missing in our understanding of how genomes and 
inheritance function. These discrepancies present us with questions 
that may now be answered through the involvement of an 
additional layer of information encoding and inheritance: the 
epigenome. 
For biologists, a surprising feature of the Human Genome 
project was the degree to which it required constant revision of our 
definition and understanding of what constitutes a gene. Nature   is 
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subtle, and the genome turned out to be much more  richly 
elaborate than originally understood. We discovered that genes 
were more varied, complicated, and surprising in their structure 
and function that anybody could have foreseen. Despite our 
fascination with these units of heredity, it is clear that another 
adjustment, this time of seismic proportions, is  presently 
underway: biologists and physicians are coming to grips with an 
additional level and order of information encoding - the 
epigenome. The epigenome may explain familial tendencies to 
diabetes, obesity, addictions, or even certain social behaviors. The 
implications of this new science are vast. For example, your health 
might be affected by what your grandparents ate, or when they 
started smoking. Your future health disposition might be affected 
by the season of your birth, or the socioeconomic status of your 
parents. Even schooling matters…not only for your own sake, but 
perhaps also for your descendants. 
The epigenome affects how DNA is architecturally bound 
into chromosomal form and how genes are regulated. This 
architectural modification of packaging turns out to have dynamic 
and interesting implications not merely for how our genes behave, 
but consequently for how we are primed to respond to stressors. 
Moreover, the complex code of modifying factors involved appear, 
in some instances, to be heritable, and this is forcing  a 
reassessment of our appreciation of the intricacies of heredity. 
The epigenome can be thought of as a malleable stamp that 
massages gene behavior in pervasive but subtle ways. It is an 
integral part of the routine regulation of gene activity. The ink of 
this stamp comprises a complex mix of accessory protein and RNA 
molecules that decorate and reconfigure chromosomes in response 
to changing environmental demands. They alter chromosomal 
architecture so that specific combinations of genes are predisposed 
to be active or silent. Our genome responds to, and in some cases 
records its interaction with the environment through this dynamic 
epigenetic    re-packaging.    DNA    sequence    fidelity     remains 
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untouched, but the genes are induced to behave differently, turning 
on or off in different patterns. This change in DNA packaging is 
referred to as the epigenetic or epigenomic imprint. The bands that 
you see in images of chromosomes reflect attributes of this 
packaging – some large areas are densely packed, others less so. 
Importantly, imprints alter the way that your genome behaves 
without altering the sequence of DNA itself. For example, with the 
exception of the unmatched X and Y sex chromosomes in males, 
we all normally inherit paired chromosomes - one from each 
parent. By virtue of their location on paired chromosomes, our 
genes are similarly present as two copies. Even if you were to 
sequence the paired copies of a particular gene and found their 
DNA to be identical, they might behave differently  depending 
upon which parent they were inherited from. The gene copy 
inherited via a maternal chromosome might be active, and the copy 
inherited via the paternal chromosome might be silent. 
Many factors impinge upon the epigenome to turn genes 
on, off, or somewhere in between. We now know that the changes 
they install can have consequences for patterns of long term and 
even trans-generational health. Imagine the benefit for future 
generations if nutritional scarcity could prime human eggs and the 
consequent embryos (ie; subsequent generations) to grow larger 
and more efficient placentas without requiring genetic changes? 
Imagine if these changes could be installed within a generation? 
This, in fact, happens… While changes to our own long-term 
health might be subtle, when measured in aggregate, the thousands 
or millions of individuals that constitute a community potentially 
translates to huge demographic and societal costs. Consequently, 
our understanding of epigenomic health will have important 
implications for medicine, social justice, ethics, law, social policy, 
privacy, and economics. 
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1.2 Why Do We Need to be Concerned About 
Epigenetics? 
When the impetus for epigenetic change is caused by 
stressors, a period of starvation for example, epigenetics provides a 
powerful evolutionary advantage: it deploys a tool that records the 
challenge and can prime genes to efficiently respond to similar 
threats in the future. The issue for public health is that the 
challenges met at one point of life, or in one generation, might not 
be appropriately answered when epigenetic programming meets 
different circumstances in the future. In other words, a metabolic 
program installed to provide support during times of scarcity might 
instead, during times of plenty, predispose to obesity, diabetes, and 
heart disease. The news is not all bad. We are not necessarily 
slated to be the victims of our ancestral metabolic and 
environmental histories: many of the factors that influence your 
epigenetic status are controllable, and some are even reversible. A 
non-comprehensive list includes: quantity and quality of diet; 
socioeconomic status; social environment; quality of parental care; 
educational experience; prescribed and illegal drug use; 
geographical/environmental exposure to contaminants; and stress. 
Epigenetics presents a challenge when the stimulus for 
change is the product of inadvertent manipulation by medical 
procedures and prescriptions, contamination by pollutants, or 
adverse and transient social or geographical conditions. Since 
individuals control neither the origin and behavior of their parents, 
the care that they receive as children, nor the quality of the 
environment into which they are born, epigenetic health will 
inevitably become entangled with issues of social and 
environmental justice - these will require intervention or regulation 
at the political level. 
Clearly most of the items on our list of epigenetic 
influences carry a social, ethical, legal, economic and political 
dimension. The costs of ignoring epigenetic threats are likely to be 
long-lived and expensive: who should bear them? Individuals, 
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society, or future generations? Who should be responsible for a 
person’s epigenetic state? Solely the individual?  If we each inherit 
the baggage of our parents’ metabolic and social crimes and 
misdemeanors, is it fair that we be responsible for the attendant 
costs? How should we be empowered to rectify deficits  - should 
we be granted privileged access to the medical histories of our 
progenitors? Should our children have access to our own? Should 
we impose sanctions for overfeeding children if the consequences 
of their weight and inactivity might last generations? And what 
about the environmental, social, and economic actors over which 
we hold no sway? Where do the boundaries for freedoms and 
obligations lie? If an industry inadvertently creates a product or 
waste that affects our epigenetic state, but this is undiscovered for 
decades, who is liable, and who should make redress? Can a 
balance be found that will protect exposed populations without 
drastically stifling innovation? Establishing precisely where to 
place the onus of responsibility and costs among individuals, 
businesses, governments, and society will be thorny issues. 
An intelligent response to both preventive and remedial 
epigenetic health is obtainable, but requires a sophisticated 
understanding of the influences and outcomes, as well as a 
comprehensively mounted and politically inclusive response. Key 
to this will be education. Epigenetics provides additional and firm 
data to support social investments that will address long term 
economic and productivity imperatives while simultaneously 
addressing issues of social and environmental justice. 
 
1.3 The Challenges of Understanding and Studying 
Epigenetics 
Unlike genes, an epigenomic imprint can change from cell to cell. This 
makes it difficult to assess an individual’s overall epigenetic status. For 
example, some epigenetic imprints might be accessible via a blood 
sample, others only through a biopsy of specific tissues such as brain, or 
liver, or muscle. Moreover, the complexity and combinatorial nature of 
epigenetic modifications means that there are different patterns of 
packaging changes that can produce the same end result, and there are
7  
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also many shades of grey in between “on” and “off” insofar as 
gene activity is concerned. Epigenetic imprints act a little like a 
complicated audio volume knob that can muffle or blast a signal 
from a gene, with every increment in between. Being dynamic, 
imprints also change with age, and can sometimes be enhanced 
or even reversed by multiple influences. Finally, in some cases, 
an imprint might be transmissible to offspring: this is not always 
the case – some epigenetic imprints are pervasive, others are 
highly tissue-specific and exclude eggs, sperm, and future 
generations. The basic mechanics of epigenetics, the complexity of 
the  combinatorial code that it embodies, and how it can be 
experimentally or diagnostically assessed are covered in Chapter 2. 
This next chapter will be helpful to understand the diversity and 
nuances of the mechanics, but it will not be necessary for 
understanding the gist and implications of ensuing chapters. We 
also include  some further information on specific diagnostic 
strategies for the adventuresome reader with a recent biology 
background – these latter technical sections of Chapter 2 are not 
required reading. 
There is a wealth of data that links specific epigenetic 
mechanisms revealed in animal models (mice and rats  in 
particular) to environmental cues. The same trends are seen in 
human epidemiological studies, however many of the larger social 
conclusions have relied upon inferences drawn by comparing 
animal and human studies. Not all organisms necessarily  respond 
to environmental and epigenetic challenges in the same way, and 
there is an inherent risk in applying the mechanisms discerned in 
rodents to trends revealed by retrospective epidemiological studies 
in humans. That said, persuasive data is emerging to link specific 
epigenetic changes in humans to particular dietary or other 
challenges. In short, the data is looking good and delivers the 
message that we need to address epigenetic effects and health in a 
serious, comprehensive, and sustained manner. 
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1.4 The Astonishing Range of Effects 
Examples of how epigenetic architectural modifications can 
affect cellular activity, or even how they can offer avenues for 
treatment, are especially evident in emerging studies on cancer 
(outlined as a concrete example of how the mechanisms of 
epigenetics can operate in Chapter 3). Since cancer is a genetic 
disease caused by mutation, any mechanism that alters gene 
behavior has the potential to exacerbate or to  mitigate the 
damaging effects of DNA mutations. The profound influence  of 
the epigenome in cancer biology is an area of intense research, and 
already diagnostic, prognostic, and treatment opportunities are 
being developed. For example, epigenetic changes can signal 
specific changes in cell behavior that have diagnostic and 
prognostic value. Indeed some of these epigenetic changes are 
deleterious and are coming to be known as “epimutations.” But 
wouldn’t it be lovely to circumvent a genetic mutation by 
encouraging epigenetic behavior modifications that can rectify or 
compensate for the anomaly? As promising as these  avenues 
might be, the question of just who will have access to the resources 
to diagnose and mitigate health via epigenetic tools will prove to 
be a socially, ethically, and economically challenging question. 
We should not become obsessively nervous about this 
attribute of our biology: in all seriousness, stress itself can modify 
the epigenome. Rather, we will argue that a little foreknowledge 
and preventative maintenance can go a long way to improving 
quality of life through to our declining years and on through to our 
children. Demographically, however, there is an urgent need to 
make immediate, comprehensive, though relatively modest 
investments in nutrition, health, as well as legal, social, and 
educational structures: these investments could mitigate much 
larger long-term costs. Case in point, as we will see in Chapter 4, 
periods of starvation or over feeding can alter the epigenome to 
influence a person’s health status decades later, and can even 
transmit   across   generations:   apparently   you   are   what    your 
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grandparents ate! By the same token, contemporary parents  need 
to exercise care regarding what and how much they feed their 
children - it could have an effect upon prospective grandchildren. 
Should parents be regulated or taxed regarding the burdens they 
might be placing upon the future? What defines child- and 
generational-abuse? Should individuals enjoy the freedom to 
indulge in risky behavior, even before they become parents, when 
there may be long term costs? Alleviating nutritional challenges 
and educating stakeholders becomes a matter not merely of social, 
but also of generational justice. 
Factors that can influence our epigenome surround  us – 
they are ubiquitous. This means that the compounded effects of 
these influences can be hard to separate and to distinguish from 
each another. We are coming to realize that xenobiotics, such as 
drugs and environmental toxins, affect how our DNA is packaged 
and how it behaves. The number of studies that have examined 
long-familiar drugs and toxins and found profound epigenetic 
effects is expanding in a startling way. Drugs and their excreted 
metabolites, pesticides transmitted via our food and water supply, 
manufacturing and production contaminants - all of  these 
categories of chemical are known to elicit deleterious and long- 
term epigenetic damage. Providing environmental justice will 
demand that we pay attention to geographical, political, legal, 
regulatory, economic and even to cultural frameworks in a manner 
that is much more long-viewed and cautious. The trick will be to 
achieve these objectives without stifling creativity and innovation 
(Chapters 5, 8). For example, like nutritional  challenges, 
xenobiotic stressors might elicit an effect that remains hidden for 
decades or even generations. The legal implications of this lag time 
in terms of product and manufacturing liability are profound. If 
epigenetic effects are not seen for decades, how can litigation 
successfully compensate affected individuals: statutory limits 
might have expired; businesses might have expired or sub-licensed 
production and responsibility; the state of knowledge at the time of 
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manufacture might not have been sufficient that a business could 
reasonably have been expected to appreciate the risk; or the 
epigenetic modifications that are produced could be hard to link 
causally due to the complex and combinatorial susceptibility of the 
epigenome to multiple influences (Chapter 8). 
For example, as we are coming to realize, the burden of 
toxicants leaking into the environment can exert unforeseen 
consequences upon our reproductive health, and most 
predominantly through endocrine disruption. Fungicides, the 
excreted metabolites of prescribed hormones and drugs, and 
bisphenol A, are just a few of the compounds documented to affect 
us, but the recent dimension of epigenetic harms they cause should 
give us reason to pause (Chapters 5, 6). 
The endocrinology of birth is complex, so in retrospect, it 
should have come as no surprise that factors affecting conception, 
and the manipulations attendant with fertility and birth, such as in 
vitro fertilization, hormonal priming, Caesarian section, induced 
labour, and breast feeding decisions, also have discernable 
epigenetic effects upon human infants (Chapter 6). The relative 
novelty of technologies associated with assisted reproduction 
means that potential long-term effects upon the human epigenome 
are still unknown – the first generation of “test-tube” babies is only 
just now beginning to produce its own children. Will  late life 
health changes and cross-generational effects be seen? It  is too 
early to say. Preliminary manipulations of rodents suggests that 
care and caution need to be exercised, and close monitoring of 
procedures should be required of physicians in a field that, in many 
countries, deploy proprietary practices. At the very least, long term 
monitoring of the health of progeny derived by artificial means 
would seem to be prudent. 
Are there some individuals who should be dissuaded from 
propagating? Should people be taxed according to the  likely 
burden to society that they might transmit, and how would their 
past behavior be assessed and quantified in terms of risk? As    pre- 
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conception and prospective parents, what do we owe to our 
hypothetical offspring? What obligations does society owe to us 
and to them? How should multigenerational interests be balanced? 
Not all influences are chemically direct: how we are 
socialized plays a role in epigenetic health. As will see in Chapter 
7, the addictions, stress, and violence that often attend poverty can 
have devastating long-term consequences that ensure more of the 
same in subsequent generations. One mitigating influence – the 
number of years that you attended school!  A  reassuring note: if 
you are reading this, you might already be a member of an 
epigenetically privileged cohort – school is good for your 
epigenetic health! 
If we are willing to concede that epigenetics plays an 
important role in our lives, then we must also admit that 
information regarding the behavior and health of our ancestors as 
well as ourselves is important both to our future health as well as 
to our children. Who should have access to that information? And 
even if medical, genetic, and epigenetic records are kept 
confidential, how much can be inferred about our epigenetic status 
from: surveys of our browser history; educational affiliations; 
parental data footprint; geographical location and history; marital 
status; dietary preferences; religious affiliation and practices (diet 
as well as communal comfort or stress); and hobby or sports 
activities? So your internet usage indicates that you play electronic 
games or stream videos for hours on end… should you be as 
insurable as your neighbor the yoga fitness instructor? Your 
telephone record suggests that you lived near an industrial park 
when you were a child – does your father’s socioeconomic status 
and your exposure to heavy metals mean that you are more likely 
to suffer cancer, depression, or cardiovascular disease as an adult? 
Should prospective employers have the right to make use of this 
commonly available information to make inferences regarding the 
cost of your health benefits and the potential number of sick days 
that you might be disposed to take? Privacy will be a much more 
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complicated right to protect regarding epigenetic health and social 
data than perhaps any other feature of your medical history 
(Chapter 9). 
 
1.5 An Agenda for Change 
Each chapter concludes with a short list of provocative 
questions, as well as some solutions that should give you pause to 
either consider or worry. Neither list is intended to be 
comprehensive, but both should help to expand the horizons under 
consideration. In Chapter 10, we sum up by discussing some 
practical steps forward that will encourage stakeholders to become 
cognizant and engaged with the implications of their life styles, 
histories, and choices. While many of the issues that we will 
address (social, health, legal, and geographical justice) already 
have common currency in debate, nevertheless epigenetics will 
provide impetus to consider these matters more urgently – their 
ramifications do not reside merely in the present or near term 
futures – they are of generational consequence. Moreover, they are 
all linked by a biological mechanism, and this suggests a need for 
careful and comprehensive coordination to maximize  benefit. 
Since epigenetics is evolving rapidly as a science, and the 
procedures for studying it are still somewhat young, our toolkit for 
understanding, tracking, and evaluating will no doubt continue to 
evolve. 
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Chapter 2 
 
A Beginner’s Guide to the Mechanisms 
and Assessment of Epigenetics 
 
Natalie Gosselin and Curtis Foreman 
 
 
Abstract 
Epigenetics refers to the decoration and remodeling of 
chromosomal material to both package and regulate the behavior of 
enfolded genes. This repackaging is dynamic, complex, and 
involves many different proteins and RNA molecules. Together 
these players interact with DNA to make architectural changes, but 
the changes alter gene behavior without altering DNA sequences. 
The combinatorial possibilities of factors involved in this process 
exceed the informational complexity of the DNA that  comprises 
our genomes. This chapter outlines the different interacting 
structural proteins and enzymes, as well as the diverse set of RNA 
molecules that help to modulate chromosomal  form and function. 
It is helpful to get feeling for the diversity and complexity of 
epigenetic packaging options in order to understand some of the 
challenges that researchers and physicians face when trying  either 
to define an individual’s epigenetic status, or to clarify how their 
epigenetic status is affected by environmental stimuli.  The 
technical challenges are several fold. First, different cells can carry 
different epigenetic imprints, and even in a single organ, similar 
cells can reach the same epigenetic effect by different paths. 
Second,  epigenetic  imprints  are  susceptible  to  many     different 
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influences – it is hard to define specific causes and effects. Third, 
some epigenetic states are transient, others are less so. Fourth, 
depending upon which tissue experiences epigenetic re- 
programming, the effect may be heritable or not. Fifth, some 
epigenetic states might be reversible. Lastly, epigenetic states 
change with age. We conclude in section 2.6 with a list of 
assessment tools used in epigenetics. This last section provides 
technical details for interest’s sake. If the technology does not 
interest you, relax… it is not necessary to understand how these 
tools function to understand the rest of the book. 
 
 
2.1 Introduction to Epigenetic Mechanisms. 
Deoxyribonucleic acid (DNA) is the hereditary material of all 
non-viral organisms on earth. It is found in every living cell, and 
each living thing has a unique DNA sequence that distinguishes it 
from every other. DNA sequences are the major focus of studies 
ranging from biology, to medicine, pharmacology, and heredity. 
Recently, this perspective has been challenged by the discovery of 
epigenetics. Epigenetics is the study of stable changes in the 
packaging of the genome that are independent of any changes to 
the genome sequence itself (Berger et al. 2009). A huge variety of 
epigenetic modifications can occur, and these changes engender a 
new informational “code” that augments and  modulates the 
activity and information carried by DNA nucleotide sequences. 
Epigenetic changes, like DNA itself, can also convey information 
in a heritable manner. By regulating the packaging of DNA, 
epigenetic mechanisms regulate gene activity, and in a real sense, 
mediate and inscribe a record of the genome’s interaction with its 
experience and environment. 
The structure of DNA is one that is familiar to many, even 
those uninvolved in the study of biology: two strands of 
nucleotides are coiled into a double-helix. While this is the basic 
structure of DNA at the simplest level, it does not fully reflect  the 
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way that DNA is packaged in a cell. The DNA double-helix is 
itself  coiled  around  complexes  of  cellular  proteins  known    as 
 
 
nucleosomes (Figure 2.1). Each nucleosome is composed of eight 
histones comprised of four pairs of: H2A, H2B, H3 and H4 
(Figure 2.2). 
 
Figure 2.1: The structure of DNA wrapped around histones. 
DNA (shown in purple) wraps two times around each 
nucleosomal protein complex in a reiterative  pattern 
reminiscent of pearls on a string. 
 
 
 
 
 
Figure 2.2: Histone proteins compose the nucleosome. Each 
nucleosome contains two each of histones H2A, H2B, H3, and 
H4. 
 
Afterwards, an even higher order of architectural 
complexity is established by interactions with multiple accessory 
proteins and RNA molecules that serve as a scaffold to further coil 
and organize DNA/nucleosomes into chromatin. 
The genes encoded by DNA are functional in the sense that 
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they code for either protein or RNA molecules that will carry out a 
function in the cell. The ordered complex of DNA, RNA, and 
protein that resides in the nucleus of the cell and that constitutes a 
chromosome is called chromatin. Loosely packed chromatin is 
known as euchromatin, whereas tightly packed chromatin is called 
heterochromatin. The degree to which DNA is wrapped around 
nucleosomes and other proteins/RNA largely  determines the 
extent to which the embedded genes can be exposed, active, and 
expressed. When DNA is wrapped around nucleosomes loosely, it 
is easier to activate the genes that are located in that region. 
Conversely, heterochromatin comprises DNA that is  tightly 
wound around nucleosomes where it forms a more densely packed 
architecture that inhibits the activation of encompassed and even 
neighboring genes. This packaging can prevent gene activation by 
excluding factors, such as activating proteins called transcription 
factors, that are necessary for genes to turn on and to serve as the 
template to transcribe RNA. These alternatively wound 
conformations of chromatin constitute opposite ends of the 
spectrum of activity. Chromatin can, however, exist on a spectrum 
of varying levels of compaction, not only the aforementioned 
polar-opposite states (on versus off). In other words, chromatin 
packaging can vary gene activity like a audio volume knob: on, 
off, and all levels in between. 
We will briefly outline some of the players in this differential 
packaging of genes. If you have the interest and fortitude to get 
more technical, the attributes of each are expanded in Sections 2.2, 
2.3 and 2.4. The nucleotide bases that comprise DNA can be the 
site of a modification known as methylation.  In particular,  one 
of the four nucleotide bases, known as cytosine, is a base that may 
be decorated by addition of a small methyl group. Methylation of 
DNA is typically associated with a repressed chromatin state, 
however the effect depends on the location of the methylation 
(Bird and Wolffe 1999). This will be discussed further in section 
2.2. 
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DNA decoration by methyl groups can alter the suite of 
proteins that are recruited to chromatin, and moreover, some of 
these proteins can themselves also be  modified.  For example, 
each histone in the nucleosome has sites on it that can be 
modified: histones can be methylated, acetylated, phosphorylated, 
ubiquitinated, glycosylated, and/or SUMOylated. It is not 
necessary to know what all these different modifications are to 
understand that there is quite a repertoire of possibilities given that 
several of these features can be altered at multiple sites, in 
combination, over the span of a single histone molecule. 
Methylation of histones, like methylation of DNA, is associated 
with tight packaging and repressed gene activity, whereas 
acetylation is associated with activation of the region of 
associated DNA. However, the large variety of histone 
modifications that occur can induce different effects when 
combined in various ways. Section 2.3 will expand further upon 
histone modifications and their epigenetic effects on gene 
expression, however it is safe to say that the complexity of histone 
modifications in combination may comprise a code more complex 
and subtle than that of  DNA itself. 
Other actors can play a role in modifying gene packaging – 
we will briefly list some of them here, and then expand upon them 
later in Section 2.4. Long noncoding RNA (lncRNA) molecules 
are those RNA molecules that can have either a repressive or 
expressive effect on regions of the genome. A famous example of 
a lncRNA is involved in X-chromosome inactivation in the cells 
of females. The human genome is optimized to work best with a 
certain number of active genes: males have only one X 
chromosome and a very much smaller Y. The X  carries many 
more genes than the Y chromosome, so a type of gene dosage 
regulation must be achieved to compensate for the gender 
difference. Since human females are born with two X- 
chromosomes, one must be inactivated by compaction (into what 
is called a Barr body). The lncRNA involved in this case is  called 
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XIST. Where this RNA molecule attaches to a chromosome, that 
chromosome is packaged to within an inch of its life and it is 
rendered, to all intents and purposes, quiescent.  lncRNA 
molecules provide gene regulation in ways that proteins cannot 
(Lee 2012). 
MicroRNA (miRNA) molecules are smaller RNA molecules 
that associate with a protein and RNA complex to either cleave an 
mRNA transcript or halt protein synthesis (Schwarz et al. 2003). 
They tend to bind to targets with a degree of promiscuity, so one 
individual miRNA can regulate the products of multiple genes 
(Lim et al. 2005). 
miRNAs are themselves regulated by circular RNA 
(circRNA) molecules. These RNAs are resistant to miRNA- 
mediated degradation due to their circular shapes. They have the 
ability to bind miRNA molecules and to sequester them, thereby 
preventing them from performing their full function (Franco- 
Zorrilla et al. 2007). RNA species and their effects on epigenetics 
will be discussed further in section 2.4, but as you might perceive, 
the combinatorial complexity of these gene packaging components 
(proteins, lncRNA, miRNA, and circRNA) is vast. 
Since the epigenetic changes discussed in this chapter alter 
the packaging, behavior, and responsiveness of genes  to 
challenges and environmental cues, they have many implications 
for human health. In order to use epigenetic information to 
diagnose and characterize diseases, there must be a way of 
assessing the state of these modifications. Assessment of 
epigenetic states is described in section 2.5. 
 
2.2 DNA Methylation. 
2.2.1 Methylation and CpG dinucleotides. 
The four nucleotides that make up DNA are: cytosine, 
guanine, adenine, and thymine (C, G, A, and T). In a DNA strand, 
nucleotides can be joined in any linear sequence, but when DNA 
assembles into a double stranded duplex, each  nucleotide in    one 
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strand binds a complementary nucleotide on the other (A to T and 
C to G; Figure 2.3). 
 
 
 
Figure 2.3: Cytosine and guanine form bonds across double 
helices. Cytosine followed by guanine along the length of a DNA 
strand constitutes a CpG sit to which a methyl group (CH3) can 
bind. 
 
DNA methylation involves the addition of a methyl group. A 
methyl group is simply a carbon atom bound to three hydrogen 
atoms denoted CH3. DNA methylation occurs only on the 
cytosines (C’s; Figure 2.4), and specifically when the cytosines 
reside beside a guanine (G). The methylation sites are known as 
CpG dinucleotides or islands. In double stranded DNA, the 
complementarity of base pairing (C-G, and T-A) means that on the 
opposite strand, a CpG sequence will sit across from a CpG 
sequence oriented in the opposite direction. CpG sites occur 
throughout the genome, and the majority of them are methylated. 
The methylation of these CpG dinucleotides is important because 
they provide stability to DNA and silence regions of the DNA that 
must remain stable and inactive. An example of silenced DNA 
are retrotransposons: these are remnants of viral DNA  that 
inserted into our ancestors’ genomes. These CG-rich regions have 
been kept from harming us by methylation-mediated gene 
silencing. 
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Figure 2.4: The structure of cytosine and 5-methylcytosine. The 
methyl group is shown in green as an addition attached to 
carbon five of cytosine. CpG dinucleotides are typically not 
methylated when they occur in regions of the genome that 
contain active genes or gene regulatory regions called 
enhancers and promoters. Repression of genes by DNA 
methylation is a common cause of diseases such as cancer, but 
also occurs as a natural part of the mechanism to turn genes off 
when they are not needed. 
 
2.2.2 DNA Methyltransferases (DNMTs). 
DNA methylation is carried out by proteins known as DNA 
methyltransferases (DNMTs). These proteins are enzymes that 
catalyze the addition of methyl groups to cytosines. There are two 
main varieties of DNMTs: de novo methylases and maintenance 
methylases. De novo methylases are those that add methyl groups 
onto previously unmethylated DNA. Maintenance methylases are 
DNMTs that maintain the methyl pattern of DNA as it is 
replicating. DNA is replicated in a semi-conservative manner: 
each of the two strands of DNA provides a template for the 
synthesis of a new, complimentary strand of DNA during 
replication. While the template strands will continue to carry the 
original methylation pattern, the newly-synthesized strands will be 
free  of  methylation  until  acted  on  by  maintenance  methylases 
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(Klose and Bird 2006). 
As mentioned previously, DNA methylation typically has a 
repressive effect (Bird and Wolffe 1999). If methylation occurs on 
a gene, it usually acts to recruit the suites of proteins necessary to 
compact that region, and this in turn represses expression of the 
gene. This effect can vary. Not all DNA regulatory regions 
activate genes – some repress. If methylation occurs in  a 
repressive regulatory region of DNA, it would inhibit the 
repression and thus the gene would be activated. Moreover, it is 
often the case that genes are regulated by the interactions of 
several different proteins with different DNA regulatory sites. 
Methylation could preferentially inhibit one interaction while 
facilitating another. For these reasons, it cannot be assumed that 
methylated DNA is necessarily repressed. 
 
2.2.3 Methyl Binding Proteins (MBPs). 
Methyl groups are relatively small when considering the size, 
scope, and complexity of a DNA molecule: a DNA sequence 
might encompass tens of thousands or even millions of 
nucleotides. While methyl groups have the ability  to directly 
block some proteins (such as transcription factors) from binding to 
DNA, their main action occurs through the recruitment of 
accessory and metabolic proteins to form a complex. Proteins that 
recognize methylation marks specifically are methyl-binding 
proteins (MBPs). MBPs recognize methylated DNA, and recruit 
other protein and RNA factors to this region to  assist in 
remodeling and repression. Some proteins that may be  recruited 
by MBPs are histone-modifying proteins, which will modify 
neighboring histones, and thereby further propagate and amplify 
the change caused by DNA methylation. MBPs provide a link 
between DNA methylation and histone modifications, as well as 
overall chromatin state changes (Jones et al. 1998). 
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2.2.4 Demethylation. 
DNA demethylation is a controversial topic. Some 
investigators believe that it plays a critical role in balancing DNA 
methylation states, whereas others deny it. One mechanism that is 
proposed for demethylation is the conversion of 5-methylcytosine 
to 5-hydroxymethylcytosine (Figure 2.5). This is carried out 
through the action of a group of enzymes known as Ten-Eleven 
Translocation proteins (TETs) (Tahiliani et al. 2009). Other 
mechanisms of active demethylation have been proposed but most 
are not widely accepted. A mechanism of passive demethylation 
has received more approval. Passive demethylation means that 
demethylation is occurring simply due to lack of maintenance of 
the methylation status. This means that DNA is replicated without 
the methyl marks being replaced when new strands of DNA are 
synthesized during cellular proliferation. This task is normally 
carried out by maintenance methylases. Without maintenance 
methylases, demethylation occurs (Klose and Bird 2006). 
 
 
 
Figure 2.5: Demethylation can occur through a 5-hydroxy- 
methylcytosine intermediate. 
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2.3 Histone Modifications. 
2.3.1 Nucleosome and histone structure. 
As was previously discussed, DNA wraps around assemblies 
of histone proteins to form nucleosomes (Figure 2.1). 
Approximately 147 base pairs of DNA wrap around each 
nucleosome, with up to 80 base pairs separating one nucleosome 
from the next. Histones each have an amino terminal tail that is 
pointed outwards away from the nucleosome and is available to be 
modified. 
 
2.3.2 Histone Acetylation. 
Acetylation involves the addition of an acetyl group. The 
addition of an acetyl group to histones neutralizes the positive 
charge on the lysine amino acid residues of the histone. This 
positive charge is usually a driving force for interaction  of 
histones with negatively-charged DNA. Without the positive 
charge, the attraction between the histones and DNA relaxes, 
altering the intimacy of their interaction, and thereby also 
increasing the availability of DNA for interaction with other 
factors – in essence, genes are now available to be activated. 
Addition of acetyl groups is mediated by histone 
acetyltransferases (HAT) (Roth et al. 2001). Removal of acetyl 
groups is typically performed by histone deacetylases (HDACs) 
(Grozinger and Schreiber 2002). Both HATs and HDACs are key 
enzymes in regulating chromatin structure through modification of 
histones. HDACs have been shown to combine with MBPs  to 
form a larger complex in response to DNA methylation. 
Associations between HDACs and methyl binding proteins would 
stimulate histone deacetylation in regions of DNA that have been 
methylated. This is consistent with the idea  that  acetylation 
causes a more relaxed, activated chromatin state, whereas 
deacetylation is associated with a more repressed and inactivated 
state. 
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2.3.3 Histone Methylation. 
Histone methylation is similar to DNA methylation in that 
methyl groups are added. They are different in terms of what 
proteins mediate these processes. Recall that DNA methylation 
occurs through the action of DNMTs (DNA methyl transferases). 
Histone methylation is carried out by two different types of 
enzymes depending upon the site of the methylation. Histone 
methylation occurs on either arginine or lysine amino acid 
residues. The addition of methyl groups onto arginines is done by 
protein arginine methyl transferases (PRMTs) (Lee et al. 2005). 
Lysines can be mono-, di-, or tri- methylated (Figure 2.6, 2.7) 
(Lachner et al. 2004). This process is mediated by histone lysine 
methyltransferases (HKMTs) (Lachner et al. 2003)). Conversely, 
demethylation can also occur from both arginines and lysines, 
through multiple different mechanisms. Arginine demethylation 
occurs through deiminases which convert methylated arginine to 
another amino acid called citruline (Bannister, 2005). Lysine 
demethylation occurs through the action of an enzyme called 
lysine-specific demethylase 1 (LSD1) (Shi et al. 2004). The 
methylation state of histones can have varying effects on the 
resultant gene expression depending upon the site of methylation 
and other modifications that may be present. 
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Figure 2.6: Modifications that occur on lysine amino acids. A 
Lysine in its native state. B Acetylated lysine. The acetyl group 
is shown in blue. C-E Mono-, di-, and tri-methylated  lysines. 
The methyl groups are shown in green. 
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Figure 2.7: Methylation can occur on arginine amino acids. 
Methyl group is shown in green. 
 
2.3.4 Phosphorylation. 
Phosphorylation is probably the most commonly discussed 
protein modification. It is mediated by histone kinases which  add 
a phosphate group onto proteins. Phosphorylation occurs  on 
serine (Figure 2.8), threonine, and tyrosine amino acids. 
Dephosphorylation is carried out by protein  phosphatases. 
Histone phosphorylation typically causes an increase in gene 
expression or a general loosening of chromatin in the region. 
 
 
 
Figure   2.8: The    structure    of    serine    before    and after 
phosphorylation.  Phosphate group is shown in red. 
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2.3.5 Ubiquitination. 
Ubiquitination is the addition of ubiquitin groups onto a 
protein. Ubiquitin is unlike any of the previously mentioned 
histone modifications in that it is not a small molecule. Rather,  it 
is a large peptide (protein sub-fragment) that represents a 
significant addition to a histone protein if attached. Ubiquitin 
groups highlight or mark a protein for degradation and removal. 
The outcome of ubiquitination can be either positive or negative in 
terms of overall gene expression in that region (Muratani and 
Tansey 2003). 
 
2.3.6 SUMOylation. 
SUMOylation is the addition of SUMO groups  to the 
histones. SUMO groups are, like ubiquitin, peptides. These have 
an exclusively repressive outcome. They achieve this by either 
blocking acetylation from occurring at the site of SUMOylation or 
by recruiting HDACs to remove acetyl groups (Yang et al. 2004). 
In some contexts, SUMO groups compete with ubiquitin. 
 
2.3.7 Combinatorial aspect. 
The above-described modifications can occur in 
combinations. The outcome with respect to DNA packaging, 
conformation, and activity depends upon the  various 
modifications that are present. Detection of an acetyl group on a 
histone does not necessarily mean that gene expression is 
occurring in that region. All other modifications that are also 
present in that same region must be taken into consideration. 
Histone modifications are referred to as combinatorial for that 
reason. Indeed, the “histone code” is liable to be more varied and 
complex than the sequence of DNA itself.. 
 
2.4 RNA Species. 
2.4.1 Overview of ncRNA. 
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There are many species of RNA that can exert functions 
themselves without being translated into protein. RNA molecules 
known as messenger RNA (mRNA) are those that are translated 
into protein (Figure 2.9). However, there are other types of RNAs 
that do not get translated into protein such as transfer, ribosomal, 
and telomeric RNA (tRNA, rRNA, and telRNA), to name a few. 
These latter are involved in the machinery of protein synthesis and 
consolidation of the structural ends of chromosomes without 
themselves encoding a protein. These functional RNA molecules 
are broadly classified as noncoding RNA (ncRNA). This is 
because they are RNA molecules that do not encode a protein, but 
perform a different function in cellular life. Finally, there is a 
constellation of new RNA species that are now being discovered 
and that play an important role in epigenetics. 
 
 
 
Figure 2.9: The Central Dogma of molecular biology. 
Illustrated is the transcription of DNA into transient RNA 
molecules that act as messengers for the translational coding of 
protein molecules. 
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While proteins are very important in cellular processes, 
noncoding RNA molecules are not to be  overlooked. 
Interestingly, only around 1% of the genome transcribes mRNA 
that encodes proteins, whereas somewhere between 70% and 90% 
of the genome is transcribed into non-coding RNA at some point 
(Lee 2012). RNA molecules can be transcribed from almost 
anywhere in the genome, including areas that overlap with known 
protein-encoding genes. The speculation is that there are around 
ten noncoding RNA molecules transcribed from within the span of 
any “regularly” coding gene (Lee 2012). This means there is a 
huge volume of DNA that is being transcribed, the product of 
which has yet to be understood and characterized for the most 
part. Some lesser-understood ncRNA molecules are those that are 
implicated in epigenetic mechanisms. These include long 
noncoding RNA (lncRNA), microRNA (miRNA), and circular 
RNA (circRNA), which will all be discussed for the remainder of 
this chapter. 
 
2.4.2 lncRNA. 
Long noncoding RNA molecules are RNA molecules that are 
not translated into protein, and are not associated with either 
quotidian metabolic processes (such as tRNA and rRNA), nor are 
they characterized by specific cleavage and folding patterns (as is 
miRNA) (Ernst and Morton 2013). They can be thousands of 
nucleotides long. Long-noncoding RNA molecules are known for 
being allelic in nature (Lee 2009). This means that regulation by 
lncRNA can be specific to one of either the maternally inherited or 
paternally inherited chromosome. This can be illustrated by the 
example of X-inactivation in females. We  know  that females 
carry two X chromosomes, as opposed to the X and Y carried by 
males. The Y chromosome is very small compared to the X. In 
order to compensate for having double the genetic complement of 
men (and thereby preserve a correct “dosage” of  functional 
genes), women turn off one X chromosome via a process known 
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as X-chromosome inactivation. The mechanism by which this 
occurs involves a very important lncRNA known as XIST (Brown 
et al. 1992). The key in X chromosome inactivation is that one 
chromosome must be fully compressed and shut down whereas the 
other is fully active; there cannot be any variability in the 
expression from either one. This is known as allelic specificity 
(Lee 2009). 
The way that RNA molecules are able to achieve such a high 
level of specificity is because of the way they are produced, their 
stability, and the way they are compartmentalized and stored in 
specific regions. RNA molecules are nucleic acids, just like DNA. 
In this sense they have a sequence, and this can bind to 
complementary sequences of DNA to interact with only specific 
target sequences, in this case DNA. There are many proteins that 
bind to DNA: numerous examples can be found among the 
transcription factors (DNA activating and repressing  proteins). 
The difference between proteins and RNA is  that proteins 
typically recognize short DNA sequences to bind, whereas RNA 
molecules are able to bind to long sequences, giving them a 
specificity that proteins may lack (Lee 2012). 
DNA is an extremely stable molecule. It needs to be, since it 
will direct cellular activities throughout the life of the cell. RNA 
on the other hand, is a labile molecule. It is synthesized to pass a 
message along, either to encode proteins or to fulfill one of many 
other functions. Once it has done this, it often needs to  be 
removed immediately from circulation by degradation. This is an 
aspect of lncRNA that is manipulated in certain biological 
processes, ie: those that require brief signaling or signaling 
specific to the site of RNA transcription. This is how lncRNA is 
able to act in an allelic manor. In the case of X-activation and 
other cases, lncRNA is degraded almost as soon as it is made. 
This means that it doesn’t have an opportunity to diffuse away 
from the site of synthesis; the lncRNA is likely to act near the X 
chromosome from which it is transcribed, not upon a  neighboring 
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chromosome (Sun, 2006). Furthermore, even if small amounts of 
lncRNA are actually able to diffuse from their site of synthesis, 
the rates of degradation by cellular machinery ensures that 
concentrations would likely become insufficient for remote 
activity (Lee 2012). 
lncRNA molecules can also restricted to a distinct region of 
action via the binding of tethering proteins. Tethering proteins 
will bind to RNA molecules during synthesis and anchor them to 
that region thereby preventing diffusion away from the target 
DNA sequence (Lee 2012). 
In the example of the lncRNA involved in X chromosome 
inactivation, the XIST lncRNA specifically recruits proteins 
involved in chromatin repression. This is what causes the 
inactivation of the chromosome (Wutz 2011). However, it is not 
always true that lncRNA will silence any given region. In fact, 
there are lncRNA molecules that are involved in turning on 
expression of DNA (Lee 2012). 
While there has been a lot of research focusing on various 
lncRNA molecules in recent years, it is still unclear what their 
importance is to the cell. Most of the hypotheses derive from 
experiments where certain lncRNA are turned off. Many of these 
experiments do not result in a noticeable change in cell physiology 
leading many to speculate that lncRNA molecules have redundant 
functions (Lee 2012). More research is needed to clarify the 
functional importance of most lncRNA molecules. 
 
2.4.3 miRNA. 
MicroRNA (miRNA) molecules are much shorter than 
lncRNA molecules, and once processed, they average roughly 23 
nucleotides per molecule (Bartel 2004). Their action is specific 
and targeted to repress genes. The way that miRNA molecules 
function is through interaction with a complex known as an RNA- 
induced silencing complex (RISC) (Schwarz et al. 2003). 
miRNA molecules are formed through the folding of an initial 
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RNA transcript and then its subsequent cleavage to produce a 
double-stranded RNA molecule, one strand of which will be 
recognized by, and pair with, the RISC. Together, RISC and the 
miRNA bind to a specific protein-encoding mRNA . The miRNA 
provides the sequence specificity to target specific mRNA 
molecules (Schwarz et al. 2003). While there is some  specificity 
in gene targeting, there are miRNA molecules that can recognize 
up to hundreds of different gene products – in other words, related 
families of mRNA sequences (Bartel 2009; Shukla et al. 2011). 
Most miRNA molecules bind to the untranslated region (UTR) of 
an mRNA. If multiple mRNA sequences share a conserved UTR 
motif, then one miRNA can recognize any one of these mRNA 
molecules (Lim et al. 2005). 
When the RISC/miRNA complex binds to a target mRNA 
molecule, there are different fates that can arise for the mRNA. 
Binding can stimulate the RISC complex to cleave the protein- 
encoding mRNA molecule, effectively precluding production of 
the protein. This typically occurs when the miRNA and mRNA 
sequences are very similar so that binding is strong. Alternatively, 
when binding is weaker, the RISC and miRNA complex will bind 
to the mRNA and then either: halt translation of the mRNA 
through the ribosomes (protein factories); allow more miRNA to 
bind; or send the mRNA for processing and eventual degradation 
(Baulcombe 2004). Regardless, the fate of the mRNA is to be 
either destroyed or at least not translated, meaning the product of 
that gene is effectively turned off. 
 
2.4.4 circRNA. 
As we saw above, miRNA molecules regulate genes at a post- 
transcriptional level. The genes that encode miRNA are 
themselves subject to regulation like any other gene, including 
those that encode proteins. However, there is another layer of 
activity that regulates the activity of miRNA. This level requires 
circular RNA (circRNA) molecules.  circRNAs have the ability  to 
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bind miRNAs and to inhibit them. Their circular structure allows 
them to bind miRNA without being rendered susceptible to 
degradation via the mechanism that miRNA uses to induce mRNA 
cleavage (Franco-Zorrilla et al. 2007). Currently, our 
understanding of circRNA molecules is limited, but it appears to 
promise another layer of complexity to be considered when 
analyzing gene regulation and epigenetics. 
Through this chapter we’ve seen various RNA species that 
can interact and regulate one another, as well as various genes. 
The interactions are summarized in Figure 2.10. 
 
 
Figure 2.10: The Central Dogma of molecular biology with 
feedback and interactions between RNA species. DNA  is 
transcribed into a pool of different RNA species. The traditional 
mRNA is translated into protein. miRNA and lncRNA inhibit 
protein-encoding mRNAs. circRNA potentially reverses this by 
inhibiting the miRNAs. lncRNA can also effect the DNA directly, 
either by affecting transcription of new RNA molecules, or by 
physically covering DNA or altering its shape sufficient to preclude 
interaction with other protein or RNA factors. 
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While DNA and proteins are typically the most discussed 
components contributing to chromatin structure, this section 
describing the impact of RNA on epigenetics has hopefully 
provided some enlightenment about why RNA is an equally 
important player in the regulation of gene expression and 
chromatin structure. 
 
2.5 Introduction to the Assessment of Epigenetic 
States. 
Understanding the molecular subtleties of epigenetics  is 
one thing, assessing these epigenetic marks in a way that advances 
the field is quite another. Before diving into the gory details of 
epigenetic assessment techniques there are some preliminary 
difficulties with epigenetic assessment as a whole,  especially 
when it comes to human subjects. Firstly, epigenetic states are 
dynamic and can vary substantially between different tissue types. 
For example, epigenetic patterns change with age, and at different 
rates in different tissues. This means that a mouth swab of oral 
epithelial cells is not representative of the epigenetic status of the 
whole body - epigenetic marks might affect only a single gene in a 
single cell type. If that cell type happens to reside in the brain, 
then a blood test will reveal nothing. From a human patient’s point 
of view, this might mean uncomfortable prospect of biopsies of 
sensitive tissues like liver, brain, or gonad. Imagine having to 
request a brain biopsy from a living colleague to test  for 
epigenetic effects (although there may be some colleagues in 
whom the lost material passes unnoticed!). Furthermore, if you do 
not know in advance which gene or suite of genes are liable to be 
affected by epigenetic changes, it can be hard to design a test to 
screen for effects. That said, if epigenetic changes are detected in 
blood samples, they do not necessarily covey information 
concerning organs, nor whether the imprint will have been 
transmitted to the germ line for propagation to future generations. 
Finally,  as  will  become  clear  in  the  ensuing  chapters,     many 
35  
Epigenetics Mechanisms and Techniques 
 
different influences act upon the epigenome, so establishing a 
discrete causal link can be very difficult – there are simply too 
many confounding factors at play. 
Even presupposing the availability of a tissue sample, what 
is to be epigenetically assessed? DNA methylation, histone 
modification, regulating RNA species, etcetera? In most cases, 
there is far too little scientific literature to systematically narrow 
down which epigenetic path to examine. It is also not feasible to 
collect sufficient tissue samples and have the financial  resources 
to perform all tests. Furthermore, one should also consider how 
much of an effect the biopsy itself may have on the epigenome of 
the tissues implicated. 
Another issue is that the definition of epigenetics is not 
static, but rather is ever-evolving, much like the definition of a 
gene has over the last few decades. Some believe that epigenetics 
must be considered heritable (Berger et al. 2009). Others believe 
that only mechanisms that change chromatin structure should be 
considered to be epigenetic (Bird 2007). Perhaps the safest 
definition is one that conveys the notion that absolutely any 
mechanism that changes the expression of a gene, and that doesn’t 
involve change in nucleotide (DNA) sequence, is epigenetic. 
Adopting the latter definition, the possibilities of “what is 
epigenetics?” becomes nearly endless. 
Finally, given the number and complexity of potential 
DNA methylation sites, as well as the innumerable ways in which 
histones and other chromatin proteins may be modified, it may 
often be hard to assess the meaning of the state of a DNA 
sequence or its associated histones. For example, a single gene 
might have a half dozen or more CpG islands available for 
methylation, and different numbers and arrays of them might be 
methylated (or not) in different cells even within the same tissue. 
Without even having approached the evaluation of histone 
modifications, the epigenetic code is already complex and subtle. 
To  make this  section  brief,  only two  putative epigenetic 
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modifications have been explored for assessment, methyl DNA 
and histone modification. These assessment techniques may be 
used on all tissues using very small sample (biopsy) quantities. 
One exception used to be the strategies that employ bisulfite 
treatment to identify methyl DNA: the technique is now  very 
much more efficient. 
The importance of epigenetic assessment is apparent in the 
correlation of epigenetic marks with predispositions to, and 
involvement in, disease. Indeed, a better understanding of the role 
of epigenetics in disease may facilitate the discovery of 
preventative measures, accurate prognostic assays, treatments, or 
even cures (see Chapter 3). Epigenetic assessment is facilitated by 
specialized biomolecular techniques that are capable of identifying 
methylated DNA regions, genes under the control of modified 
histone proteins, and epigenetically active RNA species. These 
techniques include DNA amplification by polymerase chain 
reaction (PCR), DNA sequencing, and immunoprecipitation 
(IP). Often, these techniques are used in combination. This chapter 
will cover the basics of today’s popular epigenetic assessment 
techniques, and identify their limitations and some ramifications 
from the consumers’ point of view. 
 
2.6 Methylated DNA (MeDNA) Assessment 
DNA methylation (MeDNA) is one of the best 
understood epigenetic markers with a plethora of assessment 
techniques, many involving the bisulfite treatment of DNA. A 
simple approach is to use restriction enzymes to cut the genome 
into manageable sizes. One variation of this approach employs 
restriction enzymes that have a differential ability to cut at 
methylated CpG sites. A sample can be digested, and depending 
upon where it is methylated, differently sized fragments will be 
cut. The strategy is then either to visualize these differences on a 
gel, cut them out, and then clone/sequence them, or, to use 
polymerase   chain   reaction   (PCR)   to   amplify   the  fragments 
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following the addition of adapter sequences to their ends. In this 
latter instance, the PCR sequences can be cloned or sequenced 
(Esteller 2005). 
Another strategy requires that methylated C’s be 
chemically converted to make them stand out. Bisulfite converts 
any unmethylated cytosine residues in DNA to uracil (Frommer et 
al. 1992). These changes can be then be detected by conventional 
DNA sequencing or PCR (polymerase chain reaction)  approaches 
– comparisons are made to DNA samples that have not been 
bisulfite treated, and this highlights the nucleotides that must have 
been methylated (and protected from bisulfite conversion). 
Treating DNA with bisulfite to find methylated C’s is  analogous 
to using a black light used to find bodily fluids on surfaces and 
clothes. Since the base pair complement of uracil is converted to 
adenine instead of guanine, sequencing techniques are ideal for 
accurately locating unmethylated cytosines within DNA. 
Unfortunately, bisulfite treatment also degrades a large portion of 
the initial DNA template, and this reduces its effectiveness with 
scarce DNA samples (Grunau et al. 2001). Another limitation is 
that 5-hydroxymethylcytosine, like 5-methylcytosine, is also 
resistant to bisulfite treatment. This is a problem since the 
consequence of 5-hydroxymethylcytosine on gene transcription is 
different from 5-methylcytosine as described earlier. The Tet 
family of enzymes (Section 2.2) may mitigate this problem by 
converting 5-hydroxymethylcytosine to 5-carboxylcytosine that is 
read as a thymine when sequencing bisulfite treated DNA. 
An alternative to sequencing bisulfite treated samples, is to 
use polymerase chain reaction (PCR) conditions that will 
discriminate between untreated and bisulfite-converted sequences. 
Depending upon the DNA primers used to amplify a target 
sequence, bisulfite treated sequences can alter whether or not the 
sequence can amplify – a comparison of PCR products on a gel 
will tell you if the target sequence was originally methylated or 
not (Figure 2.11). 
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Figure 2.11: Flow chart of methyl DNA (MeDNA) assessment by 
MSP. Methyl specific PCR takes advantage of a PCR technique 
using methylated CpG island specific primers for the rapid 
assessment of DNA methylation status. 
 
Bisulfite treated DNA opens many doors to PCR and 
sequencing techniques. The difference between PCR and 
sequencing is that PCR amplifies targeted DNA sequences 
thousands of times until they are abundant enough to be visually 
detectable, while sequencing is the systematic identification of 
each nucleotide base in the sequence. Bisulfite  sequencing 
benefits from being more in the way of a brute-force approach – 
you do not necessarily need to know anything about the DNA 
sequences to begin with – you can capture sequence data in an 
unbiased manner. DNA enrichment was initially required for this 
treatment due to severe degradation of DNA from bisulfite 
treatment and these clones had to be amplified for any direct 
sequencing sensitivity. Any kind of cloning is labor intensive and 
expensive, thus other sequencing techniques are now preferred 
(Tost and Gut 2007). Unlike the old method  of bisulfite 
sequencing (dideoxy chain termination), pyrosequencing does not 
require enrichment of DNA and it is therefore not quite as labor 
intensive (Tost and Gut 2007). Nucleotide incorporation is 
identified and reported by a light signal as a complementary 
sequence  of  DNA  is  polymerized  by  sequencing  enzyme. The 
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light signal intensity may then be quantified. The trade-off is that 
the technology itself is expensive and the sequence read length is 
short – 300-500 base pairs instead of the 1000 base pairs formerly 
achievable. 
 
 
Figure   2.12:   Flow  chart  of   MeDNA  assessment  by    BSP. 
 
 
Bisulfite specific PCR, unlike MSP, amplifies upstream regions 
of DNA with primers not containing possible methylated CpG 
islands. The products produced are then assessed by using a 
secondary rapid technique. 
 
Essentially two PCR techniques are commonly used: 
methyl specific PCR (MSP) (Figure 2.11) and bisulfite specific 
PCR (BSP) (Figure 2.12). The key difference between the two is 
primer composition. MSP includes CpG sites in their primers and 
BSP does not. Due to the nature of MSP primers, a PCR  product 
is observed when a CpG site is methylated (Herman, 1996). If the 
template is unmethylated then the MSP primer would  not 
hybridize to the template DNA resulting in an absent PCR product 
as shown in Figure 2.11. PCR products are DNA fragments 
resolved on agarose or acrylamide gels into singular bands.  This 
is a cheap and fast 5-methylcytosine assessment of a single or 
small collection of genes. The limitation of MSP is that the 
template DNA sequence must be known in order to design primers 
(Herman  et  al.  1996).  Other  problems  arising  from  any   PCR 
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technique is non-specific primer hybridization which requires 
careful annealing temperature optimization for each primer set. 
 
Figure 2.13: The figure represents a melting curve using 
methylation specific high resolution melting (MS-HRM) of two 
BSP PCR products.  The red melt curve is representative of   the 
 
 
PCR product that contained a methylated cytosine and therefore 
requires a higher temperature to dissociate the double stranded 
DNA to single strands. The red product lacked one or more 
methylated cytosines and acquired the weaker uracil bases 
resulting in a lower temperature melt curve. 
 
The power of BSP is that it does not require detailed 
knowledge of a gene or genes of interest. Primers may  be 
designed for highly repetitive DNA sequences that do not include 
CpG islands. Excellent examples are the Alu elements. Alu 
sequences are often found upstream from many genes’ non- 
transcribed regions including the promoter, repressor, and 
enhancer domains that may be littered with CpG islands (Yang, 
2004). After PCR, the DNA fragments can be subjected to methyl 
DNA (MeDNA) assessment using a variety of techniques 
including: sequencing, Southern blot analysis, combined   bisulfite 
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restriction analysis (COBRA), and methylation specific high 
resolution melting (MS-HRM). 
 Southern blots allow a MeDNA specific DNA primer 
conjugated to a fluorescent or radioactive reporter to probe 
a collection of DNA fragments that have been previously 
immobilized on a membrane. 
 COBRA uses a CpG island-specific restriction enzyme 
approach (Xiong and Laird 1997). Restriction enzymes 
reduce PCR products to smaller fragments by double 
stranded breaks. The number and size of these fragments 
of bisulfite treated DNA containing methylated CpG 
islands will differ from those without methylation. The 
restriction enzyme approach is easy, accurate, fast and 
cheap. 
 Finally, another technique involves methyl sensitive high 
resolution melting (MS-HRM). This techniques takes 
advantage of the differential melting properties of DNA 
based on nucleotide length and composition (Wojdacz and 
Dobrovic 2007). A higher cytosine-guanine composition 
present in bisulfite-treated methylated CpG island DNA 
fragments will result in a higher melting temperature than 
unmethylated CpG island fragments. Figure  2.13 
illustrates this phenomenon as a melt curve with the y axis, 
dF/dT, representing the change in fluorescence over 
change in temperature. In this instance, the fluorescent 
molecules are designed to fluoresce only when bound to 
double stranded DNA: as the temperature increases the 
DNA melts into single stranded DNA, and fluorescence 
declines in proportion. The increased  cytosine  and 
guanine content results in a higher  melting temperature 
due to the triple bond between them, resulting in more 
energy required to break compared to  double bonds 
formed by thymine or uracil and adenine. Like COBRA, 
MS-HRM is relatively fast, easy, cheap and very accurate 
42  
at   determining   methylated   CpG   islands    at a   locus 
(Wojdacz, 2007). 
 
The previously discussed techniques are often combined 
for confirmation and accuracy of results. As an example, MSP 
amplified fragments may be subjected to pyrosequencing for 
methylated CpG island confirmation (Shaw et al.  2006). 
Combined techniques may also elucidate additional information of 
a DNA sample such as methylation heterogeneity  when 
combining pyrosequencing with MS-HRM (Candiloro et  al. 
2011). Most importantly, combining BSP and sequencing 
techniques results in global methylation assessment (Yebra and 
Bhagwat 1995). Global methylation has great significance in 
medical diagnostics since cancers often exhibit a particular 
methylation signature that is detectable in blood samples (Delpru, 
2013). 
Other MeDNA global assessment techniques that do not 
require bisulfite treatment include methyl DNA 
immunoprecipitation (MeDIP) and methyl binding domains 
(MBD). The two use the similar concept of isolating digested 
methylated DNA by binding 5-methylcytosine and immobilizing it 
and the attached DNA sequence – this can later be processed and 
analyzed (Jacinto et al. 2008) (Fig. 2.14). 
 MeDIP uses an antibody approach and MBD utilizes 
proteins that bind preferentially to 5-methylcytosine. To 
help conceptualize immunoprecipitation imagine the 
following: When fishing, a fisherman wants to catch a 
particular fish (5-methylcytosine) and to do this he will use 
a specialized bait (antibody). Once the fish is caught the 
fisherman will use rod and line to isolate the fish 
(immunoprecipitation). Isolated DNA may then be subject 
to sequencing or a microarray (Palmke et al. 2011). 
Microarrays use a myriad of microscopic complementary 
DNA spotted and dried in arrays on a glass – each spot 
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might potentially bind specific sequences present in your 
sample. There may be hundreds to thousands of distinct 
DNA sequences spotted on a slide. Your DNA sample of 
interest can be PCR amplified, fluorescently labeled, and 
then incubated upon the microscopic dots. Complementary 
strands stick to each other: since your sample DNA is 
labeled, a fluorescent signal can be detected and linked to a 
known sequence upon the array. These experiments 
provide a massive amount of information. Microarrays are 
often used in medical diagnostics since they provide 
comparative information between two cell types, for 
example, those deriving from cancer and normal tissue 
(Palmke et al. 2011). The drawbacks of microarrays  are 
not inconsiderable: they are expensive; results may be 
inconsistent; the massive amount of information they 
provide is not necessarily useful; and validation and 
analysis of results can take a long time (Chagovetz and 
Blair 2009). 
 
There are not many methods outside of chromatin 
immunoprecipitation (ChIP) for assessing the epigenetic states of 
histones (Huebert et al. 2006; Pillai and Chellappan 2009). ChIP 
uses the same isolation strategy as MeDIP, but with a different 
target using a different bait. In this technique, a DNA sample 
prepared so that multiple species that are 146bp long can be cross- 
linked to nucleosomes: the exposed DNA between nucleosomes is 
then degraded. Once the cross-linked DNA is immobilized on the 
nucleosomes, antibodies are used to specifically recognize and 
bind to particular histone modifications; some antibodies will 
recognize acetylated histones, other will bind methylated, 
SUMOylated, ubiquitinated, glycosylated, or phosphorylated 
histone. The repertoire of antibodies available for this approach is 
quite large and specific. For example, there are reagents available 
that are sufficient to discriminate between histone H3  methylation 
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at the 4th, 9th, and 27th amino acid position on the protein, and 
even between different methylation sites at each of those positions 
etc.. This might give you a glimmering of how varied  and 
complex the combinations of modifications can be. 
 
Figure 2.14: Flow chart of histone modification assessment by 
immunoprecipitation. Antibodies are designed to target a 
specific histone modification like in this example, histone 
methylation. 
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Epigenetic 
assessment 
technique 
Mechanism Information provided 
by technique 
Direct bisulfite 
sequencing 
DNA sequencing of 
clonal vectors following 
bisulfite treatment 
Methylome in its entirety, 
global MeDNA, and 
single gene MeDNA 
assessment 
MSP DNA amplification of 
template DNA via CpG 
containing primers after 
bisulfite treatment 
Single gene MeDNA 
assessment 
BSP DNA amplification of 
template DNA via non- 
CGI containing primers 
after bisulfite treatment 
Global MeDNA and 
single gene MeDNA 
assessment 
Pyrosequencing Short read sequencing 
technique involving a 
luminescent reporter 
Global MeDNA, single 
gene MeDNA, and global 
gene identification under 
a histone modification 
assessment 
MeDIP/MBD Immunoprecipitation of 
DNA containing methyl 
cytosine which is then 
probed or sequenced 
Global MeDNA and 
single gene MeDNA 
assessment 
ChIP Immunoprecipitation of 
targeted histones with 
desired mark followed 
by sequencing of cross- 
linked DNA 
Global gene identification 
under a histone 
modification 
Table 2.1: Summary of epigenetic assessment techniques 
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Whatever DNA/histone combination is bound and 
precipitated by antibody is then cleaned up and the DNA is un- 
cross-linked and made available for analysis by sequencing or 
microarrays (Huebert et al. 2006; Pillai and Chellappan 2009). 
146bp sequences are more than enough to identify which gene or 
genes are associated with the targeted histone modification. Much 
work to be done with regard to assessing histone modifications. 
In yeast alone there are 51 conformations of modifications 
identified by mass spectrometry (Jiang et al. 2007). Different 
combinations also have different implications on gene expression 
(Jiang et al. 2007). Linking histone modification assessment data 
with genetic expression will be quite the undertaking, but it will 
greatly expand our understanding of the role of combinatorial 
histone modifications in gene expression. 
 
2.7 Conclusions 
Epigenome analysis is liable to be fraught with many  of 
the same challenges and concerns that were elicited by genome 
sequencing. For example, who should have access to data, and 
under what circumstances? How will privacy be protected, and 
how long will samples and data be stored? If direct-to-consumer 
epigenome testing kits become available, how will they be 
regulated, and how will individuals be taught to employ and 
interpret them with intelligence, caution, and integrity? Will it be 
possible to quantify an individual’s epigenome given that all 
tissues and cells within that person are liable to carry a slightly 
different imprint? Or will generalized and averaged assays be 
sufficient to indicate general health trends? If epigenomes can 
change with time and experience, will this immensely complex 
fingerprint ever find utility to identify and characterize people? 
Epigenetics is a quickly growing field of biology, but there 
is still much more to be explored. Individuals interested in getting 
their methylome assessed will not only have to consider which 
tissues to assess but also when, since methylation patterns differ 
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between tissues and over time. For example, 5-methylcytosine 
deamination is a product of aging and accumulates over time. 
Perhaps at some stage some people will advocate that we assess 
the global methylation status of an individual’s gametes before 
they manifest the intent to reproduce? This practice would ensure 
that epigenetically healthy material is inherited by the offspring, 
and this would help to indicate corrective dietary measures, or to 
minimize the transmission of possibly deleterious trans- 
generational effects (Chapter 5). However, after  assessment 
should individuals commit to life changing decisions based on 
what is, after all, relatively dynamic information? There is  also 
the issue of financially disadvantaged populations: should money 
determine who can afford the expense of a methylome 
assessment? Who should pay to mitigate epigenetic harms? What 
should be done for the equal opportunity of epigenetic 
assessment? These ethical issues are of the realm of eugenics and 
are discussed in Chapter 8. 
In summary, epigenetic tools are abundant for global 
MeDNA, single gene MeDNA and global histone modification 
assessment. However, the analysis of the massive amounts of data 
they provide has not yet matured into something suitable for 
solving today’s ethical, legal, and scientific complications. 
 
Provocative Questions 
 How can an epigenome be characterized if the marks that 
differentiate cell are so complex and varied? 
 Since epigenetic imprints vary from cell to cell, and tissue 
to tissue, will biopsies be required from every tissue type? 
 If an epigenome is to be modified by drugs or diet, given 
the aforementioned constraints, how will success be 
monitored? 
 Who will bear the cost of assessing an individual’s 
epigenome, and will simple blood tests  become 
sufficiently sophisticated to provide generalized prognostic 
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information? 
 Given the rapidly changing and complex methods of 
assessment, how will non-specialists, such as physicians 
manage to keep abreast? 
 Given that there are many different epigenetic routes for 
cells to reach a particular endpoint, is there value in trying 
to assess an epigenomic imprint? Will a result that 
comprises averaged status be informative? 
 Will it be possible to predict whether or not a person’s 
epigenetic status will convey to the next generation? 
Should such an attempt be made? 
 How will the huge datasets derived be housed and secured 
from intrusion? 
 Given that an individual’s epigenomic imprint changes 
with time, how often should their imprints be re-assessed? 
 How will the cost to benefit balance of epigenetic testing 
be assessed? 
Possible Solutions 
 Given the epidemiological scale, longevity, and trans- 
generational effects of epigenetics, resources should be directed 
to developing comprehensive, accessible, and reliable methods 
to assess epigenetic imprints. 
 Multiple and representative samples should be  assessed 
globally to define variation between individuals, genders, ages, 
economic strata, geographical areas, and genetic backgrounds. 
 Education of policy makers, health officials, medical 
practitioners, as well as science and health teachers should be 
updated to include consideration of epigenetic effects and 
mechanisms. 
 Economists, medical practitioners, ethicists, and social 
scientists should be engaged to evaluate the relative costs and 
benefits of epigenetic assessments and interventions for both 
individuals and for society at large. 
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Chapter 3 
Cancer: An Example of Epigenetic Peril 
and Promise 
By Sandy Zakaria, Marisa Market, Jessica Hebert 
 
 
Abstract  
Cancer  epigenetics  offers  a  good  introduction  to how 
both the mechanisms and tools of epigenetics are utilized by 
clinicians and researchers to unravel new possibilities for 
diagnosis, prognosis, and manipulation (treatment). For example, 
hyper-methylation appears to play a role in silencing tumor 
suppressor genes, while the overexpression of some miRNA 
genes exacerbates this condition. We discuss how epigenetic 
markers can serve as indicators of tumor aggression and 
progression. By screening for these epigenetic markers (like 
lowered global methylation status and a loss of acetylation and 
methylation on histone proteins), a more accurate diagnosis and 
prognostication of tumor character and stage can be made. 
Finally, by manipulating epigenetic states via either global or 
target-specific means, prospective therapies for cancer treatments 
have potential to offer effective solutions to formerly intractable 
problems. 
 
 
3.1 Introduction 
Over the past decade, research into cancer epigenetics has 
begun to reveal the mechanisms by which normal cells adopt 
cancer phenotypes.    In 2000, a consistent relationship was  shown 
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between DNA hypermethylation (many methyl groups attached) in 
tumor suppressor genes and cancer phenotypes (Esteller et  al. 
2000; Bygren et al. 2001): aberrant methylation and acetylation 
patterns are now known to contribute to cancer.  Epigenetic 
analysis permits researchers to examine cancer profiles by 
comparing normal to cancer cells (Hedenfalk et al. 2001). More 
recently, global hypomethylation (few methyl groups attached), 
was identified in all cancer cells (Kaneda et al. 2004). We now 
know that carcinogenesis is governed in part by epigenetic 
mechanisms in which the degree of hypermethylation of tumor 
suppressor genes, the level of global hypomethylation,  and 
aberrant histone modifications are indicative of cancer 
development and progression. The importance of epigenetics as a 
causative agent in cancer will be assessed in this chapter, as well as 
its importance for prognosis and treatment. 
 
3.2 How Epigenetic Mechanisms Induce Cancer 
Development and Progression 
Epigenetic mechanisms of methylation and acetylation 
modify the structure of DNA, histones, and miRNA (microRNA) 
and can, on occasion, lead to cellular malfunction (Esteller 2007; 
Suzuki et al. 2012). The same epigenetic mechanisms that control 
normal functions can be deregulated to induce uncontrollable cell 
growth and rapid proliferation. If this happens, the newly attained 
cellular functions can produce cancer cells that will compromise 
the health of the individual. Examples of this can be seen in Figure 
3.1. 
An individual’s DNA is susceptible to epigenetic 
modification at cysteine residues (as mentioned in Chapter 2). 
When cysteine residues become modified with methyl groups, this 
will lead to a new epigenetic signature (Esteller 2007). In general, 
hypermethylation will decrease gene expression and downstream 
gene targets, whereas hypomethylation will increase gene 
expression and downstream gene targets. 
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3.2.1 DNA Hypermethylation of Tumor Suppressor Genes 
Cancer cells display elevated methylation at the CpG sites 
of tumor suppressor genes. Tumor suppressor genes encode 
proteins that maintain the integrity of numerous cellular processes, 
but especially those that are involved in cell division or 
programmed cell death (apoptosis). The gating of entry into either 
division   or   death   is   critical   to   normal    cellular      function. 
 
Figure 3.1 Stages of carcinogenesis I-V. 
Stage I: the epigenome is unaltered allowing for normal function 
of cells. Stage II: epigenetic modifications occur to encourage benign cell 
proliferation. Stage III: genetic and epigenetic modifications begin to 
accumulate and cells will adopt a more aggressive and invasive phenotype. 
Stage IV: cancer cells are transformed into malignant cells due to an 
increasing accumulation of genetic and epigenetic modifications and now 
have the potential to migrate through circulatory system. Stage V: cancer 
cells exit bloodstream to establish a secondary tumor site and begin to 
proliferate. Accumulations of epigenetic modifications such as 
hypermethylation of tumor suppressor genes and miRNA, global DNA 
hypomethylation, and aberrant histone modification will compound and 
amplify and the genome will in turn become more unstable. Cancer cells 
will attain a malignant phenotype that will adopt invasive and aggressive 
cellular properties. 
 
When tumor suppressor genes become hypermethylated, 
their activity is down-regulated and they are often silenced. As a 
result, aberrant cellular processes develop, such as premature cell 
cycle entry,  avoidance  of apoptosis, defects in DNA repair,     and 
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impaired cell adhesion. All of these processes will contribute to 
cancer formation and progression (De Carvalho et al. 2012). 
Tumor suppressor genes are not merely essential for 
regulating the cell cycle, but they are consequently vital for 
maintaining genome stability. A well-studied tumor suppressor 
gene known as TP53 is needed to ensure proper cellular genetic 
composition before cellular division. The role of this gene’s 
encoded protein, p53, ensures genetic integrity and stability  of 
cells thereby minimizing the possibility that gross genetic and 
chromosomal anomalies will be passed down to daughter cells. An 
in vivo study has shown that p53 function is essential for tumor 
prevention and cellular senescence  (Agarwal et al., 1995;  Qian 
and Chen 2013). The antitumor activity of p53 is essential. Cells 
that have suppressed p53 activity via hypermethylation will lose 
genetic integrity and stability. Other tumor suppressor genes that 
operate to regulate the cell cycle such as retinoblastoma (RB) and 
p16 can also be subjected to methylation of their regulatory regions 
to induce gene silencing (Murao et al. 2006). For example, in 
cutaneous squamous cell carcinoma, tumorigenesis is associated 
with hypermethylation of RB/p16 pathways (Murao et al. 2006). 
Tumor suppressor genes such as CDH1 and CDH13 are 
needed for cellular adhesion to maintain the complex architecture 
of cells as they form organized tissues (Graff et al. 1995; Toyooka 
et al. 2001). Several types of cancer can arise when CDH1 and 
CDH13 are hypermethylated. The silencing of CDH1 and CDH13 
affects downstream genes in their respective signal cascades, and 
this causes cells to lose adherence to their neighbours. 
Subsequently, cells acquire the ability to migrate and  metastasize 
to establish secondary sites of growth elsewhere via the circulatory 
system. According to the National Cancer Institute, an individual 
with ovarian cancer that has metastasized has a 5 year survival rate 
of 44% whereas an individual with ovarian cancer that has not 
metastasized has a 92% chance of survival after a 5 year period. 
The consequence of hypermethylating CDH1 and CDH13 is that 
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cancer cells become more aggressive and invasive, thereby 
dramatically decreasing survival rates. Hypermethylation of CDH1 
is associated with metastasis 74% of the time in these tumors 
(Yeucheng et al., 2006) 
DNA repair mechanisms ensure the integrity of the 
genome. Tumor suppressor genes that are responsible for DNA 
repair mechanisms can fail to work properly when they are 
hypermethylated at CpG sites. Without proper repair functionality, 
cells cannot overcome mutations that arise within their genome, 
and they become even more susceptible to mutations and this 
contributes to carcinogenesis. For example, hypermethylation is 
apparent in the BRCA1 gene that is associated with breast and 
ovarian tumors, and the DNA repair gene hMLH1 is 
hypermethylated in colorectal, endometrial, and gastric tumors 
(Esteller et al. 2001; Esteller 2005). 
 
3.2.2 Global DNA Hypomethylation of Epigenomes 
Tumor suppressor genes aside, most regions of the tumor 
epigenome have a trend of global DNA hypomethylation. 
Epigenomes of cancer cells undergo a decrease of DNA 
methylation of approximately 20-30% compared to normal cells 
(Esteller 2005). Epigenetic hypomethylation is also a critical factor 
for maintenance of genome integrity. For example, normal 
methylation of the epigenome is needed to silence repetitive 
sequences left by ancestral viral invasions such as transposable 
elements (Esteller 2005). These viral remnants constitute almost 
42% of our genome, and are normally kept stable and inactive by 
methylation. When hypomethylation occurs, these ancient viral 
sequences can become mobile and take chunks  of chromosome 
with them as they translocate, leading to the chromosomal 
translocations that are a hallmark of mutation and cancer (Esteller 
et al. 2001; Esteller 2005). Mobilized sequences can also have dire 
effects upon gene expression when they re-insert into a random 
location that might  include a formerly intact  and vital  gene:   this 
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can either disrupt the “host” gene’s regulation or its function 
(Walsh et al. 1998). Chromosomes require special organization of 
their middles and ends (centromeres and telomeres). 
Hypomethylation of centromeric regions of DNA can enhance 
susceptibility to the formation and progression of tumor cells by 
disrupting chromosomal segregation during mitosis – daughter 
cells receive abnormal numbers or parts of chromosomes, and this 
also enhances the descent to gross mutational disruption (Esteller 
2005). 
In addition, the loss of methylation of other genes, such as 
those encoding growth factors or cell cycle regulators, will induce 
aberrant cell growth and division leading to carcinogenesis. For 
example, global DNA hypomethylation can reduce the methylation 
status of imprinted genes (IGF2 and H19) to result in their 
overexpression whereby they contribute to carcinogenesis (Esteller 
2005). 
Even though the degree of global DNA hypomethylation is 
an indicator of tumorigenesis and progression, global 
hypomethylation initially exerts its effect through only a minority 
of affected genes (Esteller 2005; Fraga et al. 2005). Later, the 
hypomethylation of many genes and transposable elements have 
consequences that are, ultimately, reflected in increased rates of 
mutation, chromosomal degradation, and tumor progression. 
The assessment of an individual’s global methylation 
status should be interpreted very carefully as there is a tendency to 
lose methylation with age (Dunn 2003). This makes it difficult to 
calibrate relationships when considering hypomethylation as a 
driver of carcinogenesis. For example, two mouse lines that were 
deficient in two different genes were crossed and then a tumor 
assessment was made. The first mouse line possessed a disrupted 
gene for the enzyme DNMT1: it could not attach methyl groups to 
cysteine residues and this resulted in hypomethylation of several 
gene regions (Esteller 2005). The second mouse line had a genetic 
mutation in the tumor suppressor gene adenomatous polyposis  coli 
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or APC. This mutation predisposed mice to develop colon tumors 
(Esteller 2005). Data was collected that showed two separate 
outcomes: decrease in colon tumor formation and increased  risk 
for the formation of lymphomas (Laird et al. 1995; Gaudet et al. 
2003). 
Correlation studies suggest a relationship between 
hypomethylation and carcinogenesis. Whether hypomethylation is 
a consequence or causative factor of cancer likely depends  upon 
the initial genes targeted by the disruption, and the genetic context 
within which these disruptions occur. 
 
3.2.3 Histone Modifications 
The packaging of DNA around histones into nucleosomes 
is particularly important for the expression of genes (Chapter 2). 
To review briefly, histones comprise a family of five proteins: H1, 
H2A, H2B, H3, and H4. These histone proteins can be subjected to 
posttranslational modifications to affect the intimacy of their 
interaction with DNA sequences and thereby regulate expression 
of multiple genes at once (Herranz and Esteller 2007; Davie, 
1998). Most commonly, histone tails extending from H3 and H4 
proteins are epigenetically manipulated by methylation and 
acetylation. As explained in Chapter 2, methylation of histone 
terminal tails causes DNA configurations around histone  proteins 
to inhibit gene expression whereas acetylation of histone terminal 
tails relaxes nucleosomal configuration to promote gene expression 
(Herranz and Esteller 2007). The combination of histone 
modifications present in our epigenome, by virtue of the number of 
ways that histones are modified, is quite complex. These 
modifications are sometimes referred to as the histone code, and 
the combinations and information carrying capacity they embody 
exceeds the informational capacity of the genome’s DNA 
sequence! 
A common feature of cancer cells is an epigenetic 
modification  of  H4  histones.  H4  histones  can  be  subjected   to 
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numerous modifications at the N-terminus tail. Specifically, many 
cancer cells have a loss of trimethylation at lysine 20 and a loss of 
acetylation at lysine 16, predominantly where the  histone 
associates with repetitive DNA sequences (Fraga et al. 2005). The 
degree of loss of acetylation and methylation at histone H4 dictates 
tumor progression: larger decreases in acetylation and methylation 
correspond to higher a degree of tumor aggressiveness (Fraga et al. 
2005). These histone modifications can therefore provide a 
predictive indicator for aggressive cancers. Generally, aberrant 
histone modification appears to be responsible for aberrant 
epigenetic status in the cancer epigenome (Fraga et al. 2005). For 
example, acetyltransferase recruitment to H4 histone  was 
decreased near the tumor suppressor TP53 gene, thereby silencing 
the tumor suppressor activity of p53. Abnormal functions of 
methyltransferases, such as MLL, have also been linked to 
malignant cancer phenotypes (Fraga et al. 2005). 
In hematological cancers, chromosomal translocation can 
arise from dysfunction of histone acetyltransferases such as EP300, 
CREBBP, NCOA2, MYST3 and MYST4 (Rodriguez-Paredes and 
Esteller 2011). Also, histone modification enzymes can interact 
with other proteins to induce hematological and solid cancers. For 
example, EP300 and CREBBP can associate with oncoprotein E1A 
and SV40 large T antigen to cause hypoacetylation of histone 3 at 
lysine 18 (Rodriguez-Paredes and Esteller 2011). This change to 
the epigenome results in the activation of genes that allow for 
cellular growth and proliferation (Rodríguez-Paredes et al. 2001). 
Furthermore, genetic mutation of EP300 is correlated with 
increases in malignant transformation phenotypes in colorectal, 
gastric, breast, and pancreatic tumors (Gayther et al. 2000). The 
overexpression of histone deacetylases such as HDAC1, HDAC2, 
and HDAC6 also play a role in tumorigenesis (Rodriguez-Paredes 
and Esteller 2011). 
Histone methyl modification enzymes have many 
downstream gene targets that encourage cell transformations. It   is 
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estimated that 80% of infant leukemia cases and 5-10% cases of all 
other lymphocyte leukemia cases result from a methyltransferase 
atypically interacting with 50 gene targets (Rodriguez-Paredes and 
Esteller 2011). These leukemia promoting genes will elicit 
abnormal recruitment of enzymes to histone 3 – lysine 79 
(Krivtsov and Armstrong 2007; Rodriguez-Paredes and Esteller 
2011). The overexpression of histone methyltransferase is  also 
seen in other cancer profiles. For example, extra recruitment of 
enzymes to histone 3 – lysine 27 effectively produces an 
overexpression of the methyltransferase EZH2 in prostate and 
breast cancer. Also, studies show SMYD3, a histone 3 – lysine 4 
methyltransferase, is overexpressed in colorectal cancer 
(Rodriguez-Paredes and Esteller 2011). 
Recently, a relationship between the extent of aberrant 
histone modifications and DNA methylation has been elucidated. 
For instance, the loss of histone acetylation and the loss of histone 
methylation on histone 3 – lysine 9 will result in the recruitment of 
DNA methyltransferase 1 to the regulatory regions of genes and 
increase DNA methylation (Herranz and Esteller 2007). We must 
infer that not only does methylation of DNA allow for histone 
modifiers to be recruited to the neighbourhood, but that the reverse 
is true as well -histone modifiers also help to regulate methylation 
of DNA. 
 
3.2.4 Hypermethylation of miRNA Genes 
miRNA are small non-coding RNA molecules. They 
constitute approximately 22 nucleotides and have the ability to 
affect gene expression post-translationally (Suzuki et al. 2012). As 
we saw in Chapter 2, miRNA have the ability to bind to mRNA 
molecules via complementarity to either inhibit activity or to 
promote degradation of the targeted mRNA (Suzuki et al. 2012). 
miRNA genes  can be subjected to epigenetic modifications  such 
as hypermethylation which will silence them, and indirectly permit 
the  expression  of  the  targeted  mRNA.  Evidence  suggests   that 
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miRNA silencing is involved in cancer formation and progression. 
For example, the down regulation of expression of miRNA-15, 
miRNA-16, and miRNA let-7 by hypermethylation are linked to 
chronic lymphocytic leukemia and Ras oncogene expression. 
miRNA expression patterns are also linked to histone modification. 
miRNA molecules were assessed in control and acute 
lymphoblastic leukemia patients. Acute lymphoblastic leukemia 
patients showed: hypermethylation at CpG islands of thirteen 
miRNA; high prevalence of histone marks that reduce gene 
expression (dimethylation of histone 3 – lysine 9); and low 
prevalence of histone marks that allow for gene expression 
(trimethylation of histone 3 – lysine 4) compared to control 
patients (Roman-Gomez et al. 2009). 
The miRNA-124 family has tumor suppressor properties 
since miRNA-124 regulates the cell cycle. Aberrant function of 
miRNA-124 leads to activation of cyclin-dependent kinase 6, 
inducing cancer cells to enter the cell cycle and allowing for 
inactivation of the tumor suppressor Rb gene by phosphorylation 
(Lujambio and Esteller 2007; Lujambio et al. 2007; Agirre et al. 
2009). Epigenetic silencing via hypermethylation of miRNA-124 is 
apparent in 70% of colorectal cancers (Suzuki et al. 2012). miRNA- 
124 are also hypermethylated in acute lymphoblastic leukemia 
where miRNA-124 methylation status is indicative of higher 
mortality rates (Agirre et al. 2009). 
An essential role of the miRNA-34 family is to target p53 
pathways. miRNA-34 can be subjected hypermethylation at its CpG 
sites: this causes cells to grow uncontrollably and permits 
avoidance of apoptosis (Suzuki et al. 2012). Silencing of miRNA- 
34 is prevalent in many types of cancers; oral, esophageal, gastric, 
colorectal, pancreatic, breast, lung and renal cancer (Suzuki et al. 
2012). The miRNA-34 family has two main classes: miRNA-34b 
and miRNA-34c. When they become methylated, metastasis as well 
as higher reoccurrence and mortality rates can result (Wang et al. 
2011). 
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The miRNA-9 family also plays a role as a tumor 
suppressor: methylation within CpG sites of its promoter is 
prevalent in breast and pancreatic cancers (Suzuki et al. 2012). In 
gastric cancer, methylation of miRNA-9 is correlated  with 
increased metastasis, proliferation, and invasion (Lujambio et al. 
2008). Other mi-RNA molecules that act as tumor suppressors are 
miRNA-1, miRNA-125b,  miRNA-129-2, miRNA-137, and   miRNA- 
145. All are found to be methylated at CpG sites and are associated 
with several cancers (Suzuki et al. 2012). 
 
3.3 Clinical Applications of Epigenetics in the Field of 
Oncology 
DNA methylation and histone  modification patterns 
provide indicators for carcinogenesis - they are signposts of tumor 
stage, and they can identify tumour sub-type and provide 
prognostic measures for treatment. An individual’s susceptibility to 
cancer is dependent upon various factors including; the degree of 
DNA hypermethylation of tumor suppressor genes, the global 
hypomethylation of genes, or the extent of aberrant histone 
modifications. Since cancer cells have specific epigenetic marks 
associated with development and progression, these marks will 
have great utility in the field of clinical oncology for cancer 
detection, and ultimately, for pharmacoepigenetics (Rodriguez- 
Paredes and Esteller 2011). 
 
3.3.1 Cancer Cell Detection 
Sample DNA and histones can be assessed for epigenetic 
marks to characterize an individual’s epigenetic susceptibility to 
cancer, or for the presence of abnormal cells. Technological 
advancements have provided the methods to assess the DNA 
methylation status of normal versus cancer cells (Rodriguez- 
Paredes and Esteller 2011). In some cases, non-invasive samples 
can be obtained to assess epigenetic status (Laird 2003). For 
example, feces can be collected from colorectal patients, urine  can 
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be collected for bladder cancer assessment, and sputum can be 
collected for lung cancer assessment (Rodriguez-Paredes and 
Esteller 2011). Early detection methods are based upon the 
principle that hypermethylation of select CpG sites occurs early in 
tumorigenesis. Hypermethylation of CpG sites has been detected 
early in tumor suppressors p16INK4a, p14ARF and MGMT, which are 
involved in colorectal cancer development (Rodriguez-Paredes and 
Esteller 2011). Increased DNA methylation of tumor suppressor 
genes may be an indicator for cancer progression. 
Early detection methods are also very useful for individuals 
who inherit genetic risks for cancers such as mutations in BRCA1 
and BRCA2 (Rodriguez-Paredes and Esteller 2011). Early 
screening could improve timely detection and increase survival 
rates. Also, aberrant histone modifications are present in low grade 
prostate tumors (Esteller 2007). For example, the most promising 
early detection biomarker for prostate cancer is the 
hypermethylation of the GSTP1 gene. The specificity of  the 
GSTP1 gene to prostate cancer as compared to tumor tissues such 
as breast, liver, and kidneys makes GSTP1 ideal (Rodriguez- 
Paredes and Esteller 2011). Approximately 80-90% of CpG sites 
are hypermethylated in GSTP1 in prostate cancer and obtaining 
biological specimens such as urine or serum is relatively simple 
(Brooks et al. 1998; Rodriguez-Paredes and Esteller 2011). Finally, 
GSTP1 hypermethylation is not found in benign proliferating cells 
but only in pre-malignant and malignant cells making GSTP1 a 
specific marker for malignant prostate cancer. Presumably the 
repertoire of markers will expand to the extent that physicians will 
also be able to differentiate between the prostate tumors that need 
immediate attention, and those that can be left in situ 
 
3.3.2 Tumor Prognosis 
Tumor prognosis is a measurement taken to assess the 
characteristics and severity of a tumor. A tumor prognosis 
evaluation  is  based upon levels  of  DNA  methylation and histone 
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modification. For example, DNA hypermethylation of tumor 
suppressors DAPK, p16INK4a, and EMP3 are correlated with tumor 
invasiveness in lung, colorectal and brain cancer (Esteller 2007). 
Technological development in the field of epigenetics has allowed 
for the development of prognostic dendrograms where levels of 
global DNA can be assessed using CpG arrays (Rodriguez-Paredes 
and Esteller 2011). Prognostic dendrograms have identified unique 
and useful markers of aberrant methylation patterns in lung cancer 
reoccurrence and metastasis in colorectal patients (Rodriguez- 
Paredes and Esteller 2011). In breast cancer, the degree of histone 
modification is an important factor in tumor prognosis. Individuals 
who have low to moderate levels acetylation at histone 3 – lysine 
18, acetylation at histone 4 – lysine 12, dimethylation at histone   3 
– lysine 4, trimethylation at histone 4 – lysine 20, and 
dimethylation at histone 4 – arginine are classified with a poor 
prognosis (Chervona and Costa 2012). It was also discovered that 
histone modifying enzymes are responsible for certain tumor 
characteristics. The over-expression of the methyltransferase 
EZH2, which methylates histone 3 – lysine 27, results in tumor 
aggressiveness and poor prognosis in breast cancer patients 
(Chervona and Costa 2012). Several other specific histone 
modifications are seen in lung, prostate, leukemia, esophageal, 
gastric, kidney, liver and pancreatic cancers that are reflected in 
poor patient prognosis (Chervona and Costa 2012). 
 
3.3.3 Pharmacoepigenetics 
The field of pharmacoepigenetics uses an assessment of an 
individual’s epigenetic architecture to evaluate the best method for 
cancer treatment options. For example, hypermethylation of the 
MGMT gene is associated with chemoresistance. In normal cells, 
the DNA repair enzyme MGMT repairs the damage caused by 
chemotherapeutic drugs, however, in cancer cells with 
epigenetically silenced MGMT, the protein is unavailable to repair 
the  mutations.  Therefore,  a  strategy  that  epigenetically silences 
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MGMT might make tumors more susceptible to chemotherapy 
drugs (Baylin and Jones 2011). Other hypermethylated DNA repair 
genes can be used to predict or modify chemotherapy response. 
These include the MLH1 response to cisplatin treatment in lung 
cancer, and WRN response to irinotecan treatment in colorectal 
cancer (Rodriguez-Paredes and Esteller 2011). In short, epigenetic 
mechanisms can be used both to assign the most effective 
chemotherapy to individuals, as well as to bend a tumor’s 
epigenetic characteristics to make it more susceptible to treatment. 
 
3.3.4 Epigenetic Marks for Therapeutic Drugs 
Therapeutic drugs can be used to target aberrant DNA 
methylation and histone acetylation (Figure 3.2). This is 
accomplished by inhibiting enzymes responsible for DNA 
hypermethylation to re-activate tumor suppressor genes  and 
prevent global histone acetylation in cancer cells. Demethylating 
drugs that inhibit DNA methyltransferase activity such as 5-aza- 
cytidine or 5-aza-2-deoxycytidine (Decitabine) are promising in 
this regard. Success has been seen in treating acute promyelocytic 
leukemia, however, the lack of specificity of the drug target is an 
issue (Herranz and Esteller 2007). In large doses, demethylating 
drugs can non-specifically demethylate genes in normal cells and 
contribute to overall global hypomethylation: the consequence of 
these “off target” effects are unknown. 
Hypoacetylation can be reversed to the original epigenetic 
state via inhibition of histone deacetylases. Histone deacetylase 
drugs fall into four classes: hydroxamates (TSA and SAHA), short 
chain fatty acids (valproic acid), cyclic peptides (desipeptide) and 
benzamides (MS-275) (Herranz and Esteller 2007). These drugs 
have antitumour activity by causing cellular differentiation, cell 
cycle arrest in G1/G2, and apoptosis. They have been successful in 
treating hematological cancer and solid tumors (Herranz and 
Esteller 2007). 
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Figure 3.2 Mechanisms of epigenetic drug treatment. 
Epigenetic drugs are used for cancer therapy where inhibition of 
enzymes can induce epigenetic changes. Inhibiting DNMT (DNA 
methytransferase) through epigenetic drugs will prevent the 
recruitment of methyl groups to DNA that can be useful for preventing 
hypermethylation of tumor suppressor genes. Inhibiting HMT  and 
HDM (Histone methylation modifiers); HDAC and HAT (histone 
acetylation modifers) can prevent aberrant histone modifications that 
contribute to carcinogenesis. For example, loss of trimethylation at 
lysine (K) 20 and a loss of acetylation at lysine 16 on H4 histones, a 
hallmark of cancer cells, can be manipulated by epigenetic drugs to 
restore original epigenetic architecture. 
 
The most promising demethylating drug to date is Zebularine. 
Zebularine, an oral drug, is chemically stable and has low toxicity 
in normal cells (Yoo et al, 2004; Cheng et al., 2004a; Cheng et al., 
2004b). Using 5-aza-2-deoxycytidine, there is an impressive 40- 
54% response rate in myelodysplastic syndrome patients. The 
high response rate to 5-aza-2-deoxycytidine has encouraged the 
FDA to approve it for patients with myelodysplatic syndrome. 
Clinical trials of histone deacetylases are also showing great 
promise. Phase one trials with depsipeptide show a partial response 
with minimal side effects in patients unresponsive to  conventional 
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chemotherapy treatments (Herranz and Esteller 2007). Also, 
clinical trials of valproic acid and SAHA are in the final phase: 
SAHA has been found to have antitumour activity in solid and 
hematological cancers (Herranz and Esteller 2007). 
 
3.4 Conclusions 
Presently, there is evidence for several correlations that 
confirm environmental toxins as a causative factor for the 
development and progression of cancer. Environmental toxins such 
as bisphenol A, RDX, contaminated drinking water, air pollution, 
benzene, chromium, aluminum, mercury, lead and pesticides have 
the ability to alter epigenetic mechanisms (Hou et al. 2012). 
Statistics suggest that thirteen million people die annually from 
environmental toxins, where 24% of these deaths are preventable 
(Hou et al. 2012). DNA methylation and/or histone modification 
are providing a causative link between environmental exposure and 
cancer. Eliminating all possible environmental toxins would be 
difficult: society is supported by commerce which is fueled by the 
products that utilize many of these toxic chemicals.  Nevertheless, 
it is unethical to knowingly expose individuals to chemicals with a 
proven causative link to cancer. Therefore, government subsidies 
and grants should be directed to epigenetic research in order to 
elucidate epigenetic mechanisms and to develop new therapies. 
Epigenetics has proven to be an early biomarker for cancer 
development, an indicator of tumor progression, and a predictor of 
pharmacological efficacy. Governments and policy makers should 
recognize that epigenetics has huge potential to become a powerful 
detection method and eventually, to be used in treatments for 
cancer. Health care systems will ultimately have to provide 
epigenetic testing to the public to permit early detection and 
improved treatment outcomes at reduced costs to the health system 
and the affected individual. Funding can also provide opportunities 
to improve current DNA demethylation and histone deacetylase 
drugs, which have shown great success in clinical trials. Overall, 
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epigenetic mechanisms must be regarded as the mechanism that 
links the environment and cancer. As such, epigenetics offers a 
unique and useful tool for diagnosis, prognosis, and treatment. 
 
Provocative Questions 
 Will epigenetics facilitate a personalized assessment and 
treatment of cancer? 
 What will the cost of epigenetic screening be? Who would 
have access? When would individuals be screened? Given 
that an epigenome changes over life, how often will testing 
be necessary? 
 Where would the information be stored? How would it be 
protected? 
 So much potential… So little information – Are epigenetic 
marks causative or coincidental? 
 
Possible Solutions 
 Research needs to be directed to differentiating causative 
versus merely associational relationships between 
epigenetics and cancer 
 We need to develop faster, cheaper, and more efficient 
ways to assess an epigenome. 
 All stakeholders need to be consulted on how data will be 
stored, analyzed, and shared. Confidentiality protocols 
need to be ensured. 
 The field is fast moving – physicians, patients, and policy 
makers need to enjoy a mechanism to provide timely and 
pertinent education, intervention and treatment. 
 There should be more clarity regarding intellectual property 
rights – should they be restricted to drug products, or will 
confusion reign with respect to ownership of mechanisms 
elucidated (much like patent law vacillated over the status 
of newly discovered genes) 
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Your Parents Ate? 
 
Lina Chaker, Roni Hetzel, Kaela Scott, and Marisa 
Market 
 
Abstract 
The epigenome can be modified by many different factors, one 
of which is diet. This chapter focuses on both acquired and inherited 
nutrition-dependent epigenetic modifications that occur  within or 
across generations. We begin by differentiating between acquired and 
inherited epigenetic modifications. Intra-generational and inter- 
generational epigenetic effects are considered acquired, while trans- 
generational epigenetic effects are considered inherited. Intra- 
generational refers to effects seen in the same generation as the 
environmental change; inter-generational refers to effects seen in their 
children, likely exposed either in utero or as precursor gametes; trans- 
generational refers to effects seen in future generations that were not 
exposed, even as gametes, to the environmental change. We explore the 
multivariate diseases, such as obesity, diabetes, eating disorders, 
Crohn’s, and Coeliac disease, that can be associated with nutrition- 
dependent epigenetic modifications. Specifically, potential trans- 
generational epigenetic effects are examined through two retrospective 
studies: the Dutch Famine and the Överkalix cycles of overfeeding and 
malnutrition. These studies are compared to established epigenetic data 
available from rodent studies. By examining the pattern of disease 
development  in  people  exposed  to  different  nutritional     conditions 
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during different periods of development, a link can be established 
between nutrition and the epigenome. The inherent weaknesses of 
retrospective studies in humans are then discussed. Finally, we address 
some of the ethical and social implications that dietary and lifestyle 
decisions might convey to our progeny and to society at large. 
 
4.1 Introduction 
It is common sense that what you eat today will affect your 
health tomorrow. What may not be commonly acknowledged, 
however, is that nutritional challenges experienced by your parents 
or grandparents could lead to health consequences for you as an 
adult. The method by which this is likely to occur is through 
modification of your parents’ or grandparents’ epigenome (via 
certain mechanisms that are discussed in Chapter 2), which  leads 
to alterations in your own gene expression. Therefore, it is 
epigenetics or other non-genetic mechanism that provides a likely 
explanation for how nutritional challenges or surpluses can exert 
effects upon individuals much later in life, as well as between 
parents and offspring, and onwards through to subsequent 
generations. 
 
Acquired vs. Inherited Epigenetic Changes 
Broadly speaking, epigenetic changes can either be acquired or 
inherited. In order for an epigenetic change to be considered 
acquired, the epigenome must be directly affected by an 
environmental event. Thus, if an adult, child, fetus, or even the 
gametes that eventually give rise to an individual are exposed to an 
insult that results in epigenomic modification, this would be 
considered an acquired epigenetic change. This last point might be 
a bit confusing, and understanding the process and timing of 
gametogenesis will make it easier to understand how the gametes 
of a fetus may acquire an epigenetic change. Gametogenesis is the 
process by which haploid gametes (egg or sperm) are produced 
from  diploid  germ  cells.  Although  the  purpose  of      oogenesis 
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(development of eggs) and spermatogenesis (development of 
sperm) is the same, these processes differ in many ways, including 
developmental timing. In females, oogenesis begins in the fetus 
and egg development is soon arrested in Meiosis I – a sort of 
suspended animation that stores the egg in nearly mature form until 
it is needed. Thus, females have gametes  already present while 
they are growing as fetuses in utero. While the bulk of eggs are 
stored this way, recent research has also discovered oogonial stem 
cells are responsible for the development of some eggs into 
adulthood as well (White et al. 2012). By contrast, males initiate 
spermatogenesis when the primordial cells go into meiosis during 
their slow growth period, just before puberty (Pembrey et al. 
2006). Thus, sperm are not present in the male fetus during 
gestation. Therefore, it is possible for a female to be exposed to an 
environmental change at any time throughout her life, from fetus 
through to adulthood, and for this change to affect her gametes 
through epigenetics. This change to the epigenome of her gametes 
will then lead to an altered epigenome being expressed in her 
children (Figure 4.1). Hence, even though her children were not 
present during the environmental change, the prospective effects 
on their epigenome are still considered to be acquired because the 
gametes that led to the creation of her children were present during 
the environmental challenge. In males, the environmental 
challenge is most likely to exert a long term effect in progeny if it 
occurs during the pre-pubertal slow growth phase of development, 
or to a lesser extent, afterwards into adulthood. This concept is 
examined in more detail in Section 4.4 under Trans-generational 
Mechanisms. 
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Figure 4.1: The environment has a direct effect on all three generations. 
 
 
 
 
Figure: 4.2: Environmental changes during specific times in 
gametogenesis, the meiotic formation of the gametes (sex cells or germ line 
cells), could theoretically modify sex chromosome epigenetic imprints 
(Pembrey et al. 2006). The left image depicts a change transmitted through 
a parent to the first generation F1; thus the change is inherited since it 
occurs first in the F1 cell precursor to gametes. The F1 cell that gives rise 
to the gametes may have been exposed at any point in its development. The 
right image depicts a change after gametogenesis, where the mature 
gamete is directly affected by the environmental stimulus and transmits the 
effect to the next generation, the F2s. 
 
Inherited epigenetic changes, however, refer to changes that  occur 
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in one generation and are passed on to future generations via germ 
cells not yet present at the time of challenge. Therefore, inherited 
epigenetic effects are passed on to offspring due to epigenetic 
changes that occurred in pre-gametic cells, which then become 
gametes (Burdge et al. 2011). Figure 4.2 highlights the differences 
between epigenetic changes that occur in pre-gametic cells and 
those that occur in gametes. 
 
Intra-, Inter-, and Trans-generational Epigenetic Effects 
The differences between acquired and inherited epigenetic 
modifications help us to distinguish between intra-generational, 
inter-generational, and trans-generational epigenetic effects (Figure 
4.3). Intra-generational and inter-generational epigenetic  effects 
are both considered to be acquired, despite the different way that 
they develop. In either case, the changes to the epigenome are 
induced de novo (spontaneously) within a single lifespan, thus 
affecting only the exposed individual. However, it is the type of 
environment that induces these changes that separates the meaning 
of these two terms. Intra-generational effects occur within the 
exposed individual’s lifespan, and result in later life changes. For 
example, the food you eat or the pollution to which you are 
exposed could lead to effects some years later. Contrastingly, inter- 
generational effects are due to changes that are imposed during the 
gamete or fetal stage of life (ie; direct exposure but before birth): 
the environmental challenges are transmitted to the gametes or 
fetus via the parental environment. Parental environmental stresses 
upon the sperm or egg that eventually contribute to a new person 
define one sub-category. Another sub-category arises when the 
change is installed in embryos in utero. This latter is also known as 
developmental or fetal programming (Gabory et al. 2011). An 
example of these effects would be a situation in which the food a 
mother ate while she was pregnant elicited an epigenetic change in 
the fetus that resulted in her child having an altered phenotype. In 
either instance, epigenetic changes would not necessarily be passed 
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to future generations and therefore could not be considered trans- 
generational. 
Finally, trans-generational epigenetic effects are inherited 
and therefore they occur in one generation and are passed down to 
the offspring, and onward through successive generations (Skinner 
and Guerrero-Bosagna 2009). The mechanisms by which 
epigenetic modifications lead to intra-, inter-, and trans- 
generational effects will be discussed in the following sections. 
 
 
 
Figure 4.3: A change occurring in the mother’s somatic cells will not 
affect the fetus; it is an acquired change and called intra-generational. 
Likewise, a change occurring in the fetal somatic cells will not affect its 
gametes; it is an acquired change and called intergenerational. 
 
With respect to nutritional-dependent  epigenetic 
modifications, a period of malnutrition or surplus food would be 
considered to be the epigenetic “event” or “challenge”  that we 
have been referring to. This chapter focuses on these changing 
nutritional  circumstances  and   the  role  that  diet  plays  in      the 
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modification of the epigenome and consequently, upon gene 
expression. How changes to the epigenome can contribute to the 
development of multivariate diseases, including obesity, diabetes, 
eating disorders, Crohn’s disease, and Coeliac disease, is also 
examined. This is done primarily through the analysis of 
retrospective studies. 
Simply put, our nutritional status alters  the  packaging of 
our DNA on a continuous basis, and this in turn alters the behavior 
of genes. Especially when the conditions during the time of 
challenge do not reflect conditions later in life, our near-, mid- and 
long-term predisposition to disease is altered as well. Although 
some experimental information (molecular characterization of 
epigenetic states) is available in mammals regarding the influence 
of environmental shifts on the phenotypes of successive 
generations (Burdge et al. 2011), the majority of our knowledge 
comes from retrospective studies. In this field, two historical 
cohorts are of particular interest, the Dutch Famine cohort and the 
Swedish Överkalix cohort. Finally, we will conclude by outlining 
possible consequences and ethical concerns that epigenetic data 
may pose for society. 
 
 
4.2 Intra-generational Epigenetic Effects 
Intra-generational epigenetic effects are an important 
contributing factor to the development of certain multivariate 
diseases over the lifetime of a person. Obesity and its related 
condition, diabetes, are both considered global epidemics and 
major public health concerns by the World Health Organization 
(WHO 2014a; WHO 2014b). While it is true that unhealthy eating 
habits and a sedentary lifestyle are contributing factors, there are 
multiple additional influences that contribute to the pathology of 
these diseases, some of which may include epigenetic changes. 
(Melzner et al. 2002; Lefterova et al. 2008; Nielsen et al. 2008; 
Vucetic et al. 2012). 
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4.2.1 Obesity 
In the U.S., more than one third of adults are obese (have a 
body mass index (BMI) above 30 kg/m2). In addition, another third 
are classified as overweight (have BMI of 25-30 kg/m2) (CDC 
2014a; CDC 2014b). Worldwide, obesity has nearly doubled since 
1980 and more than 10% of the world’s adult population is 
currently obese (WHO 2014a; WHO 2014b). Being overweight 
presents as a major risk factor for the development of heart disease, 
hypertension, stroke, certain types of cancer, and diabetes 
(specifically type 2 diabetes mellitus), which encompass some of 
the leading causes of preventable death (WHO 2014a; WHO 
2014b). 
Although obesity arises from biophysiological, 
psychological, social, and economic factors, epigenetic factors 
appear to modify physiological processes and to contribute to 
obesity at the cellular level. Adipogenesis is the key physiological 
process in fat tissue production by which lipocyte precursors 
become mature adipocytes (fat cells). A transcription factor called 
peroxisome proliferator-activated receptor gamma (PPARγ) is 
considered to be a master regulator of adipogenesis and it activates 
a large suite of other genes to produce a mature adipocyte 
(Lefterova et al. 2008; Nielsen et al. 2008). This master regulator 
of fat cell growth seems to be regulated by, and causes some of its 
effects through, epigenetic mechanisms. The promoter of PPARγ is 
demethylated during adipogenesis, and as a consequence, it 
activates itself and other targets by increasing the transcription of a 
histone monomethyl transferase (Fujiki et al. 2009;  Wakabayashi 
et al. 2009). 
The dysfunction of epigenetically regulated appetite and 
reward pathways in the brain may also play a role in obesity. 
Dopamine is a key player in the reward pathway, and is 
synthesized in response to a pleasure-invoking stimulus. A chronic 
high fat diet reduces the activity of dopaminergic pathways in   the 
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brain, which means that an individual needs to eat more in order to 
receive a sufficient feeling of pleasure and reward (Vucetic et al. 
2012). An epigenetic explanation is offered by a study in which 
rats were fed a high fat diet. They displayed, along with decreased 
reward circuitry, DNA methylation associated repression of the 
promoters of genes involved in dopamine synthesis and transport 
(Vucetic et al. 2012). A high fat diet in rats has also been shown to 
decrease the expression of the transmembrane opioid receptor 
(μOR), decreasing the pleasure stimulus that results from eating 
and thus requiring that a person eat more to enjoy a certain reward 
level (Vucetic et al. 2011). This decreased expression is correlated 
with repressive features such as increased DNA methylation, 
increased H3K9 methylation and decreased H3 acetylation 
(Vucetic et al. 2011). 
Leptin, the hormonal product of the Ob(Lep) gene, is 
produced in adipose tissue and plays a significant role in 
monitoring the “appetite center” of the brain’s hypothalamus 
(Figure 4.4) (Cripps et al. 2005). The leptin gene has CpG islands 
in its promoter that can control its expression epigenetically 
(Melzner et al. 2002). In pre-adipocytes, there is a high degree of 
DNA methylation and no expression of leptin, whereas mature 
adipocytes express leptin, correlating with promoter demethylation 
(Melzner et al. 2002). Constantly high levels of leptin may impair 
its function in inhibiting appetite via hypothalalmic receptors, 
however, more research is necessary to fully understand the 
connection between obesity and the epigenetic regulation of leptin 
(Ling and Groop 2009). 
Our final example of a possible physiological mechanism 
by which epigenetics may promote obesity through acquired intra- 
generational modifications may be through maternal “flavour 
preference” (Mennella et al. 2004). This phenomenon is thought to 
occur during the period of breastfeeding where flavours/fats 
ingested by the mother are carried through to the milk (Mennella et 
al., 2001).   Early exposure to specific  flavours  may alter   certain 
84  
neurological processes that then lead to a distinctive pleasure 
reinforcement response when the food is consumed later in life 
(Delport and Pollard 2010). Whether or not epigenetics plays a 
role in this development of dietary preference remains to be seen. 
 
 
 
 
 
Figure 4.4: When you have not eaten in a while and your fat 
stores are low, you will have low levels of leptin and feel hungry. After you 
have eaten and your fat stores increase, your leptin levels will increase. 
Leptin will then signal to your brain to make you feel full. If you are obese 
and have a constant amount of large fat stores, your body will constantly 
have high amounts of leptin. However, the constant high amount impairs 
regulation and your brain does not receive the “fullness” signal. Thus, you 
feel hungry even when you have plenty of fat stores. 
 
4.2.2 Diabetes 
Diabetes is a chronic disease that occurs either when the 
pancreas does not produce enough insulin, as in type 1 diabetes, or 
when the body cannot effectively use the insulin it produces, as in 
type 2 diabetes mellitus or gestational diabetes mellitus (WHO, 
2014b). This can lead to hyperglycemia, or raised blood sugar, 
which over time leads to serious damage of many of the body’s 
systems, especially the nerves and blood vessels (WHO, 2014b). 
As of 2011, approximately 347 million people worldwide have 
diabetes, and the World Health Organization projects it will be  the 
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seventh leading cause of death by 2030 (Danaei et al. 2011; WHO 
2014b). 
Many studies have supported the idea that epigenetic 
mechanisms are involved in insulin regulation and diabetes. In 
pancreatic beta cells, the insulin gene displays active epigenetic 
marks including hyperacetylation of H4 and hypermethylation of 
H3 at lysine 4. Importantly, these epigenetic marks are not seen 
near the insulin gene in other cell types (Mutskov et al. 2007). 
Furthermore, the transcriptional co-activator PPARGC1A 
(peroxisome proliferator activated receptor gamma coactivator-1 
alpha) gene is involved in mitochondrial  oxidative metabolism, 
and appears to be expressed differently in diabetics versus non- 
diabetics (Ling et al. 2008). DNA methylation of the PPARGC1A 
promoter is elevated in pancreatic islets (groups of cells that make 
the insulin) among patients with type 2 diabetes mellitus compared 
with healthy subjects (Ling et al. 2008). When PPARGC1A is 
methylated, its expression is reduced in diabetic islets (Ling et al. 
2008). Importantly, PPARGC1A expression is  positively 
correlated with glucose-stimulated insulin secretion in human 
pancreatic islets, suggesting that this epigenetic axis of regulation 
may ultimately have an effect on insulin levels (Ling et al. 2008). 
 
4.2.3 Eating Disorders 
Like obesity and diabetes, eating disorders also show 
multivariate origins that are not based solely upon genetic or social 
anomalies. Epigenetic disturbances may contribute to anorexia 
nervosa and bulimia nervosa symptoms by affecting neuronal 
dopamine signaling. This is crucial because the dopaminergic 
system is involved in the regulation of body weight, eating 
behavior, and the reward system (Frieling et al. 2010).  In one 
study, patients showed an elevated expression of dopamine 
transporter gene activity when compared with control patients, and 
this was correlated with hypermethylation of the dopamine gene’s 
promoter  (Frieling  et  al.  2010).     This  means  that    individuals 
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exhibiting anorexia nervosa or bulimia nervosa symptoms show 
altered dopamine function compared with individuals without a 
disorder. Although down-regulation of the dopamine receptor 2 
gene was seen in both nervosa groups, it was accompanied by 
hypermethylation of the gene’s promoter only in patients with 
anorexia nervosa (Frieling et al. 2010). 
Atrial natriuretic peptide (ANP), a hormone that has anti 
anxiety effects, may also have implications in the pathophysiology 
of eating disorders via epigenetic regulation (Strohle et al. 2001; 
Frieling et al. 2008). Patients suffering from both anorexia nervosa 
and bulimia nervosa showed decreased activity of the ANP gene, 
correlated with hypermethylation of the ANP gene’s regulatory 
region (Frieling et al. 2008). However, whether these epigenetic 
changes are causes or effects of eating disorders are questions that 
require further research (Frieling et al. 2010). 
 
4.3 Inter-Generational Epigenetic Effects - Overfeeding 
and Supplementation 
In addition to intra-generational effects contributing to the 
increased incidence and prevalence of multivariate diseases, inter- 
generational effects probably also play a role in the development of 
these diseases. This first part of this section focuses on inter- 
generational effects that arise from overfeeding, specifically with 
respect to the development of obesity and diabetes. Over the last 
few decades, the prevalence of obesity and  diabetes among 
children and adolescents has increased dramatically (Pinhas- 
Hamiel and Zeitler 2005; CDC 2014b). An explanation for these 
trends suggests that both adult and childhood obesity and diabetes 
rates may be due to a cyclical propagation of these diseases 
through generations. This propagation could be mediated by 
epigenetic modifications in utero, also known as developmental 
programming (Gabory et al. 2011). Furthermore, the mechanisms 
by which epigenetics plays a role in predisposing these conditions 
are likely similar to those mentioned in Section 4.2. 
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4.3.1 Obesity 
Since inter-generational epigenetic effects are often due to 
changes that are imposed during the fetal stage of life, these 
environmental challenges are thus transmitted to the fetus via the 
maternal environment. This means that examining the nutritional 
state of the mother during pregnancy could provide insight into the 
development of obesity and other diseases in the offspring. 
Numerous studies have reported that maternal pre- 
pregnancy body mass index (BMI) and gestational weight gain are 
positively associated with the BMI of offspring at birth as well as 
during infancy, childhood and early adulthood (Gale et al. 2007; 
Mamun et al. 2009; Rooney et al. 2011). At the time of birth, 
infants born to obese women tend towards increased adiposity (fat 
tissue), insulin resistance, and cord blood leptin levels (Battista et 
al. 2011). Another study suggests that children born to obese 
mothers are twice as likely to be obese by two years of age 
(Whitaker 2004). Furthermore, large cohort studies point to an 
increase in adolescent and adult obesity for at least 25 years if 
individuals weigh more at birth (Curhan et al. 1996a; Curhan et al. 
1996b). A study in rats has supported the idea that maternal obesity 
is a risk factor for later obesity in offspring. First, obesity was 
induced in rat dams (mothers) through an obesogenic liquid diet 
before mating and throughout pregnancy (Shankar et al. 2008). 
After birth, the pups were cross-fostered to lean dams.  Compared 
to those born from lean dams, the offspring from obese dams 
exhibited increased adiposity and insulin resistance (Figure 4.5) 
(Shankar et al. 2008). 
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Figure 4.5: Obesity was induced in a normal weight mother 
(therefore, the propensity for obesity was not due to genetics). The 
pups from the obese mother were then cross-fostered - that is, raised 
and fed by a normal weight mother. These pups that were cross- 
fostered ended up with increased adiposity compared to the true 
offspring of the cross-foster dam. 
 
4.3.2 Diabetes 
Similar to the development of obesity, looking at the 
nutritional state of the mother may provide important clues as to 
the mechanism by which diabetes is propagated. Population based 
studies have demonstrated that the offspring of diabetic mothers 
have an increased risk for glucose intolerance and type 2 diabetes 
mellitus (Silverman et al. 1995).  A study of the Pima Indians of 
89  
Dietary Epigenetics 
 
Arizona, who have the world’s highest incidence and prevalence of 
diabetes, showed a genetic transmission component (Knowler et al. 
1978). The study also revealed that the cycle of inter-generational 
diabetes can be explained by environmental factors, since the 
strongest single risk factor for type 2 diabetes mellitus was 
exposure to maternal diabetes in utero (Dabelea et al. 1998). 
Children born to diabetic mothers showed a 10-fold increase in the 
prevalence of diabetes by early adulthood compared with children 
whose mothers did not develop diabetes until after delivery 
(Heerwagen et al. 2010). This inheritance could be in part due to 
exposure to a diabetic intrauterine environment (Dabelea et al. 
2000). 
In another study, individuals whose cord blood or amniotic 
fluid insulin levels were elevated had a three to fourfold risk of 
developing glucose intolerance and type 2 diabetes mellitus during 
childhood (Pinney and Simmons 2012). This suggests that 
persistent fetal exposure to hyperinsulinaemia in the uterine 
environment contributes to the development of diabetes through 
epigenetic mechanisms. This notion is supported by studies 
showing that impaired glucose tolerance of adolescent offspring is 
associated with maternal hyperglycemia and not with the specific 
type of diabetes of the mother (Silverman et al. 1995). A study in 
rats also showed that although an intrauterine environment that 
provides normal glucose concentration cannot overcome a genetic 
predisposition to diabetes, a hyperglycaemic intrauterine 
environment significantly increases the risk of diabetes in the adult 
life of the offspring (Gill-Randall et al. 2004). 
 
4.3.3 Maternal Diabetes and Offspring Obesity 
Obesity and type 2 diabetes mellitus are closely related; 
consequently, there are many studies where maternal diabetes 
seems to predispose offspring to obesity. One study showed that 
newborn infants of women with gestational diabetes have 20% 
more  body  fat  than  infants  of  women  with  normal       glucose 
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tolerance, regardless of birth weight (Catalano et al. 2003). The 
aforementioned Pima Indian study also looked at the differing 
BMIs of siblings born before their mother was diagnosed with 
diabetes compared to those born after the diagnosis. The results 
showed that the mean BMI was 2.6kg/m2 higher in offspring of 
diabetic pregnancies than in offspring of non-diabetic pregnancies 
(Dabelea et al. 2000). In contrast, there were no significant 
differences in risk of diabetes or BMI between offspring born 
before and after the father was diagnosed with diabetes (Dabelea et 
al. 2000). This is similar to what was discussed in 4.3.2 and 
therefore supports the idea that this difference might also be based 
on exposure  to a hyperglycemic uterine environment. 
Researchers have also studied the effect of maternal 
diabetes on offspring using a mouse model of insulin deficiency 
created via injections of streptozotocin, a chemical that induces a 
diabetic-like state (Steculorum and Bouret 2011b; Steculorum and 
Bouret 2011a). Insulin deficient dams had offspring with 
significantly higher pre and post-weaning body weight  compared 
to the offspring of control mice. Moreover, they had increased 
fasting glucose levels, increased insulin levels, and displayed 
increased food intake during their adult life (Steculorum  and 
Bouret 2011b; Steculorum and Bouret 2011a). 
Insulin deficiency and hyperglycemia during pregnancy 
might also exert inter-generational effects in offspring metabolic 
regulation via leptin resistance. In the study previously mentioned, 
streptozotocin injections caused the offspring to develop 
abnormally organized feeding pathways in the hypothalamus. As 
adults, these offspring showed increased food intake and leptin 
resistance (Steculorum and Bouret 2011b; Steculorum and Bouret 
2011a). This reduced ability of leptin to activate neurons within the 
hypothalamic feeding pathway may contribute to the  mechanism 
by which uterine hyperglycemia leads to obesity. Further study is 
required to discover any epigenetic mediator of this long lasting 
environmental effect. 
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The maternally imprinted mesoderm-specific transcript 
(MEST) gene is involved in growth of the embryo and placenta, 
and is also implicated in a mechanism by which a hyperglycaemic 
uterine environment could predispose offspring to obesity 
(Lefebvre et al. 1998). MEST showed decreased methylation levels 
in the umbilical cord blood and placentas from mothers with 
gestational diabetes compared to samples from mothers without the 
condition (El Hajj et al. 2013). In other studies, an enlargement of 
adipocytes and fat mass expansion occurs where MEST is 
overexpressed (Kamei et al. 2007). Likewise, decreased blood 
MEST methylation levels were observed in adults with morbid 
obesity when compared with normal control animals (El Hajj et al. 
2013). In sum, these observations suggest that decreased 
methylation of the MEST gene, possibly due to a diabetic in utero 
environment, could cause its over-activity leading to increased fat 
cell growth in the offspring later in life. 
 
4.3.4 Maternal Supplementation 
A change in gene activity due to diet-related epigenetics 
changes is associated with the development of other diseases, 
including schizophrenia and cardiovascular diseases, among others 
(Kirkbride et al. 2012a; Kirkbride et al. 2012b). Methylation of 
these gene regulatory regions can sometimes be restored to their 
original state using dietary supplements administered during 
pregnancy. Deficiencies with respect to methyl donors – the 
metabolic substrates that provide the methyl groups for epigenetic 
modifications– such as vitamin B12 and folate, are responsible for 
decreased methylation within genes and regulatory regions 
(Kirkbride et al. 2012a). Numerous studies have revealed that 
neural tube defects can be significantly reduced by vitamin B12 or 
folic acid supplementation during early pregnancy (Brown et al. 
1996; Susser et al. 1996; Kirkbride et al. 2012a). In fact, studies 
show that the offspring may develop increased cognitive function 
and a reduced risk of autism by supplementation with these methyl 
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donors (Schmidt et al, 2011; Kirkbride et al., 2012a). In addition to 
vitamin B12 and folic acid, a methyl donor proven to have long- 
term epigenetic effects is a protein called genistein, a soy-derived 
isoflavone and phytoestrogen. This nutrient has been  shown to 
shift coat color distribution in mice via methylation of sequences 
near the agouti gene (Dolinoy et al. 2007). In addition to changing 
the coat colour phenotype, genistein also protects offspring from 
obesity (Dolinoy et al. 2006). Another study concluded that methyl 
donors can reverse demethylation caused by the estrogen mimic 
bisphenol A (BPA). BPA was identified as a common contaminant 
that leached from food packaging and plastics. In the study, BPA 
perturbed coat colour, obesity, and diabetes in mice (Dolinoy et al., 
2007). To conclude, these studies support the hypothesis that 
maternal diet may play a role in modulating the epigenome. Thus, 
not only does the type and quality of food have an effect, but also 
the quantity. 
 
4.4 Potential Inter-generational Epigenetic Effects - 
Dietary Restrictions and Starvation 
As previously explained at the beginning of this section, 
inter-generational epigenetic effects arise due to maternal exposure 
to an environmental event while the offspring is still in utero. 
While the first half of Section 4.3 focused on the effects of 
overfeeding and supplementation on the epigenome and thus 
offspring development, this half will focus on the effects of dietary 
restrictions and starvation. In sum, the environmental event or 
challenge here is a decreased level in the quality or quantity of the 
diet. 
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CASE STUDY: Nutrition Supplements in 
Guatemala 
A nutritional supplement study was conducted 
between 1969 and 1977 in El  Progreso, Guatemala. 
The results of this study may provide  information 
about the relationship between nutrition and the 
epigenome (Behrman et al., 2009). This study differs 
slightly from the above studies in that the supplements 
were given while the mother was still in her youth, 
before pregnancy and even prior to puberty. Two 
villages were given a high calorie protein supplement 
drink called atole while two similar villages  were 
given fresco, which was low in calories and did not 
contain protein. Records of supplement consumption 
were kept for children aged 0 – 7.  Subsequently, 
during a follow-up, a comparison of the offspring of 
the women who received these different supplements 
as children were evaluated on measures  of birth 
weight, height for age scores, and weight for  age 
scores (from ages 0-12). Children, particularly sons, of 
mother’s who received atole had a significantly higher 
birth weight, height, and weight (Behrman et al., 
2009). Therefore, the results of this study support the 
relationship between supplements and an altered 
offspring phenotype, perhaps through altered 
methylation as the epigenetic mechanism. 
 
 
 
 
4.4.1 Dietary Restrictions 
The term “dietary restrictions” may imply  restricting 
caloric intake to some drastic level, much like extreme dieting. 
However, for the present instance, “dietary restrictions” will  mean 
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total caloric intake, while still providing essential nutrients. In 
terms of epigenetics, dieting in this sense is considered to be one of 
the most effective methods of achieving a maximum lifespan 
(Tollefsbol 2014). Reducing total caloric intake by 25–60% while 
still providing essential nutrients led to a 50% increase in lifespan 
in rhesus monkeys. This is due to DNA methylation affecting the 
activity of histone deacetylases (enzymes introduced in Chapter 2) 
(Tollefsbol 2014). 
Another form of dietary restriction involves  limiting 
glucose intake. However, the epigenetic results of glucose 
restriction differ depending on cell type. In most cells, glucose 
restriction causes an increase in hTERT (human telomerase reverse 
transcriptase) and a decrease in p16, a gene that slows cellular 
replication. Both components have the potential to enhance life 
expectancy. Possibly, one way that they might achieve this is via 
their effects upon pre-cancer cells: hTERT and p16 can induce 
apoptosis (programmed cell death) of the cells (Figure 4.6) (Li et 
al. 2010). Thus, dietary restrictions can have a profound impact on 
gene expression in different cell types. 
 
 
 
Figure 4.6: This flowchart describes the differing impact of glucose 
restriction on precancerous and noncancerous cells. 
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Malnutrition, however, is the dietary restriction of  all 
foods and therefore has negative consequences for the body. There 
is evidence to indicate that telomere shortening, a sign of cellular 
senescence, is accelerated by malnutrition: a protein, TORC1, that 
is deployed in the maintenance of telomere length in organisms as 
diverse as yeast and humans mediates this effect (Ungar et al., 
2011). In humans, telomere shortening is cumulative and 
irreversible: acute fetal malnutrition results in shortened telomeres 
even if an adequate diet is restored (de Rooij and Roseboom, 
2013). Therefore, as was concluded at the end of the Maternal 
Supplementation subsection, not only does the quality of the diet 
affect the epigenome, as is seen with the development of diseases 
such as obesity and diabetes (discussed earlier in this chapter), but 
the quantity of the diet in terms of restricting both calorie and 
glucose consumption has also been proven to affect a person’s 
lifespan. 
 
4.4.2 The Dutch Famine 
Near the end of World War II, German forces imposed 
restrictions on the transportation of supplies to the  west 
Netherlands between October 1944 and May 1945 (Lumey 1992; 
Roseboom et al. 2011). It is estimated that the food intake dropped 
to below 1000 calories a day per person (Burger, 1948 as cited in 
Lumey, 1992; Roseboom et al., 2011). This defined time period, 
location, and level of malnutrition provides a level of control not 
always possible with retrospective studies, and it represents an 
exceptional opportunity to examine the epigenetic effects of 
nutrition in people who lived through this event. The long term 
consequences of the Dutch Famine on the health of prenatally 
affected individuals was marked. A broad range of adult onset 
symptoms and diseases appeared in time-sensitive (exposure/onset) 
(Ravelli et al. 1999; Roseboom et al. 2006) and gender-specific 
ways (Ravelli et al. 1999; Tobi et al. 2009). 
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Timing-specific effects 
Studies show that regardless of the fetus’ gender, early 
gestation is the most vulnerable time, since this is the busiest 
trimester in terms of establishing the body plan of an embryo. 
Famine exposure was shown to increase risk of obesity and 
coronary heart disease much later in life, and to raise prognostic 
indicators such as lipid levels and blood clotting dynamics 
(Roseboom et al. 2006). Some of the later onset metabolic and 
cardiovascular diseases may be due to changes in the 
hypothalamic-pituitary-adrenal response to stress, which was also 
higher in these individuals. 
During mid gestation, organs continue to develop and the 
fetus grows in size and weight (Roseboom et al. 2006). Thus, a 
fetus affected during this stage would experience organ and 
growth-specific impairments. Late-onset consequences include 
renal dysfunctions related to diabetes, as well as obstructive airway 
diseases (Roseboom et al. 2006). 
Fetuses exposed to famine during the third trimester 
exhibited the common trend of decreased glucose tolerance 
(Roseboom et al. 2006), independent of birth size and body 
proportions. Although fetuses exposed at this time point had the 
lowest birth weights, overall they were the least affected by the 
famine (Stein et al. 2004). Furthermore, an increase  in 
hypertension and high blood pressure was seen in both men and 
women who were exposed during gestation, compared to  their 
same sex siblings who gestated under normal nutritional 
circumstances (Stein et al. 2006). 
Recent studies suggest that both men and women conceived 
at the height of the famine had a two-fold increased risk of 
developing schizophrenia (Susser et al. 1996). Schizophrenia can 
be caused by the reduced expression of the Reelin gene. Since this 
gene’s regulation is dependent upon DNA methylation, an 
epigenetic mechanism may be implicated (Kirkbride et al. 2012b). 
Finally,  fetuses  exposed  to  famine  during  any  point   in 
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gestation were more likely to have decreased glucose tolerance and 
increased rates of type 2 diabetes mellitus. 
 
Gender-specific effects 
Many studies provide evidence to support the idea of 
gender-specific effects due to famine exposure. One study found 
modifications in methylation levels of two genes involved in 
cardiovascular disease that were restricted to men (Tobi et al. 
2009). In terms of obesity, both male and females who were 
prenatally exposed to the famine displayed abnormal fat 
distribution in adulthood (Ravelli et al. 1999). The gender 
specificity of obesity is determined by the timing of fetal exposure. 
Men exposed to the famine during early gestation had an increased 
chance of becoming obese in adulthood, while those exposed 
during late gestation had a decreased chance of obesity later on in 
life. For females, there was an increase in obesity only if they were 
affected by the famine in early gestation, and were properly 
nourished throughout the rest of the pregnancy (Ravelli et al. 
1999). The suggested mechanism is a modified central endocrine 
regulatory mechanism. Table 4.1 provides a summary of the 
differences between men and women who were exposed to the 
famine at different periods during gestation. 
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Table 4.1: Famine impacts on fetuses are specific to the timing of famine 
exposure and fetal gender. 
 
In summary, those conceived during the famine had: an 
increased risk of schizophrenia and depression; a more severe 
atherogenic plasma lipid profile; adverse responsiveness to stress; 
and twice the rate of coronary heart disease. They also performed 
worse in cognitive tasks, which is a sign of accelerated aging. 
Moreover, a higher incidence of type 2 diabetes mellitus and 
increased glucose intolerance were observed in both genders. 
A possible mechanism by which exposure to an 
environmental challenge, such as the Dutch Famine, in utero could 
result in long-term health consequences for the adult offspring is 
provided by the fetal origins hypothesis (Roseboom et al. 2006). 
This hypothesis implies that adaptations for the survival  of the 
fetus occur at the potential cost of long-term consequences 
(Roseboom et al. 2006). Stress in utero may “program” changes 
that  enable  the  child  to  cope  with  an  immediately  challenging 
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environment while coincidentally leading to the development of 
disease later in life, perhaps via an altered hypothalamic-pituitary- 
adrenal response to stress (Gluckman et al. 2005a; Gluckman et al. 
2005b; Roseboom et al. 2006; Bogdarina et al. 2007). Possibly, if 
the environment experienced in utero fits the actual environment 
after birth, the fetus will thrive; however, if mismatched, the 
individual may suffer a pre-disposition to disease later in life. 
Numerous Dutch Famine studies provide mechanistic 
evidence to support the fetal origins hypothesis (Painter et al. 2005; 
Roseboom et al. 2006). For example, the insulin-like growth factor 
2 gene (IGF2) is central to many of the results in the Dutch Famine 
studies. This gene plays a crucial role in early development, and 
plays a role in brain growth and development. Certain epigenetic 
modifications to this gene and adjacent sequences may later result 
in the development of schizophrenia (Pidsley et al., 2012: 
(Kirkbride et al. 2012b). Early data supporting the idea that 
prenatal exposures have long lasting epigenetic effects was based 
on the methylation levels tested at the IGF2 locus. At the age of 
sixty, the women who experienced the famine in utero showed 
hypomethylation of the IGF2 locus compared to women who were 
not exposed in utero (Heijmans et al., 2008). Although the level of 
methylation on this gene was not associated with birth weight, the 
level of methylation increased with age (Heijmans et al. 2008). A 
separate study monitored methylation levels of the IGF2 gene in 
relation to a methyl donor, namely folic acid (Hoyo et al. 2011). It 
demonstrated that low methylation of these regions deregulated the 
IGF2 gene, but that this could be reversed with folic acid intake. 
This was also demonstrated in a rat study, where folic acid had a 
permanent restorative effect upon methylation levels on the IGF2 
gene, even after the nutrient was removed from the rats diet 
(Waterland et al. 2006). 
These studies indicate a potential for epigenetic 
intervention via dietary rectification of methylation levels. The 
significance  of  the  timing  of  fetal  exposure  in  determining the 
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gender specificity of many of the epiphenotypes described above 
suggests an interaction between sex hormones and DNA methyl 
transferases (DNMTs), enzymes that play a role  in methylation, 
and this will be important to study in the future (Tobi et al. 2009). 
 
4.4.3 Crohn’s and Coeliac Disease 
If epigenetic changes can be induced in fetuses of starving 
mothers, then it is reasonable to assume that diseases that disturb 
adequate nutritional absorption could also cause epigenetic 
modifications. Examples of these diseases include  Crohn’s 
disease and coeliac disease. In Crohn’s disease, the preponderance 
of female patients may be related to the female-to-female specific 
imprinting of a predisposition to the disease (Zelinkova et  al. 
2012). This is supported by a speculative study that showed no 
sex-specific pattern for Crohn’s disease when the disease was 
transmitted through the father, but showed significantly higher 
rates of daughters being affected when the disease was inherited 
maternally (Zelinkova et al. 2012). These gender specific effects 
are reminiscent of the inter-generational effects of the Dutch 
Famine, but no mechanistic evidence of epigenetic phenomena 
have yet been identified in the evolution of these diseases. 
The relationship between epigenetics and coeliac disease 
has also been examined. Parental coeliac disease may contribute to 
the etiology of non-syndromic cleft lip and palate through 
epigenetic mechanisms. Unlike Crohn’s disease, both maternal and 
paternal coeliac disease appears to perturb offspring equally, and 
the effect is postulated to be mediated by genomic imprinting 
(Arakeri et al. 2010). Again, since no mechanistic evidence is 
presented that links the phenomena to epigenetics, the  hypothesis 
is interesting, but speculative. 
 
4.5 Potential Trans-generational Epigenetic Effects 
An epigenetic effect cannot be said to be truly trans- 
generational  unless  an  exposure  in  one  generation  produces   a 
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measurable outcome in a following generation that was never 
exposed to the altering factor (Pembrey et al. 2013). Few studies 
on the trans-generational effects of nutrition have been conducted, 
so retrospective studies on human cohorts have provided an 
alterative approach. As was explained in Section 4.3, the defined 
duration, location, and level of malnutrition during the Dutch 
Famine has provided an important cohort from which to study the 
effects of nutrition upon the health of future generations. There is 
also another cohort, the Överkalix cohort, which has been used to 
infer the effects of nutrition cycles upon the epigenome and the 
predisposition to disease in future generations. Unlike the Dutch 
cohort, the Overkalix data relies solely upon demographic 
measures: investigators have yet to examine the epigenetic 
biochemistry of potentially affected genes. Both of these cohorts 
will be examined in this section in order to illustrate effects that are 
good candidates for epigenetic modifications and that can be 
passed down trans-generationally. 
 
4.5.1 The Dutch Famine 
Nutritional deficits during fetal development not only result in 
intra-generational epigenetic effects, transferred from mother to 
fetus, but also promote defects through subsequent generations 
(Skinner and Guerrero-Bosagna 2009). Pregnant women and their 
fetuses experienced this starvation. Although fetal death due to 
malnutrition was high, many of those that did survive nevertheless 
developed normally and went on to have children of their own 
(deJong et al., 1981 as cited in Lumey, 1992). The study of these 
children constitutes the bulk of the trans-generational studies done 
on humans. As with the inter-generational studies, the relationship 
between the timing of in utero famine exposure of fetuses that 
went on to become mothers, and its effect upon the birth weight of 
this generations’ firstborn offspring was examined (Figure 4.7). 
Studies conducted using these children looked at both timing-   and 
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gender-specific effects, similar to what was described in Section 
4.3. 
 
Figure 4.7: Generational terminology as a pictogram. The term mother in 
the following section refers to the female fetus grown up, and the term 
offspring refers to her children (red), the grandchild of the first person 
affected.. 
 
Timing-specific effects 
The fetuses that were exposed to famine in the first 
trimester (early gestation) later as adults delivered firstborn babies 
that were statistically lower in birth weight, even if the mothers’ 
own birth weight was not depressed (Lumey 1992). A lack of 
similar results in the parents exposed during their second and third 
trimester suggests that epigenetic modifications are more likely to 
occur during early gestation. Contrarily, a second study of a 
different cohort found that mothers exposed to the famine in the 
first trimester had babies within the normal weight range, however 
instead of delivering subsequent babies with progressively heavier 
birth weights (the normal trend), the firstborn was the heaviest, and 
subsequent offspring were progressively lighter (Lumey et al. 
1995). Although the results are not consistent, they reveal that the 
mother’s nutrition in the womb may have an effect on the 
offspring’s birth weight. Why is this important? It is important 
because low birth weight is associated with increased susceptibility 
to cardiovascular disease, obesity, and type 2 diabetes during adult 
life (Jimenez-Chillaron et al. 2009). 
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Gender-specific effects 
Subsequent studies looked at both men and women exposed 
to malnutrition at an early stage of their fetal life and its effect on 
their offspring (Painter et al. 2008). The children  of 
undernourished female fetuses were found on average to  be 
shorter, to have a higher ponderal index (adiposity) at birth, and to 
experience higher rates of autoimmune disease later in life (Painter 
et al. 2008; Roseboom et al. 2011). The children of men exposed in 
utero had a higher BMI and weight, while women’s children 
showed no difference in either characteristic (Veenendaal et al. 
2013). Gender specific trans-generational effects of in utero 
exposure are still being studied, as is the effect of the timing of 
famine exposure. Thus far, an effect of lower overall health can be 
seen: there is an association between the in utero nutrition of your 
mother and father, your birth weight, and health later in life. 
 
Supporting Mammalian Studies 
Prenatal underfeeding 
Experiments on rodents and other mammals also 
demonstrate both timing-specific and gender-specific results, 
providing support to the retrospective Dutch Famine studies. One 
study revealed the effects of a parental (F0) protein restricted diet 
during pregnancy and/or lactation upon the grand-offspring (F2) 
generation in rats (Figure 4.8) (Zambrano et al. 2005). It should be 
noted that the rodent lactation period is developmentally equivalent 
to the third trimester in humans, and it is usually folded into the 
accounting as such. First generation females (F1) received a low 
protein diet in utero or during initial feeding. This affected the 
glucose and insulin metabolism of their offspring (F2). Female F2 
offspring maintained higher glucose and lower insulin 
concentrations than F2 males. These results depended on the 
timing of the protein restriction of their parents, whether it was 
only during pregnancy, only during lactation or during both 
pregnancy and lactation. Both male (if restricted during   lactation) 
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and female (if restricted during pregnancy) F2 showed decreased 
insulin sensitivity (Zambrano et al. 2005). This indicates that 
maternal protein restriction timing affects male and female 
offspring differently. 
 
Figure 4.8: Generational designations (F0, F1, F2, and F3) for  rat 
studies. 
 
In another study, the female F1 generation was exposed to 
either an adequate or protein-deficient diet in utero  and during 
early development (Benyshek et al. 2006). The F2 generation was 
found to be insulin resistant and the great-grandchildren (F3) 
showed altered glucose homeostasis. The F3 generation showed 
gender specific effects. F3 females exhibited higher glucose levels 
and F3 males exhibited lower glucose levels than controls, though 
a trend towards normalization could be seen in both cases 
(Benyshek et al. 2006). Even though the magnitude of the 
epigenetic effects lessened, they persisted as far as the great- 
grandchildren! 
In Jimenez-Chillaron et al.’s (2009) study, F0 females 
received either a normal diet or a calorie restricted diet (50%) 
throughout   pregnancy.   Therefore   both   male   and   female   F1 
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offspring were malnourished in utero. This resulted in impaired 
glucose tolerance and insulin resistance in both male and female 
F2 offspring. This was found to be passed through both maternal 
and paternal lines. F2 males and females had increased adiposity, 
which progressed through the maternal line. However, in contrast 
to retrospective human studies, low birth weight in mouse F2 
offspring was affected by their fathers, the F1 malnourished males 
(Jimenez-Chillaron et al. 2009). Human studies initially revealed 
only a maternal effect Lumey (1992), however the Överkalix study 
has since revealed the potential for transmission through both 
parents. Therefore, these studies support the idea that protein 
restriction has an effect on inherited glucose tolerance and insulin 
resistance, but that the gender-specific effects may vary according 
to species or the nature of the dietary challenge. 
 
Prenatal Overfeeding 
In contrast to studies where rats were placed on a restricted 
diet, Burdge et al. (2011) put rats on a high protein diet. Three 
generations of mothers (F0, F1, and F2) were given this increased 
protein diet during pregnancy and lactation. It was found that the 
high protein diet improved the ability of offspring to regulate 
glucose and fatty acid metabolism. Here the F1, F2, and F3 
generations are the analyzed offspring. The high protein diet led to 
an increased ability to maintain glucose and lipid levels and to 
regulate body weight by the F2 generation. Such changes were also 
inherited by the F3 generation. This suggests that, with regard to 
over-feeding, both the in utero environment (intergenerational 
epigenetic changes) as well as the modified maternal epigenome 
(trans-generational epigenetic changes) contribute to affect traits in 
offspring (Burdge et al. 2011). What does this all mean for 
humans? Glucose regulation and metabolic alterations can be 
passed through generations. This is important, since insulin 
resistance is known to be related to heart disease, high blood 
pressure,  obesity,  and  diabetes,  which  are  all  related  to  a poor 
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health prognosis later in life. 
 
4.5.2 Överkalix: Cycles of Overfeeding and Malnutrition 
Överkalix, Sweden, experienced periods of low food 
production interspersed by periods of high food availability 
throughout the 1800’s. During high food availability periods, 
residents overfed as compensation for the periods of malnutrition 
(Kaati et al. 2007). The Överkalix cohorts provide us with distinct 
periods of varying food availability and defined groups of 
individuals for study, much like the Dutch Famine cohort. Before 
we delve into the findings, some background information is 
necessary to fully understand the studies. A male’s slow growth 
period (SGP) occurs between the ages of 9-12 and a female’s 
between the ages of 8-10 (Bygren et al. 2001; Pembrey et al. 2006; 
Kaati et al. 2007). This slow growth period is the period just before 
puberty, leading up to the pre-pubertal growth spurt (Bygren et al. 
2001). 
Kaati et al. (2002) looked into the effects of overfeeding 
and famine exposure during the slow growth period of 
grandparents and parents and tied them to health changes in the 
grandchildren. They found that nutritional changes had trans- 
generational effects with respect to the risk of diabetes and 
cardiovascular disease, mainly through the male line (see figure 
4.9). If the paternal grandfather was overfed during his slow 
growth period, his grandchildren were likely to have a shorter 
lifespan and a four-fold risk increase of death due to type  2 
diabetes mellitus (Kaati et al., 2002). By contrast, if his exposure 
was to famine, he passed on a resistance to diabetic death among 
his grandchildren (Kaati et al., 2002; Bygren et al., 2001). 
Therefore, paternal grandfather overfeeding in his slow growth 
period increases health risks in grandchildren and underfeeding 
decreases them. Paradoxically, overfeeding during the slow growth 
period of the father offers protection from diabetes as the cause of 
death (Kaati et al., 2002). Paternal famine exposure and    maternal 
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overfeeding during the SGP decreased the risk of cardiovascular 
disease of the offspring (Kaati et al., 2002; Pembrey et al., 2010). 
The paternal grandmother’s exposure to famine also decreased the 
risk of cardiovascular disease in grandchildren (Kaati et al., 2002). 
These complex results demonstrate how your parents’ and 
grandparents’ eating patterns may have an effect on you (Table 4.2 
and Figure 4.9). 
 
Supporting Mammalian Studies 
Mammalian studies support a male-mediated pattern of 
adverse results evident in humans. In contrast to epigenetic 
modifications that may result from in utero experiences that are 
dependent solely upon the mother, paternal transmission must 
involve epigenetic modifications before or during spermatogenesis. 
Ng et al. (2010) tested whether the diet of male rats had an effect 
on offspring health using males fed a high fat diet or control diet 
throughout life. The paternal high fat diet was linked with 
decreased glucose tolerance and insulin secretion in female 
offspring, which is similar to the finding in humans that paternal 
obesity is linked to increased risk of diabetes in children (Ng et al. 
2010). Specifically, the pancreatic β -cells that produce insulin 
were found to have altered expression of 642 genes. These 
expression differences are thought to be caused by epigenetic 
mechanisms. 
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Table 4.2: The effects of overfeeding or famine exposure during the SGP 
as found by Kaati et al. (2002). The dashed lines indicate that the results 
were not mentioned for these particular conditions. 
 
 
Figure 4.9: Flow chart depicting male line pattern inheritance. It is 
through transmission by the grandchild’s father that grandparental effects 
occur. Furthermore, gender effects were found to occur: Kaati (2007) 
found overfeeding in the father’s slow growth period increased mortality 
rate in sons. However, these results were not significant in Bygren et al.’s 
2001 study. Only the paternal grandfather’s access to surplus food that 
showed a negative effect on lifespan (Bygren et al., 2001). Furthermore 
they found that both parents’ food intake affects the daughter’s mortality, 
where good parental food conditions increase mortality risk and poor 
conditions decrease it. They also determined that paternal grandfather’s 
food supply during his slow growth period affects the mortality risk only of 
grandsons (high food intake means higher risk of mortality and vice versa) 
and that the paternal grandmother’s food supply in fetal, early life, and 
slow growth period only affects granddaughters (Pembrey et al., 2006; 
Kaati et al., 2007). This suggests that the father’s sperm may carry 
information about the ancestral nutrition from either his mother or his 
father (Kaati, 2007). 
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For instance, hypomethylation was seen in the Ill3ra2 gene, 
the gene that showed the highest difference in expression (Ng et al. 
2010). In another study, male mice born to overfed mothers passed 
features of metabolic syndrome (insulin resistance and impaired 
glucose tolerance) onto their male offspring and grandchildren, 
though there was a progressive weakening of the phenotype 
(Pentinat et al. 2010). This demonstrates male-line inheritance, 
supporting Kaati et al.’s (2007) human cohorts. In summary, these 
studies support the idea that environmental effects causing obesity 
in males may have long-term health implications such as obesity 
and diabetes in their offspring and grandchildren, possibly 
transmitted via epigenetic modifications. 
 
Trans-generational Mechanisms 
The last question you may be wondering is: “if these trans- 
generational effects are due to epigenetics, then how are these 
epigenetic changes passed through the generations?” Epigenetic 
inheritance is a strong candidate for three reasons; some epigenetic 
states can be transmitted to the next generation(s); specific 
nutritional exposures can alter the epigenetic state; and trans- 
generational methylation responses to specific exposures  have 
been shown in experimental animals (Kaati et al. 2007). This type 
of research is barely underway, and technology has only recently 
been developed to examine epigenetic modifications. So the short 
answer is we do not know – but we have some ideas, and a few 
hypotheses have been advanced. 
 
1. The Feed-forward Control Loop 
Similar to the fetal programming hypothesis for inter- 
generational epigenetic mechanisms, a feed-forward control loop 
has been proposed as the link between grandparents’ nutrition and 
the grandchild’s growth (Pembrey 1996; Bygren et al. 2001; Kaati 
et al. 2002). The mechanism could be a specific response to the 
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parents’ nutritional state, which directly modifies the setting of the 
gametic (sex cell) imprint on one or more genes determining 
growth in the offspring (Pembrey, 1996). For example, a change 
may occur in an individual’s epigenome or the epigenetic imprint 
of their gametes by starvation during their slow growth  period. 
This imprint may facilitate the efficient conservation of calories 
and may be passed to successive generations. If starvation 
conditions continue, future generations will already be 
epigenetically prepared for them. 
 
2. Sex Cell and Sex Chromosome Involvement 
The involvement of the sex chromosomes in trans- 
generational effects was suggested by Pembrey et al. (2006). The 
role of the Y chromosome might explain paternal grandfather to 
grandson effects as these could be mediated by an imprint carried 
on the Y chromosome. Perhaps something about the unmatched Y 
and X chromosome in fathers permits a different erasure and re- 
establishment of an epigenetic imprint? The X chromosome, along 
with any epigenetic modifications, would therefore be passed from 
grandmother to granddaughter via an intermediary father only, 
explaining paternal grandmother to granddaughter effects 
(Pembrey et al., 2006) (Figure 4.10). Alternatively, the trans- 
generational transmission of imprinted states could have nothing to 
do with the sex chromosome per se, but instead reflect the 
differential capacity of sperm to carry miRNA that are packaged in 
response to environmental challenges: these miRNAs would 
presumably impart cues for subsequent epigenetic modification 
(Dias et al., 2013; Marczylo et al., 2012). 
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Figure 4.10: The blue pathway indicates paternal grandfather to grandson 
effects. The red pathway indicated paternal grandmother to granddaughter 
effects. 
 
The sex cell hypothesis has several  attractive attributes. 
For example, environmental changes during specific times in 
gametogenesis could modify sex chromosome epigenetic imprints 
(Pembrey et al., 2006). Since trans-generational effects must 
involve the germ line, this process would not be expected to have 
the same timing in males and females. As was explained in the 
Introduction, gametogenesis occurs later in males (Pembrey, 
2013). Spermatogenesis, the formation of mature sperm cells, 
occurs just before puberty, during a male’s slow growth period. 
This is when trans-generational effects of starvation in males are 
their most profound. Oogenesis, the formation of primary oocytes 
or ovum, occurs mainly during fetal life. However, recently it has 
been suggested from mice studies that oogenesis continues beyond 
the fetal period, presenting a reason why a female’s slow growth 
period could also be associated with multigenerational and gender 
specific effects (Pembrey et al., 2006). 
Research done by Anway et al. (2008) gives support to this 
hypothesis. They found that the critical period to influence the 
germ line epigenome through methylation is during the epigenetic 
programming of the germ cells when they migrate to the gonads 
during sex determination. Inducing permanent alterations in the 
germ  line  DNA  methylation  pattern  would  therefore  allow  the 
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phenotype to become trans-generational (Anway et al. 2008; 
Anway and Skinner 2008; Burdge et al. 2011). In Anway et al.’s 
(2008) study, rats were exposed to vinclozolin, a compound 
previously shown to cause changes to hormonal systems during the 
embryonic period (Gore and Dickerson 2012). The toxin  altered 
the expression of 196 genes in the testes in the F1, F2, and F3 
generations. Most of these genes showed decreased expression. 
Since the F2 germ line (presumptive sperm) is also  exposed 
directly to the vinclozolin, it is the F3 generation that manifests 
trans-generational effects (Anway et al. 2008). This study also 
showed that effects are mediated through the  paternal line. 
Pembrey et al. (2010) coined this the “Y dipstick hypothesis”: sex- 
specific segregation of diet influencing information transmits via 
the Y chromosome. He put forward the idea that DNA sequences 
within the non-recombining part of the Y chromosome may 
accumulate epigenetic marks in response to early experience. Thus, 
it is the Y chromosome imprint that is more significant (Pembrey 
2010). Moreover, the X chromosome is inherited relatively 
unmodified since in the father the X and the Y are unmatched - 
there is no other chromosome to act as an imprinting template. The 
consequence could be that the X imprint is transmitted with less 
degeneration. Thus epigenetic gametic inheritance is one possible 
mechanism for an environment’s ability to affect multiple 
generations. The major failing, however, is that even fourth 
generation offspring (F3), sometimes of both genders, have 
exhibited effects in rodent diet/epigenetic studies. 
To conclude, epigenetic changes may reach the F3 
generation by a combination of de novo imprinting and the 
retention of some epigenetic memory. Studies have subsequently 
shown that metabolic syndrome effects fade by the third 
generation; this reinforces the idea that trans-generational 
phenotypic changes may occur through imprinting (Benyshek et al. 
2006; Pentinat et al. 2010). Epigenetic modification can occur 
gradually  over  a  few  generations,  but  genetic  changes  due   to 
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selection or genetic drift require a longer period of change. This 
supports epigenetics as a potential answer to inherited effects  due 
to nutritional changes. Moreover, genetic defects tend to be 
irreversible over the span of a couple of generations, and yet we 
have seen that folic acid can reverse some of the effects discussed 
in rodent studies. Thus, the role of epigenetic mechanisms in trans- 
generational nutritional effects is gaining more support through 
these studies. 
 
4.6 Inherent Weaknesses of Retrospective Studies 
Despite the usefulness of retrospective studies, they have 
their drawbacks. For example, the reliability of reported years and 
the severity of starvation and overfeeding in Sweden can be 
questioned. Although these challenges  spanned well-defined 
years, different individuals would have had varying access to 
resources: the reported caloric intake values during these periods 
and specific lengths of starvation may not be accurate. The fact 
that these retrospective studies relied upon telephone interviews, 
data based on participant responses, and food estimates based on 
municipal boundaries adds variability via the distancing effects of 
time and memory. This in turn leads to the over-  or 
underestimation of trans-generational effects. Furthermore,  both 
the Dutch Famine cohort and the Överkalix cohorts resided in 
specific geographical regions. There could be confounding 
environmental effects experienced by these cohorts that would not 
occur in a randomized sample. Moreover, although both cohorts 
are relatively homogenous Northern European populations, given 
the historical patterns of settlement, marriage, and propagation, 
they might have represented a narrow genetic background, and 
have responded idiosyncratically to potential epigenetic 
modifications. One must then ask, how generalizable are these 
results? 
Despite possible drawbacks, these historical alterations to 
human   nutrition   offer   unique   opportunities   to   study    trans- 
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generational nutritional effects in humans. It is neither possible nor 
ethical to collect a randomized group of individuals, place them in 
an environment without confounding variables, and starve or 
overfeed them to observe the epigenetic effects. 
 
4.7 Implications for Society 
Epigenetics allows us to understand the ways in which 
environmental cues, such as diet, impact the expression of our 
genes and our prospective descendants. However, the knowledge 
of this relationship also raises new medical, legal, and ethical 
concerns that have implications for both political leaders and the 
average citizen alike. 
 
4.7.1 Obesity as a Disease 
Discovering more about the uncontrollable factors in 
disease development could lead to patients refusing individual 
responsibility for their condition. For example, as of June 2013, the 
American Medical Association has labeled obesity as a ‘disease’ 
(AMA 2013), although it can be combatted through diet and 
lifestyle changes. 
Although framing obesity in this way  could promote 
greater social acceptance of this condition, researchers say that this 
could also perpetuate the perception that weight is unchangeable or 
fated and thereby make self-regulatory efforts seem futile (Hoyt et 
al. 2014). In this latter study, an online survey revealed that 
participants who read articles about obesity being a disease placed 
less importance on healthy eating and weight loss, and expressed 
less concern over weight when compared to obese people who read 
control articles. These findings suggest that the messages people 
hear about the nature of obesity - like conceptualizing it as a 
disease, passed on by ancestors through genetics or epigenetics – 
could take the onus off individuals and lead them to point an 
accusing finger at their genome or epigenome (Hoyt et al. 2014). 
This  would  not  only  have  consequences  for  the  way     certain 
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diseases are perceived, but it would also have consequences for 
healthcare costs and resources as a whole. 
 
 
CASE STUDY: The Chinese Famine 
The 1959-1961 Chinese Great Leap Forward 
famine will likely provide a new cohort that can help to 
test the generalizability of the previous human studies, and 
whether or not these effects are solely specific to Northern 
European populations. In the 1959-1961 famine cohort, 
both intra- and inter-generational impacts have been 
reported. Preliminary inter-generational studies reveal that 
children born to mothers who had experienced the famine 
in utero have a higher risk of mortality in infancy (Song 
2013). Gender effects are also seen, with maternal 
exposure more significantly affecting the sons and paternal 
exposure more significantly affecting the daughters (Fung 
and Ha 2010). Surviving offspring only just reaching the 
age at which adult diabetes or cardiovascular disease risk 
usually emerges. Will this cohort, which is genetically 
different from the Dutch famine or Överkalix cohorts, and 
which also presents a much larger demographic, exhibit 
similar health risk factors and predispositions? And what 
kind of trans-generational effects might be seen? 
 
 
 
 
4.7.2 Obesity in Children: A Case for Child Abuse? 
If a parent makes poor choices before, during or after 
pregnancy, could the negative epigenetic impact upon the 
prospective child be considered child abuse? Child neglect is 
typically defined as placing a child at risk for serious harm through 
the failure of caregivers to seek or provide necessary care, medical 
or otherwise (Varness et al. 2009).  Thus, childhood obesity   could 
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be considered neglect by contributing to the development of 
conditions such as severe obstructive sleep apnea, uncontrolled 
type 2 diabetes mellitus, and advanced fatty liver disease. Not only 
does childhood obesity increase the risk for serious harm during 
childhood, it also increases the risk for the development of diseases 
as an adult (Varness et al. 2009). While the law states that parents 
have a duty to protect their children from harm, the law also 
supports parents raising their children according to their own 
values and beliefs (CYH.COM 2012). Hence, this issue can be 
approached from numerous perspectives, making it difficult to 
discern whether or not childhood obesity is, in fact, child abuse. 
While it is clear that parents are responsible for their 
children, however, parental responsibility to unborn children in 
terms of inherited epigenetic propensities to certain diseases is not 
as clear.  For example, Canadian law does not grant person  status 
to a fetus. Similar debates have met with mixed results in the 
United States. Where a pregnant woman has the right to refuse 
medical treatment that is in the best interest of the fetus and 
abortion is legal, maternal autonomy often rules (ACOG 2005). 
However, in the past, criminal charges have been brought against 
women for their abuse of alcohol during pregnancy (Lisko 2006). 
Could it then be argued that a mother who abuses food during 
pregnancy, and therefore exposes her unborn child to epigenetic 
consequences, should also be charged? The extent of maternal 
responsibility is a grey area in many jurisdictions. Opponents of 
criminalization of certain maternal behaviors during pregnancy 
argue that it violates the mother’s constitutional rights, and that 
this type of regulation is a slippery slope (Lisko 2006). 
Indiscriminant or biased dissemination and deployment of 
epigenetic knowledge may add fuel to these arguments. 
Epigenetic risks incurred during pregnancy could place an 
unjust burden of responsibility on women (Chadwick and 
O'Connor 2013). While the majority of human fetal effects 
discussed were effects  of in  utero exposure, recent  evidence  also 
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points to epigenetic paternal contributions to obesity and diabetes. 
Responsibility of the parents could then extend to regulating their 
activities prior to conception to prevent epigenetic harm to the 
gametes that may create children in the  future  – where does the 
line get drawn? Chadwick and O’Connor (2013), argue that “trans- 
generational justice demands not that those alive today live their 
lives slavishly devoted to the yet- to-be-born, rather, that the 
interests of current and future generations be balanced”. 
 
4.7.3 Governmental Control of Nutrition 
Ideally, governments enact laws in order to protect the citizens 
of that country. A current topic of discussion is how to regulate the 
kinds of foods that are available to the public, potentially providing 
them with better nutritional choices: but how will this be 
accomplished without infringing upon the rights and freedoms of 
the public? For example, from 2002 to 2013 the mayor of New 
York City, Michael Bloomberg, proposed a ban on large sugary 
drinks. This policy would have prohibited restaurants and other 
eateries from serving soda pop or other sugary beverages larger 
than 16 ounces. This was thought to be an important first step in 
fighting rising obesity rates. It was unlikely that the proponents of 
the move were conscious of the potential for epigenetic harms - 
these arguments were not advanced. Opponents, however, rejected 
government encroachment upon freedom in decision-making. The 
New York City’s board of health unanimously passed this law, but 
it was invalidated by a New York Supreme Court Judge six months 
later (Grynbaum 2014). Although policies such as these may have 
the potential to increase public health and decrease health care 
spending, will personal freedom be the cost? How willing are we 
to live in a country where the government has control over our 
nutritional, exercise, and health choices? Should the needs and 
health of the prospective many trump the freedoms of those 
currently living their lives? Given the demographics of obesity, 
diabetes, and health, how are future health costs to be controlled? 
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4.7.4 Correlational Conclusions 
Links between the nutritional intake of one generation and 
its effects on subsequent generations are correlational in nature. 
Since the multiple mechanisms of action and influence upon the 
epigenome cannot be definitively separated, quantified, and 
defined, causation cannot be explicitly characterized. This affects 
the ability of governments and institutions to enact laws or policies 
regulating the environmental conditions that may exert adverse 
epigenetic effects. It also constrains the ease of assigning 
responsibility to current generations for the negative consequences 
that they may impose upon their descendants. 
 
4.7.5 Privacy 
The epigenome and epigenetic effects will eventually 
embody a substantial dataset that patients will want to keep safe- 
guarded. Privacy, as we will see in Chapter 9, is important with 
respect to any type of health information. Equipped with the 
knowledge of trans-generational effects, we now know that your 
parents’ and even grandparents’ health can have far reaching 
effects on your current and future health. Therefore, your parents’ 
and grandparents’ information could become a privacy issue, as it 
could affect you particular job prospects or insurance coverage if 
information is leaked. In sum, how can protective policies be 
created in a non-discriminatory way? Conversely, descendants 
might have a legitimate claim upon the health records of their 
antecedents – how do we balance their respective interests? 
 
4.8 Conclusion 
The food we eat can affect us long after our meal has 
ended. Furthermore, our dietary and lifestyle choices can impact 
our children and grandchildren, through acquired and inherited 
epigenetic modifications that give rise to intra-, inter-, and trans- 
generational   effects.       All   of   these   factors   and   modes    of 
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transmission can affect our future society’s health, productivity, 
and economy. Understanding how the epigenome is modified and 
how diet can lead to epigenetic changes will allow for more 
effective medical strategies to deal with this category of health 
effects. For example, knowing that obese and diabetic mothers 
transmit epigenetic modifications to their child in utero, thereby 
contributing to disease predisposition, could facilitate strategies, 
education, and interventions to reduce the prevalence of obesity, 
diabetes, and related disorders both in the mother and her offspring 
via epigenetic-based medicine (Lehnen et al. 2013). It is crucial to 
understand the effects and mechanisms that overfeeding and 
malnutrition have on the transmission of generational diseases, and 
retrospective studies have been an important part of the discovery 
process. Could 21st century North America be the newest cohort 
for the study of overfeeding, and trans-generational effects, the 
likes of which have yet to be seen? If we do not change our path, 
the answer may be grim. 
 
Provocative Questions 
 
• Retrospective studies 
Is the information researchers receive from patients about 
reported years and the severity of periods of starvation or 
overfeeding reliable? Are we over- or under-estimating inter- 
generational or trans-generational effects? 
• “Not my fault” 
Could deeming multivariate conditions, such as obesity, a 
“disease” induce patients to minimize their sense of individual 
responsibility for their condition? 
• Epigenetics and disease in children- child abuse? 
Mothers who abuse alcohol during pregnancy have been 
convicted. Could a mother who abuses food causing lasting 
epigenetic harm to her child, also be tried? 
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• Governmental control of nutrition 
Should governments enact laws and dietary regulations? Where 
should the line between public good and personal freedoms be 
drawn? Since studies have indicated gender and cultural 
differences in epigenetic effects and disease risk, how can 
protective policies be made non-discriminatory? 
• Correlational conclusions 
Current retrospective studies and experiments on model 
organisms provide a strong case for the link between nutrition 
and epigenetics. However, the evidence still remains 
correlational. Should governments enact nutritional policies 
based strictly on correlational data? 
 Privacy 
How can we protect privileged information, such as where your 
parents and grandparents grew up and what they ate, so that it 
does not affect job prospects or insurance coverage? Should we 
all have the right of access to the health records of our parents 
and grandparents? 
 
 
Possible Solutions 
 
 Education is currently our only tool to mitigate epigenetic 
harms and diseases that are due to diet and nutrition. 
Perhaps people might change their behaviors if they knew 
that their actions would affect their children and 
grandchildren as well. 
 Education could be specially targeted to expectant-mothers 
to help improve the epigenetic prospects in utero. 
 Feeding, nutrition, and educational food preparation 
programs could be implemented to teach schoolchildren the 
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importance of nutrition with respect to the epigenome. 
Starting younger is better. 
 Finally, the possibility of government-imposed restrictions 
or taxation regimens on dietary choices could prove to be 
beneficial for the public, depending on their willingness to 
accept the intervention. 
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Abstract 
We interact with chemicals every day – they arrive in the 
form of recreational drugs, prescriptions or by environmental 
exposure. All can have an effect on our epigenome. They are 
externally derived substances that we ingest, and we call them 
xenobiotics. The xenobiotic chemicals discussed are thought to 
have a basis in epigenetic modification and may cause changes 
over both the near and long term. Pharmaceutical drugs can 
both negatively (DES) and positively (valproic acid and ritalin) 
affect the epigenome; alterations caused by alcohol, 
amphetamines, cocaine, nicotine and morphine have been 
linked to addiction. Cautionary measures as well as the legal 
and ethical responsibilities of pharmaceutical companies are 
also discussed. Environmental factors show variable effects 
upon the epigenome: environmental toxicants are most often 
associated with human diseases, but chemo-preventative 
receptors are involved in preventing and correcting harmful 
epigenetic variations. For the most part though, air pollutants 
and dietary xenobiotics have been correlated with disease and 
adverse health effects. Liability, insurance, governmental 
action, chemical safety protocols, and personal awareness    are 
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needed to deal with drugs, environmental toxins, and their 
population-wide epigenetic effects. 
 
5.1 Introduction 
When most people hear the word “chemical”, they think of 
strange liquids bubbling in vats or test tubes. In fact, everything 
you can see or touch is some kind of chemical, and life itself can 
be reduced to a series of chemical reactions. Humans are quite 
good at harnessing chemical properties to manipulate the complex 
reactions in our body with drugs to produce desired effects or to 
suppress disease. Understanding chemical reactions allows us to 
protect crops, build homes, and create everyday objects. Just as 
drugs can exert powerful effects on pathogens, environmental 
chemicals can also invade and interfere with processes of the body, 
and some of these effects are now known to be epigenetic  in 
nature. They can be elicited both intentionally and incidentally. 
Chemicals not normally manufactured within our bodies, but that 
find their way there by one means or another are called 
xenobiotics, and they will be the focus of this  chapter. 
Recreational and medicinal drugs, as well as chemicals in our 
environment can leave marks and alterations upon our epigenome 
that science is only recently revealing. We will examine these 
interactions, beginning with drugs following which we will tackle 
the environmental chemicals with which we live. 
 
5.2 Epigenetics and Drugs 
In 2003, the Human Genome Project reached completion, 
affording us the information and tools to study our own biological 
blueprint. While the Human Genome Project will doubtless lead to 
advances in research practices and safer drugs, the promise of easy 
and safe genetic manipulation remains largely unfulfilled (Wrobel 
et al. 2009; Verma et al. 2011; Brunschweiger and Hall 2012). This 
is because of the unexpected complexity of the genes themselves, 
and  in  part,  because  the  technology is  still  too  blunt  to finesse 
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without causing collateral damage. Epigenetics is an example 
of unexpected complexity, but it may also offer a tool to 
manipulate gene activity. Epigenetics is now understood to play a 
role in regulating gene activity in most animals and plants 
Gene therapy has delivered promising results in clinical 
trials, but is showing limited success in practice (Tani et al. 2011). 
There is another way to alter gene expression without 
physically changing the genetic code. As outlined in Chapter 2, in 
the case of certain genes, epigenetic changes can provide a 
regulatory function. By modulating the intimacy of interaction 
between histones and DNA, problematic genes that cause certain 
diseases can be “turned off” without having to alter a single 
nucleotide. While drugs that change epigenetic factors circumvent 
the challenges of traditional gene therapy, they come with their 
own risks and problems. Research is revealing that many of the 
adverse effects of addictive drugs can be attributed to 
epigenetic factors and pharmaceutical drugs previously considered 
safe may have extensive epigenetic consequences, including 
cancers and birth defects. In this section, we will discuss the 
unintended epigenetic side effects of pharmaceutical drugs that are 
presently in widespread use, the beneficial effects of marketed 
drugs and the epigenetic changes that contribute to making drug 
addiction heritable. 
 
5.2.1 Epigenetic Side Effects of Prescribed Drugs 
Clinical and/or experimental evidence has demonstrated 
that a number of drugs already on the market have persistent 
epigenetic side effects that need to be addressed. While the extent 
or severity of these risks is unclear, it might be prudent to assume 
that any drug presently available has the potential to affect the 
epigenome. 
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Negative Drug Effects 
On September 19th, 1941, diethylstillbestrol (DES) was 
approved by the United States Food and Drug Administration. The 
drug was prescribed to pregnant women to prevent the risk of 
pregnancy complications and miscarriage. Not only was the drug 
ineffective at preventing pregnancy complications, but we now 
know that it had epigenetic consequences for the children exposed 
to the drug in utero. Women born to mothers who had taken DES 
experience impaired fertility and are predisposed to cervical 
cancer, breast cancer, and clear cell adenocarcinoma (Palmer et 
al. 2001; Troisi et al. 2007; Hoover et al. 2011). Men who  had 
been exposed prenatally to DES suffer a higher incidence  of 
genital malformations, most commonly epididymal cysts and 
hypoplastic testes (Wilcox et al. 1995). It is now known that DES 
causes measurable epigenetic changes: the methylation patterns of 
genes in the estrogen pathway are altered (Li et al., 2003). It is 
unknown how these changes affect development – do they  alter 
cell responsiveness and behavior, or do some cell types form 
abnormally or die out altogether? 
There are concerns that the effects of the drug could propagate 
even further to subsequent generations. For example, preliminary 
reports suggest that DES causes increased risk of ovarian cancer in 
the granddaughters of woman who had taken DES while pregnant 
(Titus-Ernstoff et al. 2008). There are not enough third generation 
DES victims old enough to mount a comprehensive study, so 
understanding the multi-generational effects of DES will take some 
time. However, the emerging appearance of these symptoms is 
consistent with the knowledge that epigenetic alterations can 
persist through multiple generations. (For more information on 
DES and the associated legal  debate, see Chapter 8) 
While the case of DES highlights how ignorance of 
epigenetic consequences can lead to disastrous health issues, 
epigenetic knowledge can be utilized to discover novel treatments 
for disease. By regulating the genome, it may be possible to choose 
which genes are expressed and which are inhibited, creating a  new 
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strategy that can be used for medical applications. Drugs that act 
directly on the epigenome, for example valproic acid, can 
functionally accomplish the goal of changing how the genome is 
expressed without the technical challenges and risks inherent in 
gene therapy. 
 
Positive Drug Effects 
Valproic acid is a short branched fatty acid currently  used 
in the treatment of epilepsy, although the mechanism of how it 
mitigates seizures is unknown. Recent research shows that valproic 
acid acts on the epigenome by up-regulating 726 genes and down- 
regulating 577 others in rat cortical neurons, including a gene that 
is implicated in epilepsy (Fukuchi et al. 2009). The drug works as a 
histone deacetylase (HDAC) inhibitor, which means that it  acts 
on the epigenome directly to regulate DNA – histone interactions. 
Valproic acid’s epigenetic effects have become the focus of many 
research studies since it is a relatively cheap and safe compound 
and has a myriad of unexpected benefits. The drug has been shown 
to render multiple types of cancer cells more susceptible to 
radiation therapy: it arrests their cell cycle. Valproate affects 
multiple cancers from human erythroleukemic cells to breast 
cancer cells - this diversity of effect, despite the varied and 
heterogeneous nature of cancer, is impressive (Karagiannis et al. 
2006; Travaglini et al. 2009). Valproic acid also has the benefit of 
targeting cancer cells specifically - it affects  normal  cells much 
less (Travaglini et al. 2009). The benefits of valproic acid do not 
stop at cancer and epilepsy; it has neuroprotective properties that 
promise possibilities for treating multiple neurodegenerative 
diseases (Monti et al. 2009). One study even showed that valproic 
acid’s epigenetic effects facilitate the development of perfect pitch 
learning in humans and mice – a skill which  is normally 
impossible to acquire after early development (Gervain et al. 
2013). 
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We Need to Employ Caution 
Valproic has been approved as safe by the U.S. FDA, but 
DES shows that caution must be exercised with any drug that 
affects the epigenome, especially one like valproic acid that acts 
directly upon epigenetic machinery. Valproic acid was found to 
increase neural tube defects in mice by 1-2% because of its 
epigenetic effects, although it is still prescribed as an anti-epileptic 
medicine (Tung and Winn 2011). Might there be generational 
consequences? 
In fact, many currently prescribed drugs are thought to 
display epigenetic side effects. Methylphenidate (MPH) is often 
prescribed to children with attention deficit hyperactivity disorder, 
and is most commonly known by the trade name Ritalin. 
Methylphenidate alters the population of lncRNA present in the 
brain (Wu et al., 2015). Rats treated with MPH through 
adolescence exhibit different responses to emotional stimuli at 
adulthood than untreated rats. The MPH treated rats displayed 
decreased responsiveness to rewarding stimuli such as sugar and 
sex, but increased sensitivity to aversive stimuli such as swim 
stress (Bolanos et al. 2003). MPH causes up-regulation of 5 
neurotransmitter genes, including the genes Grik2 and Htr7, which 
can remain up-regulated even into adulthood (Adriani et al. 2006). 
Grik2 is linked to changes in reward perceptions, and Htr7 may 
play a role in depression (Tang et al. 2004; Guscott et al. 2005). 
This suggests that the epigenetic regulation of these genes could 
underlie the permanent effects of MPH exposure. 
Antidepressants, contraceptives, chemotherapeutics, and 
general anaesthetics are just a few more of the currently available 
pharmaceuticals that show signs of epigenetic side effects (Csoka 
and Szyf 2009). For example, fluoxetine, found in antidepressants 
like Prozac, alters DNA methylation and chromatin structure 
leading to altered cerebral gene expression and hormone levels, 
and this can result in sexual dysfunction and infertility. Oral 
contraceptive pills affect gene expression immediately and     long- 
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term, and are linked to an increased incidence of breast cancer in 
women who took the pills prior to their first pregnancy. General 
anaesthetics, may cause neuronal injuries, brain protein misfolding, 
as well as postoperative cognitive dysfunction that persists, via 
epigenetic changes, long after the surgery (Csoka and Szyf 2009). 
These side effects in some cases sound minor; a 1-2% increase in 
neural tube defects caused by valproic acid could be judged as 
inconsequential when compared to its positive effects. However, 
epigenetic side effects are distinct from most other side effects 
because they may be heritable. Heritability adds a new dimension 
when judging the cost and benefit ratio of medications: the 
patient’s long term epigenetic health and prospective descendants 
should be considered. 
 
5.2.2 Addictive substances 
Alcohol 
Alcoholism is a serious addiction that can lead to cirrhosis 
and increased risk of throat, mouth, and liver cancer (Thun et al. 
1997). There are two types of alcoholism: Type I and Type II. 
Alcoholism Type I is acquired in adulthood; Type 1 alcoholics 
often feel guilt associated with their addiction. In contrast, 
Alcoholism Type II begins as early as adolescence, and is more 
likely to cause violent behavior (McGue 1999).  An analysis  of 
577 Swedish men found that Type I alcoholism is associated with 
genetic and environmental factors in males, but Type II alcoholism 
is associated with a family history of abuse, where the postnatal 
environment plays little if any role. In reference to this latter 
etiology, men whose biological mothers were alcoholics  had 
higher incidence of Type II alcoholism, even if they were raised by 
non-alcoholic foster mothers (McGue 1999). Not only does 
alcoholism appear to be heritable, but the negative effects of 
alcoholism upon cognitive function can be inherited as well. Both 
prenatal alcohol exposure and maternal alcoholism history play a 
significant  role  in  the  propagation  of  alcohol  related  disorders 
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(Cottencin et al. 2009). The reason for heritability of alcoholism is 
a mystery, but the interplay between environmental and genetic 
effects in the development of alcoholism suggest that addictions 
operate through epigenetic mechanisms. Indeed, the questions of 
how fetal alcohol exposure leads to alcoholism, and how 
alcoholism can be passed down through family histories, may only 
have their answers in epigenetic behavior. 
Rat fathers that had been exposed to alcohol sire offspring 
with problems including congenital malformations and cancers, 
and these effects last for generations (Stockard 1913). This effect 
isn’t genetic in the classical sense - alcohol is not a mutagen that 
can install mutations inherited via the germ cells (Phillips and 
Jenkinson 2001). The offspring were never directly exposed to 
alcohol, and yet paternal exposure to alcohol had lasting 
consequences. This study adds to a growing, somewhat 
controversial body of evidence suggesting that paternal exposure to 
drugs may affect children for generations, even when the drugs do 
not mutate genes (Friedler 1996). To investigate the possibility that 
addiction heritability is epigenetic, investigators looked to see 
whether alcohol has effects on the epigenome. 
The gene TLR4 encodes a lipid sensory receptor called toll- 
like receptor 4. TLR4 activation contributes to binge drinking and 
epigenetic mechanisms are suggested to be involved (Liu et al. 
2011). A surplus of product from this gene was shown to cause 
damage to the liver and brain in mice (Pascual et al. 2011). TLR4 is 
normally important for recognizing microbes in the body and for 
signaling an immune response. Alcohol decreases the acetylation 
of the H4 histone and the activity of histone acetyltransferases 
(HATs) in the frontal cortex, hippocampus, and striatum of mice 
that carry a normal TLR4 gene. In mice with normal TLR4 
receptors, ethanol exposure normally causes inflammatory damage 
to the brain, memory loss, liver damage and behavioral disorders, 
while mice engineered to be mutant and deficient for this receptor 
gene are protected from  such damage (Pascual  et  al.  2011).   The 
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biochemical basis for this difference was tested: mice lacking 
TLR4 receptors could absorb alcohol, but would  not experience 
any decrease in the net acetylation of H4 histone measured in 
biopsied material. Other genes now known to be epigenetically 
affected in human alcoholics include: alpha synuclein which is 
hypermethylated in alcoholic patients and that is important for 
neuronal synapse function (Bonsch et al., 2005); monoamine 
oxidase A, a neurotransmission modulator that is methylated in 
female alcoholics who are co-dependent upon nicotine (Philibert et 
al., 2008); vasopressin and atrial naturetic peptide are hyper- and 
hypomethylated respectively, and this correlates with degree of 
craving (Hillemacher et al., 2009); the H19 and insulin like growth 
factor regulatory domain is abnormally methylated in the sperm of 
alcoholic males, suggesting a possible route for transmission to 
offspring (Ouko et al., 2009). Finally, alcohol appears to alter the 
epigenetic status of a gene important for neuronal function in mice, 
brain derived neurotrophic factor (Bdnf; Stragier et al, 2015). 
Whether or not these changes are of trans-generational importance 
remains to be seen. 
What could alcohol change via epigenetic modification of 
histone H4 that would result in an increased chance of alcoholism? 
Evidence suggests that alcohol affects  chemosensory systems in 
the brain to make the substance taste more palatable   (Youngentob 
& Glendinning, 2008). In this latter study, rats were inferred to 
have inherited epigenetically altered gene expression in the taste 
and olfactory systems - changes that predisposed them to develop a 
preference for ethanol compared to their non-exposed peers. This 
conclusion must be regarded with caution, however, as no genes 
were examined directly. Fetal alcohol exposure could increase the 
chance of alcoholism by simply making it taste less bitter. 
Nevertheless, olfaction and taste provide a plausible epigenetic 
mechanism that would help explain the heritability of alcoholism 
(Youngentob and Glendinning 2009). 
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Other Addictive Substances 
The epigenetic activity of addictive drugs doesn’t stop at 
alcohol. Amphetamines can, through epigenetic pathways, subvert 
their stimulation pathway to become less effective over time. For 
example, amphetamines change the imprint status of a gene called 
DeltaFosB in brain – this gene has carry-on effects in  the 
regulation of other genes such as c-Fos, histone H3 
methyltransferase, and KMT1A , a lysine methytransferase. Note 
that these last two genes are likely to alter the epigenetic status of 
additional genes. The end result is an addict needing more 
amphetamines to achieve the same high (Renthal et al.  2008). 
Zhou et al. (2011) measured the epigenetic effects of alcohol and 
cocaine in the post-mortem brains of human cocaine abusers and 
alcoholics. Cocaine has some of the same epigenetic effects as 
alcohol in the hippocampus, the area of the brain affecting 
memory, which suggests a common mechanism that both links and 
escalates addictions (Zhou et al. 2011). Although these substances 
cause several adverse effects, the following study describes a 
resistance to addictive behavior across generations. Male rat 
offspring of sires that had self-administered cocaine showed a 
resistance to cocaine abuse (Vassoler et al. 2013). This difference 
in behavior was not observed in female offspring or in male 
offspring of sires who self-administered saline (i.e. controls). 
Neither was it observed in the male offspring’s self administration 
of sucrose and, therefore, cannot be attributed to operant learning 
deficits. Thus a decreased reinforcing effectiveness is seen among 
the male sire offspring (Vassoler et al. 2013). Can this be deemed a 
‘positive effect’? 
Nicotine is argued to be a gateway drug. Levine et al. 
(2011) developed an animal model using mice to determine if 
previous exposure to nicotine primed their response to cocaine. By 
measuring addiction-related behaviors and the synaptic plasticity 
of the striatum, an increase in cocaine-associated responses was 
seen only when nicotine was administered first. Cocaine had no 
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influence on nicotine effects when the order  was reversed. 
Nicotine was found to inhibit HDAC (histone deacetylase) in the 
striatum, thereby enhancing cocaine’s ability to induce expression 
of the FosB gene, a key player in cocaine addiction (Levine et al. 
2011). 
Addiction is not only caused by ancestral and prenatal 
factors: how one is raised in early childhood also has an epigenetic 
effect on the predisposition to addiction (Schwarz et al. 2011). 
When rats are introduced to morphine, their glia increase the 
expression of a subset of cytokines. These particular cytokines are 
predictive of whether the rats will become addicted to morphine. 
Rats that were raised by nurturing and loving mothers had 
significantly more of a competitor cytokine, IL-10, which inhibits 
the activation of addiction-related ones in the offspring. Well 
nurtured mouse pups are less likely to become addicted to 
morphine upon exposure. Presumably, poor parenting decreases 
IL-10 expression, and this renders offspring more vulnerable to 
additive behavior. IL-10 gene expression is modulated by 
differential methylation patterns, where well cared rats  show 
nearly a 5-fold decrease in methylation compared to rats that were 
poorly nurtured (Schwarz et al. 2011). This explains, in part, some 
of the social influences upon epigenetics and substance abuse. A 
greater understanding of these mechanisms could facilitate cures 
and countermeasures to combat addictive drugs. 
 
5.2.3 Future of Pharmacology in an Epigenetic World 
Epigenetic pharmacology is an emerging field that should be 
treated with equal measures of caution and enthusiasm. Since it is 
now obvious that epigenetics constitute an inextricable part of the 
blueprint of life, epigenetic treatments present challenges, 
especially when it comes to safety testing and ensuring the health 
of future generations. The ability to fully understand complex 
conditions like addiction, and the prospect of creating drugs that 
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present novel solutions to medical conundrums should be weighed 
against those challenges. 
Epigenetic testing is imperfect. Pharmaceutical companies, 
armed with epigenetic knowledge, should be responsible to test 
their drugs for epigenetic changes. The tragic case of DES  stands 
as an example of the consequences of ignorance when it comes to 
epigenetic side effects; however, the cost of epigenetic testing is 
unclear. Should the epigenetic effects of every drug taken  to 
market be studied, including those already being sold? How many 
post-patient generations should be analyzed? Much of the time, 
rodents reveal epigenetic effects that are similar to those found in 
humans: we share a near-identical assembly of genes, regulatory 
pathways, and activities. But the gene regulatory pathways are 
complex and can vary in subtle but important ways between 
species. Moreover, no single epigenome map exists since, unlike 
DNA, an epigenetic map would need to take into consideration 
each and every tissue and cell type, parental legacy, sociological, 
and environmental factor in order to provide a useful reference 
point. Some steps are being taken to assemble  this information 
(The Encyclopedia of DNA Elements, called the ENCODE project 
for short), but given the combinations and variables that will need 
to be considered, the project will be mammoth indeed. Moreover, 
given the interplay of all of the aforementioned factors, cause and 
effect relationships would be difficult to determine. Finally, 
methylation patterns change naturally with age, so longitudinal 
studies showing changes in methylation, acetylation, miRNA, 
lncRNA etc., will need very strong controls to establish direct 
causation. For true confidence, multiple generations of humans 
would have to be monitored, and this is impractical since it would 
effectively slow drug development to a halt, and raise development 
costs to prohibitive levels. The current program of epigenetic 
testing undertaken by pharmaceutical companies has been 
examined and deemed reasonable, given the current understanding 
of  epigenetics  (Alyea  et  al.  2012).  As  understanding      grows, 
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though, will current testing methods continue to be adequate? It is 
clear that some responsibility must be taken by drug developers 
and purveyors for the epigenetic effects of their products. The trick 
will be to balance the expense of testing before it risks becoming 
burdensome both to developer as well as to society at large. Look 
at the stalled pipeline of antibiotic development: similar cost 
disincentives have dangerously impaired our ability to control 
infection. Clearly, care will have to be exercised when introducing 
policies, because both economic as well as epigenetic effects can 
last for generations. 
The pharmaceutical industry is no stranger to regulation, 
and for good reason. Modulating the chemical balance of any 
system as complex as a body is a dangerous and difficult task. 
Epigenetic research will not only change how companies approach 
drug safety and testing, but also how they consider waste 
management and their consideration of patient metabolites. By 
extension, patients will also have to assume some responsibility for 
safe and compliant practices. For example, it is not uncommon on 
Canadian television to see public service announcements 
encouraging safe disposal practices for expired pharmaceuticals: 
patients have to acknowledge that they are also consumers with a 
responsibility for proper disposal. The reason for this is clear: our 
water supply is becoming measurably contaminated. If substances 
that affect epigenetics are released into the environment, they 
expose humans and other animals to potentially harmful trans- 
generational effects. In fact, as you’ll read in the next section, such 
toxicants already have polluted the ecosystem, due largely to 
ignorance. 
 
5.3 Environmental Epigenetics 
According to the World Health Organization, more than 
13 million deaths occur annually due to environmental causes. As 
much as 24% of disease is caused by exposures that can  be 
averted:  pollutants  are among the list  of environmental threats  to 
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human health (Prüss-Ustü and Corvalán 2006). Compounds that 
are of natural and artificial origin, chemicals that can have harmful, 
positive, or neutral effects, and molecules that contaminate the 
environment for numerous years, all encompass our everyday 
exposure. Increasingly, scientific evidence is shedding light on the 
changes that environmental chemicals exert upon the epigenome. 
 
5.3.1 Toxicants & Chemopreventative Reversers 
The environmental chemicals we are exposed to can be 
grouped broadly into two categories: environmental toxicants and 
chemopreventative reversers (Kim et al., 2012). These variations 
induce opposite effects on the epigenome in relation to their 
primary effects upon methylation (Kim et al., 2012). 
Environmental toxicants are strongly emphasized throughout the 
literature since they present the most obvious impact on human 
disease. Various human diseases have been attributed to 
environmental toxicant effects on the epigenome, a prime example 
being cancer (Goodman & Watson, 2002; Chapter 3). Current 
evidence suggests a second category of epigenetic alteration 
effects: the “chemopreventative reversers.” These potentially 
prevent and correct harmful epigenetic perturbations. 
Environmental epigenetics encompasses how 
environmental exposure to nutritional, dietary, physical, and 
chemical factors can alter gene expression and modify individual 
genetic susceptibility through changes in the epigenome (Kim et al. 
2012). In this field of study, DNA methylation is investigated as a 
product as well as a diagnostic signpost of exposure to 
environmental toxicants (Yang and Park 2012). Mixed exposure to 
environmental toxicants and chemopreventative reversers 
simultaneously makes interpretation and understanding of the 
etiology of environmental effects complicated. However, given the 
complexity of environments, it is perhaps inevitable that many 
studies have focused upon mixed exposures of multiple 
environmental toxicants, the combinatorial nature of which    leads 
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to outcomes that are more deleterious than the additive effects of 
separate chemicals individually (Christiansen et al. 2009). By 
exposing multiple environmental toxicants simultaneously a 
“1+1=3” effect occurs: the synergisms are complex. 
 
5.3.2 Pathways of Exposure & Health Implications 
Air Pollution 
Respiratory diseases and epigenetic imprinting imparted 
by environmental exposure appear to be linked. Animal studies 
have shown that chronic exposure to air pollutants can lead to 
noticeable changes to the methylation patterns of inflammatory 
genes, in addition to changes in miRNA expression patterns 
(Jardim 2011). Recall, miRNA may act as an upstream epigenetic 
modifier that causes later biochemical alterations to genome 
packaging and the behavior (Bartel 2004; Sevignani et al. 2006) 
(Chapter 2). Even a 2 hour exposure to diesel fumes is sufficient to 
induce measurable epigenetic change (Jiang et al. 2014). 
Epidemiological studies suggest that exposure of a mother 
to tobacco smoke may transmit the risk of asthma to her children 
(Alati et al. 2006) or even grandchildren (Li et al. 2005). 
Therefore, it is important to consider air pollution as an issue not 
just of environmental but also of generational justice. Other 
common air pollutants with epigenetic implications include: 
ground-level ozone, diisocyanate, endotoxins, allergens, and 
pesticides (Miller and Ho 2008) (Table 5.1). 
Many individuals are exposed to workplace air pollution. 
For example, gas station attendants and traffic police experience 
low-dose benzene exposure that is measurable in blood samples 
(Bollati et al. 2007). This exposure is linked to global DNA 
hypomethylation and the specific hypermethylation of p15, a 
tumour suppressor gene. p15 is important because of its role in cell 
cycle regulation. These characteristics are often seen individuals 
with acute myelogenous leukemia (Bollati et al. 2007). High level 
benzene exposure has also been associated with an increased    risk 
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of this disease (Snyder 2002). Working conditions vary quite 
broadly; some individuals are much more likely to be exposed to 
hazardous substances than others (see case study on Heavy 
Metals). 
 
CASE STUDY: Heavy Metals in and Around the Workplace 
 
A significant concern relates to the exposure of workers and 
individuals to heavy metals in and around the workplace. 
Factories may use heavy metals during production; both the 
workers and people living in the area surrounding the factory 
become exposed to heavy metals by air, but also by contact. 
Numerous papers have outlined the effects of heavy metal 
exposure on the epigenome. These heavy metals include arsenic, 
cadmium, chromium, lead, mercury, tungsten, and nickel.  They 
all exhibit an epigenetic component, resulting in various cancers, 
cardiovascular disease, and trans- generational effects (Martinez- 
Zamudio and Ha 2011). One can only speculate at the long term 
effects upon people who garden, play, or inhabit structures built 
on land that is reclaimed from industrial use. 
 
Steel plant workers are exposed to inhalable particulate 
matter which is associated with an increased risk of lung cancer 
(Cantone et al. 2011). Particulate matter  contains carcinogenic 
and toxic metals such as arsenic and nickel. It was found that 
human exposure is associated with an increased amount  of 
histone 3, lysine 4 methylation and histone 3, lysine 9 acetylation 
in blood leukocyte samples, especially in individuals with more 
years of employment. These regional changes are associated with 
open chromatin states also present in lung carcinoma cells 
(Cantone et al. 2011). 
Animal models have been used to show that the DNA of 
sperm in mice exposed to air from a steel plant exhibit 
hypermethylation compared with control animals. The change 
persists even after the environmental stimulus is removed. This 
raises flags regarding trans-generational effects (Yauk et al. 
2008). 
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Dietary considerations can work synergistically with air 
pollution to promote diseased phenotypes. Dietary  supplements 
that provide methyl donors during pregnancy can increase the risk 
of respiratory disease and these effects are compounded with air 
pollution exposure (Hollingsworth et al. 2008). Table 5.1 outlines 
various research which associates the epigenetic changes of asthma 
and atopy (allergic hypersensitivity) linked genes with 
environmental stimuli. 
 
Genes Environmental Exposure First author, year 
Genomewide linkage Active Smoke Dizier, 2007 
Colilla, 2003 
CD14  Choudhry, 2005 
b2-Adrenergic receptor  Wang, 2001 
Genome screen Passive Smoke Meyers, 2005 
IL-1R  Ramadas, 2007 
GSTM1 In utero smoke Gilliland, 2002 
TNF Ozone Li, 2006 
Genomewide linkage Allergens Blumenthal, 2006 
CD14 Farm Leynaert 
Eder, 2005 
LeVan, 2005 
Toll-like receptor 2  Eder, 2004 
Innate immunity receptors  Ege, 2006 
CD14 Endotoxin Simpson, 2006 
Zambelli-Weiner, 2005 
Williams, 2006 
β2-Adrenergic receptor Obesity Barr, 2001 
IL4RA, CD-14, and IL-13 Diisocyanate Bernstein, 2006 
IL-4 Helicobacter pylori infection Pessi, 2005 
 
Table 5.1 Representative Research on Gene-By-Environment Interactions 
In Asthma or Atopy (Adapted from Miller & Ho, 2008) 
 
Dietary Exposures 
Pesticides 
The typical North American diet is contaminated with various 
xenobiotic chemicals. Extensive research has been done on the 
epigenetic  effects  of  vinclozolin,  a  commonly  used agricultural 
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fungicide, which is also an endocrine disrupting chemical. 
Vinclozolin is very difficult to wash off with water. Increasingly, 
this chemical is shown to lead to specific and adverse epigenetic 
effects such as altered methylation patterns of genes encoding a 
protein phosphatase, and another encoding a serine  threonine 
kinase (Anway et al., 2005). It is anti-androgenic and induces 
spermatogenic defects, male infertility, breast cancer, kidney 
disease, prostate disease, and immune abnormalities (Anway et al. 
2006). 
An additional pesticide, methoxychlor, is estrogeneic and 
also has been found to exert trans-generational effects including 
changes to sperm number and motility. These chemicals, among 
others, produce measurable epigenetic methylation changes within 
the germline that have been linked to impaired embryonic testis 
cord formation and increased spermatogenic cell apoptosis in the 
adult testis (Skinner and Anway 2005). These changes are also 
correlated with adult onset male infertility (Guerrero-Bosagna et 
al. 2013). 
Vinclozolin and methoxychlor are just a couple of the 
many pesticides of concern. Other examples include: DDT, 
paraquat, dieldrin, and propoxur (Collotta et al. 2013). A common 
feature of many of these contaminants is that they are endocrine 
disruptors. Herbicides, pesticides, fungicides, and heavy metals, all 
have been shown in various models to have adverse health effects 
and further research is being done to elucidate the epigenetic 
effects (Collotta et al. 2013). 
 
Plastics  
Food and beverage products are often packaged in plastics 
that leach chemicals with harmful effects. Bisphenol-A (BPA) is 
one of these chemicals. BPA acts as an estrogen mimic and is used 
in conjunction with polycarbonate plastics. The classical example 
of BPA contamination is via disposable water bottles. Studies have 
revealed that BPA induces hypomethylation of various genes    and 
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is associated with higher body weight and higher risks of  breast 
and prostate cancer (Dolinoy et al. 2007). Early stem cell 
development is sensitive to BPA. However, it has been shown that 
maternal supplementation of diet with methyl donors, such as folic 
acid or the phytoestrogen genistein, can reverse the effects of such 
hypomethylation in early development (Dolinoy et al. 2007). This 
is an example of an environmental toxicant and a 
chemopreventative reverser, this time a normal component of diet, 
working antagonistically. 
It is crucial that we are aware and understand where our 
food sources come from and what chemicals they contain. 
 
Chemopreventative Reversers 
A few supplements have been identified with the potential to 
reverse changes caused by chemicals like alcohol, BPA or even 
heavy metals (Kim et al. 2012). Methyl donors, such as folate, 
methionine, betaine, choline and vitamin B12, affect methylation. 
Downing et al. (2011) compared the Igf2 gene methylation patterns 
in the embryos of dams given alcohol during pregnancy. They 
found that the embryos of mice not given methyl donors were 
hypomethylated at the Igf2 locus while those receiving 
supplementation had increased methylation of the Igf2 gene. Thus 
the effect of alcohol hypomethylation was reversed (Downing et al. 
2011). Evidence also suggests methyl donors can reverse metal and 
BPA effects (Kim et al. 2012). Unfortunately, in contradistinction 
to these remediating effects, research also indicates that in utero 
exposure to a diet rich in methyl donors may enhance the severity 
of allergic airway disease in mice and that this predisposition has 
trans-generational effects (Hollingsworth et al. 2008). Dietary 
polyphenols, such as genistein derived from soy, are among other 
things, inhibitors of DNMTs (the genes encoding DNA 
methyltransferases – epigenome modifiers) and are implicated in 
reversing methylation of tumour suppressor genes involved in 
multiple    types    of     cancers     (Kim    et     al.     2012).    Other 
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chemopreventative reversers include vitamin D3, the tomato 
carotenoid lycopene, and selenium (Kim et al. 2012). 
 
5.3.3 Environmental Justice 
As research progresses in this burgeoning field, more 
health effects will undoubtedly be revealed. It is important to 
evaluate environmental conditions consistently, to perform 
chemical and biological risk analyses to prevent subsequent health 
complications, and to fulfill our obligations to future generations 
who will inherit both our physical environment as well as our 
epigenome. Some epigenetically associated disease examples are 
listed in Table 5.2. Research continues to reveal a growing list of 
diseases that can be attributed to epigenetic modifications. 
The environmental domain requires regulation and 
legislation to keep individuals safe from exposure and subsequent 
health effects, but responsibility should be a two way street. 
Personal chemoprevention as well as government regulation of 
environmental toxicants has been recently emphasized for 
individual and societal protection from environmental toxicants 
including cancer (Kim et al., 2012). 
 
5.4 Considerations 
5.4.1 Regulation and Liability 
Insurance 
Currently in the U.S., laws exist to protect individuals 
from insurance discrimination under the Genetic Information 
Nondiscrimination Act (GINA) (Hudson et al. 2008). By contrast, 
in Canada, a person who has their DNA tested and does not 
disclose a defect to their insurer could lose coverage. There is no 
legislation in either jurisdiction that explicitly covers epigenetic 
features. Medication and residential histories may indicate 
increased risk of epigenetic changes and consequently also 
predisposition to diseases. Should this permit insurance companies 
to charge more for health insurance based upon your  geographical 
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proximity to pollutants? This is an important question as there are 
economic and social inequalities that affect levels of environmental 
exposure, the affordability of health care, and access to insurance 
coverage. Who will protect economically disadvantaged 
individuals from under-representation or discrimination on the 
basis of parental legacy, upbringing, or other socio-economic 
factors that they could not reasonably be expected to control? What 
if effects are not manifest for a generation or more? Will  the 
burden of proof to establish causal links be too onerous to permit 
successful remedy? How short or long should statutory limits be? 
 
Toxicant Biomarker Related Disease First author, year 
Alcohol MTHFR Lung Cancer Vaissiere, 2009 
Benzene PARP-1 Leukemia Gao, 2010 
BPA Hoxa10 Abnormal uteri 
development 
Bromer, 2010 
DES Lactoferrin Uterine cancer Li, 2003 
Dioxins Foxp3 Colitis Singh, 2011 
Vinclozolin H19, Gtl2 Abnormal male 
reproductive system 
Stouder, 2010 
Arsenic p53 Various cancers Hou, 2012 
Cadmium LINE-1 Various cancers Hossain, 2012 
Chromium 45s rRNA Trans-generational 
cancer 
Cheng, 2004 
Lead COL1A2 Preterm birth Hanna, 2012 
Mercury Rnd2 Neurotoxicity Arai, 2011 
UV-B p16, 
RASSF1A 
Skin cancer Nandakumar, 2011 
Table 5.2 A Selection of Epigenetically Associated  Diseases. (Adapted 
from Kim et al. 2012) 
 
Liability 
Corporate and personal liability already presents a 
problem that needs attention as epidemiological studies reveal 
associations between epigenetic signatures and disease states 
(Chapter   8).   If   epigenetically   induced   diseases   arise   as    a 
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consequence of pharmaceutical or environmental exposures, 
questions will arise regarding who is liable, especially since many 
of the effects might not become perceivable within normal 
statutory limits. If reparative actions are pursued, there will need 
to be a framework for enforcement and determination of the extent 
of the damages. For example, if workers who are employed in 
factories that utilize hazardous chemicals later show 
epigenetically-based diseases, should the company be held liable if 
all possible precautions were not taken to limit exposure? What if 
exposure risks were unknown at the time? The same questions 
might also be asked in cases pertaining to prescription drugs. 
 
Government 
Taxation models could be developed to reserve funds and 
provide reparations when pharmaceutical or  environmental 
toxicant harms are later identified. Such reserves could ensure that 
affected citizens will have recourse to aid in future generations 
when the offending company might no longer exist. Models of 
similar funding approaches to facilitate public health solutions 
already exist, such as vaccination development programs. In the 
United Kingdom, the government has allocated money to 
incentivize vaccine development by manufacturers. This allows for 
vaccines to be more affordable because they have established a 
competitive context and market that may otherwise have been non- 
existent. This is referred to as a “pull” approach (Surowiecki 
2004). Perhaps similar approaches can be taken when considering 
corporations and the health of citizens – models could be 
developed to reward positive epigenomic maintenance throughout 
the corporate world, without placing inordinately heavy 
encumbrances upon businesses. 
As previously mentioned, some people, - those in certain 
workplaces and socioeconomic classes - are likely to be 
disproportionately affected. The government must represent all 
stakeholders. This includes those most severely affected and  those 
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who are most impoverished and lacking a voice (Mansfield 2012). 
It also includes those that are most likely inflicting harmful 
epigenetic modifications such as heavy polluting corporations and 
producers of various xenobiotic chemicals. Clearly,  the 
government has an important role to play when in mediating and 
developing policies and practices that will promote  and ensure 
both a healthy and productive population, as well as a vibrant and 
sustainable economy. 
 
Chemical Safety Analysis Protocols 
It is of utmost importance to have standardized procedures 
to effectively measure the epigenetic implications of new and 
existing chemical compounds. Techniques must be perfected to 
measure changes and to publish the epigenetic effects of toxicants 
so that risks can be understood by all (LeBaron et al. 2010). 
Government agencies, industrial stakeholders, and researchers 
could compile information as well as generate new and centralized 
databases concerning the chemical hazards in relation to 
epigenetics. Testing agencies such as the American Food and Drug 
Administration, the Canadian Health Agency, and other bodies 
should implement requirements for manufacturers to test, to 
examine potential effects, as well as to mandate policies for 
corporations to follow when performing clinical trials. As recent 
experience demonstrates, the present model for cataloguing, 
reporting, and making information from trials accessible could 
benefit from greater transparency: even negative results could be 
useful to future development and safety. When balanced against 
the potential risks of liability and litigation,  corporations might 
find it cheaper to make data public. 
 
5.5 Conclusion 
Chemical exposure, whether by intention via drug use or 
inadvertently via environmental exposure, is an important field of 
study  because  of  the  complex  mix  and  high  volume  we     are 
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exposed to each and every day. There are various questions and 
concerns that have arisen from epigenetic studies: for example, 
which commonly used but heretofore untested chemicals and drugs 
are harmful? What effects might their use have upon my children’s 
children? Research may lead to better prevention and treatment 
options even if currently employed but unsustainable practices are 
upset. This moves us into the frame of thinking of the environment 
and our place in it as a larger and more complex interactome 
(Guthman and Mansfield 2012). 
How do we create healthy environments to promote 
positive epigenomic reinforcement and to limit human disease? 
This remains a question of importance that will be addressed 
through policy initiatives, government intervention, corporate 
accountability and transparency, changing societal dynamics, and 
education. It is important that all stakeholders are aware of the 
potential consequences of chemical exposure both at a genetic and 
an epigenetic level. This means that personal education is likely to 
be as important as actions by larger bodies. 
Many chemicals that we take for granted may suddenly be 
revealed as environmental toxicants upon further inquiry. 
Exposures can have adverse health effects, whether they are from 
pharmaceutical drugs, addictive substances, air pollution, dietary 
components, or by any other route that xenobiotics can invade our 
everyday lives. Often, if a substance is not immediately or visibly 
harmful, we do not think of the effects of long term exposure to 
these chemicals. Epigenetics is increasingly likely to indicate  that 
it is no longer enough to understand how our genetic code is 
written; we must understand how it is read, stored, and accessed by 
the body. In a practical sense, in terms of immediate effect, any 
chemical that affects how our DNA is expressed deserves the same 
respect and caution that we reserve for mutagens. 
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Provocative Questions 
Chemical and pharmaceutical development. 
 How should we balance the benefits  of development 
against potential long term and inherently unknown 
epigenetic risks and costs? 
 How much can developers be encumbered before 
development ceases? Is there a middle ground between 
responsible testing and advancement? 
 
How will new products be tested? How will liability be 
assessed? 
 Different tissue and cell types can have different epigenetic 
marks - how would one determine which tissues to test? 
Can comprehensive yet simple tests be developed? Will 
they be cost-accessible? 
 How could one determine causation – how do we 
distinguish between the single compound being tested 
versus the other myriad of factors (inheritance, 
socioeconomic status, diet, aging, drugs etc.) 
 How many generations should be tested? Will this slow 
development, increase liability? 
 Who should determine the procedures and policies that 
pertain to epigenetics-oriented interventions in medicine 
law, ethics, or society? 
 Where should we draw the line between corporate and 
personal liability? 
 
Remediation 
 If a process or treatment has generational consequences, 
how will a fair cost-benefit analysis weigh competing 
interests? 
 Environmental toxicants are often distributed within 
geographically finite boundaries. Who’s responsible to 
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clean up the environment? What onus falls to society, 
business, and individuals to mitigate geographical risks? 
 What is to prevent agencies and companies from 
discriminating against individuals on the basis of their 
geographical and employment histories (ie; their possible 
exposure, epigenetic status, and possible health pre- 
dispositions)? 
 
Possible Solutions 
Chemical and pharmaceutical development will be determined 
with time and experience. 
● Laws and regulations mandating the testing for epigenetic 
effects should not only be in place, but should be reviewed and 
refined often. 
● At the very least, if testing every drug for epigenetic side- 
effects is found to be impractical, the fact that the drug has not 
been tested should be included in the list of side effects: this 
creates awareness and a market preference for drugs that are 
tested. 
 
Genetic testing was imprecise in its infancy, so it is likely that 
epigenetic testing methods will improve with time. 
● Tissues that are the target of, say, a drug, may be a testing 
priority; subsequently, tissues often involved in high risk 
diseases, like stem cells in which changes are often linked to 
rapidly developing diseases, are important to test. 
● All drugs containing substances that are known to have 
epigenetic effects should be subjected to multi-generational 
testing or monitoring, even drugs that have no previously 
discovered mechanism. 
● Privacy policies/non-discrimination laws need to be expanded 
to cover epigenetic risks and histories. 
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Remediation is a difficult problem to solve; past and current 
issues with known negative consequences, such as industrial 
pollution, highlight this point. 
● It will take time and effort by researchers and agencies to push 
companies and government to solve these issues – 
communication, education, and consultation among all 
stakeholders will be critical. 
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Chapter 6 
Developmental Epigenetics and 
Reproductive Medicine: 
Apparently Always a Parent! 
 
Marisa Market and Jessica Hebert 
 
Abstract 
If diet during pregnancy can epigenetically affect the 
fetus, then it follows that those environmental and social 
experiences that have the potential to alter maternal physiology 
might also produce fetal modifications. It is also likely that such 
changes might be mediated by the placenta. A common theme in 
epigenetic studies revolves around the role of hormones in 
effecting long term changes to patterns of DNA packaging and 
behaviour. It is not surprising then, that hormonally assisted 
deliveries, birth control, patterns of nursing, as well as the 
manipulations that underlie Assisted Reproductive Technology 
(ART), especially in vitro fertilization (IVF), are linked to 
imprinting changes. IVF involves both hormonal priming of the 
mother, as well as direct manipulation of gametes under highly 
artificial conditions. The demonstration of specific DNA 
methylation changes outlined in the previous chapters, as well as 
the generational persistence of imprinting defects in other studies 
(such as diet-induced changes), make careful assessment of  such 
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procedures all the more compelling. Medical interventions (such 
as Caesarean section or the administration of epidural analgesia 
and hormonal labour-inducing agent Pitocin) that have been 
trademarks of assisted labour and delivery are being questioned 
again in the light of their potential to modify the epigenome, as 
are some of the practices that follow immediately after  birth, 
such as breast or bottle feeding. Epigeneomics might also give us 
pause to interrogate the surprising ways in which surrogate or 
adoptive mothers might influence the development of an 
individual despite their different genetics. 
 
 
6.1 Introduction 
Your autobiography might often start with the date you were 
born. That is the beginning of your story. However, the epigenetic 
mechanisms that influence the construction of who you are and 
who you will become begin much earlier. As we have learned in 
previous chapters, it is possible to inherit epigenetic traits that span 
at least two generations. Apparently you cannot be too careful in 
your choice of parents: all joking aside, the epigenetic bonuses or 
deficits that come packaged along with your inheritance of DNA 
matter. In this chapter, we will discuss epigenetic mechanisms 
associated with: pregnancy environment, Assisted Reproduction 
Technologies (ART), oral contraception, birth, and parental 
behaviors. 
 
6.2 Epigenetic Interactions of Maternal Environment and 
Fetus 
Maternal taste preference for high-energy foods consumed 
during gestation can be transmitted to offspring, thus reproducing 
an affinity for this diet in future generations (Gicquel et al. 2003; 
Delport and Pollard 2010). In this way, attributes of the broader 
social environment can be transmitted via the intimate molecular 
connection of the mother to the fetus, and via parental social 
interactions  with  the  delivered  child.     The  mechanics  of    this 
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relationship remain somewhat hazy, however a picture is emerging 
in which epigenetics plays a prominent role. If one’s choice of 
food can be attributed to influences such as epigenetics, prenatal 
programming, and learned cultural norms, it becomes clear that 
culture and biology work in an interactive and reinforcing fashion: 
diet culminates in biological alterations, and it is these changes that 
further influence dietary choices and culture. As we saw in Chapter 
4, under-eating, over-eating, or certain nutrients can all elicit 
epigenetic changes, sometimes even pre-conception, and such 
changes are heritable. If dietary experience can affect the fetus, 
then it stands to reason that social exposures and psychological 
experiences that alter a mother’s physiology during pregnancy 
could also affect the fetus and newborn (Bale et al. 2010). 
 
6.2.1 Depression during Pregnancy 
Women who were depressed during pregnancy bore infants 
of lower than average birth weights (Gicquel et al. 2003; Laprise 
2009; Liu et al. 2012). These latter authors contend that depression 
disrupts the proper functioning of the hypothalamic/pituitary 
hormonal axis (consisting of interactions between the 
hypothalamus, pituitary, and adrenal glands), but only in the 
African American women within the study cohort. Results 
indicated a 2.4% higher methylation level compared to those 
women that identified as non-depressed. Moreover, in samples of 
umbilical cord blood, DNA methylation patterns differed for 10 
genes compared to infants born to unstressed mothers within the 
cohort. This increased methylation could contribute to a 
vulnerability to neurodevelopmental disorders (Liu et al. 2012). 
Additionally, African Americans exhibit lower levels of DNA 
methylation in umbilical cord blood samples compared to 
Caucasian participants (Adkins et al. 2011). Finally, African 
American women experience a higher rate of pre-term delivery, 
and lower birth weights, compared to Caucasians, even when 
financial incomes are comparable (Collins et al., 2007). What these 
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studies may truly indicate is that the maternal environment affects 
offspring (as has been asserted before). However, these studies 
neglect to account for the possibility that correlations made with 
race will be confounded by external cultural and economic features 
that are unrelated to genetics (see Chapter 7). 
 
6.2.2 Smoking during Pregnancy 
Maternal habits of cigarette smoking harm the fetus. Head 
circumference and low birth weight (LBW) are common side 
effects in babies born to mothers who smoke cigarettes throughout 
pregnancy. The consequences of cigarette smoke inhalation during 
gestation is at least somewhat mediated by methylation (Breton et 
al. 2009). In samples of umbilical cord blood, tests reveal 
methylation shifts in response to smoking, potentially explaining 
part of the correlation of smoking and LBW (Murphy et al. 2012). 
A major challenge of this study is that changes detected in the 
methylation of umbilical cord blood samples might not reflect 
changes in the body of the delivered baby, however, the results 
certainly raise cause for concern. Women who quit smoking for the 
duration of pregnancy were compared to a smoking and a non- 
smoking group: their newborns compared favorably to non- 
smokers relative to those who smoked. Another study of smokers 
showed down-regulation of four different micro RNAs in the 
placenta (miRNAs, Chapter 2). Recall that miRNAs are assistants 
that control essential cell activity (Maccani et al. 2010; Maccani et 
al. 2013). Since the placenta mediates the transfer of nutrients to a 
fetus, it seems likely that these changes could indicate a significant 
mechanism by which maternal smoking alters fetal health. If a 
specific miRNA is down-regulated, whatever target it is supposed 
to interact with is up-regulated. The researchers suggested that the 
down-regulation of these four miRNAs miR-16, -21, -146, and - 
182), and corresponding up-regulation of their target genes 
disturbed processes of cell cycle regulation, development, immune 
system adjustment, and growth in the placenta. These alterations 
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could also confer changes in fetal metabolic programming, 
including development of neurological structures (Maccani et al. 
2010; Maccani et al. 2013). 
 
6.2.3 The Placenta 
During the first trimester, the placenta develops from 
trophoblastic tissue and serves to nurture the fetus until birth. The 
human placenta is the first embryonic organ to develop, and it 
provides the resource for the mother and fetus to exchange gas, 
nutrients, waste, and metabolites. It is structured to permit this 
exchange between maternal and fetal blood without direct mixing. 
Nevertheless, potentially harmful substances and pathogens can 
pass across the placental barrier. Some examples include medical 
drugs (the morning sickness medication thalidomide), illicit drugs 
(heroin), alcohol, chemicals from cigarette smoke, and even certain 
pathogens (such as HIV) can cross the placental barrier. 
Changes in the epigenome of placental tissue might  result 
in low birth weight and pre-term birth. Changes in placental 
imprinting, however, may be responsible for many more diseases. 
This is due to the fact that aberrant epigenetic changes that are 
readily repaired in embryonic tissue appear to persist in placental 
tissue (Mann et al. 2004). This is not to say that imprinting 
modifications in embryonic tissue do not result in imprinting 
diseases, it highlights the major role that placenta plays in fetal 
development through epigenetic regulation. Diseases caused by 
changes in the placental epigenome include gestational diseases, 
such as Gestational Trophoblastic Disease (GTD) and pre- 
eclampsia (CASE STUDY 6.1, 6.2), as well as diseases that 
impact the rest of the child’s life. Pre-eclampsia is an umbrella 
term used describe a variety of deficiencies that result in 
dangerously high maternal blood pressure. There are likely 
multiple different causes, some of which might be epigenetic in 
origin. 
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CASE STUDY 6.1: Gestational Trophoblastic Disease 
 
 
Gestational  trophoblastic  disease  describes  a  group  of 
rare tumors that are caused by derailed trophoblast growth in a 
woman’s  uterus.  The  cells  that  make  up  the  trophoblast  layer 
that  should  eventually  become  the  placenta  begin  to  grow 
abnormally  and  can  cause  various  tumors.  The  most  common 
type of tumor is a hydatidiform mole, which has the potential 
to develop into a carcinoma. Studies have found that the cause 
of  this  abnormal  growth  is  improper  epigenetic  marks  within 
embryonic stem cells (such as aberrant tumor suppressor gene 
methylation  and  the  hypermethylation  of  transcription  factors 
that play an important role in maintaining embryonic stem cell 
pluripotency) (Nelissen et al. 2011). 
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CASE STUDY 6.2: Pre-eclampsia 
 
Pre-eclampsia is characterized by high blood pressure 
and excessive amounts of protein in urine. From this, 
eclampsia can develop, which is characterized by the onset of 
seizures, usually in the last half of pregnancy. 
There are many factors that can lead to pre-eclampsia, 
but an important mechanism involves the fetal 
hypoxia/reoxygenation response pathway. The reduced 
methylation of genes encoding hypoxia-inducible factors leads 
to increased transcription of proteins that prevent proper 
trophoblast differentiation. This then leads to a failure of 
placental trophoblast cells to effectively invade and remodel 
maternal spiral arteries, ultimately leading to abnormal 
placental blood circulation. Due to hypoxia and re-oxygenation 
stress, pre-eclampsia can develop. The mechanism that senses 
maternal vascular pressure is disrupted and this leads to a 
generally broadcast cue to constrict arteries - high blood 
pressure ensues. This can then lead to eclampsia. Pre- 
eclampsia is a common cause of fetal growth retardation in 
developed countries, causing both pre-term birth  (PTB) and 
low body weight (LBW). Intrauterine growth retardation 
(IUGR) and LBW are negative health predictors for newborns 
and children, as they are associated with the development of 
chronic diseases expressed later in life (such as cardiovascular 
disease, hypertension and type 2 diabetes). Finally, improper 
placental development due to aberrant methylation can also 
cause harm to the mother where poor placental development is 
associated with maternal hypertension. Therefore, aberrant 
DNA methylation in the placenta impacts fetal growth, the 
development of diseases later in life, and could affect maternal 
morbidity (Blair et al. 2013). 
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Figure 6.1 Factors affecting placental development. (Nelissen et al. 
2011) Placental development is determined by many factors 
including DNA methylation and histone modifications that regulate 
gene expression, as well as environmental factors such as medical 
procedures (ART), and exposure to toxic substances (chemicals, 
alcohol, smoke), among others. Abnormal placental development can 
result in consequences for both the fetus and the mother. The fetus 
may be born pre-term, have low birth weight or could be more at 
risk of developing diseases later in life. Maternal risks include 
morbidity and death. 
 
Epigenetic changes arise in both the embryo and the placenta: 
aberrant DNA methylation and histone modification of many genes 
have been observed under the circumstances discussed in CASE 
STUDY 6.2 Such genes include H19 and IGF-2 (Li et al. 2005). 
However, epigenetic alterations in the placenta appear to be more 
common, especially in the placentas of babies that were conceived 
using assisted reproduction technologies (ART). While the  precise 
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cause of this is unknown, some theories suggest that the placenta is 
more affected since it derives from outer trophectoderm cells, 
which by virtue of being the most external cells of the early stage 
embryo, are in closer contact with the Petri dish culture medium in 
which maternal and paternal contributions are combined. They are 
also the first cells to differentiate and therefore undergo slightly 
longer exposure as differentiated cells. They might simply also be 
more strongly affected by the in vitro environment. The 
trophectoderm cells have different DNA replication patterns and 
might consequently have less capacity to maintain imprints (Mann 
et al. 2004). Furthermore, increased prevalence of diseases 
resulting from placental imprinting modifications could reflect the 
diminished capacity of presumptive placental cells to deal with 
epigenetic challenges (for example hypoxia, nutrition, disease, or 
drugs) compared to cells that go on to form the body of the fetus 
itself (Mann et al. 2004). Aberrant epigenetic marks in placental 
tissue could lead to altered placental function, which may in turn 
lead to diseases such as pre-eclampsia or placental previa. Either 
outcome results in disrupted growth and development of the fetus, 
ultimately leading to LBW or PTB (de Waal et al. 2014). 
It is important to note that aberrant methylation and histone 
modification can arise in non-ART children as well. Studies have 
shown that the environment under which the placenta develops 
(maternal diet, smoke, alcohol, chemicals, etc.) can also alter 
epigenetic marks (Nelissen et al. 2011). A disturbance in placental 
development or function through changes to the epigenome could 
alter fetal development and increase in disease susceptibility later 
in life. Not to be forgotten are the effects that anomalous fetal 
growth could have upon maternal health: difficult pregnancies and 
births can have long lasting effects. However, more research still 
needs to be done in order to fully understand the relationship 
between the placenta and long term epigenetic sequelae. 
 
6.3 Assisted Reproductive Technologies 
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The causes of male or female infertility are numerous and 
broad. There are many genes and mechanisms involved in the 
fertilization of an egg by sperm and the progression from a single- 
celled zygote through to a human baby; the cause of any one 
person’s infertility is complex and unique. Assisted reproductive 
technology (ART) has revolutionized the field of reproductive 
medicine and solved the problem of infertility for millions of 
people around the world. The first “test tube  baby”,  Louise 
Brown, was born in 1978 (Laprise 2009), and by 2008, an 
estimated five million babies were born that were conceived 
through in vitro fertilization (IVF) and other reproductive 
techniques (ESHRE 2012). 
ART is considered to be any medical technique or procedure 
that aids in the conception of a child. The extent to which 
reproductive assistance is required depends on the cause of 
infertility and can vary from helping with the production of eggs to 
injecting sperm nuclei directly into an egg. Some  examples of 
ART include: 
 Ovulation induction/ Superovulation stimulation: 
Gonadotropin releasing hormone analogues are used to 
control the timing of ovulation and the number of 
mature eggs released from the ovary (Elder and Dale 
2000). 
 Egg retrieval: Eggs are harvested from the ovary to be 
used for fertilization. They are then: cultured in an 
incubator; fertilized; cultured some more; and then 
transferred back to the female reproductive tract or to 
cryopreservation vessels. 
 Fertilization: Fertilization is the process of sperm and 
egg fusing to form a zygote and can occur in vitro or in 
vivo via artificial insemination. One variation involves 
injecting sperm nuclei directly into an egg. 
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 Embryo transfer: Following in vitro fertilization and 
culture, the embryo is inserted into the uterus to grow 
and develop further. 
 Cryopreservation: Extra eggs and sperm can be frozen 
in order to preserve them for future use, avoiding the 
need for multiple egg and sperm retrievals. Embryos 
can also be cryopreserved if too many were fertilized in 
vitro (Kaariainen et al. 2005; Iliadou et al. 2011). 
 Artificial/ Intrauterine insemination: The process of 
inserting sperm into a woman’s uterus in order to 
facilitate in vivo fertilization. 
 Third-party reproduction: This form of ART includes 
egg donation, sperm donation, and the use of  a 
surrogate or a gestational carrier. A gestational  carrier 
is a woman who carries and delivers a baby that is not 
biologically hers, while a surrogate donates her eggs for 
fertilization and gestation. In a recent innovation, a 
donated egg can be stripped of its own chromosomal 
DNA to be replaced by DNA from the prospective 
mother. Since the mitochondrial genes come from the 
donor egg, and the genomic chromosomes from the 
father and mother, these embryos have three genetic 
parents. 
 
6.3.1 In Vitro Fertilization 
In vitro fertilization (IVF) is the process that  involves 
removing mature eggs from the uterus, fertilizing them outside of 
the body, and implanting one or more embryos back into the 
uterus. This is done in order to facilitate fertilization and early 
embryonic development for people who would otherwise be unable 
to conceive. A typical IVF cycle includes: 
1. Ovarian stimulation/ Superovulation 
2. Egg retrieval 
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3. Fertilization: This step may vary depending upon the ability 
of the sperm to fertilize the egg. If the sperm are unhealthy 
or lack the ability to fuse with the egg, intracytoplasmic 
sperm injection (ICSI) may be used. ICSI  involves 
injecting a single sperm nucleus into a single egg using a 
micropipette in order to increase the odds of successful 
fertilization (Iliadou et al. 2011). 
4. Culturing. 
5. Fertilization. 
6. Culturing again for a while to assess embryo viability and 
health. 
7. Embryo transfer to a receptive womb. 
 
ART, especially IVF, has been linked to the development 
of imprinting disorders in children. These disorders are 
generally thought to be caused by aberrant DNA methylation 
and/or histone modifications that lead to the improper 
expression of certain genes, and the consequent  development 
of a disease. The imprinting disorders that have been most 
strongly correlated with ART include Beckwith-Wiedemann 
syndrome (Gicquel et al. 2003; Maher et al. 2003; Laprise 
2009; Vermeiden and Bernardus 2013), Angelman syndrome 
(Gicquel et al. 2003; Maher et al. 2003; Laprise 2009) and 
Silver-Russell syndrome (Kagami et al. 2007; Laprise 2009; 
Vermeiden and Bernardus 2013) (CASE STUDY 6.3). It is 
important to note, however, that some studies refute a link 
between these imprinting diseases and ART. It is an ongoing 
and controversial topic of research (Zheng et al. 2011; 
Vermeiden and Bernardus 2013). 
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Figure 6.2 Summary of the IVF procedures. 
IVF consists of numerous procedures. The exact procedures may 
vary, and this is based on the person(s) undergoing IVF. 
Generally, hormones are used to  induce  superovulation, eggs 
are harvested from the woman’s ovaries, these eggs are fertilized 
by sperm in vitro, the embryos are cultured on media and 
allowed to undergo multiple cell divisions before finally being 
transferred back to either the mother’s or donor’s uterus. 
 
 
In order to understand the reasons why ART might cause 
imprinting disorders, it is necessary to understand the process by 
which the epigenome is established during gametogenesis 
(production of the egg or sperm) and embryo development. Prior to 
implantation of an embryo into the uterine wall, there are two 
major phases of epigenetic reprogramming that occur: 1) at 
gametogenesis, when the sperm and egg develop, and 2) shortly 
after fertilization. 
1) During gametogenesis, the epigenetic marks that were 
present in the pre-gamete cells are largely, though not completely, 
erased. Then, new sex-specific imprints are established; a 
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paternally directed pattern is imposed in sperm, and a maternally 
directed pattern is imposed in eggs. This erasure and re-imprint is 
necessary because the chromosomes in the gametes will have 
derived from and carry a partial imprint from a mixture inherited 
from each gender of grandparent. This is known as genomic 
imprinting (Johnson 2005; Iliadou et al. 2011; Market Velker et al. 
2012). 
2) During fertilization and early embryo development, 
generalized DNA methylation patterns and histone modifications 
take place along with specialized epigenetic processes that include 
the maintenance of genomic imprints, silencing of retroviral 
elements, and X chromosome inactivation. 
Genomic imprinting allows for the expression or silencing of 
each copy of the alleles (pairs of genes) inherited from each parent 
via sperm and egg. The imprint is dependent upon whether the 
mother or the father provided that allele. These imprints remain 
intact, despite other DNA modifications that occur in early 
development, in order to protect the regulated expression of 
specific alleles from each parental chromosome. 
Retroviral elements are ancestral remnants of viral genes that 
are present in our genome (Market Velker et al. 2012). They can be 
mobile and pose a disruptive threat to genome integrity. In order to 
protect against the deleterious effects of these elements, they are 
silenced during this period by epigenetic modification. 
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CASE STUDY 6.3: Imprinting Disorders 
 
Beckwith-Wiedemann syndrome (BWS) Beckwith- Wiedemann 
syndrome is an overgrowth syndrome causing macrosomia (excessive birth 
weight). Half of BWS cases are caused by epigenetic changes at one of two 
genes on chromosome 11: H19/IGF-2 and KCNQ1OT1 (Gicquel et al. 
2003; Laprise 2009). Normally, H19 is expressed only from the maternal 
alleles while IGF-2 is expressed only from the paternal alleles. The 
KCNQ1OT1 gene is normally methylated on the maternal alleles, therefore 
being expressed solely by the paternal alleles (Gicquel et al. 2003). Loss of 
imprinting at the imprinting centers of these genes leads to aberrant 
transcriptional regulation, resulting in BWS (Laprise 2009). 
Angelman syndrome (AS) / Prader-Willi syndrome (PW) Angelman 
syndrome primarily affects the nervous system and can lead to delayed 
development. Normally, AS is caused by the loss of function of certain 
genes on the maternal chromosome 15, due to gene deletions through 
paternal uniparental disomy (Laprise 2009) (inheriting two alleles from 
the father and none from the mother). Less than 5% of AS/PW cases 
are due to imprinting errors in the gene SNRPN DMR, however, all cases 
associated with ART are due to loss of methylation on the maternal 
allele of this gene (Laprise 2009). This suggests that there is something 
about ART procedures that is increasing the incidence of AS/PW caused by 
epigenetic alterations. 
Silver-Russell syndrome (SRS) Silver-Russell syndrome is a 
slow growth disease characterized by intra-uterine and postnatal growth 
retardation (Rossignol et al. 2008), resulting in low birth weight and failure 
to thrive (Laprise 2009). SRS is a “sister” disease to BWS, as it is also 
due to epigenetic errors in genes on chromosome 11. Two-thirds of cases 
are due to hypomethylation of H19/IGF-2, while the remaining cases are 
due to  epigenetic mutations on other chromosomes (Laprise 2009). 
 
 
Finally, X chromosome inactivation is crucial during 
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development of females in order to compensate for the second set 
of genes that they receive through their XX pair. This adjustment 
of gene dosage is necessary because a male’s Y chromosome is 
smaller and carries fewer genes compared to the X chromosome. 
X chromosome inactivation is carried out by condensing it 90% 
into inactive, tightly packaged heterochromatin. Epigenetic marks 
aid in the process of DNA condensation that mediates X- 
inactivation (Market Velker et al. 2012). 
Given the timing of in vitro fertilization relative to epigenetic 
remodeling, there is a possibility that procedures will disrupt 
imprinting erasure/re-imprinting and alter the epigenome (Laprise 
2009; Feng et al. 2011). 
 
6.3.2 Contributing to the Development of Imprinting Diseases: 
The In Vitro Environment 
Despite efforts to simulate the female reproductive 
environment, a Petri dish cannot replace a uterus and fallopian 
tubes. The natural environment is extremely complex and cannot 
be completely recapitulated by the type of media and incubators 
used for embryo culture. Variables introduced by this artificial 
culture environment include composition of the medium, the 
addition of serum albumin, temperature, and the oxygen/CO2 
concentration at which the gametes and embryos are incubated. 
Studies on in vitro culture media have concluded that embryo 
culture affects global DNA methylation patterns, chromatin 
remodeling and gene expression (Market Velker et al. 2012; Feng 
et al. 2011). Early embryo development is programed to be flexible 
enough to respond adaptively to the environmental changes that 
occur as the embryo moves from the fallopian tubes to the uterus, 
and then implants (Johnson 2005). However, when subjected to the 
vagaries of artificial culture conditions, researchers suspect this 
adaptive quality is subverted. Studies have also examined the 
effects of adding serum albumin to culture media (Bavister 1995). 
Serum albumen is a supplement used to enhance cell viability   and 
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growth. Mouse studies showed that the addition of serum resulted 
in changes in the methylation and expression of numerous 
imprinted genes, including H19 and IGF-2 (Khosla et al. 2001; 
Market Velker et al. 2012). It is hard to predict the epigenetic 
consequences of media supplementation upon human embryos, 
however the addition of both serum and serum substitutes has been 
used for several years to improve human embryo viability and 
implantation success (and we are not even discussing the  subtle 
and proprietary changes that for-profit clinics might deploy). 
The temperature at which embryo culture occurs is not as 
homeostatic as the temperature an embryo would experience in 
vivo, and this may also introduce epigenetic effects. The 
eggs/embryos in their Petri dishes are removed from the incubator 
for observation under microscopes. The transition from one venue 
to another, or from the incubator to the transfer pipette, and then 
into a womb introduces temperature swings and physical stress. 
Finally, oxygen/CO2 levels in the female reproductive 
environment are dynamic from pre-implantation through to post- 
implantation and are crucial to the development of the embryo. 
However, embryos are often cultured in vitro at a static 
concentration of 20% or 5% oxygen, and removal from the culture 
chamber to the microscope introduces new variability. Therefore, it 
is possible that inappropriate gas concentrations (and attendant 
shifts in pH) could impair the development of the embryo, 
genetically or epigenetically (Rinaudo et al. 2006; Nelissen et al. 
2011; de Waal et al. 2014). In summary, the abnormal environment 
in which gametes are stored and fertilized, and where early embryo 
development takes place could affect the embryonic epigenome 
(Laprise 2009). 
Additional factors could also impinge upon success and the 
epigenetic health of the embryo. First, the physical and chemical 
manipulations that gametes and embryos undergo during the in 
vitro process could not only introduce DNA damage, but could 
also  damage  the  established  epigenome.  Second, superovulation 
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and use of immature sperm could alter the genomic imprints that 
are formed during gametogenesis or introduce incompletely 
imprinted sperm to the egg. Imprint marks are still being 
established in oocytes during meiosis. Therefore, the use of 
gonadotropins during superovulation procedures may have an 
epigenetic impact, perhaps by restricting the amount of time 
available for imprint acquisition. Although imprint marks are 
established before meiosis in sperm, immature sperm might not be 
fully developed or the use of immature sperm may cause imprint 
changes in the resulting embryo (Laprise 2009). 
Finally, the Intra-Cytoplasmic Sperm Injection (ICSI) 
procedure could lead to media or acrosome pieces (pieces lost 
during normal fertilization) being introduced into the egg, or to a 
physical disruption in the egg via the micropipette (Maher et al. 
2003; Kalra et al. 2011). Both of these situations could affect the 
embryo’s epigenome. 
 
6.3.3 In Vitro Fertilization and Low Birth Weight 
Low birth weight and pre-term birth have been associated with 
assisted conception and reproduction (Schieve et al. 2002; 
MacDonald et al. 2009; Kalra et al. 2011). It is hypothesized that 
low birth weight and pre-term birth could be due to epigenetic 
alterations that arise during IVF procedures. Potential factors that 
could induce low birth weight or pre-term birth include ovarian 
stimulation, oxygen tension, culture media type, serum addition, 
and multiple embryo implantation. 
There may be a link between the use of exogenous hormones to 
induce superovulation, and birth weight. By comparing live births 
from fresh embryo transfers (where the maternal environment had 
just experienced ovarian stimulation) with cryopreserved or 
frozen-thawed embryo transfers, researchers were able to compare 
the effects of these stimulatory hormones (Kalra et al. 2011). 
Interestingly, there was a higher incidence of low birth weight in 
children  conceived  after  fresh  embryo  transfer.  Might  freezing 
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have mitigated otherwise damaging hormone concentrations and 
effects? Could subtle damage induced by freezing have elicited 
impromptu repairs? While the mechanism by which low birth 
weight occurs is currently unknown, one possibility is that the 
reproductive environment (altered by exogenous hormones) affects 
epigenetic marks either within the placenta or the embryo during 
early development (Kalra et al. 2011). 
As previously discussed, oxygen tension (de Waal et al. 2014) 
and culture conditions (Johnson and Krasnow 1990; Market Velker 
et al. 2012) during embryo transfer affect epigenetics: these 
changes could lead to low birth weight or pre-term birth. Some 
studies have also concluded that embryo culture is the reason 
behind the higher risk for low birth weigh in IVF singletons 
(Dumoulin et al. 2010). Other studies, however, suggest that there 
is no significant relationship (Carrasco et al. 2013; Lin et al. 2013). 
Could these disparities be due to undisclosed and proprietary 
differences in embryo culture and transfer practices? Changes in 
the methylation and expression of imprinted genes such as  H19 
and IGF-2 have been reported (Market Velker et al. 2012). This is 
important because these genes are involved in growth development 
and the development of imprinting disorders. In fact, the use of 
serum in procedures used to propagate domestic  livestock  has 
been associated with Large Offspring Syndrome (Walker et al. 
1996; Market Velker et al. 2012) and Beckwith-Wiedemann 
syndrome in humans. 
During embryo transfer, often more than one embryo is 
implanted into a woman’s uterus in order to maximize the chance 
of pregnancy. Sometimes multiple embryos implant and begin to 
grow, with some terminating over the course of gestation – 
generally between 5 and 10 weeks; this is known as a “vanishing 
twin” (De Sutter et al. 2006). Singletons that result from a double 
embryo transfer (due to a vanishing twin) imply a suboptimal 
implantation environment. This environment could contribute to a 
higher miscarriage rate and less-than-ideal placental   development 
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and fetal growth leading to lower birth weight (De Sutter et al. 
2006). It is not known if this environment affects the epigenetic 
health of the remaining fetus. Alternatively, another simple 
explanation might be that in the first place, procedures are being 
deployed to aid embryos that are in some way already sub-optimal 
(see section 6.3.4 below). In summary, the loss of embryos  over 
the course of harvest, culture, transfer, and implantation may be 
the result of technical deficits, procedural insults to the embryos, or 
merely to poor egg or embryo quality. and distinguishing between 
the possibilities will not be trivial. 
Assisted reproductive technologies have provided many people 
with the welcome option to reproduce. Given the potential for 
imprinting diseases, low birth weight, pre-term birth and intra- 
uterine diseases, it is crucial to confirm or refute the relationship 
between ART and disease development. Moreover, studies based 
on animal models should only be extrapolated with caution to the 
human reproductive process: significant differences exist between 
species with regard to both fertilization and development  (Iliadou 
et al. 2011). Furthermore, there are no long term studies that track 
the development of IVF babies into late adulthood: IVF is a 
relatively recent procedure, so these children are not old enough to 
reveal late-onset diseases (Johnson 2005). Moreover, they are only 
just beginning to have children of their own, and trans/multi- 
generational effects will need to be assessed. Finally, the 
epigenetic effects of superovulation upon the mother or egg donor 
are still not clear. So, in reality, many of the epigenetic 
consequences of ART and IVF remain unknown and some people 
have suggested that a discussion is required regarding whether it is 
ethical to continue ART under these circumstances (Amor & 
Halliday, 2008; Rothstein et al., 2009; von Wolf et al., 2015). 
 
6.3.4 The Condition of Infertility 
An alternative hypothesis as to why IVF may result in 
imprinting   disorders   is   that   the   condition   of   infertility    or 
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subfertility is what is responsible for the epigenetic alterations, not 
ART procedures. If a reproductive system is not able to: produce 
gametes; undergo sperm-egg fusion; permit the embryo hatch from 
blastocyst stage or to implant properly, there must be a nutritional 
or physiological deficit, or one or more mutations that are 
inhibiting these processes. Therefore, by artificially aiding the 
reproductive process, these traits are being passed along to the next 
generation despite the fact that they are suboptimal. These genetic 
mutations and/or epigenetic alterations may be inherited  by the 
next generation and may unfortunately manifest as imprinting 
disorders. 
An example of one IVF procedure where this might be the 
case is ICSI (Intra-Cellular Sperm Injection), which was originally 
thought to be the direct cause of ART-related imprinting diseases. 
ICSI compensates for unhealthy or weak sperm that are not able to 
travel to the egg or to fertilize it without assistance. Therefore, 
ICSI circumvents fertilization barriers that have been imposed by 
evolutionary pressures (Laprise 2009). Ergo, it is possible  that 
these suboptimal sperm carry DNA damage that affects the 
epigenetic imprinting process, and that these deficits are being 
passed onto the offspring (Maher et al. 2003; Laprise 2009). 
Numerous studies have looked into this hypothesis and found that 
children were more likely to have imprinting disorders related to 
subfertility rather than ART (Vermeiden and Bernardus 2013). 
Thus, the quality of the gametes used should be taken into 
consideration and perhaps gametes with DNA damage or genomic 
imprinting defects should be avoided if possible (although it is by 
no means clear how this would be assessed – the ability to detect 
and exclude these gametes is not yet feasible). Also, in extreme 
cases, we knowingly use immature eggs or sperm if the male or 
female cannot produce fully matured gametes: this raises both 
practical and ethical issues (Laprise 2009). Likely, it is a 
combination of both the condition of infertility and ART that  play 
a role in the disruption of epigenetic marks and the development of 
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relevant diseases. 
Continued studies on ART- conceived children and adults, 
especially long-term studies, are necessary in order to better 
understand the relationship between epigenetics, ART, and disease. 
ART-conceived adults are beginning to have their own children 
now, and this could provide the opportunity to investigate the 
trans-generational effects (genetic or epigenetic) of these 
procedures. 
We have learned that the pre-conception and conception 
conditions, intrauterine environment, and external experiences of 
mothers during pregnancy can alter methylation patterns in a fetus. 
From this arises the important ethical issue of  responsibility. 
When a drug, environment, or personal decision has deleterious 
epigenetic effects for descendants two generations down the line, 
who bears responsibility for the pain and suffering that they 
endure? When a wrong has been done by people who actually 
abided by the laws of their time, can blame fairly be placed from 
the perspective and situation of more recent technological and 
ethical standards? It easy to say that it is a pregnant woman’s 
ethical obligation to create a healthy environment for her fetus, and 
that this should include avoiding drugs and dangerous work 
environments. How practical is this though, when there are social, 
economic, and cultural influences that might subvert such care? 
Given that epigenetic harms can be absorbed even before 
conception, where should lines of obligation and responsibility be 
drawn? Methylation or histone acetylation modifications incurred 
before conception or during gestation can alter gene expression in 
life outside the womb, and in this sense, biological science could 
be used to further question the “starting point” of life. Currently in 
Canada for example, criminal law does not limit abortion, nor are 
fetuses deemed to be persons (section 223 of the Criminal Code of 
Canada), thus it can be inferred that women have no legal 
obligation to their fetuses. In the process of determining legal 
responsibility,  epigenetic  studies  could  reopen  the  legal “when- 
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does-life-begin” debate. This will be tricky legal, ethical, and 
social terrain indeed. 
 
6.4 Oral Contraceptives 
Oral contraceptives can be used for a variety of reasons, but 
are generally used to treat menopausal disorders, to control a 
woman’s menstrual cycle, and to prevent pregnancy (Hilakivi- 
Clarke et al. 2013). Oral contraceptives may also be referred to as 
“synthetic estrogens” despite the fact that they contain a mixture of 
steroid hormones including estrogens and progesterones. 
Oral contraceptives prevent pregnancy by preventing the 
pituitary gland from producing the hormones (LH and FSH) 
necessary for the ovaries to release a mature egg. Furthermore, oral 
contraceptives thicken cervical mucus making it more difficult for 
sperm to travel toward the fallopian tubes. Finally, oral 
contraceptives thin the lining of the uterus so that implantation of a 
fertilized egg cannot occur. Despite the fact  that combined 
hormone oral contraceptives work by preventing  fertilization, 
many of the ethical questions surrounding the use of oral 
contraceptives stem from what some critics define as an essentially 
abortive function. This stance questions a woman’s right to control 
her bodily and reproductive functions,. Tangentially, even though 
there may be medically pertinent reasons to prescribe  the 
hormones to teenagers in order to regulate the menstrual cycle, 
some critics have voiced concerns that this will encourage early 
sexual behavior. 
 
6.4.1 Oral Contraceptives and Cancer Risk 
Since oral contraceptives disrupt certain endocrine axes, their 
potential for epigenetic effects on various cells and  tissues has 
been the focus of recent studies. Many epigenetic effects are being 
investigated including an increased risk of developing breast 
cancer, disruption of macrophage function, and changes in mRNA 
expression patterns of a wide variety of genes. 
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The link between estrogens and breast cancer appears 
controversial: some studies have confirmed a causative 
relationship, while others not (Lodha et al. 2011). An association 
between methylation on the estrogen receptor alpha CpG island 
(ERα) and breast tumor subtypes that exhibit a bleak prognoses has 
recently been identified (Izadi et al. 2012). Izadi et al. (2014) 
suggest that women who never experience a full term pregnancy or 
who wait until after 30 years of age to do so could permit 
circulating estrogens, natural or synthetic, and/or environmental 
carcinogens to induce aberrant methylation in breast tissues before 
they undergo pregnancy-triggered differentiation. Furthermore, 
some results suggest that exposure to synthetic estrogens may 
increase the risk of developing breast cancer not only in  the 
women who used these pills, but in their daughters as well 
(Collaborative Group on hormonal factors in breast cancer, 1996; 
Hilakivi-Clarke et al. 2013). The mechanisms underlying these 
trans-generational effects would presumably include epigenetic 
modifications of not only the affected mammary glands, but also of 
germ cells, thereby causing a heritable susceptibility to breast 
cancer development. 
By contrast to breast cancer, it has been well known and 
generally accepted for years now that oral contraceptives reduce 
the risk of ovarian cancer in women (Collaborative Group on 
Epidemiological Studies of Ovarian et al. 2008), only a few studies 
have examined the differences between high and low hormone 
dose regimens on cancer risk. One study found associations 
between high-dose progesterone and reduced risk, leading the 
authors to postulate that progesterone is the central component in 
the protective effect of oral contraceptives against ovarian cancer 
(Rodriguez 2003). Another found that low-dose progesterone 
offers the stronger protection (Lurie et al. 2007). However, one 
more recent study yielded interesting results that could possibly 
explain the ambiguous findings. Faber et al. (2013) illustrated that 
the estrogen potency in the oral contraceptive did not affect the 
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level of reduced ovarian cancer risk. Neither did progesterone 
alone reduce risk. The authors suggest that the protective effect 
may be due to anovulation (an egg-free menstrual cycle), finding a 
6% risk reduction for each year a woman took oral contraceptives, 
and this may be independent of estrogen and progesterone intake 
altogether (Faber et al. 2013). 
 
6.4.2 Other Epigenetic Side Effects 
Since oral contraceptives are ingested systemically, they 
disrupt the hormonal environment throughout a woman’s body and 
this has the potential to affect many biological functions, including 
the disruption of phagocytic macrophage functions. Macrophages 
in the bloodstream rely heavily on cues provided by the “milieu” in 
which they function. A decrease in global methylation was 
observed in the white blood cells of women that were exposed to 
synthetic estrogens. This hypomethylation is in turn  associated 
with a predisposition to atherosclerosis and other age-related 
chronic diseases. Furthermore, aberrant methylation of genes in 
white blood cells could impact immune function, potentially 
leading to very serious autoimmune diseases or failures to remove 
abnormal, pre-cancerous cells (Campesi et al. 2012). 
Abnormal methylation of DNA could have a plethora of 
consequences depending on the gene that is affected. A specific 
example of this is the altered expression of DNMT3a (DNA 
cytosine-5-methyltransferase 3a; a methyltransferase responsible 
for controlling gene methylation and the epigenetic imprint) within 
the developing rat amygdala following exposure to estradiol and 
dihydrotestosterone (Kolodkin and Auger 2011). The DNMT3a 
changes in turn affect multiple other genes, thereby perturbing 
amygdala function. As we will see in the chapter discussing the 
estrogen mimic diethylstilbestrol (DES, Chapter 8), there is a 
possibility that oral contraceptives may have many  more lasting 
and subtle epigenetic effects than presently appreciated. 
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6.4.3 Oral Contraceptives and Risk to Progeny 
From 1960 to today, the number of women using oral 
contraceptives in the United States has grown from about one to 
eleven million (Jones et al. 2012). In 1990, the annual FDA 
Consumer Report declared a general opinion (taken from 
government, medical, and public sources) in support of the safety 
and effectiveness of oral contraceptives. More recently, Strifert 
(2014) noted that the increased prevalence of autism spectrum 
disorder coincides with the increased use of oral contraceptives. 
He invokes the Knudson hypothesis that was developed to explain 
the development of cancer (Knudson 1971): an accumulation of 
“multiple hits” to the genome leads to cancer. In the case of autism 
spectrum disorder, oral contraceptive install the epigenetic changes 
necessary for Autism Spectrum Disorder to develop. The first “hit” 
is the damage done to the egg from continued use of the pill. The 
second “hit” could be epigenetic, environmental, or genetic and 
this compounding of damage is what yields an autistic  phenotype 
in the progeny (Stifert 2014). There is no direct evidence to 
establish a causal link between hormonal contraceptives and the 
disorder, so the relationship could just be coincidence. 
 
6.4.4 Estrogenicity of Drinking Water: Are Oral Contraceptives 
Part of the Problem? 
In vivo fish experiments have demonstrated the potency of 
EE2 (Ethinyl Estradiol-2, an artificial estrogen found in oral 
contraceptives) to be much higher than that of natural estrogens 
(E1, E2, E3) (Thorpe et al. 2003). Estrogen contamination of 
drinking water is a rising concern: the increase in intersex fish and 
human reproductive issues raises some alarms (Massart et al. 2006; 
Wise et al. 2011a). Natural estrogens (E1, E2, and E3) as well as 
synthetic estrogens (EE2) enter the water supply from many 
different sources (Table 6.1) (Velicu and Suri 2009). However, the 
compiled data depicts EE2 as playing a relatively small role in  the 
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total estrogenicity of drinking water. In The Netherlands, EE2 was 
found to account for about 1% of total human estrogen excretion, 
which is just one source of estrogens - in the United States, it is 
likely that the proportion of EE2 is less than 1% (Wise et al. 
2011a). 
Other noteworthy sources of estrogen include mimics in 
pesticides like: vinclozolin; organochlorine pesticides, a prime 
example being DDT; and atrazine, which is known to be extremely 
mobile in the environment (Thurman and Cromwell 2000; 
Solomon et al. 2008). Runoff of these pesticides are less potent 
than E2, however the quantities detected in surface waters are 
much higher and can produce deleterious effects on aquatic life at 
levels as low as 0.1 ppb (parts per billion) (Hayes et al. 2010). 
Although it has been roughly estimated that approximately 40% of 
the EE2 ingested reaches sewage as active EE2 (Johnson and 
Williams 2004), the amount of EE2 in relation to all the other 
estrogens contributing to the estrogenicity of drinking water poses 
a minimal risk to human health (Wise et al. 2011a). 
 
Source Waste 
Management 
Where does it 
go? 
Escapes 
Drinking 
water 
treatment? 
Measured 
in 
drinking 
water? 
Homes Treated Surface water YES YES 
Livestock Untreated Surface water YES YES 
Industry Treated Surface water YES YES 
Agriculture Untreated Ground water YES YES 
Landfills Untreated Ground water YES YES 
 
Table 6.1 Sources from which estrogen has the means to enter our 
water supply. Adapted from Velicu et al., 2009. 
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Only waste water from homes and industrial sources is treated 
twice. If our goal is to reduce the estrogenicity of drinking water, 
then we are going to have to look at all of the different estrogen 
sources and act on them. Wise et al., (2010) propose some general 
ways to address each identified source: improvements to waste 
water treatment, detection methods/monitoring, and estrogenicity 
tests; frequent chemical policy reform, since testing protocols and 
chemical information need updating; reduction in overall use of 
EE2; and further research in this area. 
Critics have strongly disagreed with the characterization that 
EE2 posed minimal health risk to humans (Grzybowski 2011). 
Performing his own calculations using the Dutch population 
statistics that Wise et al., (2010) presented, he concluded that EE2 
likely contributes 93% of estrogenicity in drinking water. He 
appears to have factored in a value for potency (20 times) that 
enormously increases results. 
197  
Embryos and Reproductive Epigenetics 
 
 
Figure 6.3 Estimation of percentage of EE2 from oral contraceptives 
before water treatment. EE2 is a clear contributor to increased water 
estrogenicity. The amount of active EE2 excreted and available in the 
system, even considering this is only an estimate, is astonishing. 
However, taking into account the detection rates of between 0 and 1 
per cent of EE2 in drinking water, we should have confidence in our 
water filtration and treatment plants and focus our attention on what 
we can do about other sources of estrogen coming into our drinking 
water. (Adapted from Johnson and Williams, 2004.) 
 
Wise and colleagues respond with a reiteration of two main 
points that perhaps they did not make clear in their original paper. 
The first point is that water treatment systems have become 
increasingly effective, so the amount of EE2 actually in the water 
that reaches our taps falls to virtually nothing (Wise et al. 2011b). 
But are the discussants talking about water treatment capacities   in 
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the same geographical areas, the same populations, etc.? Perhaps 
not all water treatment facilities are equally sophisticated. Wise et 
al. discussed Dutch data, and Grzybowski references German data. 
Depending on the population and its practices, the amount of 
natural and synthetic estrogens coming into the system  could 
differ. The second rebuttal point stressed by the authors is  that 
there are many other overlooked sources of estrogenenic 
compounds that can be just as harmful as EE2 from oral 
contraceptives (Wise et al. 2011b). There are still natural estrogens 
from human waste and untreated agricultural runoff, estrogenic 
plant compounds, and even other synthetic estrogens from 
industrial waste. EE2 from oral contraceptives likely plays a role in 
the estrogenicity of drinking water, but it is not a big enough role 
to be solely responsible for this growing concern. We must look to 
all estrogen sources if we want to address the issue. 
 
6.5 Birthing Method 
Dahlen et al. (2014) invites those who argue for medical 
intervention during labour and delivery to take a moment and 
consider what is being given up. These authors argue that 
physiological birth - normal vaginal delivery without medical 
intervention - could be key to the health and stability of not only 
the baby, but the future children of that baby. Our birthing day 
could be a much more significant event in our epigenetic 
construction than we have given it credit (Dahlen et al. 2013; 
Dahlen et al. 2014). EPIIC (Epigenetic Impact of Childbirth) is a 
group that specifically studies the epigenetic effects of childbirth. 
The EPIIC hypothesis posits that the physiological birth process, 
from labour to delivery, is in place to exercise purposeful and 
positive stress on the fetus in preparation for life outside the uterus. 
The argument is advanced that birth epigenetically programs 
specific genes involved in calibrating immune response, 
controlling weight regulation, as well as suppressing tumors. These 
changes to the epigenome are heritable and could conceivably lead 
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to lifelong, perhaps trans-generational, consequences to health 
(Dahlen et al. 2013) 
During a vaginal delivery, contractions of the uterus and 
fetal hypoxia stimulate a significant perinatal stress  response. 
There is an increase in stress hormones like cortisol and 
catecholamines, which serve to: mobilize fuel for the journey 
through the birth canal; trigger lung-liquid reabsorption to facilitate 
air-breathing after birth; and to activate the hypothalamic-pituitary- 
adrenal axis. These processes contribute to the maturation of 
certain organs, the nervous system, and the immune system 
(Schlinzig et al. 2009; Cho and Norman 2013). This increase in 
stress hormones is different in babies delivered by elective 
Cesarean section: concentrations rise rapidly and suddenly as 
opposed to the gradual increase that is experienced during vaginal 
birth. This altered perinatal stress pathway might have epigenetic 
consequences via modification of gene methylation  (Schlinzig et 
al. 2009). Altered DNA methylation has been observed in 
glucocorticoid receptors in the hippocampus, which leads  to 
higher stress sensitivity, and in genes involved in the pathway that 
regulates T-helper cell type populations, possibly contributing to 
the development of immune diseases (Cho and Norman 2013). 
 
6.5.1 Medical Intervention During Birth - The Caesarean 
Section 
There is no question that Caesarian deliveries save lives. 
However this procedure has expanded beyond necessary  to 
elective use. During an elective Cesarean section, an incision is 
made in the lower abdomen in order to remove the baby without 
having it pass through the birth canal. Since Cesarean sections are 
surgical procedures, there are potential issues and complications 
that do not arise during a vaginal birth. This could cause the 
mother or baby more harm if the procedure is carried out 
inappropriately. On one hand, a physician must respect their 
patients’ decisions, but also must not expose the mother or baby  to 
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unnecessary harm (Muula 2007). 
Hematopoietic stem cells were extracted from the 
umbilical cord and analyzed for differential methylation between 
infants born by Caesarean section and infants born by vaginal 
delivery (Almgren et al. 2014). Cesarean newborns showed more 
methylation than vaginally delivered newborns and these results 
were independent of maternal and infant characteristics such as 
age, weight, gender, and parity. Just over half of the differentially 
methylated positions were linked to known genes. Surprisingly, 
about three quarters of the differentially methylated positions  in 
the Cesarean newborns were hypomethylated when compared to 
the vaginally delivered newborns. Affected genes were mainly 
those with responsibilities in the metabolism of sugar, and in 
regulating cell apoptosis. At least one gene related to the immune 
system was differently methylated, and this particular gene has 
strong associations with a genetic predisposition to type I diabetes 
(Lie et al. 1999; Almgren et al. 2014). 
The clear evidence that the epigenetic profile of the 
hematopoietic stem cells in umbilical cord blood is altered  by 
mode of delivery could become an issue for umbilical cord blood 
banks. Can this blood be used for transplants if it is not 
epigenetically programmed? Almgren et al. (2014) theorize that 
these differentially methylated positions do not take immediate 
effect, but rather require a successive “hit” or “hits” to trigger 
disease. The next logical step is to compare adolescent and adult 
hematopoietic stem cells of Cesarean versus vaginally delivered 
individuals to see whether or not the differentially methylated 
positions retain their epigenetic marks over a lifespan. Cesarean 
sections lead to a higher incidence of certain diseases including: 
asthma, allergies, lower respiratory infections, type 1 diabetes, 
celiac disease, peripheral and central adiposity, obesity, and 
inflammatory bowel disease (Magnus et al. 2011; Azad and 
Kozyrskyj 2012; Bager et al. 2012; Cho and Norman 2013; 
Flemming et  al.  2013;  Mesquita et  al.  2013). So, not  only is our 
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birth day a critical life event, but perhaps more importantly our 
birth way makes all the difference: unquestionably, emergency 
Caesarian sections can save lives, but how should  physicians 
weigh the cost/benefits of the procedure, and how much should we 
worry about elective procedures? 
 
6.5.2 The Cesarean Section and the Microbiome 
The human body is covered in mutualistic and commensal 
microorganisms that constitute our normal microbiota (Penders et 
al. 2006). In utero, however, humans are generally considered to be 
microbe-free (although this has recently come under scrutiny – see 
Aagaard et al., 2014; Romano-Keeler et al., 2015). It is during 
birth that normal microbial populations are established in the 
infant. These microbes are acquired primarily during the journey 
through the birth canal, and then later from the environment when 
breathing, breastfeeding, and contact with the parents begins. 
Babies delivered vaginally are colonized by bacteria from the 
mother’s birth canal and perianal region, while those delivered via 
Cesarean section are colonized by bacteria from maternal and non- 
maternal skin, and from the hospital environment (Penders et al. 
2006; Cho and Norman 2013). The “hygiene hypothesis” suggests 
that an altered neonatal gut microbiome leads to changes in the 
neonatal immune system, potentially predisposing babies to 
develop certain diseases such as asthma and allergies (Schlinzig et 
al. 2009). Gut bacteria prime the immune system (Penders et al. 
2006) and change the proportion of T-helper cell types so that the 
immune system can mature. A disrupted balance of microbes in a 
neonate’s gut could prolong this maturation period and impair 
functional efficiency. This in turn increases the risk for immune 
diseases later in life (Schlinzig et al. 2009). Moreover, it is also 
important to note that babies delivered by Cesarean section are 
more likely to receive antibiotics: the composition of the neonate’s 
microbiota can be changed for years. An altered  microbiome 
would  result  in  unusual  metabolite  production.  These metabolic 
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products could in turn alter the environment for developing cells, 
influence epigenetic marks and change the expression of certain 
genes. These are confounding factors when discussing the 
differences in the microbial flora of babies that were delivered 
vaginally as opposed to by Cesarean (Schlinzig et al. 2009). 
Notwithstanding these differences and influences, the establishing 
human microbiome can both alter, and be influenced by, numerous 
factors and biological processes, including epigenetic regulation. 
 
6.5.3 Medical Intervention During Birth - Epidural Analgesia 
and Pitocin 
Epidural analgesia, more commonly referred to simply as an 
epidural, is a common and effective pain reliever during labour. An 
epidural injection contains a combination of low doses of local 
anaesthetic and opioid. Epidural analgesia desensitizes the mother 
and blocks the pain of uterine contractions. Another effect of an 
epidural is paralysis in the lower body. What does this mean for 
the physiological birth process if the woman is disconnected from 
sensation of her body? Data taken from a large cohort of women in 
Australia showed that one of these effects is a higher risk of 
Caesarean section after administration of an epidural (Bannister- 
Tyrrell et al. 2014). Fetal distress is listed as the reason for 
intervention in a small fraction of cases: the epidural seems to be 
putting more than just a block on the pain, it appears to be slowing 
labour to the point of having to perform a C-section (Bannister- 
Tyrrell et al. 2014). One tool to jump start a slow or  stalled 
delivery is to administer oxytocin to the mother. 
Pitocin, or synthetic oxytocin (synOT), is also a usual 
intrapartum (period of time between pregnancy and delivery) 
intervention. It is used to increase the frequency and intensity of 
contractions with and without epidurals (Bell et al. 2013). If 
Pitocin is administered before an epidural, the contraction pain 
becomes too intense to bear without anesthetic aid. Thus, most of 
the  time,  Pitocin  and  epidural  analgesia  go  hand-in-hand.       It 
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culminates in an increased chance of ending by Caesarean section. 
As with  research on  effects  of  epidural  analgesia, studies on 
Pitocin outcomes are just beginning to surface. One of the first 
discovered effects that synthetic oxytocin can have on  a 
developing neonate brain is higher risk for Autism Spectrum 
Disorder (ASD). Studies have shown a solid predictive correlation 
between synthetic oxytocin administration and development of 
ASD later in childhood (Kurth and Haussmann 2011). Oxytocin 
administration correlates with childhood onset of ASD almost 2:1 
compared to controls. Additionally, male infants  exposed to 
Pitocin appeared to have higher risk of developing ASD, although 
the authors admit this could simply be because of the fact that ASD 
is generally more frequent in males (Kurth and Haussman, 2014). 
Another consequence of synthetic oxytocin for the baby is 
less optimal levels of pre-feeding cues and breastfeeding behavior 
(Olza Fernandez et al. 2012; Bell et al. 2013). This latter group 
saw medium-low levels of pre-feeding cues and organization in 
75% of infants with mothers who had intrapartum oxytocin. In 
contrast, 100% of the infants with mothers who had no oxytocin 
had medium-high levels of pre-feeding cues and organization. 
Education is the key in creating an informed birth plan and 
in helping to make tough choices during labour and delivery. 
 
6.6 Breastfeeding 
Whether or not to breastfeed is an important decision that 
must be made by every new mother. It is also the topic of an 
ongoing ethical debate. Breast feeding has been associated with 
many benefits, including the provision of antibodies and vital 
enzymes to protect the baby and aid in immune system 
development (Jackson and Nazar 2006), as well as providing an 
overall increase in neurocognitive function (Quinn et al. 2001). 
Breast milk contains secretory IgA antibodies that can protect the 
baby from harmful pathogens, and with leukocytes, that are 
thought  to  influence  immune  system  development. Furthermore, 
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breast milk contains lysozyme (which destroys bacterial  cell 
walls), lactoferrin (which removes excess iron to stop microbial 
growth), as well as nucleotides and complex sugars (which help 
fight off pathogens and aid in immune system development) 
(Jackson and Nazar 2006). Breastfeeding has also been shown to: 
increase the size of the thymus gland, whose function is T 
lymphocyte development and maturation; cause an increased 
immune response to childhood vaccines; protect individuals from 
allergies and the development of autoimmune disorders (Azad and 
Kozyrskyj 2012); and to prevent the development of diabetes 
mellitus (Jackson and Nazar 2006). Breast milk also appears to aid 
in neurocognitive function, resulting in babies with higher IQ’s 
(Quinn et al. 2001). Moreover, breast milk is free, does not allow 
for extreme over-feeding, and can help mothers to lose weight. 
However, noxious substances like polychlorinated biphenyls 
(PCBs), polycyclic aromatic hydrocarbons (PAHs) and infectious 
diseases (HIV/AIDS) can also be passed from mother to baby via 
breast milk. Furthermore, breastfeeding may be painful and some 
people still consider it inappropriate or unacceptable to breastfeed 
in public. 
 
6.6.1 Breast Milk and the Epigenome 
Breast milk is a biologically active substance that includes 
genetic materials, such as miRNAs, stem cells, and organic 
substances that affect epigenetic marks and  gene expression 
(Ozkan et al. 2012). Studies have also indicated a relationship 
between post-natal nutrition, the microbiome, and epigenetic 
regulators that influence development and the predisposition to 
certain diseases. Therefore, if transmitted through breast milk to a 
baby, this material has the potential to alter epigenetic marks 
(Ozkan et al. 2012). 
The presence of stem cells that are harbored in the baby, 
but that are derived from the mother or prior siblings in the birth 
order  is  known  as  microchimerism.  These  “foreign”  stem cells 
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might also play a role in development, particularly of the immune 
system (Miech 2010; Chan et al. 2012). Breast milk is a significant 
source of maternal-fetal microchimerism (Dutta and Burlingham 
2010), and the maternally derived cells may persist in the offspring 
for years: they could perform unknown epigenetic effects. 
Furthermore, it has also been hypothesized that early post- 
natal nutrition (breast or formula feeding) epigenetically programs 
certain organs via the gut microbiome (Mischke and Plosch 2013; 
Figure 6.4). The epigenome of intestinal cells and first  line 
immune cells would be most susceptible to these changes, but so 
would other tissues that come into contact with microbial 
metabolites, such as fat and liver cells. This is because foods cause 
adjustments to the composition of gut microbiota: changing the 
type microbes present alters the cocktail of metabolites released. 
Studies indicate that breast milk stimulates the development of a 
microbiome dominated by carbohydrate-fermenting bacteria like 
bifidobacteria and ruminococci, which produce large amounts of 
the secondary metabolite folate. Folate is an essential compound in 
one-carbon metabolism that provides methyl groups to regenerate 
S-adenosyl methionine (SAM). SAM in turn provides the methyl 
groups for DNA methylation. Thus, these bacteria play a role in 
DNA methylation (and subsequently histone modification), 
potentially altering epigenetic marks in certain tissues (Mischke 
and Plosch 2013). On the other hand, formula contains more 
proteins in order to compensate for low protein quality. More 
protein therefore travels to the colon and causes an increase in the 
growth of proteolytic bacteria such as the firmicutes lactobacilli, 
clostridia, and streptococci that produce butyrate. 
Butyrate is the product of microbial fermentation of 
undigested carbohydrates and proteins. It serves as an energy 
substrate and therefore contributes to fat accumulation, but it also 
inhibits the actions of histone deacetylases. This means that in the 
presence of high levels of butyrate, histones could remain hyper- 
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Figure 6.4 Epigenetic pathways initiated by the reception of breast 
milk or formula respectively. Adapted from Mischke,  2013. The 
type of nutrients a baby receives is able to cause life-long metabolic 
changes. Breast milk has been shown to nourish bacteria that 
promote DNA methylation. This leads to a decrease in gene 
transcription and is associated with the development of certain 
characteristics (tend of be leaner as an adult, increased levels of 
intelligence, and increased immune response to vaccines). Formula- 
fed infants tend to have different gut bacteria that promote histone 
acetylation, which in turn promotes gene transcription. This leads to 
the development of other characteristics (predisposition to obesity, 
cancers, and cholesterol and lipid metabolism and storage 
disorders). 
 
acetylated, resulting in the epigenetic changes that lead to up- 
regulation of  certain  genes. This mechanism of   hyperacetylation 
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has been implicated in various cancers, sickle cell anemia, as well 
as cholesterol, lipid metabolism and storage  disorders (Mischke 
and Plosch 2013). Studies have linked these microbial mechanisms 
to the incidence of obesity in breast fed versus formula fed 
children: breastfed children are generally leaner well  into 
adulthood (Mischke and Plosch 2013). None of the aforementioned 
precludes a role for the bacteria that are transferred from mother to 
child by the intimate contact of breastfeeding. More research is 
required to understand the role of epigenetics as a link between 
breast milk and offspring characteristics/ disease development. 
 
6.7 Maternal Programming 
We still struggle with questions of nature versus nurture: 
how much of who we are is genetic and how much is influenced by 
our experiences? Studies of twins, for example, provide a way of 
exposing those differences that are derived solely from 
environmental variables (Haque et al. 2009). Now, mechanisms of 
methylation and histone modifications offer an entrée to solving 
this puzzle: environment, genetics, epigenetics, and psychology 
have never been more entwined. Any infant’s environment 
includes a caretaking individual(s) who shape(s) the infant’s 
immediate world. Early nurturing or rearing deficits now appear to 
lead to epigenetically encoded mental stability or disorders 
respectively in later years (Sullivan and Lasley 2010). 
One such disorder is chronic physical aggression (CPA). 
This behavior constitutes an aggression that usually diminishes 
before kindergarten but that instead persists through to adulthood 
with predictable consequences for criminality and family stress. 
Provencal et al. (2013) studied a group of males diagnosed with 
childhood physical aggression on a CPA trajectory and found they 
showed lowered cytokine activity, associated with epigenetic 
modification, compared to the control group. The underpinning 
causes of the association between CPA trajectory and methylation 
remains a prominent question (Provencal et al. 2014; Provencal   et 
208  
al. 2015): which came first: the methylation or the childhood 
physical aggression? What events during fetal development or 
extremely early infant life could be contributing factors? For a 
more on this study, refer to Chapter 7. 
 
6.7.1 Imprinted Maternal Care Behavior 
In rats, mothering behaviors can be inherited and some of 
this character may be transferred across generations when the 
mother fails to nurture sufficiently, and the pup is stressed. This 
has an impact upon its epigenetic imprint: if a female pup was 
cared for by a good mother, the pup grew up to be a good mother 
herself and treat her pups to the same high standard of 
licking/grooming care to which she had been treated (Sapolsky 
2004; Weaver 2007; Weaver 2009). Other studies corroborated 
these results, and demonstrated the epigenetic mechanisms that 
underpinned the perpetuation of this behavior: a gene in the stress 
response pathway, glucocorticoid receptor, is marked by post-natal 
experience. Pups absorbed not only maternal caregiving attributes, 
but differential sensitivity to stress. The imprint is reversible by 
fostering. Subsequently, another gene in the stress response 
pathway, brain-derived neurotrophic factor (BDNF) was found 
to be affected by maternal care patterns (Blaze et al. 2013). Pups 
that were maltreated by their caregivers and pups that were pulled 
away from their biological mothers, even though they were well- 
nurtured by their foster caregivers, all had significant methylation 
on their BDNF gene. Finally, the effects of fear and stress upon 
the epigenome, during early and adult life, can be passed on to 
progeny (Sullivan and Lasley 2010; Dietz et al. 2011). These 
features are discussed in more fulsome manner in Chapter 7, but 
they raise concerns for the effects of parental care and skills upon 
epigenetic health in humans. 
 
6.7.2 Depression and Suicidal Tendencies 
Unfortunately,  depression  is  a  common  mental condition 
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that can open the gateway to even more serious conditions such as 
Major Depressive Disorder (MDD), otherwise known as clinical or 
unipolar depression. This condition is usually a crucial casual 
element of suicidal behavior (Dwivedi 2009). We know that 
epigenetics is a factor in susceptibility to depression, MDD, 
suicidal behaviors, as well as other psychological disorders. 
Programmed cell death, or apoptosis, can be caused by pan75 
neurotrophin receptor impairment. Neurotrophins, are proteins that 
help to maintain the function, growth and survival of neurons. The 
methylation status of BDNF and pan75 is linked: low activity of 
the BDNF gene impairs the availability of the pan75 receptor. 
Suicidal behavior is also associated with lower expression of the 
BDNF gene and the TrkB receptor. The reduced expression of both 
of the genes is partly due to methylation changes that  are 
detectable in autopsy specimens of suicide victims. Clearly, 
suicidal behavior may have a more complex etiology than formerly 
supposed (Dwivedi 2009). The experience of depression and its 
consequent effects upon the epigenome are not tied solely to the 
individual who experiences them. Recall in the beginning of the 
chapter we explored the epigenetic effects of depressed mothers on 
fetuses during gestation. This kind of cyclical epigenetics is part of 
what makes causative relationships so extremely difficult to define. 
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CASE STUDY 6.4 – Post Traumatic Stress Disorder (PTSD) 
 
Adverse social environments, in utero challenges to infant biology, 
a history of familial PTSD, and traumatic childhood experiences such as 
sexual or physical abuse are all ways in which epigenetic mechanisms play 
a role when it comes to vulnerability to PTSD (Yehuda and Bierer 2009). 
We, like rats, are all born with a pre-programed attachment system 
allowing us to identify, remember, and bond with our primary caregivers. 
In a healthy environment, the caregiver is strongly associated with safety, 
effectively turning off fear. On the other hand, in an abusive environment, 
a child can become desensitized to the difference between safety and fear. 
Instead of turning off fear, the attachment system turns off the ability to 
fear, because no matter what we always seek out attachment in early life 
(Sullivan and Lasley 2010). In rats, Sullivan and Lasley (2010) found that 
once the rats became older and started to venture from  the  nest, their 
ability to learn fear from outside the nest functioned properly and they 
demonstrated behaviour comparable to repressing and possibly snuffing 
out previous fear, avoidance, maybe even memories, associated with the 
nest. The same could be thought to occur in adults who experienced abuse 
as children (Sullivan and Lasley 2010). The likelihood of an underlying 
epigenetic connection is a topic for further research. 
 
 
 
 
 
6.8 Conclusions 
Evidently, some conditions might not necessarily be the 
consequences solely of our life choices – we may inherit 
predilections from our progenitors and  environment.  This raises 
the question of whether epigenetic mechanisms will be used as a 
scapegoat. Will we take responsibility for what we can control, or 
will we evade it claiming that ultimately our health and behavior is 
the fault of various external drivers of our methylation status? 
Because methylation can change over a lifetime and generations, it 
is extremely difficult to know which epigenetic markers are 
inherited, which are acquired through our own life choices, nor 
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which are combinations of both and to what degree. 
Remediation is not necessarily impossible: when two 
Agouti mice homozygous for the Agouti mutation mate and 
conceive pups, the pups will inherit the Agouti coat colour and 
obesity traits. However, if during pregnancy, the mother is fed a 
methyl-rich diet, it changes the activity of the Agouti gene. In this 
case, too, methylation patterns can be improved (Waterland and 
Jirtle, 2003). Epigenetic alterations can be large or small. They can 
affect any chromosomal region, and thereby alter patterns of gene 
expression. We have only begun exploring all of the epigenetic 
pathways connecting environment, gene expression, and behavior. 
So what is a responsible strategy to pursue if we want to be 
healthy and to provide the best for our prospective descendants? 
We should live in a way that promotes our own epigenetic health 
and be considerate of the epigenetic health of prospective future 
children. Unfortunately, the epigenetic disadvantages that we 
inherit, we must live with, however, if we are proactive with regard 
to diet, behavior, and environment, then perhaps these 
disadvantages will not affect us as severely, or perhaps they can be 
reversed. The field of epigenetics provides a deeper understanding 
of human biology and psychology and it poses both difficult 
questions as well as promising possibilities. 
 
Provocative Questions 
 Who is at fault when it comes to epigenetic disadvantages, 
especially ones resulting in major deficiencies? Should 
there be a law outlining legal epigenetic responsibility? 
 Infertility treatments – Are they worth the risk and cost? 
 Birth control – do formulations of the pill cause cancer via 
epigenetic means? What are the long term effects of the 
pill, both for the individual, her offspring, and the 
environment? 
212  
 How much should we worry about estrogen and mimics in 
the environment – how severe will their effects be upon our 
epigenetic health, reproduction, and development? 
 There seems to be a strong case for breastfeeding and birth 
free of medical intervention. Will epigenetic research push 
women to decide against epidurals and scheduled C- 
sections? Who gets to decide? 
 How do we deal with pre-conception damage and liability? 
Should we? 
 Could targeted treatment reverse methylation changes and 
therefore cure psychological disorders like  PTSD and 
MDD (massive depressive disorder)? 
 Allocating legal epigenetic responsibility could potentially 
necessitate extremely intrusive laws and policies that 
overwrite parental freedoms to varying degrees. How far 
should we go? 
 
Possible Solutions 
 Many consequences of Assisted  Reproductive 
Technologies are still unknown. A focus must be turned to 
educating parents on all potential deleterious effects of 
fertility treatment options so informed decisions can be 
made. Long term studies spanning generations should 
follow-up IVF/ART progeny. 
 Birth control may provide the conditions in the body where 
vulnerability to breast cancer is higher and susceptibility to 
ovarian cancer is lower. However, we do not know exactly 
what effects birth control has on eggs in the ovary – more 
study is needed. 
 A mother always has the right to have an epidural, or refuse 
it. Her right to her own birth experience, and her own 
assessment of pain she can or cannot handle, should not be 
compromised. Pain is scary, and this makes birth scary. The 
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more women learn about physiological birth and the 
disruption of natural epigenetic processes, the better. With 
the proper care and intrapartum support, women will be 
endowed with better tools to make informed decisions. 
 Novel treatments for psychological ailments such as 
depression and PTSD as well as physical disorders will be a 
future avenue for epigenetic study. Ethical concerns will 
inevitably surround epigenetic treatment since behavioral 
modification has a history fraught with baggage. As in the 
case of human fetal subjects, determining the effectiveness 
of epigenetic treatment in humans will inevitably begin in 
animal models and move to human clinical trials. 
 Education needs to be pursued in a comprehensive, 
continuous, and evolving way to enable all stakeholders to 
make informed decisions, and help to construct fair 
regulatory, social, and legal frameworks. 
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The Epigenetics of Opportunity: Culture 
and Socialization 
Nadia Timperio, Kaylyn Tobin, Jessica Hebert, and 
Aaron Hegazi 
 
 
Abstract 
This chapter will explore the effects that culture can have on an 
individual’s epigenome, as well as how an individual’s epigenome 
may affect her place in society. For example, obesity, addiction, and 
depression plague traditionally marginalized demographics, but their 
persistence throughout generations may have epigenetic roots. We 
have known for a long time that mothers who smoke or suffer from 
depression tend to give birth to babies with lower birth weights, but 
we now know that this effect is correlated with measureable 
epigenetic changes in the infant. Additionally, maternal care during 
early childhood can cause demethylation: poorly nurtured rats display 
poor parental care themselves and treat their own pups badly, thereby 
perpetuating the cycle. Moreover, stress, fear, and drug addiction can 
have trans-generational effects on the epigenome, at least some of 
which might be reversed through diet. Finally, surveys are now 
demonstrating that socioeconomic status and exposure to aggression 
exerts effects upon the epigenome. Given that the human genome is 
now known to hold lineage-dependent differences, some investigators 
have  interrogated  the  role  of  race  in  epigenetic  modification.  We 
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discuss how these studies lack a fulsome analysis of non-biological 
differences: components of culture such as diet, geographic location, 
and social/religious practices are likely to be playing a confounding 
role. We conclude with a discussion of culture’s place in the study of 
epigenetics, and outline some of the challenges that society will have 
to face when epigenetics is integrated into how we understand culture. 
 
 
 
7.1 Introduction 
Humans exist and act both within a biological sphere as 
well as within a well-established social arena. Humans shape and 
guide society to fit their needs, but epigenetics now provides a tool 
that permits us to see how the societies we build can in turn affect 
us on a biological level. Conceptually, this is not new: genetically 
similar links have been long understood – for example lactose 
tolerance. Lactose tolerance is the result of genetic mutations that 
arose and conferred an advantage as humans developed agrarian 
societies (Laland et al. 2001). This genetic change was the  result 
of a random mutation that became fixed by a cultural shift towards 
the domestication of livestock. The use of milk as a food source, 
where lactose tolerance could accommodate it, provided a reliable 
dietary supplement that rendered populations more  likely to 
survive and propagate the genetic trait (Laland et al. 2001). Natural 
selection usually takes centuries to change the sequence of DNA 
and to produce a beneficial phenotype, however, culture can move 
much more quickly, and, as it transpires, so does epigenetics. The 
epigenome can change within a single generation (Szyf 2007; 
Dupras et al. 2012). Moreover, it is sometimes reversible and 
provides a flexible framework that can keep up with frequent 
cultural or ecological shifts. In sum, the epigenome provides a 
direct biochemical mechanism that links the influence of 
constructed environmental attributes, both physical and social, 
with the long-term packaging and behavioral patterns of our genes. 
Among the  most  significant  components  of  existing social 
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frameworks is culture. Culture informs patterns of child nurturing 
and rearing, as well as patterns of organized behavior, diets, 
socioeconomic stratification, and education. Culture refuses simple 
definition, but at its simplest, it can be considered to be a 
constructed framework of interacting elements that include world 
views, beliefs, traditions, artifacts, and behaviors. These concepts 
are transmitted between generations and other cultural groups 
through social learning (Laland et al. 2001). Thus, culture can be 
simplified as a fluid collection of learned traits, artifacts, and 
practices that help to express, and at times codify, an individual’s 
behavior. Considering that enculturation is achieved pre- 
dominantly through social means, culture can be considered to be 
among the most potent mediums for addressing the effect of the 
social environment on the epigenome. 
In order to facilitate research, the sometimes nebulous 
concept of culture is often broken into discrete components to 
permit quantitative measurement (Laland et al. 2001). Cultural 
focal points for investigation may include dietary choices, social 
and physical activities (examples include drinking, smoking, 
exercise), religious denomination, and even the geographical 
spread of migrating populations (Braam et al. 1998; Laland et al. 
2001; Toyooka et al. 2003; Delport and Pollard 2010). The 
evidence of socioeconomic impact upon an epigenetic profile 
contributes to the larger conversation regarding the role that 
socioeconomic status can have upon human health: it adds an 
additional layer of complexity upon the interactions that are 
manifest in our experience of geographical location, food sources, 
disease, climates, and social interactions. 
No robust discussion of culture and geography can ignore 
issues of race, so the question arises, to what degree are the hard- 
wired genetic underpinnings (haplotypes) that differentiate races 
separable from the effects promulgated by cultural practices? This 
is understandably one of the more controversial and technically 
challenging elements to distinguish. Indeed, we might even ask if it 
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is even possible to identify a biologically sensible notion of race in 
the context of epigenetic studies? Race and links to epigenetic 
health factors have been addressed in the literature, however we 
will argue that some researchers have been too quick to claim that 
the minute biological differences between races have can explain 
epigenetic differences between populations. 
The influence that maternal care, cultural practices, 
socioeconomic status, geographic location, and race have in 
facilitating changes to the epigenome will be addressed 
sequentially while we will also highlight the intricacy of their 
interactions. We will discuss potential avenues through which 
continued research and greater education concerning cultural 
effects upon the epigenome could be broadcast to benefit the larger 
community. 
 
7.2 Socioeconomic Status and the Epigenome 
7.2.1 Introduction to SES-methylation patterns and research 
methods 
Socioeconomic status (SES) is a term that attempts to 
quantify level of opportunity/life chances that an individual or 
family enjoys, and it takes into account their hierarchical position 
in society, occupation, education level, and affluence. Not 
surprisingly, SES is tied to health, with individuals in less 
privileged socioeconomic positions more likely to be afflicted with 
multiple chronic health disorders up to 15 years earlier than 
individuals who occupy higher socioeconomic strata. (Barnett et al. 
2012). Certain illnesses, such as heart disease, diabetes, and mental 
illness, are known to affect those with low SES at  greater 
frequency compared to the more advantaged members of society 
(Adkins et al. 2011). Recently, research has examined the 
epigenetic mechanisms by which socioeconomic factors influence 
human gene expression, and ultimately, health and morbidity. 
SES is an important determinant of the quality of one’s life – 
it impinges on life opportunities: access to health care, to healthy 
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food, to education, to security as well as to opportunity. Low SES 
is associated with lower educational attainments, and lowered 
educational achievements are a predictor of employment status and 
income – a self fulfilling cycle. Health will likely suffer if one is 
born into a poorer family with a history of lower educational 
success. Consider the following scenario. As far back as 1999, in 
an insured household in the U.S., if one was diagnosed with a 
serious health problem, the individual, on average, will lose   about 
$17,000 in out-of-pocket healthcare expenses and  employment 
over the next year, not to mention the years following (Smith, 
1999). A decrease in the individual’s ability to work, in 
combination with medical costs, results in the reduction of SES. 
Evidence of direct inheritance of poor health and opportunity is 
sparse, but social epidemiology at the statistical level provides 
support for these claims (Loi et al. 2013). 
Factors that affect patterns of DNA methylation  include 
diet, lifestyle, cigarette smoking, and insufficient maternal care or 
diet. Other epigenetic modifiers, such as exposures to harmful 
substances such as water pollutants, pesticides, and other 
environmental toxins, are linked to poor SES and related sub- 
optimal geographical location and substandard living conditions 
(Rothstein et al. 2009). It is becoming clear that these factors can 
have adverse effects on populations via stable epigenetic changes, 
increasing risk in individuals and to specific strata of socio- 
economic cohorts (Rothstein et al. 2009). To better understand the 
influence that epigenetics can have on socioeconomic status, and 
how researchers can correlate methylation and socioeconomic 
status, consider the pSoBid cohort in the Case Study below. 
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Glasgow experiences high levels and distribution of 
population morbidity and mortality that cannot be explained by 
conventional risk factors. McGuinness et al. (2012) found an 
association between the SES of an individual and global DNA 
methylation patterns. The test subjects were a subset of the 
pSoBid cohort, a cross-sectional population-based study 
established in 2005 by the Glasgow Centre for Population 
Health (GCPH). The study was designed to  track and 
investigate the psychological, behavioural, and biological 
determinants of ill health. Researchers hypothesized that social 
deprivation would be associated with a reduced methylation in 
the genome (i.e. hypomethylation) and that this would 
consequently account for enhanced inflammation and increased 
risk for disease, specifically cardiovascular disease (CVD). 
Participants in the study comprised a subset of 239 
participants (from a cohort of 666) that provided DNA for 
analysis. Participants were ranked using multiple deprivation 
indicators to define most and least deprived areas in Glasgow. 
The criteria were based on the Scottish Index for Multiple 
Deprivation (SIMD). Participants were then stratified so as to 
maintain a comparable distribution as in the original cohort. 
Other lifestyle factors such as diet, cigarette smoking status, and 
alcohol consumption were added to the base model, which 
already consisted of age, gender, and deprivation group. 
Following the extraction of DNA from peripheral blood 
leukocytes, a qualitative and quantitative analysis of DNA was 
performed. Researchers measured total DNA methylation level 
in blood samples as a percentage of the total DNA present. This 
method of analysis, therefore, did not reveal specific patterns of 
methylation that are associated with particular traits, but served 
as a general indicator of methylation extent and of epigenetic 
health. 
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Researchers applied linear regression models to reveal 
associations between global DNA methylation and SES lifestyle 
factors. Results showed that the middle age group, aged 45-54 
years were the least methylated of the three age categories, and 
16% less methylated than the youngest age group, 35-44 years 
old, and 10% less methylated than the 55-64 year old age group. 
The most socioeconomically deprived group was found to be 
17% hypomethylated relative to the more privileged. Manual 
workers showed 24% more hypomethylation than non-manual 
working counterparts. Each year of education attained resulted 
in as much as 2.4% more methylation relative to less-educated 
participants. 
Researchers analyzed sixteen biomarkers in hopes of 
finding a particular biomarker to help link socioeconomic status 
to risk of cardiovascular disease (CVD). Interleukin-6 (IL-6) 
and fibrinogen were studied in depth because they showed 
inverse relationships with respect to an increase in methylation. 
IL-6 had its greatest decrease by 20% in the oldest age group, 
whereas fibrinogen had its largest decrease by 7% in the 
youngest age group. Neither IL-6 nor fibrinogens were affected 
by any of the other lifestyle factors; therefore, any variable 
besides the base model, consisting of age, gender, and 
deprivation, had no effect on the amount of IL-6 and fibrinogen 
present. Since IL-6 is a biomarker of heart disease, its 
expression suggests a relationship between global DNA 
methylation and systemic inflammation (McGuinness et al. 
2012). 
 
 
In summary, global DNA hypo-methylation was associated 
with the most deprived participants. DNA hypo-methylation found 
in the most deprived could be the result of diet over a lifetime, or 
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during in utero development, environmental exposures, or any 
combination of factors (McGuinness et al. 2012). Although these 
are important findings, global methylation levels help little when it 
comes to pinpointing causal chains between the factors measured – 
effects could be indirect or coincidental (Landecker and Panofsky 
2013). Another challenge the study presents is the limitations 
presented by the sample size; participants used for the study only 
represented the bottom 5% and top 20% of Scottish Index for 
Multiple Deprivation score. Ethnicity was not accounted for, the 
only related criteria deployed was to select for English speakers. 
The assumption was that the Glasgow cohort was ethnically mixed 
to an extent comparable to Liverpool and Manchester, where 
morbidity was not as severe. This could probably not be argued to 
represent the full population spectrum. Precisely why Glasgow 
citizens experience such a prevalence of cardiovascular disease 
remains uncertain, however, further studies concerning the 
relationship between hypo-methylation and increased expression of 
biomarkers should contribute to this conversation. 
Similar studies corroborate these findings. Borghol et al. 
(2012) chose to focus on the regulatory sequences of specific genes 
to see if associations between childhood socioeconomic status and 
DNA methylation in adults could be identified (Borghol et al. 
2012). Participants for the study came from the British  Birth 
Cohort Study, an ongoing, longitudinal study, tracking males born 
in the same week during 1958.  Researchers  collected samples 
from forty males, aged forty-five years old at the time, and 
analyzed data based on participants’ SESs in both childhood and 
adulthood. They were able to identify 1252 gene promoters whose 
methylation levels are associated with childhood SES (666 in high 
SES and 586 in low SES) and 545 associated with adult SES. 
Intriguingly, there was little overlap in  the differentially 
methylated promoters associated with childhood versus adult SES 
(Borghol et al. 2012). Moreover, they also found clustering in 
specific regions of the genome linked to specific functions; in   low 
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SES individuals, there was evidence of higher methylation, and 
thus repression, of sensory perception of smell and taste. Since 
DNA was only available in adulthood, it is unknown whether the 
methylation occurred in childhood, or if findings reflect 
experiences delivered in the prenatal environment. Further 
investigations exploring the relationship between pre-natal, 
childhood, and adult socioeconomic status health warrants future 
attention. 
 
7.2.2 Socioeconomic Status and Diet 
In the United States, being socioeconomically disadvantaged 
correlates with a higher likelihood of obesity: a lack of healthy 
food stores, safety, and places to exercise were the main factors 
holding back the disadvantaged (Lovasi et al. 2009; Rundle et al. 
2009). Dietary choices are guided by many factors: economics, 
geography and cultural practices to name a few. In recent history, 
changes to the human diet (particularly in North America) have 
corresponded with a cultural shift from a nomadic lifestyle towards 
extreme sedentarism. This transition was facilitated largely by 
agricultural surplus and high carbohydrate/sugar diets (Chapter 4). 
Delport et al. (2010) specifically identify obesity as a product of 
both biological and cultural forces. Obesity can perpetuate itself 
trans-generationally through epigenetics, which can in turn make it 
even harder to escape the socioeconomic factors that  can 
contribute to obesity: a Swedish study of 700,000 found that obese 
males performed significantly worse in school even when adjusting 
for intelligence and socioeconomic position. This discrepancy is 
attributed to discrimination in the educational system and general 
society (Delport and Pollard 2010). 
The trans-generational effect of maternal food choices is 
associated with circulating levels of the hormone leptin, a protein 
that originates from adipocytes (fat cells) and plays a vital role in 
determining an individual’s appetite via the hypothalamus. 
Energy-dense and highly processed diets during the third  trimester 
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of pregnancy can cause the up-regulation of lipid transport across 
placental membrane. This will cause the fetus to develop more fat 
cells within its adipose tissue. As a consequence of the high fat 
intake and the increased leptin levels, the child will likely be born 
heavier and with an increased appetite during post-natal 
development. In adulthood, the expression of numerous genes 
within adipose tissue has been implicated in an individual’s body 
mass index (BMI) calculations (including the methylation of leptin 
gene promoters), so it appears that epigenetically-driven 
phenotypic changes may account for body weight changes (Stoger 
2008). 
Socioeconomic status and culture not only affect  diet 
content, but also meal frequency. The reality for many of the 
socioeconomically disadvantaged is not lack of food but 
inconsistent access and poor quality (Oldewage-Theron et al. 
2006). Could there be an epigenetic consequence to  consistent 
short term fasting, even if an individual does not starve? Funato et 
al. (2011) conducted research on the effects of fasting on the 
expression of histone deacetylase (HDAC) within mice. You will 
recall from Chapter 2 that HDACs are responsible for histone 
deacetylation at specific genomic sequences to either repress or 
enhance gene activity, a function that has been previously linked to 
behavioral changes (Funato et al. 2011). The latter results showed 
that dietary alterations have an impact on the expression of 
different HDAC transcripts (numbered 1-11) in the medial 
hypothalamus, an area of the brain responsible for  regulating 
eating and body-weight (Funato et al., 2011). After 16 hours of 
fasting, there was an increase in HDAC3 and HDAC4 expression 
and a decrease in the normally high hypothalamic levels of 
HDAC10 and HDAC11. 
Other effects of fasting include the decrease in HDAC8 
expression in a portion of the hypothalamus previously shown by 
other studies to exhibit changes in the expression of proteins 
associated  with  feeding  behavior  (such  as  TRH:     thyrotropin- 
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releasing hormone). Another area of the hypothalamus involved in 
aggression and reproductive activity was shown in this study to 
exhibit lower histone acetylation levels. Cumulatively,  these 
effects indicate the extensive impact that fasting can have on 
expression levels in the brain, with meal time influencing a variety 
of potential functions ranging from eating patterns and homeostasis 
to aggressive and reproductive behavior (Funato et al. 2011). 
Xu et al. (2012) addressed the impact of fasting on 3-day old 
chicks at both 6 and 24 hour fasting lengths. Like Funato et al. 
(2011), Xu et al.’s (2012) research showed changes in expression 
levels within the hypothalamus. The study focused on the 
methylation of histone 3 at a specific amino acid: lysine 27, here 
referred to as H3K27.  Fasting resulted in the significant  increase 
in di- and tri-methylation of H3K27. EZH2, the H3K27-specific 
histone methyltransferase (HMT) responsible for the transfer of 
methyl groups to lysine, showed an increase in concert with the 
increased methylation (Xu et al., 2012). This alteration occurs 
within the pre-optic/anterior region of the hypothalamus, an area 
associated with maintenance of body temperature and  feeding. 
This is similar to the functions of the hypothalamic locations 
addressed in Funato et al.’s (2011) research (Xu et al. 2012). 
Alongside these methylation events, a significant increase in 
thyrotropin-releasing hormone, an integral component to the 
metabolism-regulating hypothalamic-pituitary-thyroid axis, 
occurred after 24 hours of fasting (Xu et al.  2012).  Fasting 
appears, therefore, to have an influence on metabolic regulation, 
particularly during early chick development. 
Although these mechanisms and results cannot necessarily be 
directly applied to humans, they still serve to display the profound 
effect of diet on the epigenome and indicate the potential for 
human fasting practices to likewise produce epigenetic effects. 
Short-term fasting as a religious activity, however, is common; it is 
a component to belief systems such as Christianity, Islam, Judaism, 
and  others.  Since  Funato  et  al.  (2011)  and  Xu  et  al.     (2012) 
234  
discovered alterations to the epigenome in mice and chicks after 
fasting durations of less than twenty-four hours, there is potential 
for short-term and culturally motivated fasting in religiously 
observant humans to also impinge on the epigenome. 
 
7.3 Epigenetic Factors, Culture and the Mental State 
7.3.1 Early childhood, stress, depression, and anxiety 
There is a strong, consistent correlation between mental 
illness and low socioeconomic status, and while this link is not 
necessarily causative, nevertheless the relationship suggests a 
connection (Hudson 2005). Certainly, those who are mentally ill 
and have a low SES will have worse health than people who have 
the same mental illness but have a higher SES (Barnett et al. 2012). 
Mental illness also presents a vicious cycle, since by its nature it 
can limit opportunities for social mobility, not to mention adding 
to burdens by attaching a cultural stigma. The study of mental 
health stands to benefit greatly from ongoing research into 
epigenetics. While personality and mental disorders have clear 
roots in genetics, there are still many environmental factors that 
shape who we are. 
Maternal behavior can be inherited by female offspring. 
Sapolsky et al. (2004) found that rat pups that experienced high 
levels of licking and grooming from their mothers grew up to be 
mothers who licked, groomed, and cared for their own pups well. 
Demethylation and acetylation responses were a direct 
consequence of maternal care and caused permanent and heritable 
changes to the epigenetic packaging of specific gene loci that 
influenced behavior later in life (Sapolsky 2004). Specifically, 
pups that experience high quality grooming have increased 
serotonin levels and demethylation of the glucocorticoid receptor 
gene. This in turn results in more glucocorticoid receptors being 
expressed in the brain, and lower levels of circulating 
glucocorticoid, a stress-related hormone (see figure 7.1). 
Ultimately, high quality maternal grooming behavior and a  greater 
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resilience to stress emerged (Sapolsky 2004). Weaver et al. (2008) 
discovered that reciprocal fostering of pups by good and bad 
mothers reversed the imprints inherited by the pups. So, if they had 
a mother who maltreated them, despite whether she was a 
biological or foster mother, the rat grew up to be a bad mother and 
to have a lower capacity to cope with stress. If the infant had a 
mother who licked, groomed, and cared for them properly, despite 
whether she was a biological or foster mother, the rat grew up to be 
a good mother, and in turn passed this trait onto her  young 
(Weaver et al. 2005). 
 
 
 
 
Mother rat exhibits 
high licking/grooming 
behaviour 
 
 
 
 
 
Happy pup 
 
 
Increased serotonin 
in pup 
 
 
 
Demethylation of and 
acetylation of histones 
around glucocorticoid 
receptor gene 
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hippocampus of pup 
 
 
NGF1-A 
 
GR 
 
 
 
 
Pup as an adult = 
High licking/grooming 
behaviour 
 
Figure 7.1 Epigenetic mechanisms associated with imprinting of 
high licking/grooming behavior. Adapted from Sapolsky, 2004. 
Rat pups who experienced high levels of licking/grooming from 
their caregivers demonstrated increased expression of NGF1-A 
in the hippocampus as well as a demethylation of and acetylation 
of the histones around the glucocorticoid receptor gene. These 
two conditions combined result in adult (previous pups) 
expression high hippocampal glucocorticoid receptors, low 
glucocorticoid levels, and ultimately high licking/grooming 
behavior toward their own pups. Epigenetic imprints due to 
maternal care behavior remain throughout the rats’ lives and 
impact their own mothering style. 
 
In another study, investigators studied infant rats reared by 
either  a  good  or  a  negligent  mother  (Blaze  et  al.  2013).  Like 
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Weaver et al. (2008), they discovered that depending upon whether 
the rats were reared by a biological parent or fostered, the female 
pups would be imprinted as good or bad mothers by the context of 
their conditions, and grow up to perpetuate that  legacy (Figure 
7.1). These behavior differences, as well a sensitivity  to stress, 
were linked to epigenetic imprinting of the stress-related 
glucocorticoid receptor gene (Weaver et al., 2008). Interestingly, 
Blaze et al. (2013) also found increases in methylation of the 
regulatory region of the gene for brain-derived neurotrophic 
factor (BDNF) in both males and females of the foster groups 
despite the nurturing environment. Finding increased methylation 
in the maltreated groups was expected. The BDNF gene encodes 
brain-derived neurotrophic factor, a member of the neurotrophin 
family of proteins that assist in nerve growth and maintenance. 
BDNF regulates patterns of neuronal sprouting and connectivity. 
Changes in methylation of BDNF are associated with high levels 
of stress-induced release of glucocorticoid. In this case, even the 
stress of being pulled away from their biological mother was 
enough to induce methylation of the BDNF gene (Blaze et al., 
2013). 
Abnormal packaging of the BDNF gene is a significant but 
small piece of evidence showing that early life trauma can have 
long-term consequences for brain wiring, and consequently  also 
for behavior (Roth and Sweatt 2011). Mice that are reared in a 
communal nest and that enjoy surplus maternal attention and care 
grow up to enjoy a predilection for adult social interactions, 
specifically ones that coincide with higher hippocampal BDNF 
protein levels (Branchi 2009; Branchi et al. 2009). By contrast, 
stress induces hippocampal atrophy, thought to be mediated by 
BDNF, and depression is the result (Warner-Schmidt and Duman 
2006). The hippocampus is the brain region that forms and stores 
cue and context stimuli learned from fear conditioning, and that 
processes information from short-term to long-term memory. 
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Figure 7.2 Maternal care behaviors exhibited in the three study 
group mothers. 
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A – caregiver was a good biological mother B – caregiver was a 
good foster mother to a pup from a poor one, and C – environment 
imposes maltreatment conditions. Adapted from Blaze et al., 2013. 
Biological relation to pups made no significant difference in caring 
behavior in a normal environment. It could be hypothesized that the 
cross-foster rat pups still received the imprint of good mothering 
despite the stress-induced methylation from being pulled away from 
their biological mother. 
 
In mice, both male and female offspring of socially 
defeated fathers exhibit depression and anxiety-like behavior. 
Interestingly, these results were not usually observed when the 
offspring were created via IVF (Dietz et al. 2011). This could 
suggest that the epigenetic modification inherited by the offspring 
to induce the depressive or anxious behavior is inherited when 
fertilization occurs in the fallopian tube and the natural process of 
implantation ensues. Alternatively, it could be hypothesized that 
the IVF process sometimes reverses or overwrites the epigenetic 
change inherited from the father. 
Chronic and unpredictable maternal separation experienced 
by infant mice induces depressive-like behavior, and the male pups 
that experience maternal separation pass this behavior onto their 
offspring (Franklin et al. 2010). This is related to a phenomenon 
called learned fear. If something repeatedly results in a negative  or 
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harmful outcome, an association is made between the event and the 
outcome, usually resulting in fear of that particular event. 
Normally, remembering danger is absolutely necessary for 
survival, so early memories based on fear cannot be overwritten 
and therefore will persist over the lifespan (Sullivan and Lasley 
2010). Should this learning by fear give rise to any epigenetic 
modifications, they could be inherited by future offspring. 
For example, the regulation of chromatin structure and 
DNA methylation is an important manager of gene transcription in 
the central nervous system: Zovkic and Sweatt (2013) found 
methylation changes in factors affecting the transcription of genes 
in the hippocampus. These changes also have the potential to be 
inherited. Therefore, if a parent learns a fear trigger and this causes 
alterations in chromatin structure and DNA methylation, the 
offspring could inherit these modifications and his or her 
hippocampus could develop so that it is more or less sensitive to 
the same stimulus as the parent (Zovkic and Sweatt 2013). This 
learned fear is also correlated with post traumatic stress disorder 
(PTSD) (Takei et al. 2011). 
Early experiences are not the only way for epigenetic 
modifications to occur around DNA. Traumatic stress that  occurs 
in adult rats can induce central nervous system gene methylation 
(Branchi 2009; Branchi et al. 2009; Roth et al.  2011). 
Hippocampal dysfunction in adults is also a response to traumatic 
stress that may be caused by epigenetic changes to the BDNF gene 
(Roth et al. 2011). It is reasonable to hypothesize that these brain 
and nervous system gene methylation patterns also happen in 
humans not only during childhood, but also in adulthood (Roth et 
al. 2011). Interestingly, susceptibility to PTSD in children of 
traumatized parents appears to reveal an epigenetic dimension that 
is trans-generational. For example adults whose parents survived 
the Holocaust were more susceptible to PTSD and recovered more 
quickly than their control counterparts (Yehuda et al., 2015; also 
see chapter 6, specifically Case Study 6.4) 
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After Roth et al. (2011) found increased methylation in 
stressed rats compared to non-stressed rats, Roth and  Sweatt 
(2010) hypothesized that a drug with the ability to reverse 
methylation may also reverse the abnormally low BDNF 
expression. After administration of a demethylating drug, BDNF 
was restored to normal in stressed rats (Roth and Sweatt 2011). 
There is potential to reverse the behavioral consequence of this 
methylation, thus opening up novel treatment options  for PTSD 
and other psychological conditions linked with epigenetic 
mechanisms. Weaver et al. (2005) also saw some success in 
methylation treatment in adult rats. In this case, they added dietary 
methyl donors to restore normal maternal parenting skills  and 
stress responsiveness, thereby reversing the epigenetic effect of 
poor maternal behavior on offspring DNA (Weaver et al. 2005). 
Further research needs to be done to determine if the reversion of 
normal expression in the adult brain directly results in reversion to 
normal maternal care behavior as well. 
These experiments all find epigenetic causes of traits linked 
with depression, anxiety and PTSD, providing  scientific context 
for the common wisdom that early childhood nurturing  is 
important for proper growth. Should these mechanisms prove 
persistent in the human epigenome, they would have implications 
for family structure decisions. This information would place more 
pressure on parents to stay home with their children, which for 
many is not an economically viable choice. The trans-generational 
effect of early nurturing deficits would also help to contribute to a 
poverty loop. The solutions seem simple however (albeit  difficult 
to implement depending on the political climate): either increased 
paid parental leave or increased access to high quality preschool. 
 
7.3.2 Aggression 
Another element of stress is the experience of aggression. 
Recent evidence suggests that DNA methylation of both cytokine 
gene  regulatory  regions,  and  the  transcription  factor  genes that 
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regulate them, operate in response to environmental factors, such 
as social signals and parental behavior (Provencal et al. 2013a). 
Cytokines are important signaling molecules for the immune 
system. Boys who maintain high levels of  aggressive behavior 
from kindergarten, through to adolescence, tend to be “impulsive, 
hyperactive, oppositional and rejected by their peers”. Oftentimes, 
the domestic environment and familial relations of these 
individuals fail to encourage emotional regulation (Provencal et al. 
2013a). The hypothesis was  that  stressful  early life experiences 
are associated with methylation changes that could contribute to a 
chronic physical aggressive (CPA) trajectory. Recognizing the 
prevalence of physical aggression in this cohort of young boys, 
Provençal et al. (2013a) set out to test levels of cytokines in the 
blood with long-term regulation of physical aggression in them as 
young male adults (Provencal et al. 2013b). 
Two groups were part of the study: one group of seven males 
on a CPA trajectory and one control group of twenty-five males on 
a normal trajectory. Aggressive behavior was monitored by 
schoolteachers each year from ages six to fifteen. Provençal et al. 
(2013a) analyzed DNA methylation profiles of five cytokine genes 
that were known to show lower plasma levels in aggressive males. 
The methylation study employed blood samples taken from the 
males after they reached adulthood (Provencal et al. 2013b). 
Teacher-assessed hyperactivity and opposition disorder during 
childhood and adolescence predisposed the males in the CPA 
group to aggressive behavior into early adulthood. 71% of the CPA 
group had a criminal record by age twenty-one, compared to 20% 
of the control group, and 57% of the CPA group reported acts of 
physical violence by the age of twenty-one, compared to 10% of 
the control group (Provencal et al. 2013a). Clearly early patterns of 
behavior tend to predispose to similar patterns in adult life. 
Tests for associations between DNA methylation and 
cytokine levels revealed 48 differentially methylated regions 
associated with aggression (Provencal et al. 2013b; Provencal et al. 
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2014). Measured twice, at ages 26 and 28, for both the CPA and 
control group, the CPA group showed higher methylation and 
significantly lower concentrations of inflammatory cytokines when 
compared to the control group. The study found agreement with 
literature suggesting that associations exist between cytokines and 
CPA, suggesting that there was an inflammatory immune response 
elicited by conditions of aggression behavior and oppositional 
environments (Provencal et al. 2014) Their results  also 
demonstrate the value of conducting gene-wide analysis of DNA 
methylation; restricting their observations solely to gene regulatory 
regions would not have allowed them to identify many of the 
differentially methylated areas implicated (Provençal et al., 
2013b). This suggests that future research in the field should not 
limit analyses to known gene regulatory regions. 
Provençal et al. (2013a) only tested adult blood samples and 
therefore had no way of determining when aggressive behavior 
becomes associated with methylation and cytokine levels in 
humans. It should also be noted that the methylation tests were 
made using blood samples, and are correlational – no assay could 
be made of brain tissues that would be more directly indicative of 
gene function in cells of the brain. This study and others 
highlighted within this chapter suggest that early experiences can 
have lifelong effects on individuals, but it is still unknown when 
methylation and demethylation begins and how patterns of 
methylation change throughout developmental growth, through 
infancy to adulthood. Finally, given that these studies were 
performed using a cohort that lived within a particular sub-district 
of Montreal, in the future it might be interesting to examine the 
role of habitat quality and physical environment as a contributing 
factor. 
 
7.3.3 Addiction 
Even when mental illnesses are not caused by epigenetics, 
epigenetic changes to the mental state can make life significantly 
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harder for some people, especially the  disadvantaged. Consider 
that increased aggression is one of the most significant mental 
factors in delinquency (Nagin and Tremblay 1999). Addiction to 
illegal substances physically compels people to commit  illegal 
acts. Status as a criminal severely impacts one’s position within 
cultural and social spheres, and can prevent already disadvantaged 
people from being able to find jobs or educational opportunities. 
Many current prisons do not place an emphasis on rehabilitation, 
but how much blame can be placed on someone with the deck 
stacked against them biologically? 
Misuse of drugs and alcohol is a common factor in criminal 
behavior, especially since most “recreational” drugs are illegal. 
Now, studies demonstrate that drug and alcohol misuse could have 
an epigenetic dimension that provides a mechanism for 
transmission of addiction behavior across generations. Repeated 
abuse of drugs results in persistent epigenetic changes that could 
play a role in long-lasting alterations in behavior. Byrnes et al. 
(2013) exposed rats to morphine during adolescence, before they 
began reproducing. Their eventual offspring had no fetal exposure 
to the drug, but nevertheless inherited weakened locomotor 
sensitization even after being treated with a drug to increase 
locomotion. The grandchildren of the original morphine-exposed 
rats, also inherited weakened locomotor sensitization. In humans, 
this could imply greater vulnerability to addiction (Byrnes et al. 
2013). 
Epigenetic changes might also provide targets for new 
treatment plans including reversal of addiction (McQuown and 
Wood 2010; Wong et al. 2011). There is potential for epigenetic 
reversal: Weaver et al. (2005) were able to reverse epigenetic 
changes to the stress hormone receptor in rats by feeding them a 
methyl-rich diet to reverse the demethylation of DNA. In this 
study, stress-induced behavior was also reversed (Weaver et al. 
2005). 
Needless to say, epigenetic effects are not necessarily   going 
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to be confined to illegal and addictive drugs: prescribed 
medications also have effects - recall the example of the estrogen 
mimic DES (in Chapters 5 and 8). Presently though, the evidence 
for trans-generational effects has been more thoroughly elucidated 
with respect to addictions, and in rodent models. 
More and more, we see a combination of the epigenetic 
advantages and disadvantages that we make for ourselves, and 
those that we are born with and born into. Distinguishing between 
our choices, what we can control, and our circumstances, at least 
those that we cannot control, can be a convoluted puzzle. Let us 
look next at a circumstance over which we have no control: our 
ethnicity. 
 
7.4 Epigenetics: Race and Ethnicity, or Culture? 
7.4.1 Introducing Race and Ethnicity 
The terms race and ethnicity, while similar, refer to specific 
aspects of the human experience. Race as a concept refers to broad 
sets of physical features (such as genetically encoded  ranges of 
skin colour, facial bone structure) that are associated with the 
indigenous people that first flourished in different areas of the 
world. Ethnicity, while it is often associated with race, actually 
relates to a group of people who express cultural practices,  and 
who hold beliefs, languages, and family history in common. While 
someone who identifies as Irish might have the same race as 
someone who identifies as Welsh, their ethnicities inform their 
respective cultures much more than their shared “race.” 
This distinction is crucial. Ethnicity is a social construction, it 
provides cultural and demographic context. Race is arguably also 
largely a social construct insofar as people will often self-identify, 
but it is only hypothetically a definition that is based upon physical 
characteristics – look hard enough at the genome, for example, and 
you will find segregations of specific DNA sequence markers that 
correlate with  ancestral  patterns of  dispersion  and  interbreeding. 
245  
Social and Cultural Epigenetics 
 
These markers, called haplotypes, mix over time, and over 
centuries of military, commercial, or social interaction, they have 
been exchanged by intermarriage etc. This mixing confuses the 
definition of race to the point that for the purposes of our 
discussion, it is almost useless. With regard to the mechanistic 
processes that contribute to the epigenome, “racial” differences 
have been very small and hard to find, and indeed, social 
characteristics carry more weight in the identification  of factors 
that contribute to health predispositions (Kuzawa and Sweet 2009; 
Arbour et al. 2012). Ethnicities are useful when looking at a group, 
as they give insight into broad traditions or trends that allows for 
easier understanding of the actual cause of epigenetic differences. 
Racial and ethnic trends are only of interest when used statistically, 
almost always when study participants have self-identified 
That being said, there is a controversial representation  of 
racial disparities in the scientific literature as it pertains to 
epigenetics. Racial differences are suggested to correlate with 
variations in epigenetic profiles in a number of different health 
areas. Within a research setting, race is often employed to 
determine the etiology and risk factors of diseases. However, the 
variability of results that stem from the studies may indicate that 
the effectiveness of utilizing race is questionable. Our discussion 
will focus on an overview of studies on race that pertain to the 
epigenetics of cancer, atherosclerosis, cardiovascular disease, and 
methylation alterations made during gestation. 
 
7.4.2 Ethnicity and Epigenetic Studies 
One cancer study focused on the tendency for “Hispanic 
whites” to have improved survival over “non-Hispanic white” and 
“Black” sufferers of non-small cell lung cancer, a cancer that was 
addressed above in relation to smoking (Saeed et al. 2012). This 
embodied the concept of the “Hispanic paradox”: despite 
demographically existing within the lower socioeconomic tiers 
associated with less access to resources, health care, and wealth, 
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Hispanic whites enjoy a higher survival likelihood. Saeed et al. 
(2012) list family structure and lower tendencies to smoke within 
this population group as factors in creating this paradox. 
Studies with an ethnic dimension have also been conducted on 
health issues associated with atherosclerosis and cardiovascular 
disease (CVD). Analysis of leukocyte methylation in patients with 
atherosclerosis across numerous ethnicities indicates that “white” 
and socioeconomically advantaged participants exhibit higher Alu 
and lower LINE-1 methylation compared to “African-American” 
and “Hispanics” (Subramanyam et al. 2013). Alu and LINE-1 
elements are ancestral remnants of retroviral invasion. They were 
once thought to be “junk” DNA, but are now known to play a role 
in chromosomal structure and gene regulation. They tend to be rich 
in CpG sequences and to undergo preferential methylation as a 
consequence. The number and distribution of these elements 
differs from one individual to the next, as well as between ethnic 
groups. Professed shortcomings of this investigation include the 
choice of Alu and LINE-1 as the focus of study. They are highly 
polymorphic or variable, and their functional significance as 
pertains to disease is unknown. As well, leukocytes in the 
bloodstream may not necessarily be the direct target of the social 
factors of interest in this study, and this could explain the 
disparities in results between this and other investigations of 
leukocyte methylation (Zhang et al. 2011; Subramanyam et al. 
2013). Again, authors list social and cultural behaviors as  factors 
in shaping the epigenetic differences found in this study 
(Subramanyam et al. 2013). 
Most of the above studies show correlative relationships 
between race and epigenetic alteration patterns. However, an 
interesting study conducted on women provides a contrast to the 
other investigations addressed thus far. When women across 
different racial categories were subjected to controlled folate diets 
(folate has previously been shown to be associated with 
methylation – it is part of the vitamin B complex that acts as a 
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methyl donor), no significant variation in global leukocyte DNA 
methylation emerged – a simple dietary supplement superseded al 
else (Axume et al. 2007). Thus, race itself was not a significant 
factor in the actual mechanism of methylation in humans, rather, 
the trends that correlated with race and epigenetic effects more 
likely stem from cultural (eg; dietary) differences. 
Liu et al. (2010) analyzed 196 individuals from five ethnic 
groups - Caucasian, Latino, Native American, African American, 
Asian, and mixed populations. They identified a total of four 
population specific factors that could differentiate between groups 
(Liu et al. 2010). Three of these factors are genetic single 
nucleotide polymorphisms (SNPs); differential frequency of each 
SNP delineates a different racial category. The fourth was a 
population-specific methylation factor. In this case, differential 
methylation level was the population determinant: Caucasians had 
the highest methylation, followed by Latino and mixed 
participants, and lastly Native and African  Americans.  Despite 
this association between race and methylation levels, this factor 
only accounted for 0.2% of total methylation variance (Liu et al. 
2010). This indicates that despite subtle genetic differences having 
an influence on methylation patterns, their role does not appear to 
be a large one relative to more substantial factors such as the 
environment. 
Although this study provides an interesting perspective on 
methylation profiles and their connection to race,  some aspects 
may affect the legitimacy of the results.  Firstly, the sample size  of 
196 participants is small, especially considering  the study’s 
attempt to divide the individuals into 5-6 ethnic groups. Secondly, 
there appears to be a significant over and under-representation of 
different ethnicities across the groups: there are numerous 
Caucasian and Latino participants while there are few African 
American individuals. In the entirety of the study, there is only 
one Asian participant (Liu et al. 2010). These discrepancies in 
sample  size  and  quality  may have  compromised  the  results and 
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conclusions of the study. 
What can be conveyed by critical analysis of this research 
is that racial conclusions in scientific research need to be carefully 
evaluated. This does not imply that conclusions linking ethnic 
background and epigenetics should be dispelled. Rather, we  need 
to be sensitive to that fact that multiple elements including 
historical background, geography, culture, and social environment 
unite to influence epigenetic modifications: race-associated genetic 
haplotypes appear to play a relatively minor role. 
 
7.4.3 Race and Geography 
Culture is often tied to the geographical location of a 
population. This is because cultural traits are learned and 
transmitted within both families and communities, and often in 
response to environmental cues. As a result, epigenetic alterations 
influenced by culture can be patterned in a global  sense.  The 
social and habitual activity of smoking illustrates this connection 
between methylation patterns and  geography.  When comparing 
the methylation levels of seven genes associated with non-small 
cell lung cancer in Toyooka et al.’s (2002) investigation, the 
studied countries were sorted into two groups. Group A consisted 
of USA and Australia, while group B encompassed Japan and 
Taiwan. Results showed that group A had significantly higher 
overall mean methylation index (MI) and higher methylation rates 
of the specific genes MGMT and GSTP1 (Toyooka et al. 2003). 
Toyooka et al. (2002) cited geography, culture, or race as potential 
contributors to the discrepancy. The data  demonstrated 
methylation changes that coincide with the act and exposure to 
smoking. Cultural and social norms specific to  different 
geographic regions may dictate the amount and variety of an 
individual’s exposure. Examples of this could include: social 
stigmas on smoking near others; whether it is polite to accompany 
someone to smoke; or whether smoking reflects a recreational or 
group activity.   Relative to smoking health risks, these    behaviors 
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could potentially influence the methylation profile of an individual 
or a geographically delimited population. 
Just as differences in epigenetics between countries can give 
context for the shifts in culture between large populations, 
epigenetic anomalies between areas within a country can be vital to 
study, especially when dealing with environmental consequences 
and xenobiotics (See Chapter 5). Mansfield’s 2012 study of 
epigenetics and xenobiotics found that indigenous populations near 
bodies of fresh water were exposed to methyl mercury at a high 
rate, This toxin has epigenetic consequences and is a common 
contaminant of continental fish stocks. Indigenous people are more 
likely to be the most frequent consumers of fish as a result of their 
economic and cultural status: their proximity to the rivers and fish 
stocks that are exploited for subsistence or traditional fishing is an 
accident of economics, culture, and geography (Mansfield 2012). 
For these populations, fish is a vital and necessary food source. 
Government health advisories dispensed advice against fishing in 
the waters, but the information given out not only ignores the 
cultural dietary patterns of Native Americans, it places the burden 
of avoiding the xenobiotic on the people living by the water rather 
than the companies or processes that are polluting the lakes. Native 
Americans were given a warning that did not accurately reflect 
their needs. Moreover it was a warning that they could not  act 
upon for economic and cultural reasons. In fact, the  warning 
simply gave the polluters more support: someone ignorant of the 
cultural reality of the people affected could make the argument that 
the populations were warned against methyl mercury levels. The 
burdens of change should not be placed on those who  are 
powerless to change them. 
 
7.5 Conclusions 
Policymakers and scientists must be incredibly careful that 
they understand the intricacies of ethnicity and race, especially   as 
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the world becomes more globalized and diverse. Research needs to 
focus on cultures instead of races, and include countries outside of 
North America so that we can collectively benefit by knowing the 
relationship between epigenetics and cultural factors such as diet, 
socioeconomic status, and even the way children are raised. You 
cannot change one aspect of society without causing a  ripple 
effect, and all too often cultural factors reinforce themselves in 
feedback loops that are difficult to escape. There are no easy 
answers when dealing with the interaction between culture and our 
epigenome. 
With its focus upon DNA alterations, biology of the 
epigenome has been necessarily reductionist in nature: 
anthropologist Jorg Niewohner argues that it will be necessary to 
broaden perspectives and to question assumptions if the full 
complexity and complexion of inputs is to be fully accommodated 
(Niewöhner 2011). Niewohner proposes the idea of the “embedded 
body”; an entity through which the cumulative contributions of the 
social, political, historical, environmental, evolutionary, and 
numerous other spheres can be adequately assessed. This  method 
of redefining the body and the self as an entanglement of external 
contexts will guide scientists to expand their field of research 
beyond the restrictive focus on purely biomechanical machinery. 
He is not alone in his appeal – the genome scientists themselves 
are beginning to reference a new concept – the “interactome” (Li et 
al. 2014). It is difficult to design experiments that can take such a 
myriad of factors into account, but as the field of epigenetics 
grows, so too will our understanding of the interaction between the 
outside world and the individual’s interior complement  of 
packaged genes. 
 
Provocative Questions: 
 Will holding parents societally responsible for the 
epigenetic health of their children disproportionately 
burden marginalized or disadvantaged groups? 
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 Will epigenetic research be used to dispel racial 
biases, or reinforce them? 
 Should we alter our epigenome to program a social or 
behavioral advantage? 
 What policies should the government follow 
regarding data collection on the epigenetic trends of 
certain ethnicities? Should policies be developed to 
manipulate epigenetic trends? 
 Should criminals be treated differently if they are 
epigenetically predisposed to crime? 
 Stress causes epigenetic damage – should all bullying 
or intimidation be defined as a form of physical 
abuse? 
 To what extent should governments, healthcare, 
social, legal, and educational systems intervene to 
educate or even moderate parenting skills and styles? 
 If there is a family history of addictive behavior, 
would it be ethical to market or to administer medical 
interventions to treat offspring not yet addicted? 
 
Possible Solutions 
 Early education about epigenetics to parents and 
children 
 Education for policy and law makers 
 Epigenetic information freely available and tailored to 
specific cultures 
 Research focusing on diverse populations across 
countries 
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Chapter 8 
 
Epigenetics and Law: The Quest For 
Justice 
 
Florida Doci, Clare Venney, Candace Spencer, and 
Kendall Diemer 
 
Abstract 
 
 
Epigenetic  cases  pose  problems  within  the  current  legal 
system. When epigenetic harms occur, individuals should have 
recourse to legal action. Laws regarding who can take legal action, 
the time frames in which it can be taken, and the roles of various 
parties are examined using the challenges of  diethylstilbestrol 
(DES) as a case study. We examine the ability of the legal system to 
encompass epigenetics within the context of  statutory limits, 
dilution of liability, victim attenuation, and the challenges in 
identifying records and of proving direct causation. We then look at 
epigenetic harms with respect to testing policies and the  directions 
in which they should be developed. These include establishing tests 
that look at not only epigenetic effects upon individuals, but also 
upon the reproductive and trans-generational effects a product might 
have. Finally, the chapter considers how privacy law and epigenetic 
cases intersect. 
 
8.1 Introduction 
Presently, epigenetics is not a term, mechanism, or process 
that is explicitly enshrined in law – the concepts and science are 
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simply too new, and the implications are too poorly understood. 
As we discussed in Chapters 1 and 2, epigenetics involves 
modifications to chromatin structure that alter the way that genes 
behave without altering the sequence of DNA itself. The 
modifications are to attached chemical groups and to associated 
proteins, and the informational complexity of the "histone code" 
exceeds that of DNA. Some epigenetic imprints are heritable, and 
they permit us to record experience of our environment upon the 
packaging of genes to alter/prime subsequent behavior.  Diet, 
drugs, environmental chemicals, traumatic experience, socio- 
economic status, parental care, even education, can affect your 
epigenome, and this has implications for your future health. 
While genetics has been explicitly addressed in the United 
States under the Genetic Information Non-Discrimination act 
(GINA), there have been no cases to define whether or not 
epigenetics will fall into this same category and be protected. For 
example, epigenetic alterations do not change DNA sequence, so 
genetic non-discrimination may not apply to epigenetic  cases. If 
the legal term genetics was expanded to include chromatin – the 
assemblage of DNA, RNA, and protein molecules that comprise 
chromosomes, then epigenetics would be covered under the act. A 
definition of genetic has not been fully explored by the courts. The 
few instances where epigenetics has been tested indirectly are in 
tort law. 
The establishment of liability has specific requirements. A 
plaintiff must prove: that a harm has occurred; that the defendant 
was, through their inaction or negligent practice, the direct cause; 
that the defendant knew, should have known, or was negligent of 
the risks to which the plaintiff was exposed; that the complaint is 
made within statutory limits. Given the long lag time before 
epigenetic effects might become obvious, this class of case will 
present huge challenges for injured parties seeking remedy or 
compensation. In both the United States as well as in Canada, the 
principle  of  discoverability  can  introduce  a  loophole  to    strict 
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statutory limits. Instead, a suit must be  brought  within a 
reasonable timeframe following the first discovery of an effect, 
even if this occurs after normal statutory limits have expired. 
Epigenetic effects tested to date have become manifest well after 
statutory limits have expired, and since they are sometimes trans- 
generational in nature, the issue of dilution also comes into play. It 
can be hard to reconstruct who prescribed, manufactured, or 
dispensed a drug, and given the complex and combinatorial nature 
of epigenetic imprints, it is also hard to demonstrate direct and 
unadulterated cause and effect. The litigation surrounding 
diethylstilbestrol (DES) is illustrative of the complexities. 
 
8.1.1 Diethylstilbestrol (DES): a case study in Tort Law 
Beginning in 1938 diethylstilbestrol (DES),  an 
unpatented, low cost synthetic estrogen was being distributed as a 
remedy drug for menopausal symptoms, senile and gonorrheal 
vaginitis, excessive menstrual bleeding and to suppress lactation 
(Downey and Gulley 1983; t Hoen and Dukes 2007). Many 
manufacturers that were producing DES eventually began 
promoting it for use in the prevention of miscarriage. The FDA 
requested that the manufacturers agree upon a standard chemical 
formula and uniform labeling, which in 1941 led these companies 
to form the “Small Committee” (Downey and Gulley 1983). DES 
was widely prescribed to pregnant women for the next three 
decades even though there were indications as early as 1947 that 
there was a threat of cancer to the user (Mascaro 1991). Women 
who had taken DES experienced a 30 – 40 % increased risk of 
breast cancer, preterm delivery, pre-eclampsia and miscarriage, 
while in utero daughters and sons suffered increased risk of genital 
defects and infertility. Between five and ten million individuals 
affected by the drug are prone to more than twelve medical 
conditions including a higher risk of cancers and infertility (NCI 
2011). 
The drug was withdrawn in 1971 after it was found to be 
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ineffective in preventing miscarriages and to be carcinogenic (t 
Hoen and Dukes 2007). However only recently, in the light of 
epigenetics, have studies revealed the mechanism that underlies the 
trans-generational impact of DES including, but not limited to, 
increased incidences of cancers and infertility (NCI 2011). DES is 
known to affect the methylation and therefore the regulation (but 
not the DNA sequence), of genes that encode proteins in the 
estrogen production pathway. Whether or not it is these changes 
that leads to later defects in function remains to be determined. 
 
8.1.2 Legal Action Concerning DES Effects 
One of the first examples of epigenetic harms being 
addressed by the legal system occurred in the United States when 
mothers and daughters exposed to diethylstilbestrol (DES) began 
suing manufacturers for damages due to reproductive problems and 
cancers in the exposed daughters. After successful first- and 
second-generation claims (mother and daughter exposed in utero 
respectively), third-generational claims were made by the 
granddaughters of DES-exposed mothers. However, the courts 
ruled that the manufacturers of DES were only responsible for the 
first and second generation effects of DES due to victim 
attenuation; the granddaughters were too far removed, or 
attenuated, from the initial offence (Rothstein et al. 2009b). Since 
the effects of DES were not evident until later in the daughters’ 
lives, the statute of limitations – the time span in which legal 
claims are valid and pursuable – had to be extended in order for the 
individuals affected to be compensated. The courts also decided 
that the statute of limitations for the DES cases begins when the 
effects of exposure become evident or might reasonably be 
expected to cause notice, not when the actual exposure takes place 
(Rothstein et al. 2009b). 
In 1990, a DES son filed a lawsuit against a drug company 
in the U.S. alleging that his in utero exposure to DES caused his 
daughter’s cancer (Mascaro 1991).  This appears to be a precedent- 
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setting lawsuit that claims DES caused injury to third generation 
victims. There have also been other third-generation DES cases for 
premature births where the babies were born with severe physical 
disabilities (Mascaro 1991). However, in his 2009 article, 
Rothstein notes that “claims brought by the granddaughters of the 
women who took DES have not been successful due primarily to 
the courts’ unwillingness as a matter of tort theory… to extend 
liability…” (Rothstein et al. 2009b). For example, in New York, 
decisions flip flopped until the NY Supreme Court cited a 
precedent setting case where pre-conception injury was deemed 
ineligible as a basis for liability (Karen Enright, An Infant & C., Et 
Al., Respondents, V. Eli Lilly & Company, Et Al., Appellants.77 
N.Y.2d   377,   570   N.E.2d   198,   568   N.Y.S.2d   550   (1991)). 
Unrecognized in the legal quagmire was that the infant did not 
solely receive injury indirectly because of physical harm done to 
the mother, but was likely to bear a significant and direct harm of 
an epigenetic nature herself. In other words, the harm  was 
probably not caused by a physical deformity of the mother 
impinging that impinged upon fetal growth, but rather, was likely 
due to inherited patterns of altered gene activity. 
 
8.2 Statute of Limitations 
Statutory limits and repose present substantial constraints 
that prevent the system from dealing with epigenetic liability cases. 
Legally, the period for litigating claims is limited, and in most 
cases it runs out before any of the epigenetic harms manifest 
themselves (Khan 2010). Epigenetic harms can have a trans- 
generational impact, and the harms are sometimes unknown until 
after one or two generations have been born and displayed the 
effects of a harmful agent. For instance, it took years before the 
side effects of DES became known. Many of the women who took 
the drug are now deceased; yet many of the side effects are only 
just now being encountered in their daughters and sons, as well   as 
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grand-daughters and grand-sons. Only time will tell if adverse 
effects will extend to further generations. It is this long latency 
period that makes it more difficult to accurately identify  the 
product responsible for the harm, or even to assign blame for the 
negative epigenetic outcomes (Khan 2010). The imposition  of 
strict time limits could eliminate future generations from filing 
claims. On the other hand, the absence of limitations could render 
the long-term nature of the economic environment too insecure to 
support vibrant business and product development. 
Richard Abood discusses the pharmacist’s Statute of 
Limitations in his book Pharmacy Practice and the Law. “The 
purpose of the statute of limitations is to prevent the litigation of 
stale claims years after the events that allegedly led to the harm, 
after memories have faded and witnesses have disappeared” 
(Abood 2010). While scientific tests might eventually confirm the 
effects of, say, a specific drug, the doses administered, the form 
they took, the identification of the specific manufacturing licensee, 
physician, and pharmacist, could be difficult, not to mention the 
difficulties in establishing patient compliance. Abood also reports 
that public policy favours the unencumbered practice of healing 
arts, “without fear of groundless and unjustified malpractice 
lawsuits, [which] has led to the enactment in many jurisdictions of 
reform laws that reduce the number of years a statute of limitations 
for medical malpractice” (Abood 2010). In many jurisdictions, 
there is a “discovery rule” which means the time limit does not 
start until the harm is discovered. For example in Ontario Canada, 
the Ontario Limitations Act 2002 provides for a two year period 
following discovery for litigation to be pursued. By contrast, some 
jurisdictions have a “statute of repose” which limits the discovery 
rule to prevent litigation decades after a  drug’s  use  (Abood 
2010). This would prevent the claimant, especially  second and 
third generation victims, from suing the individual doctor or 
pharmacist. Thus the chances of pursuing an epigenetics-related 
claim against a pharmacy is almost impossible. 
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Some states have introduced changes to their legislation 
with regards to statute of limitations to make second and third 
generation claims more sustainable in courts (Rothstein et al. 
2009a). Yet, even so, it is uncertain when statutory limits should 
expire, and for how many decades is it reasonable to hold a 
company liable. Perhaps, a potential defendant should not be 
exposed to the threat of indefinite liability, which is why statute of 
repose protects manufacturers (Khan, 2010). In the instance of 
epigenetic effects, the statute of repose sometimes runs out even 
before the injury or harm itself has been noticed or identified, thus 
making it impossible to assign blame to anyone for the epigenetic 
harms (Khan 2010). The DES cases have proven an interesting 
testing ground – second generation claims have been permitted in 
some jurisdictions and under specific circumstances. 
 
8.3 Tort Law 
8.3.1 Liability 
The next concern is how to hold parties legally responsible 
for epigenetic harms. Responsibility can belong to an individual, to 
an employer or state responsible for occupational or environmental 
exposure, or to a group of people working towards a common 
purpose, termed a collective (Hedlund 2012). Assigning legal 
responsibility to any of these types of groups requires a causal 
chain – that the actions of the individual or collective involved 
directly caused the adverse outcome of interest (Hedlund 2012). 
While no laws currently exist regarding epigenetics and assigning 
responsibility for the causation of epigenetic insults, some believe 
that the tort system could be modified to address these issues. 
Tort law is enforced to ensure public health and safety, 
thus it could potentially be used to address harms to the 
epigenome, but the requirements of tort law cases pose additional 
problems for the victims of epigenetic insults (Khan 2010). In tort 
law, the victim is required to prove that the harm was a direct 
result  of  the  defendant’s  actions  by  more  than  50% probability 
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(Khan 2008). Since individuals are exposed to thousands of 
different chemicals, and to the same chemicals from several 
different sources, it can be difficult to prove that exposure to a 
single product resulted in negative epigenetic effects (Khan 2010). 
Similarly, there has been little research on the epigenetic effects of 
the chemicals we are exposed to in everyday life, and the 
generation of such knowledge would be beyond the abilities of 
most plaintiffs (Khan 2010). 
With current tort law, injury is only recognized when it 
affects an individual at or above the cellular level. Thus, epigenetic 
mutations introduced by chemical exposure would not be 
considered harmful unless they resulted in observable negative 
effects (Khan 2010). This poses a problem since  epigenetic 
changes may not have noticeable cellular effects for years or, in 
some cases, for generations. Can a company only be held liable if 
its actions result in epigenetic effects which are immediately 
observable? (Khan 2010; Rothstein et al. 2009b). Diseases  are 
often viewed as binary, but epigenetic alterations can lead to a 
predisposition to developing a given disease: is this still grounds 
for a lawsuit (Khan 2010)? Finally, if the epigenetic effects a 
defendant has caused can be reversed by medication or other 
genomic intervention, does the defendant owe anything to the 
plaintiff? (Hedlund 2012). Should companies be held liable for 
causing epigenetic changes only when they have detrimental 
effects, or if any epigenetic alterations are proven? In addition, 
assuming that one is able to pinpoint and prove the fault of one 
particular manufacturer (defendant), how do you prove that the 
product is the sole cause of the outcomes? We are exposed to so 
many different chemicals and substances, thus making it  difficult 
to establish one sole culprit (Khan 2010). Finally, it is often 
difficult to pinpoint one product or actor responsible when  there 
are multiple manufacturers licensed to produce the same 
merchandise (Khan 2010). 
It has been argued that it is unfair to put blame on current 
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individuals for harms caused by past actors (Khan 2010). Since 
there can be a long latent period between exposure and effects, the 
makeup of individuals within a company producing an offensive 
chemical can completely change by the time the plaintiff makes a 
claim. Since the makeup of the collective could be entirely 
different, it becomes unclear if the collective can still be held 
legally responsible for the actions of its predecessors. Similarly, if 
a company that once produced harmful substances now only 
produces beneficial substances, it is uncertain whether the deadline 
of the statute of repose should be extended and the company held 
liable, as this could detract from the good the company is currently 
doing (Khan 2010). 
Joint venture liability suits have also been filed for DES 
related cases. In these suits, all the companies who manufactured 
or sold DES are held jointly responsible and therefore 
proportionately liable for damages incurred irrespective of which 
manufacturer’s doses were prescribed to a specific  patient 
(Downey and Gulley 1983). In the Netherlands, collective 
settlements have been reached using a joint venture prosecution. A 
fund for victims was set up, however, it took 20 years to reach the 
agreement and the compensation has proven to be too low as the 
settlement has to be spread among multiplying claimants who 
subsequently discover side effects (t Hoen and Dukes 2007). 
Another concern is whether preconception torts are 
legitimate claims for epigenetic cases. Preconception torts are 
claims made by offspring who are negatively affected by their 
parents’ or physicians’ actions before they were conceived, 
excluding existing genetic conditions or unintentional 
environmental exposures (Weiner 2010). These claims are similar 
to claims of wrongful life, in which parents are sued for knowingly 
conceiving and bringing a child into the world with a low quality 
of life due to a predictable disability or other illness  (Weiner 
2010). Mothers have also been charged with  child  abuse when 
their actions during pregnancy, such as drug abuse, threaten the life 
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and health of their child (Smith et al. 2013). Could cases such as 
that of DES be considered under preconception and pre-natal torts, 
thereby putting blame on the grandmothers and/or mothers for 
taking the drug while pregnant? 
While these previous tort cases lend weight to the idea of 
preconception torts, there are many concerns with holding parents, 
physicians, or companies liable for their actions before conception. 
The parents could be held liable indefinitely due to their actions 
long before they ever thought of having children (Weiner 2010). 
As well, the legal system would need to clearly define what acts 
are considered harmful and punishable by tort law (Weiner 2010). 
Successful preconception torts would also raise concerns about the 
rights of the mother during pregnancy and at which point a 
developing fetus becomes recognized as a human being: this would 
have implications for abortion laws (Smith et al. 2013; Weiner 
2010). Finally, given the latency of epigenetic effects and the lack 
of knowledge on the effects of substances on the epigenome, it is 
unclear whether unforeseeable negative effects could be punished 
by tort law (Weiner 2010). 
Others have argued that pre-conception torts need not be 
dismissed out of hand if they argue a genetic basis for injury 
(Goldberg 2007). Moreover, genetic predisposition to be 
susceptible to an industrial toxin might help plaintiffs to meet the 
two-fold “more likely to have been affected than not” standard 
required for successful litigation in cases pertaining to toxins 
(Marchant 2006). By extension, epigenetic torts might also enjoy 
an opportunity to see their day in court since, like genes 
themselves, they can also embody both the measureable harm and 
the predisposition to injury. 
 
8.3.2 Proving Causation and Obtaining Records 
A further legal concern with respect to epigenetic cases has 
been the ability to prove that a drug caused the negative epigenetic 
effects. A plaintiff in any tort case should be able to identify the 
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specific product that caused the harm and the causal chain of 
events that led to the injury must be unambiguous. This becomes 
difficult when the causal stimulus and the revealed effect are 
separated by 20 or more years, as is often the case for trans- 
generational epigenetic effects. How does one retrieve 
prescriptions that are that old, and demonstrate that a plaintiff was 
compliant with regard to the use of the drug? 
Additionally, accessing medical records has proven to be 
another concern for epigenetic legal cases. The request to access 
personal health records requires that you know where the records 
are kept and in cases involving deceased progenitors, the executor 
of the estate must give permission. In  Ontario,  medical 
information is protected for 120 years after the record was created 
or 50 years after the person’s death (IPC 2008; Personal Health 
Information  Protection  Act,  2004,  S.O.   2004,   c.   3,  Sched. 
A). However, laws regarding how long medical professionals have 
to retain a patient’s medical records vary greatly from 5-10 years 
depending where the person lived. In Ontario, the College of 
Physicians and Surgeons requires that records be retained for 10 
years, but recommends 15. When you are making a second or third 
generation claim, which is the case in most epigenetic claims, it is 
difficult to have all the required information on hand to track the 
record, and sometimes a record might no longer even exist. 
 
8.4 Models for Assigning Responsibility 
It is a common idea that one should be held accountable for 
one’s decisions, and up until today, our legal and regulatory 
framework has been concerned with assigning responsibility in a 
retrospective manner (i.e. blame causally responsible stakeholders, 
when unfavourable outcomes are identified) (Gesche 2010; 
Hedlund 2012). However, when this model is applied to epigenetic 
harms, identifying those to blame will prove to be a challenging 
task. 
Some might argue that it is an individual’s responsibility to 
268  
make healthy choices with respect to diet and nutrition, exercising, 
or other major lifestyle choices. For that matter, where should the 
cost-benefit analysis place the threshold for advisable use of 
pharmaceuticals when the trans-generational consequences may be 
unknown? Thus, should there be any epigenetic side effects or 
potential health risks resulting from these choices, the individual 
should be held responsible to remedy these effects. Others argue 
that sometimes an individual may lack the knowledge required to 
make intelligent and healthy decisions, or may lack the socio- 
economic means to make better lifestyle choices to remedy their 
situation (Hedlund 2012). Moreover, the disadvantageous 
epigenetic side effects might be so profound or insidious that the 
cost of correction is unaffordable for the individual or his/her 
family. How is responsibility and blame assigned when more than 
one individual or group is involved? Although there are ways in 
which percentage blames can be assigned, the constantly changing 
and inherently complex nature of the epigenome likely means that 
the assignment of proportional responsibility will be difficult if not 
impossible to determine with exactitude. In addition, how does one 
deal with responsibility when there are structural conditions 
(social, economic and political) that affect the well-being of the 
individual and their life choices, and which contribute to epigenetic 
side effects? Finally, can it be regarded as fair to hold individuals 
responsible for the behavior and habits of their ancestors –  these 
too affect an epigenetic imprint? The complex combinatorial 
interplay of epigenetic influences also makes it difficult to assign a 
specific cause to an effect. 
All of these factors shift the moral responsibility from the 
individual to society and the government, which will ultimately 
bear much of the cost associated with ill health and lowered 
productivity (Hedlund 2012). This raises the issue of collective 
responsibility – how can this be managed? 
One model of assigning blame is the prospective 
responsibility  model.  This  model  takes  into  account  structural 
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conditions and to some extent frees the disadvantaged from total 
responsibility (Hedlund 2012). An example of this type of program 
is the Finnish “Baby Box” program that was developed to entice 
and reward expectant mothers to attend early pregnancy 
consultations with medical professionals. The program was 
fundamental to a marked reduction in maternal and fetal mortality, 
and is discussed at greater length in Chapter 10. 
The prospective model acknowledges that even if 
individuals are complicit in damaging their own interests, this 
creates costs to society in terms of health and productivity, not 
merely insofar as the individual is concerned, but also for 
successive generations who ought not to be punished. Prospective 
responsibility accounts for the multiple other inputs from the 
economy, geography, society that play a part in the epigenetic 
effects. The model also requires contributors to debate policy 
formulation: these may include individuals who have a wealth of 
knowledge, and researchers who study the field of epigenetics 
(Hedlund 2012). 
In summary, because of the complexity of epigenetics and 
the number of interests and stakeholders that contribute to the 
system, it is difficult to determine the boundaries of responsibility 
between the individual and society, so it is economically and 
procedurally simpler to facilitate better health via societal support 
than by assigning individual blame. 
 
8.5 Protection and Prevention: Adapting Testing Policies 
In the U.S., Food and Drug Administration (FDA) rules and 
regulations are designed to prevent medical tragedies. Similar 
agencies perform a like function in other countries – in Canada for 
example, Health Canada performs this function. Many argue that it 
is time to bring new changes forward considering that our genome 
is now known to respond to external signals in a diverse and 
complicated way (Szyf 2007). Xenobiotics affect us in many 
different ways, but their activity and pathways can also be different 
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from individual to individual (Szyf 2007). Pre-market and license 
testing should therefore be required to address the epigenetic side 
effects of each drug, as well as to predict changes in the metabolic 
mechanisms whereby xenobiotics themselves could be modulated 
by varied epigenomes (Szyf 2007). Such testing should include 
both drugs that may have unintended epigenetic side  effects, as 
well as the drugs that intend to cause an epigenetic modification as 
a pathway to treat a certain disease or condition. It is 
understandable why tests would be needed in the former case, 
where epigenetic side effects are unwanted and unexpected. Yet, 
testing the drugs that are intended to cause  epigenetic 
modifications is necessary to ensure that such modifications are 
gene-specific, and not random and uncontrolled (Rothstein et al. 
2009a). 
Not only is testing a necessary measure, but there also is 
need for regulation regarding how and where the testing is done. 
Considering that epigenetic modifications are species specific, it is 
important to choose the right model organism for testing and if 
extrapolating to include humans, to do so cautiously (Rothstein et 
al. 2009a). Furthermore, testing drugs for epigenetic side effects 
should be considered with skepticism. Results from such tests may 
suggest epigenetic modifications that are not accompanied by 
symptoms, or that may not necessarily have a negative influence 
on an individual’s health (Rothstein et al. 2009a). Since it has 
been previous shown that trans-generational epigenetic effects may 
not be immediately observable it is important to revisit tests in 
order to account for this. As such the results should not be taken as 
the final word, but rather, they should be seen as a guide, and 
further investigation should follow to determine possible long term 
effects. 
Another precautionary regulation that might mitigate some 
of the risks associated with epigenetics is trans-generational 
monitoring. Not only should a clinical trial assess the reproductive 
side effects of a specific substance, but it should also track the 
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effects of the substance for at least one more generation to reveal, 
characterize, predict, and prevent further trans-generational harms. 
It is impractical to make human cross-generational studies a part of 
the approval process - this could render the development of drugs a 
lengthy and impossibly expensive process – clearly cell and animal 
models will have to be developed to prognosticate potential pit 
falls, while simultaneously, longitudinal studies on humans should 
be required even after the drugs come to market. 
 
8.6 Law and Taxation Models 
Clearly, epigenetic testing, diagnosis, treatment, and 
remedy will come at a cost – how will the new expenses be borne? 
With regards to taxation, three justice models have been suggested 
to correct for epigenetic disadvantages – the luck-egalitarian 
model, the luck-prioritarian model, and the Rawlsian- 
egalitarian model (Loi et al. 2013). These models would serve  as 
a guide for taxation and redistribution of funds towards health care 
and other assets. 
Engaging the luck-egalitarian model would serve as a 
social and economic leveler of sorts. The model operates to reduce 
inequalities to those that arise solely due to the choices an 
individual makes. Any other inequalities, for example due to 
genetics, parental legacy, or social status are corrected and 
subsidized. This includes the use of subsidized therapies to 
equalize epigenetic advantages when such therapies become 
available (Loi et al. 2013). This model would equalize social and 
genetic disadvantages so that similarly inclined individuals would 
have the same opportunities for success regardless of their starting 
position in society or genetic predispositions. 
Luck-prioritarianism is similar to luck-egalitarianism as it 
requires genetic and social intervention to equalize opportunity. 
However, luck-prioritarianism requires that helping individuals in 
the worst genetic and/or social state takes precedence over helping 
all other individuals. Thus, those in worse condition would receive 
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a greater degree of aid and/or treatment than individuals who are 
slightly better off genetically, epigenetically, or socially (Loi et al. 
2013). 
The third justice model is Rawlsian-egalitarianism, or 
moderate egalitarianism. Unlike luck-egalitarianism and luck- 
prioritarianism, Rawlsian-egalitarianism would aid those in need 
only via social tools – for example, through tax cuts or subsidized 
education. Genetic and epigenetic inequalities would be viewed as 
the loss of a “natural lottery” and would be equalized, at most, by 
the redistribution of monetary assets and social aid in the favour of 
those less fortunate genetically (Loi et al. 2013). 
Regardless of the justice model invoked, it has been 
suggested that a tax be levied on prospective parents to subsidize 
the genetic and/or social interventions for disadvantaged offspring. 
The tax would be collected for each offspring and the pooled 
money would be distributed either by a luck-egalitarian, luck- 
prioritarian, or Rawlsian-egalitarian system of social justice.  Such 
a system would remove the burden of equalizing opportunities 
from society as a whole and place it on those who opt to have 
children (Weiner 2010). The practicality of taxing families when 
they are just starting out, and when family resources are relatively 
small seems dubious. Moreover, society has an interest in 
propagating new generations to replace and support the older ones, 
so why build in reproduction disincentives? The tax would 
discourage financially limited families from having children - a 
concern due to low birth rates already threatening many developed 
countries. The taxation of parents would also privilege wealthy 
people: only they might be able to afford to have children. Finally, 
such a tax would fuel the debate regarding abortion since 
financially unstable couples could find themselves in the 
unenviable position of having to choose between terminating the 
pregnancy and of digging themselves into a financial hole. 
Since one of the major concerns with imposing epigenetic 
liability is the lack of knowledge regarding the epigenetic effects 
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of products on the market, some theorists have suggested placing a 
hefty “epigenetic tax” on products. The tax would  increase the 
costs of producing such chemicals, and this additional expense 
would no doubt be passed on to consumers. So, taxes would 
undoubtedly increase the costs of production and decrease sales. 
How could companies be given incentive to ensure epigenetic 
safety? Taxation rates could be inversely tied to investment in 
research and prevention. This would benefit companies by 
decreasing both the taxes levied, as well as the potential liability 
costs of their product. Not incidentally, the program could be 
designed to expand knowledge of epigenetic risks and benefits 
(Khan 2008). 
The pros and cons of shifting the burden of care from 
society to the individual, or vice versa, must be considered, as well 
as taxes levied to encourage epigenetic research on exposure to 
seemingly innocuous products. Eventually all stakeholders should 
be encouraged to promote environmental and social responsibility 
 
8.7 Privacy Law 
Aside from the legal concerns which arise in epigenetic 
cases, privacy law also has importance where epigenetic effects are 
concerned. Current law does not include any policies or acts which 
directly encompass epigenetics. The Canadian Privacy  Act 
includes “information about an identifiable individual that is 
recorded in any form including…information relating to the 
education or the medical, criminal or employment  history…” 
under its definition of personal information (Privacy  Act of 
Canada, 2014). Loosely one could consider epigenetic information 
to be included under this if that epigenetic information is recorded 
in a form considered to be medical history. 
With the significant role epigenetics can have on 
individuals and groups of people, assuming it can be categorized 
under the act is not enough. This is especially the case when many 
individuals are affected by unexpected negative epigenetic   effects 
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such as those resultant from taking DES. Inclusion of epigenetics 
within laws for genetics may be an option. In the United States, 
for example, the definitions of ‘genetics’ used in the existing 
genetic privacy laws presently might not encompasses epigenetics 
(Rothstein et al. 2009a). With the growing prominence of the field, 
and with legal cases of epigenetic harms presenting themselves, the 
inclusion of epigenetics into privacy law is crucial for the 
protection of individuals including for prevention of epigenetic- 
based discrimination. Privacy laws should be adapted and clearly 
define how epigenetics is encompassed, and how the privacy of 
individuals should be protected. Those who bring forth epigenetic 
legal cases should not fear breaches of their personal privacy with 
respect to their epigenetic information, especially when legal 
battles ensue and media involvement occurs, and even more so 
when information released concerning one individual can be used 
to make inferences either about either progenitors or descendants. 
We will discuss privacy more in Chapter 9. 
 
8.8 Conclusion 
With cases of epigenetic harms presenting in court, the 
explicit inclusion of epigenetics into law will become necessary, 
especially because it affects so many realms of human health and 
opportunity. The uncertainty and challenges that have arisen in the 
DES litigations indicate that current law is inadequate to handle 
epigenetics. Moreover, those who present and adjudicate cases will 
need education to understand the new concepts and implications. 
Individuals who are affected by epigenetic side effects should have 
a right to obtain justice and to present an epigenetic case within a 
legal system which is suited to handle it. In order to provide justice 
and ensure that those who are liable are held responsible, indeed to 
prevent future harms from occurring, laws that acknowledge the 
implications and effects of epigenetics must be discussed and 
formed. 
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Provocative Questions 
 If the current legal system is not suited to deal with 
epigenetic cases, how can individuals obtain justice, and 
those responsible for them be held to account? 
 How quickly can the legal system adapt to fit the needs of 
epigenetic cases? Will laws and policies concerning 
genetics be adapted or will new epigenetic-specific laws be 
formed? 
 What are the implications of required epigenetic testing, 
for organizations, such as pharmaceutical companies? How 
will liability and costs be balanced to avoid impeding 
progress? 
 Will laws for epigenetic harms due to medications or 
environmental effects be expanded to encompass epigenetic 
harms due to nutrition and lifestyle choices? 
 Should those without the socio-economic means to 
change their lifestyles be offered assistance to present legal 
cases of epigenetic harm against the government? 
 Will lack of epigenetic educational resources be a feasible 
argument for a legal case of epigenetic harm? 
 How will the cross-jurisdictional nature of globally 
distributed pollutants with epigenetic effects be dealt with? 
 How will the privacy of individuals and families affected 
by harmful epigenetic influences be protected when legal 
battles ensue? 
 
Solutions 
 Education in the field of epigenetics, and in previous legal 
cases of negative epigenetic effects. 
 Acceptance of epigenetics requiring its own place within 
law 
 Formation and discussion of epigenetic laws – locally, 
provincially, federally, and internationally – there are a lot 
276  
of cross-jurisdictional issues that will require a 
comprehensive approach. 
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Chapter 9 
Epigenetic Privacy: Hacking Your Health? 
Kendall Diemer and Melissa Woghiren 
 
 
 
Abstract  
Our improved understanding of epigenetics and how it 
can lead to ill health raises questions regarding how to acquire, 
store, manipulate, and access epigenetic health data. Epigenetic 
data will be similar in many respects to other forms of medical 
information, however, this field of privacy and privilege is 
peculiarly vulnerable to exposure in additional ways that we will 
enumerate. Although pre-existing experimental standards have 
been adapted to ensure privacy for both patients and epigenetic 
study participants, vulnerabilities have been identified in the 
management of epigenetic data, especially with the growing 
affiliation of digital platforms and the use of internet tools to 
distribute, store, analyze and present data. The rapidly evolving, 
loosely regulated online environment could threaten 
confidentiality in ways unforeseen by both researchers and 
participants. Moreover, diverse online sources can be mined for 
additional information that could permit unscrupulous surveyors 
to infer your epigenetic status. Large data sets, thus assembled 
from diverse sources, can provide additional insights into an 
individual’s prospective health status. Innocent online 
interactions could lead to exploitation of epigenetic data for 
manipulation and gain. The threats of unwarranted access by 
opportunistic enterprises, combined with limited research, 
medical, and computational resources, and violation of privacy 
afforded by reverse association, emphasize the need for 
epigenetic data protection. Discussion of the implications of   the 
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current social and legal environments, and the increasing use of 
digital networks in epigenetic study and medicine, has made 
privacy in this field a pressing issue. 
 
9.1 Introduction 
Patients have the reasonable expectation that their data - 
from medical visits, prescriptions, participation in health surveys, 
or simply providing background health information - will be 
handled with care and discretion. Despite the best of intentions, 
however, there have been some recent and spectacular breaches of 
this confidentiality. For example, in the United Kingdom, the 
National Health Service (NHS) was revealed to be selling highly 
classified information to many of the nation's insurance companies 
(Donnelly 2014). Although the data had been anonymized, 
apparently none of the civil servants involved had realized that 
insurance companies could compare their own records with those 
of the NHS to connect heath records to specific patients. Moreover, 
the sale of such information had no effect on improving patient 
care, but quite the reverse: compromised patients could risk being 
denied insurance coverage. The hazards of the aggregation of large 
medical data sets have already been articulated (Anderson 1995). 
With epigenetics becoming a more prominent field, and the 
number of studies increasing, it will only be a matter  of time 
before the detailed characterization an individual’s  epigenetic 
status becomes commonplace. Epigenetics is distinct from genetic 
data: it does not involve changes to DNA sequences per se, but to 
how those sequences are packaged and consequently behave. As 
we saw in Chapters 1 and 2, epigenetic changes to chromosomal 
architecture can take many forms, and the informational 
complexity, the differential distribution of these characteristics in 
different cell types, tissues, and individuals, and the constantly 
changing nature of an epigenome (with age, exposure and 
experience of different diets, environments, social activities etc.), 
mean that epigenomic data sets will be much larger than those 
describing   genome   sequences.   They   will   also   need periodic 
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updating for each individual. 
The absence of epigenetics as an explicitly defined term in 
regulation and law, the characteristics that make it both 
mechanistically and conceptually different from genetics, and its 
novelty in health practices means that few of the privacy issues and 
challenges that attend this new field have been identified, let alone 
discussed. We will attempt to remedy these deficits, and will show 
how epigenetic data not only embodies many of the same 
challenges as other large medical and genetic data files, but 
manifests other vulnerabilities as well. We will start  with the 
issues of informed consent and epigenetic data  collection, 
handling, storage, access and processing. We will conclude by 
outlining the accessory and somewhat novel means by which 
unscrupulous operators might develop a relatively accurate 
assessment of your epigenetic status and prospective health 
predisposition. 
 
9.2 Data Collection 
9.2.1 Collection and Data Housing Challenges in Epigenetic 
Studies 
As with all large sets of biological data, privacy is important at 
all stages - from the assessment of the epigenome, to the storage of 
data, transfer and sharing, through to its computation, analysis, and 
presentation. Who is allowed access, to what data sets, and what 
security and protective measures should be in place, are all- 
important questions concerning participant privacy in epigenetic 
medicine and research. 
Ethical practices are a constant concern in scientific research. 
Practice guidelines developed and enforced by research ethics and 
regulatory bodies ensure compliance. Defining ethics in human- 
related research requires attention to the participant’s contribution, 
and an understanding of its possible implications for the 
participant's life (Ludwin and Frideres 2014). It is  the 
responsibility of the researcher to conduct research in an ethical 
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manner that is not at the expense of the individual studied (Ludwin 
and Frideres 2014). As interest in epigenetics continues to grow, an 
adjustment of ethical standards will be necessary in order to 
maintain data integrity. Privacy in epigenetic research is a matter 
of individual well-being that may be grouped with other, even 
physical, threats (Ludwin and Frideres 2014). 
Prior to analysis, data collection is the driving force of any 
scientific study. Collection concerns and data handling are not 
unique to epigenetics (Kalapesi 2013), however, like genetic data 
repositories, epigenetic research often contains incomprehensibly 
large data sets or big data (Lohr 2013). Maintaining security 
throughout the screening process can be challenging as a result. 
Indeed, privacy assurance has been debated and proposed as a 
possible hindrance to scientific advancement (Kalapesi  2013). 
Still, the exact nature of personal risk in epigenetic studies has yet 
to be elucidated, as the implications have yet to be characterized. 
A good researcher will understand why participant permission 
is not to be assumed, nor should it derived through manipulation or 
coercion (Ludwin and Frideres 2014). It is a matter of obtaining 
informed consent (Jallo et al., 2013) built upon the principle of 
respect for the participant while understanding the gravity of their 
commitment to the study (Ludwin and Frideres 2014). The 
challenges inherent in accumulating, storing, and making sense of 
big data, as well as the globalization of data curation, analysis, and 
research, present new issues in regulating data collection (Lohr 
2013). Globally, there is a trend toward societal and digital 
decentralization: this is important to note  when formulating 
privacy legislation (Kalapesi 2013). In such geographically and 
politically distributed structures, reliance upon a single governing 
body is difficult, especially when the objective is to regulate 
information sharing among diverse international entities. In these 
collaborations, sharing often involves third party tools that 
introduce additional risks since third party motives and   intentions 
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are not always identical to those of the persons invested in the 
study. 
Although it is simple to regulate those directly involved in 
epigenetic study under scientific standards, it becomes difficult to 
hold third parties to the same standards as their goals are different 
(Kalapesi 2013). Third-party regulation is further complicated 
when the services cross jurisdictional boundaries.  For  example, 
the lack of international policies presents an impediment to 
regulation and enforcement: for example, privacy laws in Canada 
will carry no weight in France and vice versa. If some part of your 
data is stored, processed, or analyzed in a different jurisdiction, 
there is little that either you or your physician/researcher can do in 
the event of a breach of privacy. While accepting the inherently 
different goals of third parties and the tools they provide, 
investigators seeking to take advantage of these resources must 
account for these differences and limitations. 
Data is now created and collected in new and distributed ways 
via connected and social communities (Kalapesi 2013). The 
traditional need for formal study approval to collect data is easily 
circumvented by harvesting from, for example, social media. 
Participants may not be aware that their personal data is being 
used, nor what it might divulge. Participant consent and privacy 
are lost in the implicit consent engendered by online posts or 
browser histories (Kalapesi 2013). A post to social media could 
provide a means for investigators or agencies to infer epigenetic 
status without the user’s knowledge or consent. 
 
9.2.2 Privacy and Informed Consent of Participants in 
Epigenetic Studies 
Before privacy in storage and sharing of epigenomic data 
can be considered, it is important to understand how data is 
obtained. One method is collection through traditional participant- 
based studies. Due to the confidential nature of an individual’s 
epigenome, researchers will have to gain informed consent.  As for 
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any other medical or social science study, participants should 
understand the ways that their data will be stored,  shared, and 
used: this is critical to building trust and public support for 
epigenetic studies. What constitutes informed consent? During the 
recruitment process, consent is usually defined as having two 
components. The first component is the participant-signed consent 
form that provides participants with written information on the 
study and the protocol that will be followed. The second 
component requires the research team to provide information and 
answer questions (Jallo et al. 2013). 
Though the foundations of informed consent can  be 
outlined for the researchers, there are still many obstacles to 
obtaining it from the participants. Some of these obstacles can 
include a lack of knowledge of the study or field of epigenetics, 
mistrust of the purpose of the study, language and literacy barriers, 
and health and socioeconomic status. These obstacles can limit the 
diversity of study participants (Jallo et al., 2013). Another  issue 
that arises is related to the consent of individuals who are below 
the defined age of consent, as well as individuals who are unable to 
provide consent for themselves due to health problems or 
disabilities. Who has the right to consent for these participants? If 
inferences about an individual can be made from one individual’s 
data do all relatives need to provide consent in order for data to be 
obtained for a study? One need only look to the clumsy publication 
of the HeLa cell genome to see how hurtful inferences can be 
made: relations of the person from whom the cell line was obtained 
were neither consulted nor informed (Hudson and Collins, 2013). 
Additionally, with the increasing use of open-access and wide 
ranging data sharing, will these individuals have the option to 
withdraw their epigenome data if they wish to in the future? 
Informed consent can be promoted through different 
methods. It will be critical to provide study information  in 
language stripped of scientific jargon, and with metaphors 
deployed to help clarify various epigenetic concepts.  A FAQ sheet 
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can help participants to feel it is normal to have concerns and to 
ask questions pertaining to the study itself as well as to their 
privacy and anonymity concerns. Researchers should focus on 
allowing the participants to attain a better understanding, and 
should encourage questions. These methods have been shown to 
improve study enrollment rates to 89% compared to the wide range 
of 15-84% common to efforts that fail to promote  informed 
consent (Jallo et al. 2013). 
 
9.2.3 Access and Release of Epigenetic Data 
Effectively safeguarding sensitive personal information goes 
beyond maintaining respect for the individual providing it. The 
definition of protection must have the plasticity and resilience to 
survive the challenge of increasingly integrated digital societies 
where respect for privacy has become more of an artifice then an 
actual practice (Kalapesi 2013). The traditionally accepted ethical 
model of data collection involves obtaining explicit consent 
directly from the owner (Ludwin and Frideres 2014): this involves 
the education necessary to make the consent informed, and it 
reaffirms the intentions of the researcher to expand current 
knowledge for the benefit of others and society alike. Online 
scientific resources for data could formerly be considered to enjoy 
informed consent provisions as one could reasonably expect that 
the participant was informed of all potential uses (Kalapesi 2013). 
Yet, in contemporary societies, data banks are no longer just 
collections of curated information associated with traditional 
bioinformatic tools. Our extended connections have created a new 
source of readily accessible and personal “big data”. With the 
evolution of data mining of nontraditional sources, informed 
consent is often assumed to be unnecessary, however the uses to 
which the data might be put is often not transparent to the “donor” 
(Kalapesi 2013). 
Since data may now be derived in many different ways, the 
various methods of its acquisition must be evaluated separately   to 
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determine appropriate use (Kalapesi, 2013). For example, a recent 
initiative by Kaiser Permanente to retrospectively survey patient 
records and make associations regarding the health of offspring 
serves to indicate where the rules of ethical consent may be subject 
to intrusive abuse. The data had not been collected for  this 
purpose, but had potential to reveal insights that might otherwise 
be unavailable. Informed consent was assumed irrelevant as the 
inferred data was obtained derivatively through family members 
(Kalapesi 2013). The study, however, could be considered a 
violation of personal privacy in the traditional sense. Does the 
benign purpose of the study justify the questionable means of its 
data use/collection? The aforementioned example of the NHS 
privacy breach serves to indicate how informed consent can fail, 
and the incident should warn us why strict restrictions on data use 
must be upheld. 
Good intentions should not be assumed of any  private 
entity as the pursuit of profit may incentivize circumvention of the 
intent of permission – transparency regarding the uses  that data 
will be put to needs work (Kalapesi, 2013). Data  privacy 
provisions should be adaptable, while still adhering to good ethics 
of collection: models that govern data use will have to adapt to 
accommodate the potential of constant access rather than attenuate 
future collection in order to protect privacy (Kalapesi 2013). 
The United Nations recently attempted to suggest regulation to 
prevent privacy violations that are facilitated by interpolation of a 
person’s everyday digital activity, and to account for the new 
methods by which data may be collected (UN 2013). While 
promising, this report acknowledges that it will be difficult to 
globally enforce privacy resolutions –  the inter-jurisdictional 
nature of the problem means that the regulations could only serve 
as a category of moral request rather than act with the binding 
power of law. Voluntarily, UN-associated states may agree in 
principle to abide by such regulations, this agreement does not 
necessarily ensure  compliance.  Regional  interests  may supersede 
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global statements of principle regardless of consequence, rendering 
such resolutions somewhat ineffective. 
Although some regional governments have developed privacy 
legislation intended to extend borders, such as European Union 
agreements (Klein 2008), Canada's Personal Information 
Protection and Electronic Documents Act (PIPEDA) is an example 
of legislation that recognizes a need for transferability (OPCC 
2014a). The PIPEDA, building upon the principles of Canada's 
Privacy Act has been continuously expanded to protect health 
privacy. Yet, recent case law and government statements  have 
made it clear that there is a preference for maintaining and growing 
international relations over ensuring cross-jurisdictional protection 
(Klein, 2008). This creates an avenue for international  businesses 
to exploit loopholes and thereby bypass privacy provisions.  We 
risk unnecessarily jeopardizing individuals’ privacy, liberty, and 
equality of opportunity by privileging economic growth. Gaining a 
global consensus on privacy will take time to realize: 
advancements in our understanding of epigenetics will no doubt 
ensue over the interim, and protections will inevitably lag. 
 
9.3 Data Handling 
9.3.1 Online Networking and Epigenetics 
The internet, as envisioned by Tim Berners-Lee, the man 
credited with its creation, was intended to provide a path to open, 
long distance information sharing, specifically of research 
materials (Owen 2014). More than 25 years later, it has evolved 
with other networks to provide fast connections and easy access to 
large stores of data. Initially, privacy was not considered an 
important factor. Nonetheless, privacy has become a main concern 
(Owen 2014). While the internet provides a convenient  way to 
drive global collaboration between researchers, it is not without a 
degree of risk when it comes to fielding sensitive information. 
Aside from the sharing of epigenetic data from online storage 
databases, there are many opportunities for data sharing through 
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online networking, social media, and mobile apps. For researchers 
and physicians, online networking is an increasingly important 
communication tool. Social media and online networks allow for 
these professionals to communicate with the public and each other 
with greater ease without the limitations of time-based 
appointments, and irrespective of geographic distances. There is 
even a ‘Facebook of Science’, a social network site called 
ResearchGate which allows data sharing among scientists to 
facilitate collaboration and the exchange of information (Gujarathi 
and Costa 2014). The use of online communication for non- 
scientists is also becoming a common way for individuals to obtain 
health information, share similar experiences through forums, and 
to participate in pharmaceutical clinical  studies.  The difficulty 
with this increased use of online networking is that many people 
are naïve or do not understand the relatively unregulated nature of 
privacy regulations and practices. Governing the flow  of 
epigenetic data or information throughout all areas of online 
networking - social media, discussion forums, and through mobile 
apps, and patterns of digital device use - seems a near impossible 
task. A 2014 study on the issue summarized this by stating: 
“Privacy issues have been the prime disadvantage for the use of the 
internet and online data storage” (Gujarathi and Costa 2014) 
Research boards and ethics committees can often review 
specific projects but when data becomes widely shared and 
accessible online, the intervention and regulation by these groups 
becomes difficult. Consideration as to how these governing bodies 
can be adapted to regulate and deal with online networking privacy 
issues is urgent. If adaptation of these agencies is not immediate or 
palatable, then new models for regulation should be considered. 
The individual responsibility of participating  researchers and 
health companies must also be enforced. “Medical professionals 
who use social networking sites have unique responsibilities, since 
information posting and sharing could violate patient privacy. Life 
sciences  companies should also consider that communication    on 
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social networks is highly public, which allows small issues to 
escalate into public incidents” (Gujarathi and Costa 2014). 
Additionally, the individuals who share their own epigenetic 
information or that of family members online must also understand 
the implications that this distribution of data might  have. They 
need to keep in mind that there are privacy implications for 
relatives, and that breaches may also last for generations if trans- 
generational epigenetic effects are involved. 
 
9.3.2 Epigenetic Privacy vs. Genetic Privacy 
Since epigenetics has yet to reach a level of public 
awareness equivalent to genetics, many papers and studies are 
currently examining privacy concerns solely with respect to 
genetics and genomic data but not epigenetics. It is not clear yet 
what direction should be taken for epigenetics and privacy - 
whether it should be considered in conjunction with genetics or  as 
a discrete challenge and issue. Certainly, epigenetics does not fit 
into the current “DNA sequence” definition of some genetic 
privacy legislation (see below). Since epigenetics encompasses a 
wide range of factors and topics, it seems that the subject should 
have its own discussion and legislative treatment. In this regard it 
might be beneficial to look at how genetics is being handled, and 
to use genetic legislation as a model to build upon for formation of 
epigenetic-specific regulation. 
In the U.S., GINA (Genetic Information Nondiscrimination 
Act), and various other policies could be critiqued, improved upon, 
and adjusted to include elements that pertain to epigenetic privacy 
concerns. This would require broad consultation with diverse 
stakeholders and experts. The structure the GINA and the 
distinguishing reversibility/plasticity of epigenetic changes means 
that existing policy will not provide enough protection. GINA’s 
disregard for phenotype (Rothstein, 2008) will  have greater 
bearing in epigenetic protection considering the wider range of 
variation and of timing that can result from epigenetic   alterations. 
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Policy-makers that seek to use GINA or any genetic privacy 
legislation must recognize this pitfall. 
 
9.4 Storage and Access 
9.4.1 Storage, Sharing, and Use of Epigenome Data 
Once informed consent has been established, and the 
relevant epigenomic data of the individual is quantified and 
characterized, the data obtained will be stored, shared  and 
analyzed. It is more common to store big data sets such as 
epigenomic data using cloud-based systems and databases. Privacy 
concerns play a major role at this stage due to the wide availability, 
distribution, and open-access nature of these systems, which, 
although constructed to promote data sharing and collaboration 
among researchers and physicians, nevertheless engender a new 
dimension of perils. 
Before online data storage, obtaining health records and 
study findings was time-consuming, limited geographically, and 
expensive in terms of housing physical copies of files. The degree 
of ease and speed with which online data can be accessed has 
changed how frequently data is shared and transferred. “Big data” 
sets have presented a profound storage issue. “Although both 
computers and the internet have become faster, there is a lack of 
computational infrastructure that is needed to generate, maintain, 
transfer, and analyze large-scale information securely...” (Costa 
2013). Cloud computing has been suggested as the only solution 
which is viable to accommodate the scale of data collected over the 
course of epigenetic studies (Costa 2013). While some initiatives 
aim to embed privacy protection into the function of cloud 
computers (Lohr 2013), there are presently no formal industry 
standards. This is not the only cloud-based challenge. Data 
analysis, presentation, and delivery might also use distributed 
servers, agencies, and third-party tools. Moreover, given the 
complexity and specialization of analysis and presentation 
software, it might be the case that service providers are few in 
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number and geographically remote. Without even considering the 
risks that attend file transfers to remote locations, what regulations 
pertain to the privacy of data that is collected in Canada, housed 
via cloud computing in the United States or Europe, and analyzed 
using software provided by a company in Iceland? 
Does the concept of privacy need to be revised? Can an 
individual’s data really be confidential and can its use in other 
studies be regulated? Online data storage and the  subsequent 
global sharing of data has eliminated the idea of data being used 
for a single study, or by a single group of researchers. Will consent 
always be obtained for each use of the data once it is present in the 
open-access database? A recent study has asked some of these 
questions. “One approach is for the researcher to move from 
guaranteeing (and so protecting) privacy to practicing veracity, 
explaining to potential participants that their data will be accessed 
by, and shared with, others; those consenting to research have to be 
open to this.” (Clarke et al. 2012). If data sharing is occurring on a 
global level, these privacy considerations need to not only be 
legislatively addressed in each area, but the regulation of these 
laws must also acknowledge and encompass cross-jurisdictional 
considerations. 
One method currently in place to protect the privacy of an 
individual’s data in online storage is de-identification. This 
process separates identifiable markers from an individual’s data to 
prevent the data from being traced back to them specifically. 
Studies of genetic data have shown that re-identification is 
possible: researchers were recently able to identify about 50 
participants who donated to the 1000 Genomes Project of 
“anonymized” genetic information (Hayden 2013). It has been 
proposed that re-identification methods be used as tests for the 
privacy protecting ability of various data storage systems (Malin 
and Sweeney 2004). Industry leaders have nevertheless identified 
the reality of digital storage vulnerabilities and instead support the 
call for research transparency: both researchers and subjects   will 
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likely need to recognize the impossibility of complete privacy in 
research that utilizes online tools (Hayden 2013). Online data 
storage will force the re-evaluation of what is possible and 
plausible when assurances are given regarding online privacy. It 
can no longer be assumed that anonymized information is safe. 
 
9.4.2 The Social Media Problem 
The environment in which the data originates will dictate its 
handling, storage and access, and should be the focus of regulation, 
especially since many of the tools, mechanisms, and uses to which 
the data will be put are far from transparent to the provider. We are 
more connected than ever, and information sharing is no longer 
necessarily an intimate occurrence: blanket privacy protection at 
the point of collection is no longer practical (Kalapesi  2013). 
Many retailers and large corporations use data mining to drive 
statistical research on current or potential clients (Duhigg 2012). 
Predictive analytics models consumer behavior and personal 
events in order to understand future needs. While much of this 
information is collected by one's transactions with these 
companies, some may be bought from data banks that also mine a 
variety of sources including online social activity (Duhigg    2012). 
Surveys are one of the easiest sources from which to gather 
information as they tend to reveal a variety of lifestyle elements. 
This sort of strategic analysis could be extended to reveal 
epigenetic status and prospective health. Slight decreases in 
genomic methylation, indicative of epigenetic status and health, 
have been linked to groups with low socioeconomic status 
(McGuinness et al. 2012). Even the nature of one's job correlates to 
methylation patterns and presumably, to disease risk (McGuinness 
et al. 2012). Combined social and commercial predictive data 
analysis can be cross-referencing with social, geographical, and 
employment data. Governments and commercial interests could 
conceivably derive a highly accurate picture of your epigenetic 
status  and  future  health  predispositions.     Imagine  how    much 
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information could be gleaned and accurately predicted if the 
websites that were mined included blogs or chat rooms where 
people compared notes on depression, smoking, wine tasting, etc. 
Imagine how much more might be inferred about  your general 
level of activity and fitness if your patterns of web surfing, movie 
streaming, or online gaming were assessed. Finally, inaccuracies 
within this mined data set are inevitable. How are researchers to go 
about validating mined information when no controls for variances 
are set in place, and how might citizens correct errors in the data 
that will affect their algorithmic quantification (Kalapesi 2013)? 
 
9.4.3 Privacy Protection and Epigenetic Discrimination 
Data-mining is valuable in surveillance  and investigations, 
yet also provides a means for private dataveillance (collection and 
analysis of a person’s digitally encoded actions) (Rubenstein et al. 
2008). Loose online regulation provides for the essentially 
unregulated, if unethical, means to collect and store large data sets 
(Rubenstein et al. 2008). Without globally enforceable online 
privacy provisions, data-mining companies could  take advantage 
of disingenuous end-users and threaten their privacy. The issue of 
privacy being subordinated to cross-jurisdictional interests is 
highlighted by a recent ruling of the European Court of Justice in 
which Austrian Max Schrems took issue with Facebook 
transferring his digital information to U.S. based servers (European 
Court of Justice, 6 Oct. 2015). The additional problems of online 
sharing in conjunction with re-identification threats further violates 
epigenetic privacy. 
Privacy regulations must also take into account the potential 
for one’s epigenetic data to be used as a means of discrimination. 
Whether third parties such as employers or insurance companies 
should have access to an individual’s epigenomic data is an 
important question to address. While researchers and physicians 
utilize epigenetic data to better understand the factors that can aid 
in medical care, the intentions of third parties may not be as   clear. 
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What questions or data should employers or insurance companies 
have a right to ask or access, if any? How can the use of such 
information by these companies be regulated, and monitored to 
ensure no discrimination is taking place? Should they be permitted 
to make inferences and discriminate based upon your educational 
record, your geographical location, your cultural habits and 
practices, or the socioeconomic status of your parents? For 
example, in Arizona, the Pima County Board of Supervisors 
recently voted to rule job applicants who were smokers  ineligible 
to fill job vacancies… The potential for insurance services or job 
opportunities to be declined to individuals, or even their relatives, 
if their epigenetic data shows predispositions to certain health 
complications or diseases, should create a sense of unease. 
The NHS scandal exemplifies a particularly egregious lapse of 
judgment that had the potential to harm the personal privacy and 
opportunities of clients, but it is not the only “anonymized” data 
set in circulation. Indeed, releases of information like this are 
increasingly common. Newborn screening (NBS) programs, for 
example, are viewed as integral to effective postnatal care in the 
U.S. (Roberts et al. 2014). However, as with many other U.S. 
federal programs, screening results are publicly accessible. The 
original purpose was to provide early treatment for detected 
diseases: the health and societal benefits of this information as a 
predictive tool are obvious. 
With the development of more advanced screening tools and 
the potential incorporation of epigenetic information, complete 
epigenetic profiling may not be subject to privacy protection in the 
near future. Although informed consent and consent manipulation 
are topics hotly debated, the public health benefits of large scale 
surveys may have inadvertently provided an avenue for illicit 
exploitation (Roberts et al. 2014). Furthermore, direct-to- 
consumer genetic testing may not only facilitate the 
misinterpretation of one’s genetic identity, and eventually 
epigenetic identity, but it might also provide an additional resource 
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for third parties to link genetic to epigenetic information (Roberts 
et al. 2014). A prime example of this is the consumer DNA 
profiling company 23andMe that has already entered into 
agreements with pharmaceutical giants such as Pfizer to grant 
access to troll through their databases.  Germany has recognized 
this as a threat and banned direct-to-consumer genetic testing 
services based on the public health implications. Still, these 
services remain widely available elsewhere. Open accessibility to 
these data stores has enabled the identification of individuals who 
made it a point to remain anonymous in certain aspects of their 
lives (Hayden 2013) 
Additionally, if insurance companies provide extra services 
for epigenetic related issues there is a possibility for falsification of 
identity in order to obtain these services. If an individual’s data is 
publicly accessible online or not stored securely, others who are 
unable to afford the insurance coverage may steal the data in order 
to obtain services for themselves. Aside from the financial 
implications this could have, it has been proposed that “…identity 
breaches can deleteriously affect the quality of care. Incorrect 
information can infiltrate the beneficiary’s medical record and 
corrupt later medical decision making.” (Taitsman et al. 2013). The 
idea that failure to protect an individual’s privacy can also affect 
the quality of healthcare the individual may receive is disquieting 
and shows the significance of privacy in epigenetic research. 
 
9.4.4 Epigenetics and Advertisements 
The use of third-party tools in the form of networks, servers, 
processing, and storage systems is inevitable when it comes to 
epigenetic data. This raises the concern that all epigenetic data 
transactions have the potential to be monitored. Packet-sniffing 
(Ansari et al. 2002) is a powerful administrative tool to evaluate 
network function, however this tool also provides a method to 
analyze all shared information across a particular network, 
sensitive  or  otherwise   (Ansari  et  al.  2002).   One  category    of 
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business that utilizes packet-sniffing that could present a threat to 
epigenetic privacy is embodied by advertising agencies and 
marketing corporations. How would you feel if your health 
information was reflected by targeted ads over every web page you 
visited? What if billboards and TV advertisements were geared 
towards your personal health status as determined by analysis of 
your browser history or epigenomic data, or if your mailbox was 
flooded with ads and promotions related to your personal medical 
conditions? If third-party companies phoned you or came to your 
residence with offers for products or services all based on medical 
data you would consider private, how would you feel? This  level 
of intrusion already occurs. 
Google, and other search engines, monitor search inquiries as 
of way customizing advertising to each user. However, it is a part 
Google's privacy policy to refrain from ads targeted toward health 
and other sensitive identifiers (OPCC 2014b). Nevertheless, a man 
alleged that Google collected his private health information as a 
means to advertise to him after he had left webpages that he had 
visited (Lawton, 2014). In response to an admonition levied by the 
Canadian Federal Privacy Commissioner, Google asserted that the 
ad targeting was the result of remarketing campaigns (OPCC 
2014b) and non-compliant corporate users of its services. The case 
raises questions about the shortfalls of online privacy regulation. 
Despite legislation that affords health privacy protection in 
countries like Canada where the  aforementioned  man was    from, 
U.S. based companies are not held to the same standard of care and 
confidentiality. It is, however, promising that Google has taken 
steps to enforce the corporate privacy rules that it has set forth for 
its clients, some of whom are not subject to Canadian privacy law, 
as they are based outside of Canada. Still, this does not prohibit a 
company based in a country with lax privacy protection to take 
advantage and overstep the personal boundaries of end-users in the 
pursuit of profit. 
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Privacy measures to regulate the access these companies 
have as well as acts and laws to regulate the ways in which they 
utilize epigenetic data are vital. “The prospect of internet-based 
marketing corporations using access to research data  and 
electronic health records as an opportunity to  market more 
products seems both manipulative and cynical.” (Clarke et al. 
2012). A further concern with advertising agencies utilizing 
personal epigenetic data is that they can present the public with 
infomercial-type advertising that most people will lack the critical 
tools to evaluate. If individuals are unable to distinguish between 
credible epigenetic medicines or services versus scams, unethical 
companies will enjoy a golden opportunity to profit by taking 
advantage of the ill-informed and unaware. 
 
9.5 Conclusions 
Epigenetics presents challenges that are distinct from any 
other branch of health: there are presently many additional and 
commonly accessible means to assess one’s epigenetic status and 
health predisposition. Many of these avenues of assessment are 
unregulated and exposed. Privacy regarding a person’s epigenetic 
and long term health is open to inference  and  interpretation in 
ways that that other aspects of your health and life are not. Privacy 
advocates, individuals, and legislators need to take rapid action if 
they are to protect our access and opportunity to enjoy good jobs, 
healthcare, insurance, security, and privacy. 
 
 
 
Provocative Questions 
 In regions less concerned with individual rights, use  of 
open sourced epigenetic information could propagate 
human rights violations. How can this be controlled or 
discouraged? 
298  
 Will lack of de-identification safeguards lead to 
discrimination and the imposition of unfair government 
standards? 
 Can the Wild West of cross-jurisdictional data flow be 
regulated to protect privacy? 
 How can individual responsibility for personal and 
extended familial epigenetic data protection be balanced 
with rights to freedom of expression? 
 Online governance inherently undermines the principles of 
the internet and entrenched ideals of net neutrality. 
Regulatory activity tends to be reactive, not proactive. How 
can this be changed quickly in order to contain the possible 
damage? 
 Some of the largest curators of data storage are not arms’ 
length and disinterested parties – they are multinational 
corporations with vested interests and are uniquely 
positioned to exploit consumer data. How can this be 
controlled internationally? 
 Can private scientific networks be sufficiently protected 
against intrusion? 
 How can consumers be endowed with tools to detect and 
correct errors in their profiles? 
 How can the comprehensive and extensive nature of the 
privacy threat be conveyed without eliciting a knee jerk 
reaction? 
 With the growing privatization of many social services and 
a move towards business-focused models of running public 
institutions, is any organization truly focussed on public 
service and well-being? 
 
Possible Solutions 
 Protection of epigenetic privacy will be most effective 
through proactive measures. Direct linking of privacy 
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requests have been proposed in the scientific community as 
a way of giving the information owner greater control over 
their data (Lohr, 2013). 
 Epigenetic privacy provisions must be flexible to 
accommodate the rapid pace of technical and scientific 
change. 
 Education will be the greatest tool to protect privacy. It is 
not enough to educate the public - researchers and 
government officials must also be trained on the 
implications of use. 
 Data storage security must be made a priority. 
 Individuals must also understand their responsibilities must 
understand the potential risks, show some restraint, and 
consider the privacy implications of their actions for 
extended family and descendants. 
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Chapter 10 
Where Do We Go From Here? 
 
Michael Crawford 
 
Abstract  
Recent  discoveries  in the emerging field of  epigenetics 
will impinge in a profound way upon reproductive, medical, and 
environmental ethics. These discussions have  implications for 
the role of the state in our homes and in our lives. What we do in 
our lives, how we live, the opportunities that we are afforded - 
these manifest as epigenetic traits and dispositions that can be 
modified and transmitted to offspring without changes being 
made to our DNA sequences. Environment, diet, toxins,  and 
even human relations potentially can alter an epigenetic imprint 
for generations. Inevitably, political, legal, and social discourse 
will focus upon where to balance individual rights and 
obligations versus societal costs and imperatives. I will  argue 
that the complexity, longevity and time lag of epigenetic effects 
mitigate against a simple allocation of responsibility for injury or 
health. To clarify the scope of legislative and policy challenges, I 
will suggest the limitations of tort law to deal with injury, and 
deliver some of the perspectives, temptations, and directions for 
ethical solutions that will be brought to bear. 
 
 
10.1 A Bioethical Agenda For Consideration 
None of us chose our parents, no matter how much we 
might like to take the credit or avoid the blame. We enjoyed 
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control neither over our birth, early childhood economic, 
familial, educational, nor nutritional environment. Who then 
bears responsibility for repairing the health, economic, and 
environmental disparities that can exert long-term reproductive 
consequences? Whose interest is served by improvements that 
will better subsequent generations? Parents? Children? The 
state? 
Clearly, we all should all do our best to respect and 
nurture our bodies. They are the vessels that we ride into old 
age, and they are the machines that help to build future 
generations. For our own sakes, as well as for our progeny, we 
need to respect and care for ourselves as best we can. Exerting 
the necessary discipline is often hard, but if epigenetics tells us 
anything, it is that we might not be as autonomous and 
unencumbered in our proclivities and predispositions as we 
might formerly have supposed. 
At present, the legal system does not explicitly recognize 
epigenetic effects let alone the interaction that exists between 
epigenetic imprinting and the environment. However, the 
environment has always influenced the genome and the health 
of individuals, and it is becoming clear that improvements to 
the environment can translate to improvements in human 
health and prosperity (Dupras et al., 2012; Guthman and 
Mansfield, 2012). With epigenetics we have a window to see 
the mechanism by which environmental wellbeing  is 
connected to individual health: the complex interactions 
between the two could offer a tool to improve societal health 
(Dupras et al., 2012). Such a mindset would link improved 
individual health to environmental stewardship as well as the 
propagation of better medical and environmental health 
through future generations (Rothstein, 2013). 
With advances in diagnostics and epigenetic testing, the 
detrimental effects of the environment could be identified and 
possibly   even   corrected   before   they   propagate   to future 
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generations (Loi et al., 2013). With increased attention to the 
prevention of disease, rather than the treatment of conditions 
after development, the remedy of disadvantages early in life 
should take precedence. The emphasis should shift to the early 
treatment of social, educational, dietary, and genomic 
challenges: epigenetic interactions are likely to amplify health 
deficits that are the consequence of any of these realms over 
time and across generations (Loi et al., 2013). However, this 
will require a shift in strategy. Preventive treatments or 
“wellness” and education programs have the potential to 
drastically improve the quality of health care offered to 
patients yet they may introduce new forms of inequality. If 
epigenetic assessment and diagnosis are not affordable and 
accessible, the likelihood is that greater inequities regarding 
quality, efficacy, and availability of health will arise 
(Rothstein, 2013). As a consequence, enjoyment of health, life, 
and opportunities will become further stratified, and 
productivity of the community at large will be hampered. 
There is still much to be determined with regard to the 
place of epigenetics in the legal system, tax system, and health 
care systems. A change in perspective, extensive consultation, 
and increased public knowledge of epigenetics is necessary for 
changes to take place. 
We can illustrate the convoluted complexion of the 
challenge, and the inadequacies of current frameworks to 
contend with epigenetic issues, using the example of tort law 
discussed in Chapter 8. In tort law, the difficulties that attend 
identification of the origin of an imprint will prove daunting in 
assigning liability. For example, people will inherit  genetic 
and epigenetic predispositions from their parents, and  then 
they will themselves add to this historical baggage via 
behavior, experiences, and choices. Quite aside from the fact 
that a child has yet to successfully sue a parent for wrongful 
life (indeed since some jurisdictions have ruled it repugnant  to 
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assign a compensatory value for birth-associated defects that 
would place a differential value on lives) (Karpin, 2010), 
demonstrating a causal relationship between an individual’s 
actions and their consequences is too fraught with variables to 
survive close scrutiny. For example, obesity has often been 
regarded as the product of over-indulgence on the part of 
parents or individuals. Similarly, addicts, while arguably at 
least partially the product of their environment, have been 
regarded as the authors of their own dissolution. Recently it 
has become clear that there are genetic and epigenetic factors 
that need to be considered (Delport and Pollard, 2010; Byrnes 
et al., 2013): people who indulge in self-harming behavior may 
be the victim of proclivities and impulses that have a more 
complex etiology than formerly supposed. 
While individuals cannot and should not be excluded from 
exerting significant control over their epigenetic status, neither 
can they be assigned sole responsibility. Given that assignment 
of blame for epigenetic damage to individuals and businesses 
is likely to prove difficult under tort law, similarly, one must 
ask how ethical considerations can be gauged and how 
practical assignments of responsibility can be  allocated? 
Where does the balance lie between state and citizen? Indeed 
epigenetic causes and effects are so complex, so temporally 
extended in their manifestations, and so subject to multiple 
influences, that for reasons of both political as well as 
practical, it might be better to ignore where, in the spectrum of 
interactions between individuals, the state, and businesses, 
ethical responsibility actually lies. Perhaps we need to focus 
instead upon how ethics can guide our practical responses. 
Maria Hedlund makes an interesting observation: she 
points out when epigenetic responsibility is assigned 
retrospectively, individuals will tend to be identified and 
blamed (Hedlund, 2012). By contrast, she argues that when 
responsibility   is   viewed   prospectively,   the   structural and 
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contextual nature of a problem demands action by political and 
social organs. 
Let us reduce the equation solely to factors of economics 
and practicality: an argument can be made for shifting some of 
the onus of responsiveness and responsibility for epigenetic 
health from individuals to businesses and the state. The long- 
term consequences of epigenetic perturbation are costly, so by 
facilitating good practices, businesses and states can position 
themselves to control heath care costs and to minimize future 
encumbrances upon labour availability and efficiency. Given 
the difficulty of demonstrating a simple causal link between 
individual lifestyle choices and imprinting effects, 
interventions that are facilitative rather than proscriptive seem 
most likely to succeed and to provide efficiencies for both 
health and societal success. 
Facilitative experiments have met with success in the past, 
albeit with no knowledge of the epigenetic consequences  of 
the programs at the time. The Finnish “Baby Box” program 
was installed in 1939 with the objective of reducing infant 
mortality among the poor. The program is still running and 
delivers a box of useful goods to parents on condition that they 
seek free prenatal medical advice and examinations. The 
program was universalized in 1948 (Lee, 2013; Söderblom and 
Kela, 2013). Parents have the option to ignore the program, 
and even to receive monetary compensation in place of the 
boxed goods. Nevertheless, nearly everybody uses the 
program, and parents receive both a high standard of prenatal 
and delivery healthcare as well as a wealth of baby clothes, 
diapers, blankets etc.. The boxes are regarded as a “good deal” 
and the rate of infant and mortality has dropped. Similarly, in 
the State of Hawaii, intervention was forced when a cohort of 
impoverished teens was identified as poorly served by the 
existing QUEST/Medicaid programs. The cycle of addiction, 
obesity,    diabetes,    and    teen    pregnancy    presented  both 
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immediate and long term risks that were addressed by 
extending post partum health coverage from 8 weeks to 6 
months or more (Partika et al., 2008). 
 
10.2 An Agenda for Consideration 
So where do ethicists, social engineers, scientists, business 
people, and government meet to allocate resources and 
responsibility? Where might ethics help to guide  our 
response? The comprehensive and overlapping nature of 
epigenetics effects mitigates against a piecemeal approach. 
Gesche argues for a carefully integrated approach to analysis 
and policy development: she argues that it will require 
transformation of public health policy (Gesche, 2010). We’d 
argue that the scope needs expansion further still and that it 
would help to commence with discussions that pertain to 
purely practical measures: 
1. Government agencies need to coordinate centrally to 
gather and then disseminate information and advice. A 
Standing Committee should serve as a nexus for information 
and policy development, and all stakeholders should have a 
means to articulate concerns. This necessitates an inter- 
disciplinary approach, and presumably one guided by 
professional ethicists. Given the breadth, complexity, and 
ever-changing nature of the information landscape, such a 
committee needs to be constituted not merely of well-educated 
representatives of science, social policy, medicine, and 
economics, but to have additional positions that are occupied 
by topically relevant short-term “floaters.” Epigenetics will 
continue to surprise, so the participants need to be flexible and 
engaged in learning on the fly. Operational principles of such a 
Committee would have to reflect the need for this evolution of 
education and compositional flexibility. 
2. Governments, through their agencies, need to 
undertake a rapid and fulsome practical education of their 
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agents, as well as of the media, and public at large. To this 
end, initially, open participation conferences with plenary 
speakers from multiple disciplines (ethics, science, 
government, economics, healthcare delivery, business, law) 
might be a good place to start. More especially, practical 
information needs to drill down to family  physicians, 
expectant mothers, and children in elementary school on 
upwards. 
3. Individuals need help to make good lifestyle 
decisions. Options to facilitate this beyond merely educating 
might include: better labeling of food contents; “sin taxes” on 
foods that a comprise high fat content and/or high glycemic 
index; tax credits for participation in clubs and organizations 
that promote fitness (especially for pre-pubescent children); 
better public transit combined with more expensive parking for 
cars etc.; in-fill and public space development in cities to 
render them more walk-able and accessible for shopping, 
living, playing. 
4. Should incremental health service cost increases or 
service restrictions apply to individuals who abuse themselves, 
or who refuse to control unhealthy behavior? Given the 
potential for trans-generational effects, there seems little profit 
in alienating recalcitrant members of society: you might  end 
up penalizing their innocent offspring. Seeking help should be 
rewarded, and failure to succeed should not necessarily result 
in a sanction. Educational support would have to account for 
options that might be excluded by economic or cultural 
context. There is a geographical, economic, and cultural 
dimension to epigenetics - no absolute metrics are likely to be 
practical or effective. The ethical debate and social policies 
that derive will need to be managed in a sensitive manner. 
5. Should states reconsider the thresholds at which they 
intervene to protect children from abuse, and to encourage full 
parental engagement and support? The definition of abuse 
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should be re-examined beyond the scope of purely physical. 
Diet and parenting habits are clearly of trans-generational, not 
merely familial importance. 
6. Consideration should be given to maternal health and 
dietary support both pre-term and post delivery, and to 
investment in feeding and food education programs at schools 
where the habits of a lifetime may still prove open to 
modification. Given the onerous financial and human cost of 
the growing plague of obesity and diabetes, the cost of such 
early life social supports seems paltry by comparison. 
7. Consider developing a directed taxation structure 
whereby companies that produce new categories of materials, 
drugs, and waste, help to build an autonomous and protected 
investment fund for the purpose of offsetting potential 
generational consequences of unforeseen health issues. 
8. Ensure that companies are regulated and insured to 
cover the true costs of environmental degradation. It is hard to 
predict in advance what wastes will have an effect, so all 
effluents and emissions should be factored into an accounting. 
Who could have predicted that PCBs or endocrine mimics 
would exert trans-generational effects? 
9. Research in humans needs to redress a recent gender 
bias in the literature. Paternal and parental care studies in 
rodents demonstrate that females are not necessarily privileged 
in conveying an imprint to offspring. The  recent 
preponderance of focus upon human maternal effects risks 
burdening women with an unfair share of responsibility for 
generational health. The effects of pre-conception activities 
upon later fetal health might also impinge upon our perception 
of how to balance individual rights and long-term reproductive 
obligations. 
10. Medical, social, environmental, and  economic 
policy experts need to conference to both learn about 
epigenetics, and to begin developing policies to mitigate extant 
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as well as developing challenges. Little recognition has been 
paid to this field or to the long-term health and economic costs 
that will arise. By way of example, if, as rodent  studies 
suggest, the presence of endocrine disruptors in our food and 
drinking water exerts a subliminal and persistent effect, we 
could be in for interesting times. How  and  where to 
effectively marshal resources to maintain and improve 
equitable access to good health will be a complex  problem, 
and initiating discussions pertaining to health and social ethics 
is a good place to start. 
 
10.3 References Cited 
Byrnes JJ, Johnson NL, Carini LM, Byrnes EM. 2013. Multigenerational 
effects of adolescent morphine exposure on dopamine D2 receptor 
function. Psychopharmacology (Berl) 227:263-272. 
Delport T, Pollard I. 2010. Changing perspective on obesity: genetic and 
environmental health consequences in the offspring.  Eubios 
Journal of Asian and International Bioethics 20:170-173. 
Dupras C, Ravitsky V, Williams-Jones B. 2012. Epigenetics and the 
Environment in Bioethics. Bioethics. 
Gesche AH. 2010. Taking a first step: epigenetic health and 
responsibility. In: A. H, S G, editors. Epigenetics and Human 
Health: Linking Hereditary, Environmental and Nutritional 
Aspects. Weinheim: Wiley-Blackwell pp 281–285. 
Guthman J, Mansfield B. 2012. The implications of environmental 
epigenetics: a new direction for geographic inquiry on health, space, 
and nature-society relations. Progress in Human Geography 
37:486-504. 
Hedlund M. 2012. Epigenetic Responsibility. Medicine Studies 3:171- 
183. 
Karpin I. 2010. Taking care of the "health" of preconceived human 
embryos or constructing legal harms. In: Nisker JA, Baylis F, 
Karpin i, McLeod C, Mykitiuk R, editors. The 'healthy' embryo : 
social, biomedical, legal and philosophical perspectives. Cambridge: 
Cambridge University Press. pp 136-150. 
Lee H. 2013. Why Finnish babies sleep in cardboard boxes. In: BBC 
News Magazine. http://www.bbc.co.uk/news/magazine- 
22751415: BBC News. p article. 
Loi M, Del Savio L, Stupka E. 2013. Social Epigenetics and Equality of 
Opportunity. Public Health Ethics 6:142-153. 
312  
Partika NS, Ta VM, Hayes DK. 2008. A Hawaii Case Study on 
Interconception Care for Women on Quest/Medicaid. In: 
University of Hawaii. 
Rothstein MA. 2013. Epigenetic exceptionalism. J Law Med Ethics 
41:733-736. 
Söderblom A, Kela. 2013. Kela: Maternity Package. In. 
http://www.kela.fi/web/en/maternitypackage: Kansaneläkelaltos - 
The Social Insurance Institution of Finland. 
313  
Glossary 
 
 
 
acetylation involves the addition of an 
acetyl group (C2H3O) to  a molecule. 
In epigenetics, acetylation of the tail 
of histone H1 is associated with a lax 
nucleosomal conformation that is 
conducive to gene activity. 
 
acute myelogenous leukemia –  also 
known as Acute myeloid leukemia or 
acute nonlymphocytic leukemia 
(ANLL). It the most common type of 
blood system cancer. White blood cells 
proliferate in the bone marrow and 
inhibit the production of other blood 
cell types. 
 
Alcoholism – type I The tendency is to 
drink excessively in response to  a 
stress. Alcoholics of  this  type can 
avoid abuse for extended periods of 
time, but can fall into an abuse spiral. 
Type I alcoholics usually feel guilt and 
fear of their addiction. 
 
Alcoholism – type II This category of 
alcoholics tend to start  drinking from 
an early age and often have an older 
male family member who also abuse 
alcohol. Drinking tends to be 
continuous, and considerable control 
over ingestion can be exerted. 
 
algorithm: computer science; 
programming logic to efficiently 
provide output based on input. 
 
Alu elements or sequences are, like LINE 
elements, remnants of retroviral 
invasion,  and  they  constitute  roughly 
11% of the genomebut are somewhat 
shorter in length than LINES. 
 
apoptosis is a technical term that describes 
genetically programed cell death in 
response to injury, senescence, or as 
part of normal embryological 
development. 
 
autism spectrum disorder (ASD) 
encompasses neurodevelopmental 
disorders that result in varying degrees 
of social or communication deficits, 
sensory and cognitive disorders, and a 
tendency to repetitive or stereotyped 
behavior. 
 
big data: a large, complex collection of 
data that requires special processing 
considerations due its size. 
Computational analysis of these data 
sets attempt to reveal trends or 
behaviors, especially with regard to 
human commerce or behavior. 
 
bioinformatics: intersection between 
computer science and biology; using 
computational methods to analyze 
biological information. 
 
bioinformatic tools: computer software 
developed for the processing and 
analysis of biological systems and data 
 
Bisphenol-A (BPA) is used in the 
production of plastics and can leach 
from containers into food products. 
BPA can act as an estrogen mimic. 
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brain-derived neurotrophic factor 
(BDNF) is a growth factor that is 
required for neural growth, stability, 
and synapse formation. Mis-regulation 
of BDNF is linked to depression, 
schizophrenia, addiction, and 
Alzheimer’s disease. 
 
chemopreventive reversers is a substance 
that reverses the effects of an 
environmental toxin. 
 
chromatin: The “stuff” of chromosomes, 
chromatin is an assembly of DNA, 
RNA, and proteins such as histones. 
Chromatin is the higher order, flexible, 
and dynamic architecture of our 
genome. 
 
chronic lymphocytic leukemia is a disease 
of the bone marrow stem  cell 
population that contributes 
lymphocytes (white blood cells). The 
disease develops slowly with most 
tuning into an acute form of B-cell 
leukemia. 
 
chronic physical aggression (CPA) 
describes a pattern of behaviour where 
young children display physical 
aggression and who fail to moderate it 
between the ages of three and four. The 
pattern of aggressive behavious persists 
throughout school years and into 
adulthood. It is associated  with 
histories of child abuse, and/or family 
disfunction. 
 
circRNA molecules do not encode proteins 
but help to regulate the activity of 
miRNAs which in turn regulate the 
transcription and translation of mRNAs 
thereby ultimately affecting proteins 
synthesis. 
cirrhosis is a sign of advanced liver disease 
and can be the product  of alcohol 
abuse, hepatitis or other diseases. It 
represents a scaring or regenerative 
response to stressors. 
 
clear cell adenocarcinomas are  a rare 
form of tumour, usually associated with 
the female uro-genital tract. The 
tumours usually have a glandular origin 
 
cloud computing: large, connected 
networks of servers to allow fast data 
processing and storage through a single 
shell access point. 
 
coeliac disease is an autoimmune disorder 
of the small intestine that is  triggered 
by gluten-containing foods. It results in 
diarrhea, weight loss, anemia, fatigue, 
and disorders in other organs. 
 
collective responsibility is a philosophical 
concept that defines a social and moral 
duty to accommodate or remedy larger 
scale and collective harms. Groups 
such as governments, businesses etc., 
might be argued to hold collective 
responsibility for harms to individuals 
or groups. 
 
CpG sites of dinucleotides: shorthand for 
cytosine-phosphate-guanine, a DNA 
sequence that is a preferred site for 
DNA methylation. 
 
CpG islands are CG-rich regions, usually 
located in the 5’ upstream regulatory 
regions of genes. They are a frequent 
site of DNA methylation. 
 
Crohn’s disease or syndrome is an 
incurable inflammatory  bowel 
condition that can result in pain, weight 
loss, diarrhea, fever, bowel obstruction, 
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rash, and a predisposition to bowel 
cancer. 
 
cytokines are small secreted proteins used 
by cells to communicate.  They are 
often associated with responses  to 
stress or with cells of the immune 
system. 
 
data mining: analyzing large sets of 
information for specific points of 
significance. 
 
dataveillance: information technology; 
constant analysis and collection of data 
transferred over a network for purposes 
other than diagnostics. 
 
decentralization: dispersing functions 
from a central point among many 
entities for shared responsibility. 
 
developmental programming, also known 
as Barker’s hypothesis posits that a 
mother’s diet - and fetal exposure - 
during pregnancy will have an effect 
upon the onset of diseases later in the 
life of her offspring. 
 
diethylstillbestrol (DES) is a synthetic 
non-steroidal estrogen. It has a history 
of use in cattle, and in humans as: a 
cancer treatment, chemical castration 
agent (Alan Turing), and it was 
erroneously prescribed as a fertility 
enhancer from the late 1930 until the 
1970s. 
 
de-identification: bioinformatics; removal 
of all markers that could be used to 
identify the owner of a biological data 
set. 
direct-to-consumer genetic testing: 
purchasable services to analyze and 
receive information on one’s genome. 
ie. 23andme.com 
 
DNA methylation occurs when methyl 
groups are attached, usually to the C- 
nucleotide in GCG-rich regions of gene 
regulatory  regions.  DNA methylation 
is usually, but not always, associated 
with gene inactivation. 
 
DNA methyltransferases (DNMTs) are 
the enzymes that catalyze addition of 
methyl groups to DNA. They tend to 
inactivate genes. 
 
DNA sequencing determines the order of 
nucleotides that comprise a DNA 
fragment or a genome. The readout is 
then assembled and compared against a 
database to identify genes etc. 
 
eclampsia defines a health condition in 
women either during or shortly after 
pregnancy where high blood pressure, 
organ failure, or high blood protein 
levels lead to convulsions. 
 
endocrine typically describes hormones or 
the glands that produce them. Typically 
endocrine products are  secreted into 
and circulated by the  circulatory 
system, but they tend to have specific 
target tissues upon which they exert 
their effect. 
 
end-user: computer science; the person 
who is meant to access a network or 
system after it has been fully developed 
and released to market. 
 
environmental toxicants are toxic 
substances that we ingest from the 
environment  via  direct  contact,  food, 
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water, or air. Examples include 
mercury, PCBs, DDT, lead, asbestos, 
etc. 
 
epididymal cysts are benign fluid-filled 
cysts that develop in the male 
reproductive tract at the top of the 
testes. 
 
epiphenotypes encompass the 
morphologies, behaviours, or 
characteristics embodied in  an 
organism by the superimposition of 
factors other than genes. Epiphenotypes 
are often considered to be more or less 
heritable. 
 
erythroleukemic cells represent a less 
common form of blood system cancer 
where the progenitors of red blood cells 
are affected. 
 
estrogens are steroidal hormones  that are 
of primary importance in female 
reproductive development and 
reproductive function and behaviour. 
Their function is mediated by receptors 
that signal the activation of specific 
downstream genes. 
 
euchromatin is the more loosely packed 
structure of chromatin, and it often 
encompasses genomic regions where 
genes are active. 
 
feed-forward control loops result in the 
transmission of an external cue to elicit 
a defined response, but without 
monitoring or moderating how it reacts. 
 
fetal programing, also known as Barker’s 
hypothesis posits that a mother’s 
healthy diet during pregnancy will help 
to control the onset of diseases later in 
the life of her offspring. 
 
gametogenesis is the process by which the 
gametes, sperm or egg (oocyte), are 
derived from stem cell populations in 
the gonads. 
 
glia, also known as neuroglial  cells, 
support neurons in the central nervous 
system. Recent evidence suggests that 
they can participate in the transmission 
of nerve impulses, and that they secrete 
substances that modify or stimulate the 
connections made by neighboring 
neurons. 
 
global methylation is the  averaged 
estimate of DNA methylation that is 
determined by analyzing methylation, 
usually of DNA, detectable in blood 
samples. It does not predict the 
epigenetic status of specific genes, nor 
of specific cell types and tissues other 
than blood – is serves as a general 
marker of epigenetic health or age. 
 
hematopoietic stem cells have the capacity 
to proliferate and differentiate to 
populate blood. 
 
heterochromatin is the densely packed 
conformation of chromatin, and is 
usually associated with areas where 
genes are tightly packed and inactive. 
 
hippocampus is a part of the limbic brain 
and plays a role in short and long term 
memory consolidation, and in spatial 
navigation. The hippocampus is 
especially sensitive to stress and its 
shrinkage is thought to play a role or be 
caused of post traumatic stress disorder. 
 
histone acetylase or histone acetyle 
transferase (HAT) enzymes add 
acetyle  groups  to  histones,  often with 
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the result that associated DNA 
sequences (genes) become more active. 
 
histone deacetylase (HDAC) enzymes 
remove acetyl groups from histones 
which often results in lower activity 
from the associated DNA sequence 
(gene). 
histone acetylation usually occurs on the 
COOH-terminal tail of histones H1. It 
affects the intimacy of histone-DNA 
interacyion in nucleosomes, and this in 
turn regulates gene activity. 
 
histone methylation occurs when methyl 
groups are added to histones.  Within 
the context of chromatin structure, this 
can have the effect of either activating 
or repressing associated DNA 
sequences (genes). 
 
histone methyltransferase adds methyl 
groups to histone proteins. This can 
have the consequence of either 
activating or repressing the activity of 
associated DNA sequences. 
 
histone proteins: the five main classes of 
histone proteins (H1, H2A, H2B, H3A, 
H3B) assemble into groups of eight 
(octamers) and serve as the substrate 
around which DNA is wound into the 
higher order structures constituting 
chromatin. 
 
hydatidiform moles, also known as 
trophoblastic disease, are a gestational 
anomaly that occurs when an egg loses 
its genome and is inseminated by one 
or more sperm. The consequence of a 
solely paternal genome is that there is 
over-development of chorionic pre- 
placental tissues, usually  in 
combination with an absence of fetal 
tissue. 
 
hypoplastic testes: under-developed or 
smaller than normal testes 
 
immunoprecipitation employs antibodies 
that recognize a specific  antigen to 
bind, immobilize, precipitate, and 
permit the identification,  purification, 
or modification of a specific target 
molecule. 
 
inferred data: information derived 
indirectly on an individual from 
relatable sources. 
 
informed consent: permission received 
from an individual after they have been 
well educated regarding an 
investigation or procedure and its likely 
effects. 
 
joint venture liability encompasses 
partners who combine resources in a 
business venture to make  a  profit. 
They share liability for failures of 
product integrity, efficacy, or safety. 
 
LINE elements are Long Interspersed 
Nuclear Elements that represent 
roughly 20% of the human genome and 
likely constitute remnants of retroviral 
invasion. 
 
lncRNA (long non-coding RNA) molecules 
represent a new and poorly understood 
class of RNA that do not encode 
proteins, but appear to act as regulators 
of gene transcription and translation. 
 
luck-egalitarianism is a model of 
distributive justice that maintains that 
people ought to be held  responsible 
only for those things that they exercise 
control, not over inherited economic, 
genetic,    or    other    factors.      Some 
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normalizing element must enter into the 
equation to make justice equitable. 
 
luck-prioritarian models argue that the 
less fortunate (those with bad luck) 
ought to receive priority in any 
distribution or resources. Justice argues 
for resources where they will make the 
biggest difference. 
 
mass spectrometry is a tool used in 
analytical chemistry that uses the 
abundance of gas phase ions and the 
mass-charge ratio of molecules to 
identify chemical modifications to, the 
amount, or the identity of samples. 
 
methylation refers to the addition of a 
methyl group (CH3) to other molecules 
such as DNA or histones. Highly 
methylated DNA tends to be inactive, 
while methylated histones can cause 
associated gene sequences to be either 
active or inactive. 
 
microbiota describes the community of 
bacteria, yeast, viruses and other 
microscopic organisms that populate 
our bodies 
 
miRNA molecules are a class of  short 
RNA molecules that do not encode 
proteins help regulate the activity of 
other RNA transcripts. 
 
motif: any DNA, RNA, or  protein 
sequence that is shared by related 
species of molecule, and that is 
associated with a functional or 
operational significance. eg; a receptor 
binding site. 
 
myelodysplatic syndrome is a disease of 
bone  marrow  resulting  in  a  failure to 
produce enough blood cells – patients 
can become anemic. 
 
ncRNA is any category of RNA that does 
not encode a  protein.  Examples 
include lncRNA, rRNA, tRNA, 
telRNA, miRNA, circRNA etc.. 
 
mRNA is the RNA transcript that transmits 
information from genes to ribosome 
where they encode the amino acid 
sequence of proteins. They are often 
edited (spliced) prior to  being 
translated to protein. mRNA molecules 
are usually characterized by a poly- 
adenylated tail and a 5’-Cap. 
 
multivariate – having multiple component 
parts or contributing factors that may or 
may not interact directly. 
 
net neutrality: information technology; to 
view all data and access via the internet 
in an egalitarian manner so that special 
privileges will not be taken or granted 
with respect to its access or transfer. 
 
neural tube is the embryonic precursor to 
the spinal cord and brain. Defects in its 
development and progression rank 
among the most common of birth 
defects. 
 
nucleosome: one of the fundamental units 
that contributes to chromatin,  the 
higher order organization of  DNA. 
Each nucleosome is embodied by DNA 
wrapped around eight histones protein 
subunits. 
 
nucleotide: one of the fundamental 
constitutents or building blocks of RNA 
and DNA. The molecule comprises a 
nitrogenous     base,     at     least     one 
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phosphate, and either a ribose or 
deoxyribose sugar. 
 
oestrogens are steroidal hormones that are 
of primary importance in female 
reproductive development and 
reproductive function and behaviour. 
Their function is mediated by receptors 
that signal the activation of specific 
downstream genes. 
 
packet-sniffing: information technology; 
analyze data transferred over a network 
for diagnostic and quality control 
purposes. 
 
phosphorylation occurs when phosphate 
groups are added to a protein, usually 
by a kinase enzyme. Depending upon 
context, this can either activate or 
repress activity of the protein. 
 
polymerase chain reaction (PCR) is a 
process whereby a thermo-stable DNA 
polymerase is used to reiteratively 
make copies of a DNA template 
sequence. 
 
placental previa is an obstetrical condition 
where the placenta is placed near to the 
cervix and is prone to shearing or 
bleeding under the weight of the fetus. 
 
preconception torts are a category of law 
suit in which the litigant makes claims 
for injuries sustained before they were 
even conceived and born. Instances 
might include suing for negligent 
advice given by a physician to 
presumptive parent regarding genetic 
risks s. 
 
predictive analytics: the act of modeling 
consumer    behaviour    and    personal 
events in order to understand future 
needs (Duhigg, 2012). 
 
progesterone is a steroid  hormone 
involved in the menstrual cycle, 
pregnancy, and human development 
and sexual maturation. 
 
prospective responsibility acknowledges 
that in the real world, every time we go 
somewhere or o something, it comes 
with an attendant risk for which we 
must bear some responsibility. In 
epigenetics, the term has a pregnant 
meaning: both individuals and society 
share an obligation to provide 
circumstances that are conducive to 
healthy epigenomes, even pre- 
conception. 
 
Rawlsian-egalitarian model of justice is a 
variation of luck egalitarianism that 
requires the playing field be leveled so 
that everybody can compete on equal 
footing for opportunities. Social 
inequalities need to be configured to 
benefit the least advantaged, but not so 
much that they remove incentive to 
strive. 
 
re-identification: analysis of anonymous 
data and cross-referencing with other 
data sources to find similarities and 
markers that can identify the original 
producer of the information. 
 
remarketing campaigns: recording end- 
user behaviour in order to effectively 
advertise to the user based on their 
suspected interests 
 
ResearchGate: “Facebook of Science” 
(Gujarathi & Costa, 2014); a social 
medial  network  that  facilitates  global 
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interaction between those in the STEM 
fields. 
 
retrotransposons are mobile viral 
remnants that retain the capacity to 
rtranscribe from our DNA (genome) 
into RNA, then reverse transcribe back 
to DNA, and finally to reinsert into the 
genome, often at a different location. 
 
retroviral elements derive from 
retroviruses., a category of RNA virus 
that encodes, among other products, the 
enzymes necessary to reverse transcribe 
to DNA and then to integrate 
parasitically into a host’s genome. 
 
rRNA are RNA molecules that constitute 
part of the ribosomal complex  – a 
larger assembly of RNA and proteins 
that serve to build polypeptide chains 
(proteins) 
 
single nucleotide polymorphisms (SNPs) 
embody some of the DNA sequence 
variation between individuals. They are 
used as markers that associate with 
specific gene alleles (ie; the normal or 
the mutant allele for a trait) 
 
sires are the male parent in animals 
 
statutory of limits or statutes of limitations 
and repose define a period of time 
beyond which a person or agency 
cannot be prosecuted. The idea is to 
ensure that a trial can rely upon fresh 
evidence that has not deteriorated with 
the passage of time. Limits also ensure 
a reasonable expectation that 
individuals, agencies and businesses 
can enjoy an environment that is free of 
unforeseeable long term liabilities. 
stress tests are used in rodent studies and 
involve restraining the animal in a tube 
for a period of time, usually ranging 
from 15 to 30 minutes. 
 
striatum is a subcortical region of the brain 
responsible for regulating fine motor 
coordination. 
 
swim stress is a test commonly used to 
elicit or study neurological function or 
endocrine stress responses in rodents. 
Essentially it is a monitored tank filled 
with water in which the animals must 
swim to keep their head above the 
surface. 
 
telomeres are structures that protect the 
ends of chromosomes and that are 
comprised of repetitive DNA and RNA 
sequences as well as  proteins. 
Telomeres generally shorten with age 
leading to chromosomal instability. 
 
telRNA molecules are a class of non- 
coding RNA that binds to the ends of 
chromosomes (telomeres) to preserve 
chromosomal integrity. 
 
tort law is the civil branch of law where 
rights, obligations and remedies are 
argued. Litigants sue for remedy or 
relief from harms that are alleged to be 
the responsibility of the defendant. 
 
transparency: business and social 
sciences; openness of actions that 
facilitates honesty and accountability. 
 
tRNA are the species of RNA molecules 
that shuttle amino acids to ribosomes to 
help in the construction of new 
polypeptides (proteins). 
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trophoblast comprises the outer layer of 
cells in a pre-implantation embryo. 
These cells are the first to differentiate 
and will contribute to development of 
the placenta. 
 
trophoblastic disease, also known as 
hydatidiform moles, are a gestational 
anomaly that occurs when an egg loses 
its genome and is inseminated by one 
or more sperm. The consequence of a 
solely paternal genome is that there is 
over-development of chorionic pre- 
placental tissues, usually  in 
combination with an absence of fetal 
tissue. 
 
victim attenuation – a concept of 
diminished effect or liability due to 
distance between cause and effect. This 
term can cover indirect injuries, or 
injuries that do not become readily 
apparent due to transmission across 
generation. 
white hat (hacking): computer science; 
purposeful but not malicious violations 
of network security usually to identify 
and correct network vulnerabilities. 
 
X-Chromosome inactivation. The human 
X chromosome contains many more 
genes than the Y chromosome. Human 
males  are  normally  XY,   and  females 
XX. In order to maintain a similar 
dosage of active genes in females, 
during early development, one of the 
two X chromosomes is inactivated by 
making it extremely compact 
(heterochromatic) thereby rendering the 
majority of its genes inactive. The 
resultant structure is called a Barr body. 
 
xenobiotics are foreign chemicals or 
substances that are not normally 
produced in nature or ingested under 
normal circumstances. The term is 
sometimes used to describe compounds 
that are detectable at high levels when 
they are normally only found at trace 
concentrations. 
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